sequence,cdr1,cdr2,cdr3,edit_distance,cdr2_padded,cdr3_padded,padded_sequence,CNN,LR,natural_cnn_score,binding_score,pdb_id,pdb_names
HVQLVESGGGLVQAGGSLRLSCAASGSIFSSNAMSWYRQAPGKQRELVASITSGGNADYADSVKGRFTISRDKNTVYPEMSSLKPADTAVYYCHAVGQEASAYAPRAYWGQGTQVTVSS,SIFSSNA,LVASITSGGNAD,HAVGQEASAYAPRAY,17.0,LVASIT-SGGNAD,HAVGQEA-------------SAYAPRAY,SIFSSNALVASIT-SGGNADHAVGQEA-------------SAYAPRAY,2.764685,2.8377943,3.1225545,2.021718,"7me7_A,7n9t_E,7n9t_D,7n9t_F",CryoEM structure of SARS-CoV-2 Spike in complex with Nb17;CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb17 and Nb105
QVQLVESGGGSVQPGGSLRLSCVVSGYTSSSRYMGWFRQVPGKGLEWVSGIKRDGTNTYYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTAMYYCAAGSWYNQWGYSMDYWGKGTQVTVSS,YTSSSRY,WVSGIKRDGTNTY,AAGSWYNQWGYSMDY,18.0,WVSGIKRDGTNTY,AAGSWYN-------------QWGYSMDY,YTSSSRYWVSGIKRDGTNTYAAGSWYN-------------QWGYSMDY,2.6271806,2.758646,-0.99706465,-2.3331394,"7tpr_H,7tpr_G,7tpr_F",Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCAGSKITRSLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,AGSKITRSLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,AGSKITRSLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYAGSKITRSLL--------SDYATWPYDY,-0.43231764,-0.5479697,-3.4395244,0.9032739,"7z7x_E,7z7x_D,7z7x_F,7z1d_FFF",Nanobody H11-H6 bound to RBD;CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H6 nanobody complex
VQLVESGGGLVQAGGSLRLSCAVSGRTFSTYGMAWFRQAPGKERDFVATITRSGETTLYADSVKGRFTISRDNAKNTVYLQMNSLKIEDTAVYYCAVRRDSSWGYSRDLFEYDYWGQGTQVTVS,RTFSTYG,FVATITRSGETTL,AVRRDSSWGYSRDLFEYDY,14.0,FVATITRSGETTL,AVRRDSSWG---------YSRDLFEYDY,RTFSTYGFVATITRSGETTLAVRRDSSWG---------YSRDLFEYDY,0.83789665,1.3722291,-4.6705213,0.32067472,"7me7_B,7mdw_B",CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb21 and Nb105;CryoEM structure of SARS-CoV-2 RBD in complex with nanobodies Nb17 and Nb105
QVQLVESGGGLVQAGGSLRLSCAASGFPVKTEWMEWYRQAPGKEREWVAAIWSYGSGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCLVRVGSWYHGQGTQVTVSA,FPVKTEW,WVAAIWSYGSGTR,LVRVGSWY,10.0,WVAAIWSYGSGTR,LVRV--------------------GSWY,FPVKTEWWVAAIWSYGSGTRLVRV--------------------GSWY,1.059529,-0.5719735,-4.433951,-0.3323819,"8bw7_B,8bvt_B,8bvr_B,8bvs_B,8omu_B",Cryo-EM structure of rat SLC22A6 bound to tenofovir;Cryo-EM structure of rat SLC22A6 bound to alpha-ketoglutaric acid;Cryo-EM structure of rat SLC22A6 bound to alpha-ketoglutaric acid in a low occupancy state;Cryo-EM structure of rat SLC22A6 bound to probenecid;Cryo-EM structure of rat SLC22A6 in the apo state
QVQLQESGGGLVQPGGSLRLSCAASGLAFSMYTMGWFRQAPGKEREFVAMIISSGDSTDYADSVKGRFTISRDNGKNTVYLQMDSLKPEDTAVYYCAAPKFRYYFSTSPGDFDSWGQGTQVTVSS,LAFSMYT,FVAMIISSGDSTD,AAPKFRYYFSTSPGDFDS,12.0,FVAMIISSGDSTD,AAPKFRYYF----------STSPGDFDS,LAFSMYTFVAMIISSGDSTDAAPKFRYYF----------STSPGDFDS,-0.18776909,-1.4127078,-1.5644686,1.9610982,"8dqu_A,8dqu_B",Nanobody bound SARS-CoV-2 Nsp9
QVQLVETGGGLVQPGGSLRLSCAASGFTFSSYAMGWARQVPGKGLEWVSYIYSDGSTEYQDSVKGRFTISRDNAKSTVYLQMNSLKPEDTAVYYCATEGSLGGWGRDFGSWGQGTQVTVSS,FTFSSYA,WVSYIYSDGSTE,ATEGSLGGWGRDFGS,15.0,WVSYIY-SDGSTE,ATEGSLG-------------GWGRDFGS,FTFSSYAWVSYIY-SDGSTEATEGSLG-------------GWGRDFGS,1.2000089,1.4507853,-2.9627163,-2.8685677,"7b18_E,7b18_G,7b18_I,7b17_B,7kn6_C",SARS-CoV-spike bound to two neutralising nanobodies;Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3;SARS-CoV-spike RBD bound to two neutralising nanobodies.
QVQLQESGGGLVQPGGSLRLSCAASGFTFSSAIMTWVRQAPGKGREWVSTIGSDGSITTYADSVKGRFTISRDNARNTLYLQMNSLKPEDTAVYYCTSAGRRGPGTQVTVSS,FTFSSAI,WVSTIGSDGSITT,TSAGR,16.0,WVSTIGSDGSITT,TS-----------------------AGR,FTFSSAIWVSTIGSDGSITTTS-----------------------AGR,1.0256885,-0.2512365,-4.9331646,-3.0255585,"7d5u_D,7d5b_D,3zlq_C,3zlq_D,7f1g_D,4bfb_E,4bfb_D,4bel_E,4bel_D,7n4n_D,3zks_D,3zkq_D,3zkx_B","BACE2 XAPERONE COMPLEX WITH INHIBITOR;BACE-2 in complex with ligand 36;BACE2 xaperone complex with N-{3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide;BACE2 xaperone complex with N-{3-[(9S)-7-amino-2,2-difluoro-9-(prop-1-yn-1-yl)-6-oxa-8-azaspiro[3.5]non-7-en-9-yl]-4-fluorophenyl}-5-cyanopyridine-2-carboxamide;TERNARY BACE2 XAPERONE COMPLEX;BACE2 XAPERONE COMPLEX;BACE2 xaperone complex with N-{3-[(4R,5R,6R)-2-amino-5-fluoro-4,6-dimethyl-5,6-dihydro-4H-1,3-thiazin-4-yl]-4-fluorophenyl}-2H,3H-[1,4]dioxino[2,3-c]pyridine-7-carboxamide"
DVQLVESGGGSVQAGGSLRLSCAVSGSTYSPCTTGWYRQAPGKEREWVSSISSPGTIYYQDSVKGRFTISRDNAKNTVYLQMNSLQREDTGMYYCQIQCGVRSIREYWGQGTQVTVSS,STYSPCT,WVSSISSPGTIY,QIQCGVRSIREY,16.0,WVSSIS-SPGTIY,QIQCGV----------------RSIREY,STYSPCTWVSSIS-SPGTIYQIQCGV----------------RSIREY,4.030529,2.345254,-0.35789806,1.8481429,"1yc7_A,1yc7_B",cAbAn33 VHH fragment against VSG
DVQLVESGGGSVQAGGSLRLSCAVSGSTYSPCTTGWVRQAPGKGLEWVSSISSPGTIYYQDSVKGRFTISRDNAKNTVYLQMNSLQREDTGMYYCQIQCGVRSIREYWGQGTQVTVSS,STYSPCT,WVSSISSPGTIY,QIQCGVRSIREY,19.0,WVSSIS-SPGTIY,QIQCGV----------------RSIREY,STYSPCTWVSSIS-SPGTIYQIQCGV----------------RSIREY,4.030529,2.345254,-2.1876004,-3.1337044,"1yc8_A,1yc8_B,1yzz_A,1yzz_B",Humanized caban33 at room temperature;cAbAn33- Y37V/E44G/R45L triple mutant
QVQLVESGGGSVQAGGSLRLSCAASGTIHAIGYLGWFRQAPGKEREGVAALTTYDGWTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAADDGWMFPLYHNHYEYWGQGTQVTVSA,TIHAIGY,GVAALTTYDGWTY,AAADDGWMFPLYHNHYEY,14.0,GVAALTTYDGWTY,AAADDGWMF----------PLYHNHYEY,TIHAIGYGVAALTTYDGWTYAAADDGWMF----------PLYHNHYEY,0.73575073,2.1647077,-0.57008046,0.787381,"7paf_C,7paf_B",Streptococcus pneumoniae choline importer LicB in lipid nanodiscs
QVQLVESGGGLVQAGGSLRLACIASGRTFHSYVMAWFRQAPGKEREFVAAISWSSTPTYYGESVKGRFTISRDNAKNTVYLQMNRLKPEDTAVYFCAADRGESYYYTRPTEYEFWGQGTQVTVSS,RTFHSYV,FVAAISWSSTPTY,AADRGESYYYTRPTEYEF,15.0,FVAAISWSSTPTY,AADRGESYY----------YTRPTEYEF,RTFHSYVFVAAISWSSTPTYAADRGESYY----------YTRPTEYEF,-0.9483796,-1.1604441,-4.8980293,0.5980813,"7z1b_B,7z1b_D,7z1a_B,7z1a_D,7z1c_B,7z1c_D,8owv_BBB,7oay_BBB,7oay_JJJ,7oay_LLL,7oay_FFF,7oay_HHH,7oay_DDD,7zf4_F",Nanobody H11-A10 and F2 bound to RBD;Nanobody H11-B5 and H11-F2 bound to RBD;SARS-CoV-2 Omicron RBD in complex with Omi-9 Fab and nanobody F2;Nanobody F2 bound to RBD;H6 and F2 nanobodies bound to SARS-CoV-2 spike RBD;Nanobody H11 and F2 bound to RBD
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCAGFSATRSLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,AGFSATRSLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,AGFSATRSLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYAGFSATRSLL--------SDYATWPYDY,-0.13671777,-0.08886853,-3.5268898,1.0498815,"7z1b_E,7z1b_F,7z9q_E,7z9q_D,7z9q_F",Nanobody H11-A10 and F2 bound to RBD;CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex
DVQLVESGGGLVQAGGSLRLSCAASGFTFSNYVMYWGRQAPGKGREWVSGIDSDGSDTAYASSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCVKSKDPYGSPWTRSEFDDYWGQGTQVTVSS,FTFSNYV,WVSGIDSDGSDTA,VKSKDPYGSPWTRSEFDDY,15.0,WVSGIDSDGSDTA,VKSKDPYGS---------PWTRSEFDDY,FTFSNYVWVSGIDSDGSDTAVKSKDPYGS---------PWTRSEFDDY,0.71260947,1.5729405,-3.3167875,-3.30939,7n9e_D,Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB34
QVQLVESGGGMVQPGGSLRLSCAASGFTFSNYDMSWVRRAPGKGPEWVSTINTGGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTALYYCTIDRGLHYSDLGEYDYWGQGTQVTVSS,FTFSNYD,WVSTINTGGGSTS,TIDRGLHYSDLGEYDY,16.0,WVSTINTGGGSTS,TIDRGLHY------------SDLGEYDY,FTFSNYDWVSTINTGGGSTSTIDRGLHY------------SDLGEYDY,0.8187937,0.68538654,-2.0544116,-3.3032231,7pa5_B,Complex between the beta-lactamase CMY-2 with an inhibitory nanobody
DVQLQESGGGLVQAGGSLRLSCAASGSISRFNAMGWWRQAPGKEREFVARIVKGFDPVLADSVKGRFTISIDSAENTLALQMNRLKPEDTAVYYCFAALDTAYWGQGTQVTV,SISRFNA,FVARIVKGFDPV,FAALDTAY,19.0,FVARIV-KGFDPV,FAAL--------------------DTAY,SISRFNAFVARIV-KGFDPVFAAL--------------------DTAY,1.9390836,0.16300762,1.0429642,1.9015853,7n9x_EEE,CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions
AVQLVESGGGLVQPGGSRKLSCSASGFAFSSFGMHWVRQAPEKGLEWVAYISSGSGTIYYADTVKGRFTISRDDPKNTLFLQMTSLRSEDTAMYYCVRSIYYYGSSPFDFWGQGTTLTVS,FAFSSFG,WVAYISSGSGTIY,VRSIYYYGSSPFDF,28.0,WVAYISSGSGTIY,VRSIYYY--------------GSSPFDF,FAFSSFGWVAYISSGSGTIYVRSIYYY--------------GSSPFDF,-1.3790358,-1.2561848,-5.476771,-2.7052107,"8jbh_E,8jbf_E,8jbg_E",Neurokinin B bound to active human neurokinin 3 receptor in complex with Gq;Substance P bound to active human neurokinin 3 receptor in complex with Gq;Senktide bound to active human neurokinin 3 receptor in complex with Gq
QVQLVESGGGLVQAGGSLRLSCAASGRTFSSYSMGWFRQAQGKEREFVATINGNGRDTYYTNSVKGRFTISRDDATNTVYLQMNSLKPEDTAIYYCAADKDVYYGYTSFPNEYEYWGQGTQVTVSS,RTFSSYS,FVATINGNGRDTY,AADKDVYYGYTSFPNEYEY,14.0,FVATINGNGRDTY,AADKDVYYG---------YTSFPNEYEY,RTFSSYSFVATINGNGRDTYAADKDVYYG---------YTSFPNEYEY,1.0861076,1.9768924,0.9376102,-0.10170537,"7n9c_E,7n9c_D",Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting novel and conserved epitopes-CovS with NB95
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYKMNWVRQAPGKGLQWVSDISQSGASISYTGSVKGRFTISRDDAKNTLYLQMNSLKPADTAVYYCARCPAPFTRDCFDVTSTAYAYRGQGTQVTVSS,FTFSNYK,WVSDISQSGASIS,ARCPAPFTRDCFDVTSTAYAY,20.0,WVSDISQSGASIS,ARCPAPFTRD-------CFDVTSTAYAY,FTFSNYKWVSDISQSGASISARCPAPFTRD-------CFDVTSTAYAY,-0.20316163,0.52573574,-3.9363363,-2.785895,"8xgr_N,6oya_N",Structure of the Rhodopsin-Transducin-Nanobody Complex;ETB-eGt complex bound to endothelin-1
QVQLQESGGGLVQAGDSLTLSCAASGRTFSSYTMGWFRQAPGKERDFIAGITSTGSSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTADYYCARKVAGGSYYQKDKYDYWGQGTQVTVSS,RTFSSYT,FIAGITSTGSSTY,ARKVAGGSYYQKDKYDY,13.0,FIAGITSTGSSTY,ARKVAGGS-----------YYQKDKYDY,RTFSSYTFIAGITSTGSSTYARKVAGGS-----------YYQKDKYDY,1.5745248,0.9792417,-1.3160927,-0.8775398,"6rvc_E,6rvc_D,6rvc_F",Crystal structure of Patched-1 ectodomain 2 (PTCH1-ECD2) in complex with nanobody 75
DVQLQESGGGLVQAGGSLRLSCAASGSISRFNAMGWWRQAPGKEREFVARIVKGGYAVLADSVKGRFTISIDSAENTLALQMNRLKPEDTAVYYCFAALDTAYWGQGTQVTVS,SISRFNA,FVARIVKGGYAV,FAALDTAY,18.0,FVARIV-KGGYAV,FAAL--------------------DTAY,SISRFNAFVARIV-KGGYAVFAAL--------------------DTAY,2.01174,-0.38496846,0.52934724,2.0060945,"7n9v_B,7n9v_E,7n9v_F,7n9v_H,7n9v_J,7n9v_L",CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions
QVQLVESGGGLVQAGGSLRLSCAVSGRPFSEYNLGWFRQAPGKEREFVARIRSSGTTVYTDSVKGRFSASRDNAKNMGYLQLNSLEPEDTAVYYCAMSRVDTDSPAFYDYWGQGTQVTVST,RPFSEYN,FVARIRSSGTTV,AMSRVDTDSPAFYDY,18.0,FVARIR-SSGTTV,AMSRVDT-------------DSPAFYDY,RPFSEYNFVARIR-SSGTTVAMSRVDT-------------DSPAFYDY,2.3501346,2.7427864,1.9822774,1.0506151,8im0_B,mCherry-LaM8 complex
QVQLVESGGGLVQAGDSLRLSCAASGRTFENYAMGWFRQAPGKEREFVGAVSWGGGRTYYADNVKGRFTISRDNAKKNTVYLQMNSLKPEDTAVYYCAAKSVLTIATMRVPDEYNYWGQGTQVTVS,RTFENYA,FVGAVSWGGGRTY,AAKSVLTIATMRVPDEYNY,12.0,FVGAVSWGGGRTY,AAKSVLTIA---------TMRVPDEYNY,RTFENYAFVGAVSWGGGRTYAAKSVLTIA---------TMRVPDEYNY,0.6066049,-0.6105648,0.16353907,-0.26495636,"8im1_H,8im1_B,8im1_D,8im1_F",mCherry-LaM1 complex
QVQLVESGGGLVQAGGSLTLSCVASGRPFRNYRLGWFRQAPGKEREFVAAINWGGVITNYADSVKGRFTISRDDAKNTVYLQMNSLKPEETAVYYCAAFDSTGSPIVRDNYEYWGQGTQVTVSS,RPFRNYR,FVAAINWGGVITN,AAFDSTGSPIVRDNYEY,13.0,FVAAINWGGVITN,AAFDSTGS-----------PIVRDNYEY,RPFRNYRFVAAINWGGVITNAAFDSTGS-----------PIVRDNYEY,0.41727236,1.2783021,2.454683,1.6528108,"5ukb_a,5ukb_c,5ukb_b,5ukb_e,5ukb_d",VSV N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1004
EVQLVESGGGVVQPGRSLRLSCAASGFTFSSYAMHWVRQAPGKGLEWIGNIYHDGSTFYNPSLKSLVTISRDDSTNTLYLQMNSLRAEDTAIYYCARVWLYGSGYMDVWGKGTLVTVSS,FTFSSYA,WIGNIYHDGSTF,ARVWLYGSGYMDV,30.0,WIGNIY-HDGSTF,ARVWLY---------------GSGYMDV,FTFSSYAWIGNIY-HDGSTFARVWLY---------------GSGYMDV,-0.70487034,-1.7879612,-4.342287,-2.6573102,"8dm0_H,8dlx_H,8dlz_H,8dly_H",Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6);Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6;Cryo-EM structure of SARS-CoV-2 Epsilon (B.1.429) spike protein in complex with VH ab6;Cryo-EM structure of SARS-CoV-2 D614G spike protein in complex with VH ab6 (focused refinement of NTD and VH ab6)
QVQLQESGGGLVQAGGSLRLSCAASGSIFSPNTMGWFRQALGKQREMVAVISSIASTQYANFVKGRFTITRDNTKNTVHLQMNSLIPEDTAVYYCYAVDKSQDYWGQGTQVTVSS,SIFSPNT,MVAVISSIASTQ,YAVDKSQDY,17.0,MVAVIS-SIASTQ,YAVD-------------------KSQDY,SIFSPNTMVAVIS-SIASTQYAVD-------------------KSQDY,2.675601,1.6765672,-2.2009308,-2.2310421,"8g7b_C,8g7b_E,8g7a_C,8g7a_E,8g7a_F,8g73_C,8g73_E,8g73_F,8g70_M,8g70_O,8g79_M,8g79_O,8g74_C,8g74_E",SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3 (local refinement);Local refinement of SARS-CoV-2 spike/nanobody mixture complex around RBD;SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 (local refinement);SARS-CoV-2 spike/Nb3 complex with 2 RBDs up and 3 Nb3 bound at 2.5 A;SARS-CoV-2 spike/Nb3 complex with 1 RBD up and 2 Nb3;SARS-CoV-2 spike/nanobody mixture complex
QVQLQESGGGVVGPGGSLRLACAFSGRTFSDYWMAWFRQTPGEERDFVAAISRSGITTSYGDFVEGRFTITRDNAKNTVNLQMNFLKPEDTADYYCAAGTSSFLRREYDYWGQGTQVTVSS,RTFSDYW,FVAAISRSGITTS,AAGTSSFLRREYDY,25.0,FVAAISRSGITTS,AAGTSSF--------------LRREYDY,RTFSDYWFVAAISRSGITTSAAGTSSF--------------LRREYDY,1.6955425,1.5099664,-2.9119666,-0.11830568,6ze1_B,human NBD1 of CFTR in complex with nanobody G11a
QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWFRQAPGKEREIVSAVSGSGGSTYYADSVRGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAREPRIPRPPSFDYWGQGTLVTVSS,FTFSSYA,IVSAVSGSGGSTY,AREPRIPRPPSFDY,16.0,IVSAVSGSGGSTY,AREPRIP--------------RPPSFDY,FTFSSYAIVSAVSGSGGSTYAREPRIP--------------RPPSFDY,0.71981865,0.19347948,-0.40675914,1.6793306,"1ol0_A,1ol0_B",Crystal structure of a camelised human VH
QVQLVETGGGLVQTGGSLRLSCKASGRTFSNSIMGWFRQAPGKERDFVAKISWRNDYTTYADSVKGRFTISRDNASNMVYLLMNNLKPEDTAVYYCAATKAYNGGETSGRGFYYWGQGTQVTVSS,RTFSNSI,FVAKISWRNDYTT,AATKAYNGGETSGRGFYY,16.0,FVAKISWRNDYTT,AATKAYNGG----------ETSGRGFYY,RTFSNSIFVAKISWRNDYTTAATKAYNGG----------ETSGRGFYY,3.747129,3.47686,3.3413467,2.4842637,"5uk4_a,5uk4_c,5uk4_b,5uk4_e,5uk4_d,5uk4_g,5uk4_f,5uk4_i,5uk4_h,5uk4_k,5uk4_j,5uk4_m,5uk4_l,5uk4_o,5uk4_n,5uk4_q,5uk4_p,5uk4_s,5uk4_r,5uk4_t",VESICULAR STOMATITS VIRUS N PROTEIN IN COMPLEX WITH INHIBITORY NANOBODY 1307
QVKLEESGGGSVQAGGSLRLICTAPGLTHNNCGLDWYRRAPGKEREFVSSISADGTTSYADSVKGRFTISKDKVEDTVYLQMNSLKPEDTAIYSCKTAFPYFGNSCVLDYWGQGTSVTVSS,LTHNNCG,FVSSISADGTTS,KTAFPYFGNSCVLDY,24.0,FVSSIS-ADGTTS,KTAFPYF-------------GNSCVLDY,LTHNNCGFVSSIS-ADGTTSKTAFPYF-------------GNSCVLDY,2.6298616,2.43018,0.13572861,-2.8583958,"7my3_H,7my3_E,7my3_D",CryoEM structure of neutralizing nanobody Nb12 in complex with SARS-CoV2 spike
QVQLVESGGGLVQAGGSLRLSCAASGLTFSKYAMGWFRQAPGKERKFVATISWSGDSAFYADSVKGRFTISRDNARNTVYLQMNSLKPEDTAVYYCAADRGMGYGDFMDYWGQGTSVTASS,LTFSKYA,FVATISWSGDSAF,AADRGMGYGDFMDY,12.0,FVATISWSGDSAF,AADRGMG--------------YGDFMDY,LTFSKYAFVATISWSGDSAFAADRGMG--------------YGDFMDY,0.43546948,-0.098202944,-1.5817775,1.2854819,"7my2_A,7my2_H,7my2_D",CryoEM structure of neutralizing nanobody Nb30 in complex with SARS-CoV2 spike
QLQLVESGGGLVQAGGSLRLSCVASGRTFRSNAMGWFRQAPGKEREFVAAIRWSGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYLCAAGVWRSSGWDTPDYWGQGTQVTVSS,RTFRSNA,FVAAIRWSGGSTY,AAGVWRSSGWDTPDY,11.0,FVAAIRWSGGSTY,AAGVWRS-------------SGWDTPDY,RTFRSNAFVAAIRWSGGSTYAAGVWRS-------------SGWDTPDY,0.9946529,0.90736234,-2.0393736,-0.28659493,6k2i_A,Solution structure of camelid nanobody Nb11 against aflatoxin B1
QVQLQESGGGSVQVGGSLRVACAASGDTFSGYLAAWFRQAPGKGREGVAAINSKRHTTSYADSVKGRFTISKDNADNIMYLEMNSLKPEDTAIYYCAAADAIGLAEYWSTPTLSAARYKYWGQGTQVTVSS,DTFSGYL,GVAAINSKRHTTS,AAADAIGLAEYWSTPTLSAARYKY,22.0,GVAAINSKRHTTS,AAADAIGLAEYW----STPTLSAARYKY,DTFSGYLGVAAINSKRHTTSAAADAIGLAEYW----STPTLSAARYKY,2.0262172,1.239169,-2.5973856,-3.2374609,5foj_A,Cryo electron microscopy structure of Grapevine Fanleaf Virus complex with Nanobody
AVQLAASGGGAVQAGASLALSCAAAAAAAAAAAAAWARQAPGAAREAVAAAAAAAAAAAAADSAAGRFTASADAAAAAAALQAAALAAADAAAYYCAAAAAAAAAAAAAAWGAGTAVTVSS,AAAAAAA,AVAAAAAAAAAAA,AAAAAAAAAAAAAA,41.0,AVAAAAAAAAAAA,AAAAAAA--------------AAAAAAA,AAAAAAAAVAAAAAAAAAAAAAAAAAA--------------AAAAAAA,1.0503384,-0.42151284,-3.8671038,-2.4215424,"7uym_K,7uyl_K,7joo_K",850 Fab;850 Fab in complex with NANPNANPNANP peptide;Crystal structure of ICOS in complex with antibody STIM003 and anti-kappa VHH domain
QVQLQESGGGLVQPGGSLRLSCVASGSVTFNSMGWYRQAPGKQRELVAQITAGGDTHYADSVKGRFTISEHRGKNAVYLEMHSLKPEDTAVYYCHLQVPFLGGGYDYWGQGTQVTVSS,GSVTFNS,LVAQITAGGDTH,HLQVPFLGGGYDY,19.0,LVAQIT-AGGDTH,HLQVPF---------------LGGGYDY,GSVTFNSLVAQIT-AGGDTHHLQVPF---------------LGGGYDY,2.5426557,2.745822,2.6548717,2.451392,"8g70_G,8g70_F,8g70_K,8g77_K,8g77_G,8g77_F,8g78_E,8g78_G,8g78_F",Local refinement of SARS-CoV-2 spike/nanobody mixture complex around NTD;SARS-CoV-2 spike/Nb6 complex;SARS-CoV-2 spike/nanobody mixture complex
DVQLQESGGGSVQAGGSLTLSCTASGLLFRLASMGWYRQAPGKERELIATITVGGKTNYKDSVQGRFIITRDNTGDNTKSTVTLQMNRLKPEDTAVYYCNTASPAVGADTWGQGTRVTVSS,LLFRLAS,LIATITVGGKTN,NTASPAVGADT,25.0,LIATIT-VGGKTN,NTASP-----------------AVGADT,LLFRLASLIATIT-VGGKTNNTASP-----------------AVGADT,-0.3052391,-1.3444238,-1.6451693,1.4167278,5f21_B,human CD38 in complex with nanobody MU375
QVQLVESGGGSVQAGGSLRLSCVASGDIKYISYLGWFRQAPGKEREGVAALYTSTGRTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAEWGSQSPLTQWFYRYWGQGTQVTVSA,DIKYISY,GVAALYTSTGRTY,AAAEWGSQSPLTQWFYRY,15.0,GVAALYTSTGRTY,AAAEWGSQS----------PLTQWFYRY,DIKYISYGVAALYTSTGRTYAAAEWGSQS----------PLTQWFYRY,-0.038687386,1.8917929,-2.2443068,0.12212837,5m13_B,Synthetic nanobody in complex with MBP
QVQLVESGGGSVQAGGSLRLSCAASGKIHEIGYLGWFRQAPGKEREGVAALMTFQGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYWGKQSPLISWDYSYWGQGTQVTVSA,KIHEIGY,GVAALMTFQGQTY,AAAYWGKQSPLISWDYSY,14.0,GVAALMTFQGQTY,AAAYWGKQS----------PLISWDYSY,KIHEIGYGVAALMTFQGQTYAAAYWGKQS----------PLISWDYSY,-0.22313645,1.6192852,0.11560078,0.90180236,"5m15_C,5m15_D",Synthetic nanobody in complex with MBP
QVQLVESGGGSVQAGGSLRLSCAASGQIEHIGYLGWFRQAPGKEREGVAALITYTGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAEWGSQSPLTQWFYRYWGQGTQVTVSA,QIEHIGY,GVAALITYTGHTY,AAAEWGSQSPLTQWFYRY,14.0,GVAALITYTGHTY,AAAEWGSQS----------PLTQWFYRY,QIEHIGYGVAALITYTGHTYAAAEWGSQS----------PLTQWFYRY,0.51891977,1.0542333,-2.0141912,-0.01370585,"5m14_C,5m14_D",Synthetic nanobody in complex with MBP
QVQLQESGGGLVQPGGSLRLSCVVSGDRRTIYTMGWFRQAPGNQGELVATMTSSGVTTYVDSVKGRFSISRDSAEDSAKNTVSLQMNSLKPEDTAFYTCYEESRRPLGSRNTYWGQGTQVTVSS,DRRTIYT,LVATMTSSGVTT,YEESRRPLGSRNTY,25.0,LVATMT-SSGVTT,YEESRRP--------------LGSRNTY,DRRTIYTLVATMT-SSGVTTYEESRRP--------------LGSRNTY,1.0461549,1.74602,-1.0955133,-0.98716354,5mje_B,Crystal structure of the HigB2 toxin in complex with Nb8
QVQLQESGGGSVQAGGSLRLSCAASSYTISSVCMGWFRQAPGKEREGVAGIAPDGSTGYGDSVKGRFTISKDNAKNTLYLQMNSLKPEDTAMYYCAAASPGRCFLPRTALEPALYYNWGQGTQVTVSS,YTISSVC,GVAGIAPDGSTG,AAASPGRCFLPRTALEPALYYN,15.0,GVAGIA-PDGSTG,AAASPGRCFLP------RTALEPALYYN,YTISSVCGVAGIA-PDGSTGAAASPGRCFLP------RTALEPALYYN,2.695857,2.393013,-0.16741104,0.060919464,"7s2s_A,7s2s_C",nanobody bound to Interleukin-2Rbeta
QVQLQESGGGLVQAGGSLRLSCAGSGRTFSSYNMGWFRQAPGKEREFVGGISWTGRSADYPDSVKGRFTISRDNAKNAVYLQMNSLKPEDTAVYYCAAKQYGSRADYPWDDYDYWGQGTQVTVSS,RTFSSYN,FVGGISWTGRSAD,AAKQYGSRADYPWDDYDY,12.0,FVGGISWTGRSAD,AAKQYGSRA----------DYPWDDYDY,RTFSSYNFVGGISWTGRSADAAKQYGSRA----------DYPWDDYDY,0.6157137,0.33622748,2.5306156,0.6478397,"6gs1_H,6gs4_H,6gs7_H",Crystal structure of peptide transporter DtpA-nanobody in glycine buffer;Crystal structure of peptide transporter DtpA-nanobody in complex with valganciclovir;Crystal structure of peptide transporter DtpA-nanobody in MES buffer
QVQLQESGGGMVQPGGSLRLSCLASGFTFSNYAMTWVRQAPGKGPEWVSMVSNNGADTTYTDSVKGRFTISRDNAKNTLYLRMNNVKPEDSAVYYCAKRRYGGIWTGQPTDYDYLGQGTVTVSS,FTFSNYA,WVSMVSNNGADTT,AKRRYGGIWTGQPTDYDY,23.0,WVSMVSNNGADTT,AKRRYGGIW----------TGQPTDYDY,FTFSNYAWVSMVSNNGADTTAKRRYGGIW----------TGQPTDYDY,0.84162146,-0.6764218,-2.5960815,-3.182217,"6qxe_M,6qxe_O,6qpg_P,6qpg_M,6qpg_O,6qpg_N,7nk8_F,6qx3_O",1918 H1N1 Viral influenza polymerase heterotrimer with Nb8205 core;Influenza A virus (A/NT/60/1968) polymerase dimer of hetermotrimer in complex with 3'5' cRNA promoter and Nb8205;Influenza A virus (A/NT/60/1968) polymerase Hetermotrimer in complex with 3'5' cRNA promoter and Nb8205;Influenza A virus Polymerase Heterotrimer A/nt/60/1968(H3N2) in complex with Nanobody NB8205
EVQLVESGGGLVQPGGSLRLSCAASRSIISNNAMGWYRQAPGKQRELVARISSGGRTTYADSVKGRFTISRDNAKTTVYLQMNSLKPEDTAVYYCNAASLVRGPLDHWGQGTQVTVSS,SIISNNA,LVARISSGGRTT,NAASLVRGPLDH,12.0,LVARIS-SGGRTT,NAASLV----------------RGPLDH,SIISNNALVARIS-SGGRTTNAASLV----------------RGPLDH,2.3354087,2.645461,1.5633521,1.2463799,"4b41_A,4b41_B",Crystal structure of an amyloid-beta binding single chain antibody G7
EVQLVESGGGLVQAGGSLRLSCAASGRTSGALNVAWYRQATGKEREYVARLWWNDGTTYYSDSVKGRFTISSDNAKKIVYLQMNRLKPDDTAIYYCAVRTPSSQTLYWGQGTQVTVSS,RTSGALN,YVARLWWNDGTTY,AVRTPSSQTLY,18.0,YVARLWWNDGTTY,AVRTP-----------------SSQTLY,RTSGALNYVARLWWNDGTTYAVRTP-----------------SSQTLY,4.590142,3.7842927,-0.76076776,0.847084,"7r1z_C,7r23_C,7r24_C","C-terminal domain of hArc in complex with nanobodies H11 and C11, collapsed crystal form;Crystal structure of rat Arc CTD in complex with two anti-Arc nanobodies;Crystal structure of human Arc CTD in complex with two anti-Arc nanobodies"
EVQLLESGGGLVQAGDSLRLSCAASGRTFSAYAMGWFRQAPGKEREFVAAISWSGNSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAIYYCAARKPMYRVDISKGQNYDYWGQGTQVTVSS,RTFSAYA,FVAAISWSGNSTY,AARKPMYRVDISKGQNYDY,12.0,FVAAISWSGNSTY,AARKPMYRV---------DISKGQNYDY,RTFSAYAFVAAISWSGNSTYAARKPMYRV---------DISKGQNYDY,1.3033807,0.5242436,3.4770792,1.872093,"7r1z_E,7r23_B,7r24_E,8qf3_A,8qf3_E,8qf4_E","C-terminal domain of hArc in complex with nanobodies H11 and C11, collapsed crystal form;Crystal structure of rat Arc CTD in complex with two anti-Arc nanobodies;1.25-A structure of anti-Arc nanobody H11;Crystal structure of human Arc CTD in complex with two anti-Arc nanobodies;Complex between N-lobe of Arc and nanobody H11"
QVQLVESGGGLVQAGGSLRLSCAASGYIFGRNAMGWYRQAPGKERELVAGITRRGSITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADPASPAYGDYWGQGTQVTVSS,YIFGRNA,LVAGITRRGSITY,AADPASPAYGDY,7.0,LVAGITRRGSITY,AADPAS----------------PAYGDY,YIFGRNALVAGITRRGSITYAADPAS----------------PAYGDY,1.1535462,0.4892745,0.1731881,0.80573434,"7kkl_B,7kkl_E,7kkl_F,7kkj_A,7kkj_C",Structure of anti-SARS-CoV-2 Spike nanobody mNb6;SARS-CoV-2 Spike in complex with neutralizing nanobody mNb6
QVQLVESGGGLVQAGGSLRLSCAASGIIFGRNAMGWYRQAPGKERELVAGITRRGSITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADPASPAPGDYWGQGTQVTVSS,IIFGRNA,LVAGITRRGSITY,AADPASPAPGDY,7.0,LVAGITRRGSITY,AADPAS----------------PAPGDY,IIFGRNALVAGITRRGSITYAADPAS----------------PAPGDY,1.5852454,0.18521094,0.5021852,1.1501362,"7kkk_B,7kkk_D,7kkk_F",SARS-CoV-2 Spike in complex with neutralizing nanobody Nb6
QVQLVESGGGLVQPGGSLRLSCAASGFTGSINYMGWYRQAPGKQRELVARFSSGGSTNYADSVKGRFTISGDNAKNTVYLQMNSLKPEDTAVYYCNAETISYVYTVVFQDYWGQGTQVTVSS,FTGSINY,LVARFSSGGSTN,NAETISYVYTVVFQDY,10.0,LVARFS-SGGSTN,NAETISYV------------YTVVFQDY,FTGSINYLVARFS-SGGSTNNAETISYV------------YTVVFQDY,-1.4451581,-1.8326191,-0.0059877634,2.037198,7wn1_C,Structure of PfNT1(Y190A) in complex with nanobody 48 and inosine
QVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVAVARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVSS,RTISRYA,FVAVARRSGDGAF,AIDSDTFYSGSYDY,14.0,FVAVARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVAVARRSGDGAFAIDSDTF--------------YSGSYDY,-0.3579229,-0.5756862,2.5310612,1.3409057,"7sk7_K,7sk5_K,7zlg_K,7zlj_K,7zli_K,7zlh_K,7xod_Z,7xod_T,7xod_W,8wo4_H,8wo4_G,7wpf_Z,7wpf_T,7wpf_W,7wpd_Z,7wpe_Z,7wpe_W,8aci_K,8acf_K,8j9o_C,7pij_K,7tuy_K,8odx_K,8jh7_K,7q6c_K,7phq_K,7phq_F,7php_K,8r80_J,8r80_N,8jhc_K,7yuf_K,7yud_K,6ww2_K,8qot_K,8hik_N,8hij_N,8hii_N,7jhh_N,7jhg_N","The BRIL-SLC19A1/Fab/Nb ternary complex;Cryo-EM structure of inactive FZD1;Structure of Multidrug and Toxin Compound Extrusion (MATE) transporter NorM by NabFab-fiducial assisted cryo-EM;FZD3 in inactive state;Cryo-EM structure of GSK682753A-bound EBI2/GPR183;Cryo-EM structure of C-mannosyltransferase CeDPY19, in apo state, bound to CMT2-Fab and anti-Fab nanobody;Structure of human Frizzled5 by fiducial-assisted cryo-EM;Cryo-EM structure of human ACKR3 in complex with CXCL12, a small molecule partial agonist CCX662, and an extracellular Fab;Interleukin 12 receptor subunit beta-1 Fn domains in complex with antagonistic FAb4 fragment and VHH.;Structure of homo-dimeric Staphylococcus capitis divalent metal ion transporter (DMT) by NabFab-fiducial assisted cryo-EM;Cryo-EM structure of C-mannosyltransferase CeDPY19, in complex with acceptor peptide and bound to CMT2-Fab and anti-Fab nanobody;SARS-CoV-2 Omicron Variant S Trimer complexed with three JMB2002 Fab;complement C6 FIM1-2 bound to CP010 antibody;Structure of Staphylococcus capitis divalent metal ion transporter (DMT) by NabFab-fiducial assisted cryo-EM;The TPP-bound BRIL-SLC19A1/Fab/Nb ternary complex;ZIKV rsNS1 in complex with Fab EB9 and anti-fab nanobody;Structure of the argX-117 in complex with a complement C2 fragment at low pH;apo human SPNS2;Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Fab and nanobody;FZD6 in inactive state;Cryo-EM structure of ACKR3 in complex with CXCL12 and an intracellular Fab;SARS-CoV-2 Omicron Variant S Trimer complexed with one JMB2002 Fab;SARS-CoV-2 Omicron Variant S Trimer complexed with two JMB2002 Fab;FTY720p-bound human SPNS2;SARS-CoV-2 Omicron BA.2 Variant Spike Trimer with three JMB2002 Fab Bound;Cryo-EM structure of C-mannosyltransferase CeDPY19, in ternary complex with Dol25-P-C-Man and acceptor peptide, bound to CMT2-Fab and anti-Fab nanobody;Cryo-EM structure of ATP-bound fully inactive AMPK in complex with Dorsomorphin (Compound C) and Fab-nanobody;Structure of ARG-117 Fab in complex with a fragment of complement C2, neutral pH;Cryo-EM structure of C-mannosyltransferase CeDPY19, in complex with Dol25-P-Man and bound to CMT2-Fab and anti-Fab nanobody;The 5-MTHF-bound BRIL-SLC19A1/Fab/Nb ternary complex;Structure of the mu opioid receptor bound to the antagonist nanobody NbE;SARS-CoV-2 Delta RBD in complex with XBB-9 Fab and an anti-Fab nanobody"
QVQLVESGGALVQPGGSLRLSCVASGFTFSSFAMGWYRQAPGKECEWVATITITGGSTNYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCNPDPGCRGGGQGTQVTVSS,FTFSSFA,WVATITITGGSTN,NPDPGCRG,13.0,WVATITITGGSTN,NPDP--------------------GCRG,FTFSSFAWVATITITGGSTNNPDP--------------------GCRG,-0.48899975,-0.27980864,-3.5964272,-2.0157075,"8q7s_B,8q7s_E,8q7s_H,8q7s_K,8q7s_N",Crystal structure of the SARS-CoV-2 RBD (Wuhan) with neutralizing VHHs Ma6F06 and Re21H01
QVQLVESGGGLVQPGGSLRLSCAASGFTLDDYAIGWFRQAPGKEREGVSFITSSDGSTYYVDSVKGRFTISRDNAKNTVYLQMNSLTPEDTAIYYCAVGPSFSYTGSTYYRSELPWDYDYWGQGTQVTVSS,FTLDDYA,GVSFITSSDGSTY,AVGPSFSYTGSTYYRSELPWDYDY,13.0,GVSFITSSDGSTY,AVGPSFSYTGST----YYRSELPWDYDY,FTLDDYAGVSFITSSDGSTYAVGPSFSYTGST----YYRSELPWDYDY,1.9226413,1.0017661,0.9129047,2.0437582,"7ns6_G,7ns6_H,7ns6_O,7ns6_S,7ns6_U,7ns6_T,7nll_A,7nll_C",SARS-CoV-2 Spike (dimers) in complex with six Fu2 nanobodies;SARS-CoV-2 Spike RBD (dimer) in complex with two Fu2 nanobodies
QVQLQESGGGLVQPGGSLRLSCAASGKMSSRRCMAWFRQAPGKERERVAKLLTTSGSTYLADSVKGRFTISQNNAKSTVYLQMNSLKPEDTAMYYCAADSFEDPTCTLVTSSGAFQYWGQGTQVTVSS,KMSSRRC,RVAKLLTTSGSTY,AADSFEDPTCTLVTSSGAFQY,16.0,RVAKLLTTSGSTY,AADSFEDPTC-------TLVTSSGAFQY,KMSSRRCRVAKLLTTSGSTYAADSFEDPTC-------TLVTSSGAFQY,3.2675617,2.667779,1.2961098,2.1310418,5jds_B,Crystal structure of PD-L1 complexed with a nanobody at 1.7 Angstron resolution
QVQLVESGGGLVQAGGSLRLSCAASGRTFTSYAMGWFRQAPGKERESVAAISSSGGSTHYADSVKGRFTISRDNSKNTVYLQMNSLKPEDTAVYYCAAAMYGSRWPDWEYDYWGQGTQVTVSS,RTFTSYA,SVAAISSSGGSTH,AAAMYGSRWPDWEYDY,9.0,SVAAISSSGGSTH,AAAMYGSR------------WPDWEYDY,RTFTSYASVAAISSSGGSTHAAAMYGSR------------WPDWEYDY,0.71301013,1.6524009,0.7566301,1.5267053,"8t7h_C,8t7h_D,8t8m_C,8t8m_D,7dge_C,7dge_D,8tao_C,8tao_D,6n4y_H,6n4y_E,6n4y_G,6n4y_F,6n51_C,6n51_D,6n50_E",Metabotropic Glutamate Receptor 5 bound to L-quisqualate and Nb43;Quis-bound intermediate mGlu5;intermediate state of class C GPCR;Quis and CDPPB bound active mGlu5;Metabotropic Glutamate Receptor 5 Extracellular Domain in Complex with Nb43 and L-quisqualic acid;Metabotropic Glutamate Receptor 5 Extracellular Domain with Nb43
DVQLVESGGGLVQAGGSLRVSCAASGRTFSSYSMGWFRQAPGKEREFVAAISRSDNSTYYADSVKGRFTISRDSAKNTVYLQMNSLKPEDTAVYYCAATPYGSRYYLRELREYDYWGQGTQVTVSS,RTFSSYS,FVAAISRSDNSTY,AATPYGSRYYLRELREYDY,11.0,FVAAISRSDNSTY,AATPYGSRY---------YLRELREYDY,RTFSSYSFVAAISRSDNSTYAATPYGSRY---------YLRELREYDY,0.843566,2.1284523,2.7281334,1.7839682,"6ey0_H,6ey0_E,6ey0_G,6ey0_F,5lz0_A,5lz0_B",N-terminal part (residues 30-212) of PorM with the llama nanobody nb01;Llama nanobody PorM_01
QVQLQESGGGLVQAGGSLRLSCAASGIWFSINNMAWYRQTPGKQRERIAIITSAGTTNYVDSVKGRFTISRDDAKNTMYLQMNSLIPEDTAVYYCNLVADYDMGFQSFWGRGTQVTVSS,IWFSINN,RIAIITSAGTTN,NLVADYDMGFQSF,16.0,RIAIIT-SAGTTN,NLVADY---------------DMGFQSF,IWFSINNRIAIIT-SAGTTNNLVADY---------------DMGFQSF,-0.016766228,-0.5620799,-2.0933301,0.15344995,"4cdg_C,4cdg_D",Crystal structure of the Bloom's syndrome helicase BLM in complex with Nanobody
QVQLVESGGGWVQPGGSLRLSCAASGFTFSDTAMMWVRQAPGKGREWVAAIDTGGGYTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTARYYCAKTYSGNYYSNYTVANYGTTGRGTLVTVSS,FTFSDTA,WVAAIDTGGGYTY,AKTYSGNYYSNYTVANYGT,17.0,WVAAIDTGGGYTY,AKTYSGNYY---------SNYTVANYGT,FTFSDTAWVAAIDTGGGYTYAKTYSGNYY---------SNYTVANYGT,1.456005,1.6700019,-3.190706,-2.9059515,8gz3_N,Structure of human phagocyte NADPH oxidase in the resting state
QVQLVESGGGSVQAGGSLRLSCAASGYIYQIEYLGWFRQAPGKEREGVAALATWNGQTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYEGDTSPLYYEEYGYWGQGTQVTVSA,YIYQIEY,GVAALATWNGQTY,AAAYEGDTSPLYYEEYGY,14.0,GVAALATWNGQTY,AAAYEGDTS----------PLYYEEYGY,YIYQIEYGVAALATWNGQTYAAAYEGDTS----------PLYYEEYGY,-0.33725145,0.4539286,-3.6717672,0.41225344,"7p60_I,7p60_H,7p60_G",Structure of homomeric LRRC8A Volume-Regulated Anion Channel in complex with synthetic nanobody Sb4 at 1:0.5 ratio
QVQLVESGGGLVQPGGSLRLSCEASGFTLDYYGIGWFRQPPGKEREAVSYISASARTILYADSVKGRFTISRDNAKNAVYLQMNSLKREDTAVYYCARRRFSASSVNRWLADDYDVWGRGTQVAVSS,FTLDYYG,AVSYISASARTIL,ARRRFSASSVNRWLADDYDV,16.0,AVSYISASARTIL,ARRRFSASSV--------NRWLADDYDV,FTLDYYGAVSYISASARTILARRRFSASSV--------NRWLADDYDV,-1.4832044,-1.514433,-3.0957024,1.4232643,"6oq6_D,6oq5_D",Structure of the pore forming fragment of Clostridium difficile toxin B in complex with VHH 5D;Structure of the full-length Clostridium difficile toxin B in complex with 3 VHHs
QVQLVESGGGLVQTGGSLRLSCASSGSIAGFETVTWSRQAPGKSLQWVASMTKTNNEIYSDSVKGRFIISRDNAKNTVYLQMNSLKPEDTGVYFCKGPELRGQGIQVTVSS,SIAGFET,WVASMTKTNNEI,KGPEL,21.0,WVASMT-KTNNEI,KG-----------------------PEL,SIAGFETWVASMT-KTNNEIKG-----------------------PEL,1.6482569,0.6486081,-1.2255912,-2.9189286,"6oq7_C,6oq5_E",Structure of the full-length Clostridium difficile toxin B in complex with 3 VHHs;Structure of the GTD domain of Clostridium difficile toxin B in complex with VHH E3
QVQLVESGGGLVEAGGSLRLSCVVTGSSFSTSTMAWYRQPPGKQREWVASFTSGGAIKYTDSVKGRFTMSRDNAKKMTYLQMENLKPEDTAVYYCALHNAVSGSSWGRGTQVTVSS,SSFSTST,WVASFTSGGAIK,ALHNAVSGSS,22.0,WVASFT-SGGAIK,ALHNA------------------VSGSS,SSFSTSTWVASFT-SGGAIKALHNA------------------VSGSS,2.342182,2.3204513,-2.3482456,-1.6450002,"6oq5_F,6oq8_C,6oq8_D",Structure of the full-length Clostridium difficile toxin B in complex with 3 VHHs;Structure of the GTD domain of Clostridium difficile toxin B in complex with VHH 7F
QVQLQESGGGLVQPGGSLRLSCAASGRTFSNYRMGWFRQAPGKEREFVATISQSGAATAYADSVKGRFTFSRDNAKNLLYLEMLSLEPEDTAVYYCAASSRVFYTEVLQTTTGYDYWGQGTQVTVSS,RTFSNYR,FVATISQSGAATA,AASSRVFYTEVLQTTTGYDY,16.0,FVATISQSGAATA,AASSRVFYTE--------VLQTTTGYDY,RTFSNYRFVATISQSGAATAAASSRVFYTE--------VLQTTTGYDY,0.28450054,-0.0063640475,-0.62019664,1.279393,"2x1q_A,2x1q_B",Gelsolin Nanobody
QVQLQESGGGLVQAGGSLRLSCAASGRTFTSFAMGWFRQAPGKEREFVASISRSGTLTRYADSAKGRFTISVDNAKNTVSLQMDNLNPDDTAVYYCAADLHRPYGPGTQRSDEYDSWGQGTQVTVSS,RTFTSFA,FVASISRSGTLTR,AADLHRPYGPGTQRSDEYDS,16.0,FVASISRSGTLTR,AADLHRPYGP--------GTQRSDEYDS,RTFTSFAFVASISRSGTLTRAADLHRPYGP--------GTQRSDEYDS,0.7394857,0.33431822,-1.5461748,0.5310381,"2x1p_A,2x1p_C,2x1p_B,2x1p_D",Gelsolin Nanobody
QVQLQESGGGSVQAGGSLTLSCAASGYAVSRYSMGWFRQAPGKENEGVAAIDSSGVGTTYADSVKGRFTISRDNAKDTVYLRMNSLKPEDTAIYYCASGFGLSLSRYTYAYWGQGTQVTVSS,YAVSRYS,GVAAIDSSGVGTT,ASGFGLSLSRYTYAY,15.0,GVAAIDSSGVGTT,ASGFGLS-------------LSRYTYAY,YAVSRYSGVAAIDSSGVGTTASGFGLS-------------LSRYTYAY,1.1977439,1.9642693,-1.4561903,-1.328974,5ktz_7,expanded poliovirus in complex with VHH 12B
QVQLQESGGGLVQAGGSLRLSCAASGRTSSVYNMAWFRQTPGKEREFVAAITGNGGTTLYADSVKGRLTISRGNAKNTVSLQMNVLKPDDTAVYYCAAGGWGKERNYAYWGQGTQVTVSS,RTSSVYN,FVAAITGNGGTTL,AAGGWGKERNYAY,15.0,FVAAITGNGGTTL,AAGGWG---------------KERNYAY,RTSSVYNFVAAITGNGGTTLAAGGWG---------------KERNYAY,3.766396,3.4387898,2.3446183,0.2915724,"8gz6_A,8gz6_B,8gz5_B",Crystal structure of neutralizing VHH P17 in complex with SARS-CoV-2 Alpha variant spike receptor-binding domain
QVQLQESGGGLVQAGGSLRLSCAAAGRNLRMYRMGWFRQAPGKEREFVGTMVWSSDTIYYADSVKGRFIISRDNAKNTVYLQMNSLKPEDTAVYYCAAGAGWAGTMTDYNYWGQGTQVTVSS,RNLRMYR,FVGTMVWSSDTIY,AAGAGWAGTMTDYNY,11.0,FVGTMVWSSDTIY,AAGAGWA-------------GTMTDYNY,RNLRMYRFVGTMVWSSDTIYAAGAGWA-------------GTMTDYNY,0.5877779,-0.5279435,-0.47836083,0.41868204,"2x1o_A,2x1o_B",Gelsolin Nanobody
EVQLLESGGGLVQPGGSLRLSCAASGFRISDEDMGWVRQAPGKGLEWVSSIYGPSGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCASALEPLSEPLGFWGQGTLVTVSS,FRISDED,WVSSIYGPSGSTY,ASALEPLSEPLGF,17.0,WVSSIYGPSGSTY,ASALEP---------------LSEPLGF,FRISDEDWVSSIYGPSGSTYASALEP---------------LSEPLGF,3.1284149,2.7211199,0.15441267,-2.8370187,"7jkb_A,1ohq_A,1ohq_B,7obf_A,7obf_B","Crystal structure of HEL4, a soluble human VH antibody domain resistant to aggregation;Crystal structure of the human VH antibody domain HEL4;2xVH Fab"
QVQLVESGGGLIKPGGSLRLSCAASGFTVSYESMGWVRQAPGKGLEWVSAISSSGGSTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCVTPERQCKQSTCYARPRYWGQGTMVTVSS,FTVSYES,WVSAISSSGGSTY,VTPERQCKQSTCYARPRY,17.0,WVSAISSSGGSTY,VTPERQCKQ----------STCYARPRY,FTVSYESWVSAISSSGGSTYVTPERQCKQ----------STCYARPRY,1.7995114,2.3875246,-1.2998433,-1.9711058,7jkb_B,2xVH Fab
EVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVATARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVSA,RTISRYA,FVATARRSGDGAF,AIDSDTFYSGSYDY,16.0,FVATARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVATARRSGDGAFAIDSDTF--------------YSGSYDY,0.08542108,-0.32102722,2.4623938,1.9054961,7jkm_K,REGN1 Human Fab in complex with anti-Kappa VHH domain
QVQLQESGGGLVQAGGSLRLSCAVSGSIFRLSTMGWYRQAPGKQREFVASITSYGDTNYRDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNANIEAGTYYGPGRDYWGQGTQVTVSS,SIFRLST,FVASITSYGDTN,NANIEAGTYYGPGRDY,11.0,FVASIT-SYGDTN,NANIEAGT------------YYGPGRDY,SIFRLSTFVASIT-SYGDTNNANIEAGT------------YYGPGRDY,2.029425,2.3317256,1.0812833,1.6617634,"4p2c_I,4p2c_H,4p2c_K,4p2c_J,4p2c_G",Complex of Shiga toxin 2e with a neutralizing single-domain antibody
QVQLQESGGGSVQAGGSLRLSCTAPGYTDSNYYMSWFRQAPGKEREWVAGVNTGRGSTSYADSVKGRFTISQDNAKNTMFLQMNSLKPEDTAIYYCAVAACHFCDSLPKTQDEYILWGQGTQVTVSS,YTDSNYY,WVAGVNTGRGSTS,AVAACHFCDSLPKTQDEYIL,17.0,WVAGVNTGRGSTS,AVAACHFCDS--------LPKTQDEYIL,YTDSNYYWVAGVNTGRGSTSAVAACHFCDS--------LPKTQDEYIL,1.5629317,1.6040802,1.9420178,1.4187396,"6xxn_A,6xxn_C,6xxn_B,6xxn_E,6xxn_D,6xxn_F","Crystal structure of NB7, a nanobody targeting prostate specific membrane antigen"
QVQLQESGGGSVTAGGSLRLSCTAPGYTDSNYYMSWFRQAPGKEREWVAGVNTGRGSTSYADSVKGRFTISQDNAKNTMFLQMNSLKPEDTAIYYCAVAACHFCDSLPKTQDEYILWGQGTQVTVSS,YTDSNYY,WVAGVNTGRGSTS,AVAACHFCDSLPKTQDEYIL,18.0,WVAGVNTGRGSTS,AVAACHFCDS--------LPKTQDEYIL,YTDSNYYWVAGVNTGRGSTSAVAACHFCDS--------LPKTQDEYIL,1.5629317,1.6040802,1.880945,1.4629445,6xxn_G,"Crystal structure of NB7, a nanobody targeting prostate specific membrane antigen"
QVQLQESGGGSVQAGGSLRLSCTAPGYTDSNYYMSWFRQAPGKEREWVAGVNTGRGSTSYADSVKGRFTISQDNAKNTMFLQMNSLKPEDTAQYYCAVAACHFCDSLPKTQDEYILWGQGTQVTVSS,YTDSNYY,WVAGVNTGRGSTS,AVAACHFCDSLPKTQDEYIL,17.0,WVAGVNTGRGSTS,AVAACHFCDS--------LPKTQDEYIL,YTDSNYYWVAGVNTGRGSTSAVAACHFCDS--------LPKTQDEYIL,1.5629317,1.6040802,1.613834,0.697833,6xxn_H,"Crystal structure of NB7, a nanobody targeting prostate specific membrane antigen"
QVQLQESGGGSVQAGGSLRLSCARSGWPYSTYSMNWFRQAPGKEREAVAGISSTMSGIIFAESKAGQFTISQDNAKNTVYLQMNNLKPEDTAIYYCAARRDYSLSSSSDDFDYWGQGTQVTVSS,WPYSTYS,AVAGISSTMSGII,AARRDYSLSSSSDDFDY,20.0,AVAGISSTMSGII,AARRDYSL-----------SSSSDDFDY,WPYSTYSAVAGISSTMSGIIAARRDYSL-----------SSSSDDFDY,1.2423158,0.60803044,0.80740404,0.8787351,6xxo_A,"Crystal structure of NB8, a nanobody targeting prostate specific membrane antigen"
QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITVNGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAAWGYAWPLHQDDYWYWGQGTQVTVSA,SISSITY,GVAALITVNGHTY,AAAAWGYAWPLHQDDYWY,14.0,GVAALITVNGHTY,AAAAWGYAW----------PLHQDDYWY,SISSITYGVAALITVNGHTYAAAAWGYAW----------PLHQDDYWY,0.61650366,-0.5590041,-3.1613767,-0.14597648,"7mfu_C,7mfu_F",Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain
QVQLVESGGGLVQAGGSLRLSCAASGFPVQAREMEWYRQAPGKEREWVAAIKSTGTYTAYAYSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGSSYIGQGTQVTVSA,FPVQARE,WVAAIKSTGTYTA,YVYVGSSY,11.0,WVAAIKSTGTYTA,YVYV--------------------GSSY,FPVQAREWVAAIKSTGTYTAYVYV--------------------GSSY,1.1114298,0.3210845,-2.5464206,0.8601425,"7mfu_B,7mfu_E",Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain
QVQLQESGGGLVQPGGSLRLSCAASGSISSITTMGWYRQDPGKGRELVALINSVGDTTYAGSVKGRFTISRDNAKNTVYLEMSSLKPEDTAVYYCNAFMSTNSGRTGSFWGQGTQVTVSS,SISSITT,LVALINSVGDTT,NAFMSTNSGRTGSF,13.0,LVALIN-SVGDTT,NAFMSTN--------------SGRTGSF,SISSITTLVALIN-SVGDTTNAFMSTN--------------SGRTGSF,3.3907459,3.522348,-0.363653,-0.53786796,"4m3j_A,4m3j_B,4m3k_B",Structure of a single domain camelid antibody fragment cAb-H7S in complex with the BlaP beta-lactamase from Bacillus licheniformis;Structure of a single-domain camelid antibody fragment cAb-H7S specific of the BlaP beta-lactamase from Bacillus licheniformis
QVQLQESGGGLVQPGGSLRLSCAASGFAFSSYWMYWVRQAPEKGLEWVSTINTGGGITYYKDSVKGRFTVSRDNAKNTLYLQMNSLKPEDAAQYYCATDMSGTYRGQGTQVTVSS,FAFSSYW,WVSTINTGGGITY,ATDMSGTY,20.0,WVSTINTGGGITY,ATDM--------------------SGTY,FAFSSYWWVSTINTGGGITYATDM--------------------SGTY,0.35253266,0.24902123,-5.9442186,-2.991649,"6fuz_N,6fv0_F",Crystal structure of the TPR domain of KLC1 in complex with the C-terminal peptide of torsinA;Crystal structure of the TPR domain of KLC1 in complex with the C-terminal peptide of JIP1
QVQLQESGGGSVEAGGSLRLSCARSGWPYSTYSMNWFRQAPGKEREAVAGISSTMSGIIFAESKAGQFTISQDNAKNTVYLQMNNLKPEDTAIYYCAARRDYSLSSSSDDFDYWGQGTQVTVSS,WPYSTYS,AVAGISSTMSGII,AARRDYSLSSSSDDFDY,21.0,AVAGISSTMSGII,AARRDYSL-----------SSSSDDFDY,WPYSTYSAVAGISSTMSGIIAARRDYSL-----------SSSSDDFDY,1.2423158,0.60803044,0.4033801,-0.27053827,6xxp_A,"Crystal structure of NB37, a nanobody targeting prostate specific membrane antigen"
QVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQADTNNDGWIEGDELKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVSS,FPVNRYS,WVAGMSSAGDRSS,NVNVGFEY,26.0,WVAGMSSAGDRSS,NVNV--------------------GFEY,FPVNRYSWVAGMSSAGDRSSNVNV--------------------GFEY,0.414263,1.3943044,-0.2849617,-2.1056802,"6y0e_A,6y0e_B,6xzf_B",Nbe LBM;Nanobody in complex with eGFP
QVQLQESGGGLVQPGGSLRLSCAASGSFFEFGTVGWFRQAPGKQRELVSRITGNDHRYYADSVKGRFTISRDNDETTVYLQMDSLKPEDTAIYHCNILEGQRWSNYWGQGTQVTVSA,SFFEFGT,LVSRITGNDHRY,NILEGQRWSNY,19.0,LVSRIT-GNDHRY,NILEG-----------------QRWSNY,SFFEFGTLVSRIT-GNDHRYNILEG-----------------QRWSNY,0.9302397,1.4324796,-0.47016376,0.4655251,"7f5g_B,7f5g_D","The crystal structure of RBD-Nanobody complex, DL4 (SA4)"
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYKMNWVRQAPGKGLEWVSDISQSGASISYTGSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCARCPAPFTRDCFDVTSTTYAYRGQGTQVTV,FTFSNYK,WVSDISQSGASIS,ARCPAPFTRDCFDVTSTTYAY,19.0,WVSDISQSGASIS,ARCPAPFTRD-------CFDVTSTTYAY,FTFSNYKWVSDISQSGASISARCPAPFTRD-------CFDVTSTTYAY,-0.22858635,0.72427857,-3.579981,-2.882716,"8hmp_N,7cz5_N,7xou_N,7xov_N,8jhi_N,6nbf_N,6nbh_N,6nbi_N,8hmv_N,6li3_N,8j9n_N,7y35_N,7y36_N,8jis_N,8yy8_N,8hix_N,7f53_N,7f54_N,7f55_N,7f58_N,7d68_N,8hj2_N,8hj0_N,8hj1_N",FZD3-Gs complex;Cryo-EM structure of the GLP-1R/GCGR dual agonist peptide15-bound human GLP-1R-Gs complex;Cryo-EM structure of afamelanotide-MC4R-Gs_Nb35 complex;Cryo-EM structure of THIQ-MC4R-Gs_Nb35 complex;Cryo-EM structure of the human growth hormone-releasing hormone receptor-Gs protein complex;Cryo-EM structure of parathyroid hormone receptor type 1 in complex with a long-acting parathyroid hormone analog and G protein;GPR21(wt) and Gs complex;Structural insights into human brain gut peptide cholecystokinin receptors;Gq bound FZD1 in ligand-free state;Fzd7 -Gs complex;Structure of GPR21-Gs complex;Cryo-EM structure of the Teriparatide-bound human PTH1R-Gs complex;cryo-EM structure of GPR52-miniGs-NB35;Cryo-EM structure of a-MSH-MC4R-Gs_Nb35 complex;GPR21 wt with G15 complex;Cryo-EM structure of GPR21_m5_Gs;GPR21(m5) and G15 complex;GPR52 with Gs and c17;Cryo-EM structure of the Abaloparatide-bound human PTH1R-Gs complex;Cryo-EM structure of bremelanotide-MC4R-Gs_Nb35 complex;Cryo-EM structure of the human glucagon-like peptide-2 receptor-Gs protein complex
QVKLQESGGGLVQPGGSLRLSCASSVPIFAITVMGWYRQAPGKQRELVAGIKRSGDTNYADSVKGRFTISRDDAKNTVFLQMNSLTTEDTAVYYCNAQILSWMGGTDYWGQGTQVTVSS,PIFAITV,LVAGIKRSGDTN,NAQILSWMGGTDY,17.0,LVAGIK-RSGDTN,NAQILS---------------WMGGTDY,PIFAITVLVAGIK-RSGDTNNAQILS---------------WMGGTDY,-0.059933342,0.54694843,-1.957978,1.4632835,"8eln_C,8eln_D,8eln_G,8eln_H,8eln_K,8eln_L,8e1c_A",Crystal Structure of Nanobody VHH222 Bound to Its Antigen PA14 Cif;Crystal Structure of Nanobody VHH222 Specific for PA14 Cif
QVQLVESGGGLVQPGGSLRLSCAASGFTLGSRYMSWVRQAPGEGFEWVSSIEPSGTAWDGDSAKGRFTTSRDDAKNTLYLQMSNLQPEDTGVYYCATGYRTDTRIPGGSWGQGTQVTVSS,FTLGSRY,WVSSIEPSGTAW,ATGYRTDTRIPGGS,22.0,WVSSIE-PSGTAW,ATGYRTD--------------TRIPGGS,FTLGSRYWVSSIE-PSGTAWATGYRTD--------------TRIPGGS,3.01169,2.1417918,-1.5063286,-3.3333104,"7m1h_C,7l6v_E,3v0a_C",Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12;Crystal structure of BoNT/A-LC-JPU-A5-JPU-C1-JPU-H7-JPU-D12-ciA-F12;2.7 angstrom crystal structure of BoNT/Ai in complex with NTNHA
QVQLAETGGGLVQPGGSLRLSCTASTTISDFYSMGWFRQTPGNQRELVAIVRRGGDTKSGDSVKGRFTISRDNTRSTVYLQMDNLKPEDTAVYYCYANLQKSSDELGPYYWGQGTQVTVSS,TISDFYS,LVAIVRRGGDTK,YANLQKSSDELGPYY,23.0,LVAIVR-RGGDTK,YANLQKS-------------SDELGPYY,TISDFYSLVAIVR-RGGDTKYANLQKS-------------SDELGPYY,2.4418435,2.828051,2.0289536,0.876622,7m1h_E,Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12
QVQLVESGGGLVQPGGSLRLSCVVSGSDFNTYIMGWYRQVPGKPRELVADITTEGKTNYGGSVKGRFTISRDNAKNTVYLQMFGLKPEDAGNYVCNADWKMGAWTAGDYGIDYWGKGTLVTVSS,SDFNTYI,LVADITTEGKTN,NADWKMGAWTAGDYGIDY,22.0,LVADIT-TEGKTN,NADWKMGAW----------TAGDYGIDY,SDFNTYILVADIT-TEGKTNNADWKMGAW----------TAGDYGIDY,1.5384861,0.861851,-1.997381,-1.4762347,"7m1h_D,6ui1_C","Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12;Crystal structure of BoNT/A-LCHn domain in complex with VHH ciA-D12, ciA-B5, and ciA-H7"
QVQLVESGGGLVQPGGSLRLSCAASGSIFSIYAMGWYRQAPGKQRELVAAISSYGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNADIATMTAVGGFDYWGQGTQVTVSS,SIFSIYA,LVAAISSYGSTN,NADIATMTAVGGFDY,9.0,LVAAIS-SYGSTN,NADIATM-------------TAVGGFDY,SIFSIYALVAAIS-SYGSTNNADIATM-------------TAVGGFDY,0.1331527,0.08741361,0.7140281,2.064837,7m1h_G,Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12
QLQLVESGGGLVQPGGSLRLSCAASGNIFSIYYMGWYRQAPGKQREMVAIINSNGITNYGDFVKGRFTISRDNAENSAYLQMNNLTPEDTAVYYCNAGKLRRTTGWGLDDYWGQGTQVTVSS,NIFSIYY,MVAIINSNGITN,NAGKLRRTTGWGLDDY,17.0,MVAIIN-SNGITN,NAGKLRRT------------TGWGLDDY,NIFSIYYMVAIIN-SNGITNNAGKLRRT------------TGWGLDDY,0.06489035,-0.5004079,0.022823945,0.3543104,7m1h_F,Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGSEREFVARISWSGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCTAGFALPPSDYWGQGTQVTVSS,RTFSSYA,FVARISWSGGSTY,TAGFALPPSDY,10.0,FVARISWSGGSTY,TAGFA-----------------LPPSDY,RTFSSYAFVARISWSGGSTYTAGFA-----------------LPPSDY,0.5515672,0.32770145,-2.5548186,0.29768854,7dst_E,FMDV capsid in complex with M170 Nab
EVQLVESGGGLVQAGDSLRLSCTASGRTLGDYGVAWFRQAPGKEREFVSVISRSTIITDYADSVRGRFSISADSAKNTVYLQMNSLKPEDTAVYYCAVIANPVYATSRNSDDYGHWGQGTQVTVSS,RTLGDYG,FVSVISRSTIITD,AVIANPVYATSRNSDDYGH,17.0,FVSVISRSTIITD,AVIANPVYA---------TSRNSDDYGH,RTLGDYGFVSVISRSTIITDAVIANPVYA---------TSRNSDDYGH,1.1260278,-0.33716467,-0.5872936,0.10322827,"5sv3_A,5sv3_C,5sv4_A,5sv4_B",Anti-Ricin A-chain Single Domain Antibody A3C8;RTA1-33/44-198 (RVEC) bound to Single Domain Antibody A3C8
QRQLVESGGGLVQPGGSLRLSCAASGSTDSIEYMTWFRQAPGKEREGVAALYTHTGNTYYADSVKGRFIISRDKAKNMVYLQMNSLEPEDTAVYYCGATRKYVPVRFALDQSSYDYWGKGTPVTVSS,STDSIEY,GVAALYTHTGNTY,GATRKYVPVRFALDQSSYDY,17.0,GVAALYTHTGNTY,GATRKYVPVR--------FALDQSSYDY,STDSIEYGVAALYTHTGNTYGATRKYVPVR--------FALDQSSYDY,1.1622694,1.5687023,-0.30281854,0.46370643,"8t8i_A,8t9y_A,8t58_A,8t58_D,8t6i_A,7rth_a,7rth_c,7rth_e,7rth_g,7rth_i,7rth_k,7rth_m,7rth_o,7rth_q","Structure of VHH-Fab complex with engineered Crystal Kappa region;Structure of VHH-Fab complex with engineered FNQIKG elbow region;Structure of VHH-Fab complex with engineered Elbow FNQIKG, Crystal Kappa and SER substitutions;Crystal structure of an anti-lysozyme nanobody in complex with an anti-nanobody Fab """"NabFab"""";Structure of VHH-Fab complex with engineered Elbow FNQIKG and Crystal Kappa regions"
QVQLVETGGGLVQAGGSLRLSCTASGADFSFYAMGWYRQTPGNSRELVAVMNLNGVISYGDSARGRFDISRDGTKNIVFLQMNSLKPEDTGVYYCNGMRLYTRGSVRHPESWGQGIQVTVSS,ADFSFYA,LVAVMNLNGVIS,NGMRLYTRGSVRHPES,22.0,LVAVMN-LNGVIS,NGMRLYTR------------GSVRHPES,ADFSFYALVAVMN-LNGVISNGMRLYTR------------GSVRHPES,-1.4122254,-2.0178094,-3.340267,-2.4353707,7l6v_C,Crystal structure of BoNT/A-LC-JPU-A5-JPU-C1-JPU-H7-JPU-D12-ciA-F12
QVQLAESGGGLVQPGGSLRLSCAASGFTFNRYVIRWYRQAPGKERELVAGISRSGDSGRYVDSVKGRFTISRDNDKNMAYLQMSSLKPDDTAVYYCSALNLEDMEYWGQGTQVTVSS,FTFNRYV,LVAGISRSGDSGR,SALNLEDMEY,17.0,LVAGISRSGDSGR,SALNL------------------EDMEY,FTFNRYVLVAGISRSGDSGRSALNL------------------EDMEY,-0.92256707,0.026637703,0.82486534,2.646725,7l6v_B,Crystal structure of BoNT/A-LC-JPU-A5-JPU-C1-JPU-H7-JPU-D12-ciA-F12
QVQLVESGGGSVQPGGSLRLSCAAIGSVFTMYTTAWYRQTPGNLRELVASITDEHRTNYAASAEGRFTISRDNAKHTVDLQMTNLKPEDTAVYYCKLEHDLGYYDYWGQGTQVTVSS,SVFTMYT,LVASITDEHRTN,KLEHDLGYYDY,22.0,LVASIT-DEHRTN,KLEHD-----------------LGYYDY,SVFTMYTLVASIT-DEHRTNKLEHD-----------------LGYYDY,1.8022213,1.077251,-3.0505643,-1.9804966,7l6v_D,Crystal structure of BoNT/A-LC-JPU-A5-JPU-C1-JPU-H7-JPU-D12-ciA-F12
EVQLVESGGGLVQPGGSLRLSCAASGYIYRRYRMGWYRQAPGKGREFVAAISGGSSTNYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAAYRIVSDPRVYWGQGTQVTVSS,YIYRRYR,FVAAISGGSSTN,AAYRIVSDPRVY,13.0,FVAAIS-GGSSTN,AAYRIV----------------SDPRVY,YIYRRYRFVAAIS-GGSSTNAAYRIV----------------SDPRVY,0.39353794,0.343356,-1.8593714,-2.0972886,"7t83_A,7t83_C,7t83_B,7t83_E,7t83_D,7t83_G,7t83_F,7t83_H",Structure of angiotensin II type I receptor (AT1R) nanobody antagonist AT118i4h32
QVQLQESGGGSVQAGGSLKLTCAASGYIFNSCGMGWYRQSPGRERELVSRISGDGDTWHKESVKGRFTISQDNVKKTLYLQMNSLKPEDTAVYFCAVCYNLETYWGQGTQVTVSS,YIFNSCG,LVSRISGDGDTW,AVCYNLETY,21.0,LVSRIS-GDGDTW,AVCY-------------------NLETY,YIFNSCGLVSRIS-GDGDTWAVCY-------------------NLETY,2.5627706,0.6475934,-2.168855,1.5484631,5my6_B,Crystal structure of a HER2-Nb complex
QVQLVESGGGLVQAGGSLRLSCAASGIDVRIKTMAWYRQAPGKQRELLASVLVSGSTNYADPVKGRFTISRDNAKNTVYLQMNKLIPDDTAVYYCNTYGRLRRDVWGPGTQVTVSS,IDVRIKT,LLASVLVSGSTN,NTYGRLRRDV,14.0,LLASVL-VSGSTN,NTYGR------------------LRRDV,IDVRIKTLLASVL-VSGSTNNTYGR------------------LRRDV,0.2302979,0.15223241,-3.1455643,0.24291879,7apj_B,Structure of autoinhibited Akt1 reveals mechanism of PIP3-mediated activation
QVQLVESGGGPVEAGGSLRLSCAASGRSFSNSVMAWFRQAPGKEREFLSVLNWSSGRTSIADSVKGRFTMSRDPAKITVYLQMNGLKPEDTAVYYCAASNRGSLYTLDNQNRYEDWGQGTQVTVSS,RSFSNSV,FLSVLNWSSGRTS,AASNRGSLYTLDNQNRYED,16.0,FLSVLNWSSGRTS,AASNRGSLY---------TLDNQNRYED,RSFSNSVFLSVLNWSSGRTSAASNRGSLY---------TLDNQNRYED,0.6675738,1.175716,-2.7932472,-0.52313536,5e0q_A,Crystal structure of the Nup98 C-terminal domain bound to nanobody TP377
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCAQTRVTRSLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,AQTRVTRSLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,AQTRVTRSLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYAQTRVTRSLL--------SDYATWPYDY,-0.9719437,-0.530357,-4.187315,0.62678903,"7z6v_Y,7z6v_X,7z6v_Z,7z1a_E,7z1a_F",Nanobody H11 and F2 bound to RBD;CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex
QVQLVESGGGVVQPGRSLRLSCAASGSTFSIVAMGWYRQAPGKQRELVASIITGDGDTNYADSVKGRFTISRDNSKNTMYLQMNSLKPEDTAVYYCYARTGYGSSWLMGHEYDYWGQGTQVTVSS,STFSIVA,LVASIITGDGDTN,YARTGYGSSWLMGHEYDY,13.0,LVASIITGDGDTN,YARTGYGSS----------WLMGHEYDY,STFSIVALVASIITGDGDTNYARTGYGSS----------WLMGHEYDY,2.4986858,0.8368088,0.75902635,1.8006284,7d4b_B,Crystal structure of 4-1BB in complex with a VHH
QVQLVESGGGLAQPGGSLRLSCAASGSTISSVAVGWYRQTPGNQREWVATSSTSSTTATYADSVKGRFTISRDNAKNTIYLQMNSLKPEDTAVYYCKTGLTNWGRGTQVTVSS,STISSVA,WVATSSTSSTTAT,KTGLTN,15.0,WVATSSTSSTTAT,KTG----------------------LTN,STISSVAWVATSSTSSTTATKTG----------------------LTN,1.3528734,1.7678498,-2.010321,-0.59759164,"5e03_A,5e5m_H,5e5m_B,5e5m_D,5e5m_F",Crystal structure of mouse CTLA-4 nanobody;Crystal structure of mouse CTLA-4 in complex with nanobody
QVQLVQSGGGLVQAGGSLRLSCAASGRTFSDIAVGWFRQTPGKEREFVAAISWSGLIINYGDSVEDRFTISRDNAKSAVYLQMNSLKPEDTAVYYCAARIGMNYYYAREIEYPYWGQGTQVTVSK,RTFSDIA,FVAAISWSGLIIN,AARIGMNYYYAREIEYPY,17.0,FVAAISWSGLIIN,AARIGMNYY----------YAREIEYPY,RTFSDIAFVAAISWSGLIINAARIGMNYY----------YAREIEYPY,0.04159578,-1.6021245,-5.6596456,0.79313594,"8ilx_C,8ilx_D",mCherry-LaM3 complex
QVQLVESGGGLVQAGASLRLSCAVSGRTGSIYTMGWFRQAPGKEREVVARTTWTPGSTKYADSVKGRVAISRDIAKNTLYLQMNNLKPEDTAVYYCAACAYGTCYYGDRAYEYWGQGTQVTVSS,RTGSIYT,VVARTTWTPGSTK,AACAYGTCYYGDRAYEY,15.0,VVARTTWTPGSTK,AACAYGTC-----------YYGDRAYEY,RTGSIYTVVARTTWTPGSTKAACAYGTC-----------YYGDRAYEY,0.88020176,2.8505611,-0.4963327,1.0130377,6h02_B,Crystal structure of human Mediator subunit MED23
QVQLVESGGGSVQAGGSLRLSCAASGVPSSSRVMGWFRQAPGKQREFVAAISWTSGNVYYADSVKGRFTITRDNAKNTMYLQMDSLKPEDTAVYYCNARRIRFGVRVYDYWGQGTQVTVSS,VPSSSRV,FVAAISWTSGNVY,NARRIRFGVRVYDY,13.0,FVAAISWTSGNVY,NARRIRF--------------GVRVYDY,VPSSSRVFVAAISWTSGNVYNARRIRF--------------GVRVYDY,0.44422325,-0.43798572,-3.4183865,0.1498627,"7bnw_A,7bnw_C,7bnw_B,7bnw_D",Llama nanobody nb18 raised against GldL from Flavobacterium jonhsoniae
QVQLQESGGGLVQAGGSLRLSCAASGSIFSINSMDWDRQAPGKQRELVATITSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNANVKTWAGMTRDYWGQGTQVTVSS,SIFSINS,LVATITSGGSTN,NANVKTWAGMTRDY,10.0,LVATIT-SGGSTN,NANVKTW--------------AGMTRDY,SIFSINSLVATIT-SGGSTNNANVKTW--------------AGMTRDY,1.0868278,2.2439532,0.9846199,1.8788044,"3ezj_H,3ezj_B,3ezj_D,3ezj_F",Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody
QVQLVESGGGLVQAGGSLRLSCAASGRTFRNYYMGWFRQAPGKERDIVAAISWSGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNARSGGSAWQGDFGSWGQGTQVTVSS,RTFRNYY,IVAAISWSGGSTY,NARSGGSAWQGDFGS,9.0,IVAAISWSGGSTY,NARSGGS-------------AWQGDFGS,RTFRNYYIVAAISWSGGSTYNARSGGS-------------AWQGDFGS,1.5997256,0.9796237,-1.4092356,0.7343872,7bnp_A,Llama nanobody nb17 raised against GldL from Flavobacterium jonhsoniae
QVQLVESGGGLVQAGGSLRLSCAASGFPVDTQWMHWYRQAPGKEREWVAAISSTGRSTFYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCTVYVGNRYRGQGTQVTVSA,FPVDTQW,WVAAISSTGRSTF,TVYVGNRY,10.0,WVAAISSTGRSTF,TVYV--------------------GNRY,FPVDTQWWVAAISSTGRSTFTVYV--------------------GNRY,1.5747697,0.67679155,-1.8384013,-0.14469415,"7cz0_H,7cz0_E,7cz0_G,7cz0_F",Crystal structure of a thermostable green fluorescent protein (TGP) with a synthetic nanobody (Sb92)
QVQLVESGGGLVQAGGSLRLSCAASGRTFSRYAMGWFRQAPGKEREFVSAISGSGGFTDYADSVKGRFTISRDNAKSTVYLRMSSLKPEDTAVYYCAAEGSRGSSTRLDARGTYDYWGQGTQVTVSS,RTFSRYA,FVSAISGSGGFTD,AAEGSRGSSTRLDARGTYDY,11.0,FVSAISGSGGFTD,AAEGSRGSST--------RLDARGTYDY,RTFSRYAFVSAISGSGGFTDAAEGSRGSST--------RLDARGTYDY,2.526667,2.009069,2.2753665,0.5685056,"8pkc_C,8pkc_D,8pih_B",Structure of Api m1 in complex with the AM1-4 nanobody;Structure of Api m1 in complex with two nanobodies
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCAQTHYVSYLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,AQTHYVSYLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,AQTHYVSYLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYAQTHYVSYLL--------SDYATWPYDY,-2.0295331,-1.9269059,-4.2800093,0.41363263,"6zh9_FFF,6zhd_E,6zhd_D,6zhd_F,6zcz_F,6zbp_FFF",H11-H4 bound to Spike;Ternary complex CR3022 H11-H4 and RBD (SARS-CoV-2);H11-H4 complex with SARS-CoV-2;Crystal structure of receptor binding domain of SARS-CoV-2 Spike glycoprotein in ternary complex with EY6A Fab and a nanobody.
QVQMVESGGGLVQAGGSLRLSCAASGYAYTYIYMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRMTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGYELRDRTYGQWGQGTQVTVSS,YAYTYIY,GVAAMDSGGGGTL,AAGGYELRDRTYGQ,14.0,GVAAMDSGGGGTL,AAGGYEL--------------RDRTYGQ,YAYTYIYGVAAMDSGGGGTLAAGGYEL--------------RDRTYGQ,2.463873,1.8754212,-1.2706727,0.64053434,"2p46_B,2p46_D,2p45_B,2p48_B,2p47_B","Complex of a camelid single-domain vhh antibody fragment with RNASE A at 2.5A resolution: se5b-ortho-2 crystal form with five se-met sites (L4M, M34, M51, F68M, M83) in vhh scaffold.;Complex of a camelid single-domain vhh antibody fragment with RNASE A at 2.5A resolution: SE5B-TRI crystal form with five se-met sites (L4M, M34, M51, F68M, M83) in vhh scaffold.;Complex of a camelid single-domain vhh antibody fragment with RNASE A at 1.1A resolution: SE5B-ORTHO-1 crystal form with five se-met sites (L4M, M34, M51, F68M, M83) in vhh scaffold.;Complex of a camelid single-domain vhh antibody fragment with RNASE A at 2.3A resolution: SE5B-tetra crystal form with five se-met sites (L4M, M34, M51, F68M, M83) in vhh scaffold."
QVQLVESGGGLVQAGGSLRLSCAASGYAYTYIYMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRMTISRDKGKNTVYLQMDSMKPEDTATYYCAAGGYELRDRTYGQWGQGTQVTVSS,YAYTYIY,GVAAMDSGGGGTL,AAGGYELRDRTYGQ,14.0,GVAAMDSGGGGTL,AAGGYEL--------------RDRTYGQ,YAYTYIYGVAAMDSGGGGTLAAGGYEL--------------RDRTYGQ,2.463873,1.8754212,-1.3924025,0.6865287,2p44_B,"Complex of a camelid single-domain vhh antibody fragment with RNASE A at 1.8A resolution: SE5A-mono-1 crystal form with five se-met sites (M34, M51, F68M, M83, L86M) in vhh scaffold"
DVQLVESGGGLVQPGGSLRLSCVASGFTFSRVGMGWVRQAPGKGLEWVSDINASGGTGYADSVKGRFAISRDNAKNTLYLQMNRLKPEDTAVYYCAKMMDTAMIEAGIIKPAGQGTQVTVSS,FTFSRVG,WVSDINASGGTG,AKMMDTAMIEAGIIKP,17.0,WVSDIN-ASGGTG,AKMMDTAM------------IEAGIIKP,FTFSRVGWVSDIN-ASGGTGAKMMDTAM------------IEAGIIKP,0.9991644,-0.6244652,-2.900654,-2.9340518,"7zox_C,8cdt_A",Nup93 in complex with xhNup93-Nb4i and xNup93-Nb2t;Crystal structure of the xNup93-Nb2t VHH antibody
QVQLVESGGGVVQTGDSLMLSCTVSGHTIDNWAMGWFRQTPRKQREFVAAIDKRGTGAIYGNSVKGRFTVSRDNAKNMVYLRMNSLKPEDTAVYFCAVDQLNAGLGDVSYDYDYWGQGTQVTVSS,HTIDNWA,FVAAIDKRGTGAI,AVDQLNAGLGDVSYDYDY,23.0,FVAAIDKRGTGAI,AVDQLNAGL----------GDVSYDYDY,HTIDNWAFVAAIDKRGTGAIAVDQLNAGL----------GDVSYDYDY,1.984924,1.4955851,0.06185951,-3.3332589,"7zox_B,8cds_A",Nup93 in complex with xhNup93-Nb4i and xNup93-Nb2t;Crystal structure of the xhNup93-Nb4i VHH antibody
QVQLQESGGGLVQAGGSLRLSCTASGRTFSSYAMGWFRQTPGKEREFVAAITWGGSTTLYADSVKGRFTMSRDNAKNTVYLQMNSLKPEDTAVYYCAADGSQYRSTYSFRDKPDYGSWGQGTQVTVSS,RTFSSYA,FVAAITWGGSTTL,AADGSQYRSTYSFRDKPDYGS,12.0,FVAAITWGGSTTL,AADGSQYRST-------YSFRDKPDYGS,RTFSSYAFVAAITWGGSTTLAADGSQYRST-------YSFRDKPDYGS,0.19429371,-1.0876052,-2.253424,1.0498178,"4ej1_C,4ej1_D,4eiz_C,4eiz_D",Binding of Nb113 camelid antibody fragment with the binary DHFR:folate complex;Structure of Nb113 bound to apoDHFR
QVQLVESGGGLVQAGGSLRLSCAASGSSFSSYTMTWFRQAPGKEREIVAGIRWSGESPYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAARLVPPGIPIERTLESMRYWGKGTLVTVSS,SSFSSYT,IVAGIRWSGESPY,AARLVPPGIPIERTLESMRY,12.0,IVAGIRWSGESPY,AARLVPPGIP--------IERTLESMRY,SSFSSYTIVAGIRWSGESPYAARLVPPGIP--------IERTLESMRY,1.2703354,2.9238682,0.27060133,1.522016,"8sos_D,8sos_G",Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17
EVQLQESGGGLVQPGGSLRLSCAASGFTFSSYWMYWLRQAPGKGLEWVSSINSDSSSTYYRDSVKGRFTISRDNAKNTLYLQMNSLKSEDTAVYYCAKDPGGYAKGQGTQVTVSS,FTFSSYW,WVSSINSDSSSTY,AKDPGGYA,18.0,WVSSINSDSSSTY,AKDP--------------------GGYA,FTFSSYWWVSSINSDSSSTYAKDP--------------------GGYA,0.83396846,2.0185847,-7.0443587,-3.065413,"7czd_A,7czd_C",Crystal structure of PD-L1 in complex with a VHH
EVQLVESGGGLVQPGGSLRLSCAASDFSFYDYEMSWVRQAPGKALEWIGSMYHSGRTYINPSLKSLVTISRDNSKNTLYLQMNSLRAEDTAMYYCVSNWASGSTGDYWGQGTLVTVSS,FSFYDYE,WIGSMYHSGRTY,VSNWASGSTGDY,27.0,WIGSMY-HSGRTY,VSNWAS----------------GSTGDY,FSFYDYEWIGSMY-HSGRTYVSNWAS----------------GSTGDY,1.0945395,0.46022546,-1.8655717,-1.5266764,"7vnc_V,7vnb_A,7vnd_D,7vnd_V","Crystal structure of the SARS-CoV-2 RBD in complex with a human single domain antibody n3113;Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UUD-state, state 2);Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113 (UDD-state, state 1)"
QVQLVESGGGLVQPGGSLRLSCVASGFTFKNFYMGWVRQAPDKGLEWVATINSGGEIQSYADSVKGRFTISRDNAKNTLYLQMNNLRPEDTAVYYCSKQSSTPAKGQGTQVTVSS,FTFKNFY,WVATINSGGEIQS,SKQSSTPA,17.0,WVATINSGGEIQS,SKQS--------------------STPA,FTFKNFYWVATINSGGEIQSSKQS--------------------STPA,1.6458185,0.7962171,-3.1214116,-2.822285,"8pyr_H,8pyr_D",Crystal structure of the dual T-loop phosphorylated Cdk7/CycH/Mat1 complex
QVQLAETGGGLAQPGGSLRLSCAASGFTFSRAVMNWYRQAPGKERELVARIYDAGGNGSIADPVKGRFTISRDNAKNTVHLQMNSLKPEDTAMYVCNAGIFDGNYRTYWGQGTQVTVSS,FTFSRAV,LVARIYDAGGNGS,NAGIFDGNYRTY,17.0,LVARIYDAGGNGS,NAGIFD----------------GNYRTY,FTFSRAVLVARIYDAGGNGSNAGIFD----------------GNYRTY,1.1995875,2.091052,3.111032,2.6707911,"5vxj_H,5vxj_B,5vxj_J,5vxj_D,5vxj_F",2.50 A resolution structure of IpaD from Shigella flexneri in complex with single-domain antibody JMK-E3
QVQLQESGGGLVQAGGSLRLSCVVSGFFFDTVTMAWYRRAPGKHRELVASATAGGTTTYADSVKDRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNTFVRSLSWGQGTQVTVSS,FFFDTVT,LVASATAGGTTT,NTFVRSLS,14.0,LVASAT-AGGTTT,NTFV--------------------RSLS,FFFDTVTLVASAT-AGGTTTNTFV--------------------RSLS,0.831262,-1.0056177,-4.500146,-2.665229,"8jru_B,8jrv_B,6ni2_A",Cryo-EM structure of the glucagon receptor bound to glucagon and beta-arrestin 1;Cryo-EM structure of the glucagon receptor bound to beta-arrestin 1 in ligand-free state;Stabilized beta-arrestin 1-V2T subcomplex of a GPCR-G protein-beta-arrestin mega-complex
QVQLQESGGGLVQAGGSLRLSCAASGSIFDLGVMGWYRQAPGKEREQVAGIDYGGVTNYADSVKGRFTISRDNDTVYLQMNSLKPEDTAVYYCAAGIVGDEVGWIYYLYWGQGTQVTVSS,SIFDLGV,QVAGIDYGGVTN,AAGIVGDEVGWIYYLY,10.0,QVAGID-YGGVTN,AAGIVGDE------------VGWIYYLY,SIFDLGVQVAGID-YGGVTNAAGIVGDE------------VGWIYYLY,0.6996972,0.6544491,3.4939215,4.3169255,"8a67_H,8a67_D",Branched Lys48- and Lys63-linked tri-ubiquitin (K48-K63-Ub3) in complex with matured synthetic nanobody NbSL3.3Q (3rd generation)
QVQLVESGGGLVQAGGSLRLSCAASGFPVNISWMEWYRQVPGKEREWVAAIQSTGSYTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRVKVGAYYRGQGTQVTVSA,FPVNISW,WVAAIQSTGSYTW,RVKVGAYY,11.0,WVAAIQSTGSYTW,RVKV--------------------GAYY,FPVNISWWVAAIQSTGSYTWRVKV--------------------GAYY,1.2889825,-0.80543745,-1.1963905,-0.7730849,"7y9v_C,7y9v_D,7y9u_C,7y9u_D,7y9t_C,7y9t_D",Structure of the auxin exporter PIN1 in Arabidopsis thaliana in the apo state;Structure of the auxin exporter PIN1 in Arabidopsis thaliana in the NPA-bound state;Structure of the auxin exporter PIN1 in Arabidopsis thaliana in the IAA-bound state
QVQLVQSGGGVVQPGRSLRLSCAASGFTFSRYTIHWVRQAPGKGLEWVAVMSYNGNNKHYADSVNGRFTISRNDSKNTLYLNMNSLRPEDTAVYYCARIRDTAMFFAHWGQGTLVTVSS,FTFSRYT,WVAVMSYNGNNKH,ARIRDTAMFFAH,24.0,WVAVMSYNGNNKH,ARIRDT----------------AMFFAH,FTFSRYTWVAVMSYNGNNKHARIRDT----------------AMFFAH,-0.58305717,-1.3723714,-3.0806057,-2.6463902,"8a64_C,8a64_B",cryoEM structure of the catalytically inactive EndoS from S. pyogenes in complex with the Fc region of immunoglobulin G1.
EVQLVESGGGLVQPGGSLRLSCAASDSSFYDYEMSWVRQVPGKTPEWIGSMYPSGRTYINPSLKSLVTISRDNSENMLYLQMNSLRAEDTAMYYCVSNWASGSTGDYWGQGTLVTVSS,SSFYDYE,WIGSMYPSGRTY,VSNWASGSTGDY,30.0,WIGSMY-PSGRTY,VSNWAS----------------GSTGDY,SSFYDYEWIGSMY-PSGRTYVSNWAS----------------GSTGDY,2.3725598,1.6112529,-1.3657779,-1.4855387,"8i4e_C,8i4h_B,7whj_E,7whj_D,7whk_E,7whk_G,7whk_F,7whi_E,7whi_D,7whi_F","Omicron spike variant BA.1 with Bn03;The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies);The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies);The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies);Omicron spike variant XBB with Bn03"
EVQLVESGGGLVQPGGSLRLSCAASDFYFDYYEMSWVRQAPGQGLEWVSTISGLGGATYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTALYYCATRSPFGDYAFSYWGQGTLVTVSS,FYFDYYE,WVSTISGLGGATY,ATRSPFGDYAFSY,20.0,WVSTISGLGGATY,ATRSPF---------------GDYAFSY,FYFDYYEWVSTISGLGGATYATRSPF---------------GDYAFSY,0.78327227,0.8026819,-1.8915575,-2.8110871,"8i4f_C,8i4g_C,7whj_F,7whk_H,7whk_D,7whi_G","The state 1 complex structure of Omicron spike with Bn03 (1-up RBD, 3 nanobodies);The state 2 complex structure of Omicron spike with Bn03 (2-up RBD, 4 nanobodies);The state 3 complex structure of Omicron spike with Bn03 (2-up RBD, 5 nanobodies);Omicron spike variant BQ.1.1 with n3130v-Fc;Omicron spike variant XBB with n3130v-Fc"
QVQLVETGGGLVRAGGSLRLSCVDSGRTFRVYTMGWFRQAPGKEREFVAAIRWSGDRTYYGDPVQGRFTISRDKGKNTVYLQMNSLKPEDTAVYYCAAPAGGGVVYDDHKAYAYWGQGTQVTVS,RTFRVYT,FVAAIRWSGDRTY,AAPAGGGVVYDDHKAYAY,18.0,FVAAIRWSGDRTY,AAPAGGGVV----------YDDHKAYAY,RTFRVYTFVAAIRWSGDRTYAAPAGGGVV----------YDDHKAYAY,0.64706767,-0.84208894,0.5609287,1.7210612,6x06_K,Nup120 (aa1-757) from S. cerevisiae bound by VHH-SAN11
QVQLVETGGGLVQAGGSLRLSCATSGFNFRLRTMGWYRQAPGKERELVASITSGGSTDYADSVKGRFTISRDNAKNTISLEMNSLKPDDTAVYYCNIWAPTTAAITNWGQGTQVTVSS,FNFRLRT,LVASITSGGSTD,NIWAPTTAAITN,13.0,LVASIT-SGGSTD,NIWAPT----------------TAAITN,FNFRLRTLVASIT-SGGSTDNIWAPT----------------TAAITN,0.034637176,-0.007279843,0.124885604,1.4524598,6x07_B,Nic96 from S. cerevisiae bound by VHH-SAN12
QLQLVETGGGLVQAGGSLRLSCVASGRTFTSYAMGWFRQAPGKEREFVAAISRLASGTDYADSVKGRFTISRNNDKNTVYLQMNNLIPEDTAVYYCAALQALRFSLPIAMATMKNGRADSWGQGTQVTVSS,RTFTSYA,FVAAISRLASGTD,AALQALRFSLPIAMATMKNGRADS,15.0,FVAAISRLASGTD,AALQALRFSLPI----AMATMKNGRADS,RTFTSYAFVAAISRLASGTDAALQALRFSLPI----AMATMKNGRADS,-0.63531405,-0.54088306,-3.5914931,1.5953076,"6x02_C,6x03_C",Nup84-Nup133 (aa521-1157) from S. cerevisiae bound by VHH-SAN8 and VHH-SAN9;Nup84-Nup133 (aa521-1157) from S. cerevisiae bound by VHH-SAN8
QVQLVESGGGSVQAGGSLRLSCAVSGGTLSTLAMGWFRQAPGQEREFVARIGWTNGDTGYADSVKGRFTISRDNVKNTVYLQMNNLKPEDTALYYCATRRPYGSTLYPPNTESAHDNWGQGTQVTVSS,GTLSTLA,FVARIGWTNGDTG,ATRRPYGSTLYPPNTESAHDN,14.0,FVARIGWTNGDTG,ATRRPYGSTL-------YPPNTESAHDN,GTLSTLAFVARIGWTNGDTGATRRPYGSTL-------YPPNTESAHDN,3.042508,1.5337881,-1.0052795,0.14004862,6x03_D,Nup84-Nup133 (aa521-1157) from S. cerevisiae bound by VHH-SAN8 and VHH-SAN9
EVQLVESGGGLVQPGGSLRLSCAASGSISSVDVMSWYRQAPGKQRELVAFITDRGRTNYKVSVKGRFTISRDNSKNMVYLQMNSLKPEDTADYLCRAESRTSWSSPSPLDVWGRGTQVTVSS,SISSVDV,LVAFITDRGRTN,RAESRTSWSSPSPLDV,18.0,LVAFIT-DRGRTN,RAESRTSW------------SSPSPLDV,SISSVDVLVAFIT-DRGRTNRAESRTSW------------SSPSPLDV,1.8594159,1.892527,-0.92794055,-1.2329507,"4b50_A,7aej_D",Crystal structure of the HIV-1 gp41 MPER-specific llama VHH 2H10;Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors
QVQLVESGGGLVQAGGSLRLSCAASGFPVMNAGMYWYRQAPGKEREWVAAIESEGTSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDVGDNHFPYDYWGQGTQVTVSA,FPVMNAG,WVAAIESEGTSTY,NVKDVGDNHFPYDY,9.0,WVAAIESEGTSTY,NVKDVGD--------------NHFPYDY,FPVMNAGWVAAIESEGTSTYNVKDVGD--------------NHFPYDY,2.7366571,3.1939445,2.527075,3.091813,"7p5y_G,7p5y_I,7p5y_H,7p5y_K,7p5y_J,7p5y_L",Structure of homomeric LRRC8A Volume-Regulated Anion Channel in complex with synthetic nanobody Sb3
QVQLVESGGGLVQAGGSLRLSCAASGFPVGRHFMYWYRQAPGKEREWVAAIYSYGEYTEYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVYVGNEYWGQGTQVTVSA,FPVGRHF,WVAAIYSYGEYTE,YVYVGNEY,9.0,WVAAIYSYGEYTE,YVYV--------------------GNEY,FPVGRHFWVAAIYSYGEYTEYVYV--------------------GNEY,1.2854619,0.56047326,-1.1659651,2.6663613,"7p5v_G,7p5v_I,7p5v_H,7p5v_K,7p5v_J,7p5v_L,8b41_I,8b41_H,8b41_J,8b41_G",Structure of heteromeric LRRC8A/C (1:1 co-transfected) Volume-Regulated Anion Channel in complex with synthetic nanobody Sb1;Structure of homomeric LRRC8A Volume-Regulated Anion Channel in complex with synthetic nanobody Sb1
QVQLVESGGGLVQAGGSLRLSCAASGFPVYQAWMWWYRQAPGKEREWVAAIESEGQYTWYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDTGHTTNQYDYWGQGTQVTVSA,FPVYQAW,WVAAIESEGQYTW,NVKDTGHTTNQYDY,9.0,WVAAIESEGQYTW,NVKDTGH--------------TTNQYDY,FPVYQAWWVAAIESEGQYTWNVKDTGH--------------TTNQYDY,2.209109,2.4801345,-0.31204998,1.6608076,"7p5w_G,7p5w_I,7p5w_H,7p5w_K,7p5w_J,7p5w_L",Structure of homomeric LRRC8A Volume-Regulated Anion Channel in complex with synthetic nanobody Sb2
EVQLVESGGGLVQAGGSLRLSCAASGRTFSNYHMAWFRQAPGKEREFVAGISWTGRGTYYTDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAEGTLYGSGGRTHQSAYDYWGQGTQVTVSS,RTFSNYH,FVAGISWTGRGTY,AAEGTLYGSGGRTHQSAYDY,11.0,FVAGISWTGRGTY,AAEGTLYGSG--------GRTHQSAYDY,RTFSNYHFVAGISWTGRGTYAAEGTLYGSG--------GRTHQSAYDY,0.94933885,1.9118372,-1.1637349,0.25617677,8aok_B,Complex of PD-L1 with VHH6
EVQLVESGGGLVQAGGSLRLSCAASGSISSRDVMRWYRQAPGKQRELVASISSGGGTYYVDSVKGRFTISRDNAENTLYLQMNSLKPEDTAVYYCWDLGHRPYFKDYWGQGTQVTVSS,SISSRDV,LVASISSGGGTY,WDLGHRPYFKDY,13.0,LVASIS-SGGGTY,WDLGHR----------------PYFKDY,SISSRDVLVASIS-SGGGTYWDLGHR----------------PYFKDY,2.0487025,2.9750338,1.2262518,-0.12762219,8aom_V,Complex of PD-L1 with VHH1
VQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVAVARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVSS,RTISRYA,FVAVARRSGDGAF,AIDSDTFYSGSYDY,14.0,FVAVARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVAVARRSGDGAFAIDSDTF--------------YSGSYDY,-0.3579229,-0.5756862,2.5854487,1.3475101,"7zyi_K,8wnu_H,8wnu_G,8wnp_H,8wnp_G,8rqf_K",ZIKV rsNS1 in complex with Fab GB5 and anti-fab nanobody;Cryo-EM structure of human NTCP-Bulevirtide complex;ZIKV rsNS1 in complex with Fab AA12 and anti-fab nanobody;Structure of the human sodium/bile acid cotransporter (NTCP) in complex with Fab and nanobody
EVQLVESGGGLVQAGGSLRLSCAASGRSFSRDAMGWFRQAPGKERDVVAAINLNGGRTYSADSVKGRFTISRDNDKNTVYLQMSNLKPEDTAVYYCAAREGDVGLVSYKRSSNYPYWGQGTQVTVSS,RSFSRDA,VVAAINLNGGRTY,AAREGDVGLVSYKRSSNYPY,14.0,VVAAINLNGGRTY,AAREGDVGLV--------SYKRSSNYPY,RSFSRDAVVAAINLNGGRTYAAREGDVGLV--------SYKRSSNYPY,2.7102263,2.6753607,2.7513824,0.59765697,"4b5e_A,4b5e_B",Crystal Structure of an amyloid-beta binding single chain antibody PS2-8
QVQLQESGGGSVQTGGSLTLSCAASGYAVSLYSMGWFRQAPGKELEGVAGISSSGVDTTYADSVKGRFTISRDNAKDTMYLQMNSPKPEDTAIYRCAAGFGLSLSRYTYAHWGQGTQVTVSS,YAVSLYS,GVAGISSSGVDTT,AAGFGLSLSRYTYAH,18.0,GVAGISSSGVDTT,AAGFGLS-------------LSRYTYAH,YAVSLYSGVAGISSSGVDTTAAGFGLS-------------LSRYTYAH,-0.06299571,0.12601396,-2.3800151,-1.7439609,5ku2_7,expanded poliovirus in complex with VHH 7A
QVQLQESGGGLVQPGGSLTLSCAASGYAVSRYSMGWFRQAPGKENEGVAAIDSSGVGTTYADSVKGRFTISRDNAKDTVYLRMNSLKPEDTAIYYCASGFGLSLSRYTYAYWGQGTQVTVSS,YAVSRYS,GVAAIDSSGVGTT,ASGFGLSLSRYTYAY,15.0,GVAAIDSSGVGTT,ASGFGLS-------------LSRYTYAY,YAVSRYSGVAAIDSSGVGTTASGFGLS-------------LSRYTYAY,1.1977439,1.9642693,-0.3790006,-0.35741127,5ku0_7,expanded poliovirus in complex with VHH 17B
QVQLQESGGGLVQPGGSLRLSCAASGSIFSIYAMGWYRQAPGKQRELVASISSGGGTNYADSVKGRFTISGDNAKNTVYLQMNSLKPEDTAVYYCKREDYSAYAPPSGSRGRGTQVTVSS,SIFSIYA,LVASISSGGGTN,KREDYSAYAPPSGS,12.0,LVASIS-SGGGTN,KREDYSA--------------YAPPSGS,SIFSIYALVASIS-SGGGTNKREDYSA--------------YAPPSGS,-0.62703764,-0.8096568,-0.86136955,-2.0733976,"5o04_C,5o04_D",GII.10 Vietnam 026 norovirus protruding domain in complex with Nanobody Nano-26 and Nano-85
QVQLQESGGGLVQPGGSLRLSCTAPRIIFFMYDVGWYRQAPEKQRELVAQINSDVSTKYADSVKGRFTISRDNAKRTVYLQMNDLKPEDAAVYYCNVRRASADYWGQGTQVTVSS,IIFFMYD,LVAQINSDVSTK,NVRRASADY,18.0,LVAQIN-SDVSTK,NVRR-------------------ASADY,IIFFMYDLVAQIN-SDVSTKNVRR-------------------ASADY,0.25830984,-1.0456259,0.036671698,-2.3275173,"5o04_E,5o04_F",GII.10 Vietnam 026 norovirus protruding domain in complex with Nanobody Nano-26 and Nano-85
QVQLQESGGGLVQPGGSLRLSCAASGSVSRTYVMGWYRQTPGNQRELVATITSVGSTNYADSLKGRFTISRENAENTVYLQMNSLKPEDTAIYYCKYIRYSPIHAPLDYWGQGTQVTVSS,SVSRTYV,LVATITSVGSTN,KYIRYSPIHAPLDY,15.0,LVATIT-SVGSTN,KYIRYSP--------------IHAPLDY,SVSRTYVLVATIT-SVGSTNKYIRYSP--------------IHAPLDY,0.5472838,1.2161136,-0.21098997,0.9215669,"5o05_C,5o05_D",GII.10 Vietnam 026 norovirus protruding domain in complex with Nanobody Nano-42
QVQLQESGGGLVQPGGSLRLFCAASGFTFSSYAMRWYRQAPGKERELVAAITSAGGSTHYADSVKERFTISRDNAKNTMYLQMNSLKPEDTAVYYCNARRDYGDSWFTAGGGYWGQGTQVTVSS,FTFSSYA,LVAAITSAGGSTH,NARRDYGDSWFTAGGGY,13.0,LVAAITSAGGSTH,NARRDYGD-----------SWFTAGGGY,FTFSSYALVAAITSAGGSTHNARRDYGD-----------SWFTAGGGY,1.340325,2.2155228,0.80450505,2.6708767,5o02_C,GII.17 Kawasaki323 protruding domain in complex with Nanobody Nano-4
QVQLVESGGGSVQAGGSLRLSCAASGNIAYIHYLGWFRQAPGKEREGVAALSTTLGNTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYFGYSSPLAHERYMYWGQGTQVTVSA,NIAYIHY,GVAALSTTLGNTY,AAAYFGYSSPLAHERYMY,14.0,GVAALSTTLGNTY,AAAYFGYSS----------PLAHERYMY,NIAYIHYGVAALSTTLGNTYAAAYFGYSS----------PLAHERYMY,0.4166139,1.7002958,-1.5735376,0.71824676,"8oo1_B,8oo1_D,8omz_B,8omz_D",Wide inward-open liganded UraA in complex with a conformation-selective synthetic nanobody;Wide inward-open unliganded UraA in complex with a conformation-selective synthetic nanobody
QVQLQESGGGLVQAGGSLRLSCEASGRTFSSYAMGWFRQAPGKERDFVAVISWSGSNTYYADSAKGRFTISRDNAKNTVYLQMNSLKPEDTAIYYCAAPGRPHGSSWSLNKKGQGYDYWGQGTQVTVSS,RTFSSYA,FVAVISWSGSNTY,AAPGRPHGSSWSLNKKGQGYDY,13.0,FVAVISWSGSNTY,AAPGRPHGSSW------SLNKKGQGYDY,RTFSSYAFVAVISWSGSNTYAAPGRPHGSSW------SLNKKGQGYDY,1.3768865,-1.1457958,-1.5584986,1.079567,4fhb_D,Enhancing DHFR catalysis by binding of an allosteric regulator nanobody (Nb179)
EVQLVETGGGLIQPGGSLRLSCAVSGFTVSLNYMSWVRQAPGKGLEWVSSIYSGGSTFYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGLGFGELPPFDFWGQGTLVTVSS,FTVSLNY,WVSSIYSGGSTF,ARGLGFGELPPFDF,20.0,WVSSIY-SGGSTF,ARGLGFG--------------ELPPFDF,FTVSLNYWVSSIY-SGGSTFARGLGFG--------------ELPPFDF,1.2028266,0.76581657,-3.6188388,-2.934489,8c8p_H,Structure of the SARS-CoV-2 spike glycoprotein in complex with the 10D12 heavy-chain-only antibody (local refinement)
QVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVSH,FPVNRYS,WVAGMSSAGDRSS,NVNVGFEY,14.0,WVAGMSSAGDRSS,NVNV--------------------GFEY,FPVNRYSWVAGMSSAGDRSSNVNV--------------------GFEY,0.414263,1.3943044,1.6238192,3.493586,"4pfe_A,4pfe_B",Crystal structure of vsfGFP-0
QVQLVESGGGLVQPGESLRLSCAASGSIFGIYAVHWFRMAPGKEREFTAGFGSHGSTNYAASVKGRFTMSRDNAKNTTYLQMNSLKPADTAVYYCHALIKNELGFLDYWGPGTQVTVSS,SIFGIYA,FTAGFGSHGSTN,HALIKNELGFLDY,18.0,FTAGFG-SHGSTN,HALIKN---------------ELGFLDY,SIFGIYAFTAGFG-SHGSTNHALIKN---------------ELGFLDY,0.14441428,0.2953475,-2.2425601,-0.42591196,"8bgg_Y,8bev_B","Cryo-EM structure of SARS-CoV-2 spike (Omicron BA.1 variant) in complex with nanobody W25 (map 5, focus refinement on RBD, W25 and adjacent NTD);Cryo-EM structure of SARS-CoV-2 spike (HexaPro variant) in complex with nanobody W25 (map 3, focus refinement on RBD, W25 and adjacent NTD)"
QVQLVESGGGLVQAGGTLKLSCAASGSISGIVVMAWYRQAPGKQRELVASITSGGTTNYADSVKGRFTISKDNAENTLYLRMNSLKPEDTAVYYCKAFFRRDYVGYDYWGQGTQVTVSS,SISGIVV,LVASITSGGTTN,KAFFRRDYVGYDY,15.0,LVASIT-SGGTTN,KAFFRR---------------DYVGYDY,SISGIVVLVASIT-SGGTTNKAFFRR---------------DYVGYDY,1.225442,1.2363847,-3.4306753,1.459182,"5mwn_F,5mwn_E,5mwn_D,5m30_E,5m30_D,5m30_F,5m2w_A,5m2w_B",Structure of nanobody nb18 raised against TssK from E. coli T6SS;Structure of TssK from T6SS EAEC in complex with nanobody nb18;Structure of the EAEC T6SS component TssK N-terminal domain in complex with llama nanobodies nbK18 and nbK27
QVQLVESGGGLVQPGGSLRLSCAASGIMLGYFTMAWYRQAPGKQRELVATEISGGSANYADAVKGRFTISRDNARSTVYLQMNSLKPEDTAVYYCDARIWRGTVYDNISGPGTQVTVSS,IMLGYFT,LVATEISGGSAN,DARIWRGTVYDNI,15.0,LVATEI-SGGSAN,DARIWR---------------GTVYDNI,IMLGYFTLVATEI-SGGSANDARIWR---------------GTVYDNI,0.3665854,-1.2019666,-4.238413,-0.98252416,5mwn_N,Structure of the EAEC T6SS component TssK N-terminal domain in complex with llama nanobodies nbK18 and nbK27
SVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVAVARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVS,RTISRYA,FVAVARRSGDGAF,AIDSDTFYSGSYDY,15.0,FVAVARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVAVARRSGDGAFAIDSDTF--------------YSGSYDY,-0.3579229,-0.5756862,2.350669,1.3431511,"8u4v_K,9bei_K","Cryo-EM structure of human claudin-4 complex with Clostridium perfringens enterotoxin C-terminal domain, sFab COP-1, and Nanobody;Cryo-EM structure of synthetic claudin-4 complex with Clostridium perfringens enterotoxin C-terminal domain, sFab COP-2, and Nanobody"
QMQLVESGGGLVQAGGSLRLSCAVSGSIFSIITLAWYRQAPGKPRENVATITRGSRTSYADSVKGRFTISKDNAKSTVYLQMNKLKPEDTADYYCNAEGPAGYWGQGTPVTVS,SIFSIIT,NVATITRGSRTS,NAEGPAGY,18.0,NVATIT-RGSRTS,NAEG--------------------PAGY,SIFSIITNVATIT-RGSRTSNAEG--------------------PAGY,0.43700168,1.7570034,-4.589533,-1.9818292,"7ndf_C,7ndf_D",Crystal structure of nanobody Nb_MsbA#1 in complex with the nucleotide binding domain of MsbA
QVQLQESGGGLVQAGGSLRLSCAASGSIFGADWMGWYRQAPGKEREFVAGIGHGASTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVQYTQGWSGQYRSYDSLLYWGQGTQVTVSS,SIFGADW,FVAGIGHGASTY,AVQYTQGWSGQYRSYDSLLY,8.0,FVAGIG-HGASTY,AVQYTQGWSG--------QYRSYDSLLY,SIFGADWFVAGIG-HGASTYAVQYTQGWSG--------QYRSYDSLLY,1.4732779,2.1737533,1.2759327,1.1400163,"7yaj_C,7yai_C,7yah_C,7yag_C",CryoEM structure of SPCA1a in E1-Ca-AMPPCP state subclass 3;CryoEM structure of SPCA1a in E1-Ca-AMPPCP state subclass 1;CryoEM structure of SPCA1a in E1-Mn-AMPPCP state subclass 1;CryoEM structure of SPCA1a in E1-Ca-AMPPCP state subclass 2
AVQLQESGGGLVQAGGSLRLSCTASGRISSSYDMGWFRQAPGKEREFVAAISWSGGTTDYADSVKGRFAISKDNAKNAVYLQMNSLKPEDTAVYYCAAKWRPLRYSDYPSNSDYYDWGQGTQVTVSS,RISSSYD,FVAAISWSGGTTD,AAKWRPLRYSDYPSNSDYYD,14.0,FVAAISWSGGTTD,AAKWRPLRYS--------DYPSNSDYYD,RISSSYDFVAAISWSGGTTDAAKWRPLRYS--------DYPSNSDYYD,1.2581954,1.5073725,1.7089934,0.9858931,"3rjq_B,3r0m_A,3r0m_B,7ri2_B",Crystal structure of anti-HIV llama VHH antibody A12 in complex with HIV-1 C1086 gp120;Crystal structure of anti-HIV llama VHH antibody A12;Crystal structure of anti-HIV llama VHH antibody A12 in complex with C186 gp120
QMQLVESGGGLVQAGGSLRLSCAVSGSIFSIITLAWYRQAPGKPRENVATITRGSRTSYADSVKGRFCISKDNAKSTVYLQMNKLKPEDTADYYCNAEGPAGYWGQGTPVTVSA,SIFSIIT,NVATITRGSRTS,NAEGPAGY,19.0,NVATIT-RGSRTS,NAEG--------------------PAGY,SIFSIITNVATIT-RGSRTSNAEG--------------------PAGY,0.43700168,1.7570034,-5.1497626,-2.0155292,"7ph4_C,7ph4_D","AMP-PNP bound nanodisc reconstituted MsbA with nanobodies, spin-labeled at position T68C"
QVQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSGDKSDYTDSVKGRFTISRDNAKNTMYLQMNNLKPEDTATYYCARGLGIYIIRARGGYDHWGQGTQVTVSS,RTFSSYN,FVASITSSGDKSD,ARGLGIYIIRARGGYDH,15.0,FVASITSSGDKSD,ARGLGIYI-----------IRARGGYDH,RTFSSYNFVASITSSGDKSDARGLGIYI-----------IRARGGYDH,0.070333086,-0.6885049,-2.3423433,-2.7777884,"6hhd_B,6hhd_D,6her_B",Mouse Prion Protein in complex with Nanobody 484;Mouse prion protein in complex with Nanobody 484
QVQLVESGGGLVQPGGSLRLSCAASGFTFSSYPMSWVRQAPGKGLEWVSDINSSGTTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCATEGKYGRTWYGQLEYHYWGQGTQVTVSS,FTFSSYP,WVSDINSSGTTY,ATEGKYGRTWYGQLEYHY,13.0,WVSDIN-SSGTTY,ATEGKYGRT----------WYGQLEYHY,FTFSSYPWVSDIN-SSGTTYATEGKYGRT----------WYGQLEYHY,0.49765787,0.19462723,-1.8806078,-3.2969625,"6hhu_H,6qx4_H,6qx4_D",Structure of the Bacillus anthracis Sap S-layer assembly domain
QVQLVESGGGLVQAGGSLRLFCAASGSIFRVNAMGWYRQVTGKQRELVAAITSGGRTNYADSVKGRFTISRDNIKNTVYLQMNSLKPEDTAVYYCNADLGTGGRSYDYWGQGTQVTVSS,SIFRVNA,LVAAITSGGRTN,NADLGTGGRSYDY,12.0,LVAAIT-SGGRTN,NADLGT---------------GGRSYDY,SIFRVNALVAAIT-SGGRTNNADLGT---------------GGRSYDY,1.8368303,2.5456443,-1.3808037,-1.9120929,6hhu_G,Structure of the Bacillus anthracis Sap S-layer assembly domain
QVQLQESGGGLVQAGGSLRLSCAASGFTFDDYAIGWFRQAPGKEREGVSGIRRSDGSTHYADSVKGRFTISTDNAKNTVYLQMNNLKPEDTAVYYCAAAGTPSYYYTEPLSLGTYDYWGQGTQVTVSS,FTFDDYA,GVSGIRRSDGSTH,AAAGTPSYYYTEPLSLGTYDY,12.0,GVSGIRRSDGSTH,AAAGTPSYYY-------TEPLSLGTYDY,FTFDDYAGVSGIRRSDGSTHAAAGTPSYYY-------TEPLSLGTYDY,2.513273,2.3576407,2.4123626,1.1617768,8q6k_N,Human IgD Fab in complex with an orthosteric inhibitor of Phl p 7
QVQLQESGGGLVQAGGSLRLSCAASGTISPRGVMGWYRQAPGKEREFVAAINYGGTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVYYYINSQRKVLLYWGQGTQVTVSS,TISPRGV,FVAAINYGGTTY,AVYYYINSQRKVLLY,8.0,FVAAIN-YGGTTY,AVYYYIN-------------SQRKVLLY,TISPRGVFVAAIN-YGGTTYAVYYYIN-------------SQRKVLLY,2.074403,0.12605345,-1.0449989,2.371701,"8eqb_A,8eqb_J,8eqb_D,8eqb_G",FAM46C/BCCIPalpha/Nanobody complex
QVQLQESGGGLVQAGGSLRLSCTYSGQTFSAWAMGWFRQAPGKERETVATINWNGERTQYADAVKGRFTISRDNAKDTVYLEMNSLKPEDTAVYYCASMMGTYYSGSPKNWGQGTQVTVSS,QTFSAWA,TVATINWNGERTQ,ASMMGTYYSGSPKN,14.0,TVATINWNGERTQ,ASMMGTY--------------YSGSPKN,QTFSAWATVATINWNGERTQASMMGTY--------------YSGSPKN,2.1349711,2.7506943,-1.5806925,0.5807436,"8h3y_E,8h3y_D,8h3y_F",Bacteroide Fragilis Toxin in complex with nanobody 327
QVQLQESGGGLVQPGGSLRLSCAASGFTFSRYTMTWVRQAPGKGLEWVSNINSDGGRTYYADSVKGRFTISRDNTKNTLYLQMNSLKPEDTAVYYCAIPKRTYVPPSQFDDRGQGTQVTVSS,FTFSRYT,WVSNINSDGGRTY,AIPKRTYVPPSQFDD,16.0,WVSNINSDGGRTY,AIPKRTY-------------VPPSQFDD,FTFSRYTWVSNINSDGGRTYAIPKRTY-------------VPPSQFDD,0.62991333,0.20684838,-3.549215,-2.96179,8h3x_A,Bacteroide Fragilis Toxin in complex with nanobody 282
QLQLVETGGGLVKPGGSLRLSCVVSGFTFDDYRMAWVRQAPGKELEWVSSIDSWSINTYYEDSVKGRFTISTDNAKNTLYLQMSSLKPEDTAVYYCAAEDRLGVPTINAHPSKYDYNYWGQGTQVTVSS,FTFDDYR,WVSSIDSWSINTY,AAEDRLGVPTINAHPSKYDYNY,20.0,WVSSIDSWSINTY,AAEDRLGVPTI------NAHPSKYDYNY,FTFDDYRWVSSIDSWSINTYAAEDRLGVPTI------NAHPSKYDYNY,2.187638,1.5515549,1.6757785,-1.1105442,"7uie_I,7uie_C,7uie_B,7uie_E,7uie_G,7uia_B,7uia_E,7uib_B,7uib_E","Crystal structure of HcE-JLE-G6;Crystal structure of BoNT/E receptor binding domain in complex with SV2, VHH, and sialic acid;Crystal structure of BoNT/E receptor binding domain in complex with SV2 and VHH"
KVQLQESGGGLVQVGGSLRLSCKASGFTFRSSAMGWYRRAPGKQRELVASLTTTGTADYGDFVKGRFTISRDNAENTVDLHMNSLKPEDTAVYYCHEDPYGMESLRYWGQGTQVTVSS,FTFRSSA,LVASLTTTGTAD,HEDPYGMESLRY,18.0,LVASLT-TTGTAD,HEDPYG----------------MESLRY,FTFRSSALVASLT-TTGTADHEDPYG----------------MESLRY,0.17353663,0.26832563,1.4720544,-2.2455962,"4w2q_A,4w2q_C,4w2q_E,4w2q_G,4w2p_A,4w2p_C,4w2p_B,4w2p_D",Anti-Marburgvirus Nucleoprotein Single Domain Antibody C Complexed with Nucleoprotein C-terminal domain;Anti-Marburgvirus Nucleoprotein Single Domain Antibody C
KVQLQESGGGLVQAGGSLRLSCAASGGTFSINTLGWYRRAPGKEREFVARISSGGITRYADSVKGRFTISRDNGKNTVYLDMNSLKPEDTAVYYCMYRNWGGGLDVYWGQGTQVTVSS,GTFSINT,FVARISSGGITR,MYRNWGGGLDVY,13.0,FVARIS-SGGITR,MYRNWG----------------GGLDVY,GTFSINTFVARIS-SGGITRMYRNWG----------------GGLDVY,1.2731584,2.0512109,1.6474999,-1.682862,"4w2o_A,4w2o_C,4w2o_E,4w2o_G,6apq_A",Anti-Marburgvirus Nucleoprotein Single Domain Antibody B;Anti-Marburgvirus Nucleoprotein Single Domain Antibody B Complexed with Nucleoprotein C-terminal domain
QVQLQESGGGLVQAGGSLRLSCAASGGTFKSGGMAWFRQAPGKAREFAAGISWSGGSTDYEDSVKGRFTISRDNAKNTMYLQMNSLKPEDTAVYYCAAARRFRAGVVTRADDVDYWGKGTQVTVSS,GTFKSGG,FAAGISWSGGSTD,AAARRFRAGVVTRADDVDY,14.0,FAAGISWSGGSTD,AAARRFRAG---------VVTRADDVDY,GTFKSGGFAAGISWSGGSTDAAARRFRAG---------VVTRADDVDY,0.764278,1.1046987,-1.7291665,-2.4150302,6xyf_A,Nanobody 22
QVQLQESGGGLVQAGGSLRLSCAASGGTFKSGGMAWFRQADTNNDGWIEGDELKAREFAAGISWSGGSTDYEDSVKGRFTISRDNAKNTMYLQMNSLKPEDTAVYYCAAARRFRAGVVTRADDVDYWGKGTQVTVSS,GTFKSGG,FAAGISWSGGSTD,AAARRFRAGVVTRADDVDY,27.0,FAAGISWSGGSTD,AAARRFRAG---------VVTRADDVDY,GTFKSGGFAAGISWSGGSTDAAARRFRAG---------VVTRADDVDY,0.764278,1.1046987,-2.1005344,-2.8252847,"6xym_A,6xym_B",Nbe-LBM
QVQLQESGGGLVQAGGSLRLSCAASGSIFSLNDMGWYRQAPGKLRELVAAITSGGSTKYADSVKGRFTISRDNAKNTVYLQMNSLKAEDTAVYYCNAKVAGTFSIYDYWGQGTQVTVSS,SIFSLND,LVAAITSGGSTK,NAKVAGTFSIYDY,10.0,LVAAIT-SGGSTK,NAKVAG---------------TFSIYDY,SIFSLNDLVAAIT-SGGSTKNAKVAG---------------TFSIYDY,2.0215373,3.092785,-0.83123606,-1.5609283,"5jqh_C,5jqh_D","Structure of beta2 adrenoceptor bound to carazolol and inactive-state stabilizing nanobody, Nb60"
QVQLVESGGGLVQAGDSLRLSCAASGLTFNRYNMGWFRQAPGREREFVASISWSGDRTYGTDSVKGRFAISRDNAKNTMYLQMNSLKPEDTAVYYCAADRFLTRSVKYDYWGQGTQVTVSS,LTFNRYN,FVASISWSGDRTY,AADRFLTRSVKYDY,14.0,FVASISWSGDRTY,AADRFLT--------------RSVKYDY,LTFNRYNFVASISWSGDRTYAADRFLT--------------RSVKYDY,0.277724,2.2182689,0.07644437,0.71734357,"5lmw_A,6gzp_A",Llama nanobody PorM_02 structure determined at room temperature by in-situ diffraction in ChipX microfluidic device;Llama nanobody PorM_02
QVQLVESGGGLVQAGGSLRLSCTASGRTFSDYDMAWFRQAPGKERDRVSAISTKGGSTWYHDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAGAVTYYSARYEYDYWGQGTQVTVSS,RTFSDYD,RVSAISTKGGSTW,AAGAVTYYSARYEYDY,12.0,RVSAISTKGGSTW,AAGAVTYY------------SARYEYDY,RTFSDYDRVSAISTKGGSTWAAGAVTYY------------SARYEYDY,1.9160136,0.24035835,-1.7171744,0.74149126,"5lmj_A,5lmj_C,5lmj_B,5lmj_D",Llama nanobody PorM_19
EVQLVESGGGLVQPGGSLRLSCAASGFTFSTSWMYWLRQAPGKGLEWVSVINTDGGTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDWGGPEPTRGQGTLVTVSS,FTFSTSW,WVSVINTDGGTY,AKDWGGPEPT,19.0,WVSVIN-TDGGTY,AKDWG------------------GPEPT,FTFSTSWWVSVIN-TDGGTYAKDWG------------------GPEPT,1.0252331,0.21536708,-5.3479567,-3.0018313,6cnw_A,STRUCTURE OF HUMANIZED SINGLE DOMAIN ANTIBODY SD84
AVQLQASGGGLVQAGDSLRLSCAASGGTFSHYAVGWFRQAPGKEREFVAAISWSGRSTSFANSVKGRFTISRDSAKNTAYLQMNNLKPEDTAVYCCAPARFGTGSAARDEYDDCGQGTQVTVSS,GTFSHYA,FVAAISWSGRSTS,APARFGTGSAARDEYDD,20.0,FVAAISWSGRSTS,APARFGTG-----------SAARDEYDD,GTFSHYAFVAAISWSGRSTSAPARFGTG-----------SAARDEYDD,0.21529946,-0.19470662,-2.2350595,-2.4071352,"8ce4_I,8ce4_H,8ce4_J,8ce4_G,8ce4_F,8ci1_I,8ci1_H,8ci1_J,8ci1_G,8ci1_F",Human alpha7 nicotinic receptor in complex with the E3 nanobody;Human alpha7 nicotinic receptor in complex with the E3 nanobody and nicotine
QVQLVESGGGLVQAGGSLRLACAASGRIFSSDTLAWFRRAPGKEREFVAASRWSGGGTDYDSVKGRFTFSRDNTFNTMCLEMNSLKPEDTAVYYCALRTARDSYYYTRNPTGYDYWGQGTQVTVSS,RIFSSDT,FVAASRWSGGGT,ALRTARDSYYYTRNPTGYDY,20.0,FVAASR-WSGGGT,ALRTARDSYY--------YTRNPTGYDY,RIFSSDTFVAASR-WSGGGTALRTARDSYY--------YTRNPTGYDY,1.0116559,0.33035463,-1.9425671,-3.008455,8snc_C,Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer
QVQLVESGGGLVQAGGSLKVSCAASGRAFKTYRMAWFRQAPGKEREFVSGISALETTYYADSVKGRFTISRDNTKNTVSLQMDSLKPEDTAVYYCAARRYGGTDYTTTGSYDYWGQGTQVTVSS,RAFKTYR,FVSGISALETTY,AARRYGGTDYTTTGSYDY,14.0,FVSGIS-ALETTY,AARRYGGTD----------YTTTGSYDY,RAFKTYRFVSGIS-ALETTYAARRYGGTD----------YTTTGSYDY,3.0472841,2.235621,0.019304857,0.10968417,"8snc_B,8sne_B,8snd_B,7sp6_B,7sp7_B,7sp8_B,7sp9_B,7spa_B","Chlorella virus Hyaluronan Synthase bound to UDP-GlcNAc;Chlorella virus Hyaluronan Synthase in the GlcNAc-primed, channel-open state;Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer and UDP;Chlorella virus hyaluronan synthase;Chlorella virus hyaluronan synthase inhibited by UDP;Chlorella virus Hyaluronan Synthase bound to GlcNAc primer and UDP-GlcA;Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer;Chlorella virus Hyaluronan Synthase in the GlcNAc-primed channel-closed state"
QVQLVESGGGLVQAGGSLRLSCAASGFPVSSSTMTWYRQAPGKEREWVAAINSYGYYTVYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDTGQMRESYDYWGQGTQVTVSA,FPVSSST,WVAAINSYGYYTV,NVKDTGQMRESYDY,9.0,WVAAINSYGYYTV,NVKDTGQ--------------MRESYDY,FPVSSSTWVAAINSYGYYTVNVKDTGQ--------------MRESYDY,2.8249252,1.8791617,-0.7333424,1.1741393,6tej_C,Structure of apo IrtAB devoid SID in complex with sybody Syb_NL5
QVQLVESGGGSVQPGESLRLSCQASGRIVDVNDMAWYRQAPGKQRELVARIARGGSTHYGDSAWGRFTISRDNTRNTVYLQMTSLNVEDTAVYYCNGEVKVGTRLSPFRTYWGRGTQVTVSS,RIVDVND,LVARIARGGSTH,NGEVKVGTRLSPFRTY,22.0,LVARIA-RGGSTH,NGEVKVGT------------RLSPFRTY,RIVDVNDLVARIA-RGGSTHNGEVKVGT------------RLSPFRTY,2.5960567,2.4075623,0.45748204,1.3624444,8sne_C,Chlorella virus Hyaluronan Synthase bound to GlcA extended GlcNAc primer and UDP
QVQLVESGGGLVQAGGSLRLACAASGRIFSSDTLAWFRRAPGKEREFVAASRWSGGGTDYADSVKGRFTFSRDNTFNTMCLEMNSLKPEDTAVYYCALRTARDSYYYTRNPTGYDYWGQGTQVTVSS,RIFSSDT,FVAASRWSGGGTD,ALRTARDSYYYTRNPTGYDY,18.0,FVAASRWSGGGTD,ALRTARDSYY--------YTRNPTGYDY,RIFSSDTFVAASRWSGGGTDALRTARDSYY--------YTRNPTGYDY,1.2090616,-0.11937752,-1.3516204,-3.058501,8snd_C,Chlorella virus Hyaluronan Synthase bound to GlcNAc primer and UDP-GlcA
EVQLLESGGGLVQPGGSLRLSCAASGFRFDAEDMGWVRQAPGKGLEWVSSIYGPSGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKYTSPPQNHGFDYWGQGTLVTVSS,FRFDAED,WVSSIYGPSGSTY,AKYTSPPQNHGFDY,18.0,WVSSIYGPSGSTY,AKYTSPP--------------QNHGFDY,FRFDAEDWVSSIYGPSGSTYAKYTSPP--------------QNHGFDY,3.430528,2.4648414,-0.64702004,-2.8423727,"4u3x_A,4u3x_C,4pgj_A,4pgj_C",Human heavy-chain domain antibody in complex with hen egg-white lysozyme;Structure of a human VH antibody domain binding to the cleft of hen egg lysozyme
QVQLQESGGGLVQAGGSLRLSCKASGIIFSVYKMTWYRQAPGKERELVALITTNNNTMTVDSVKGRFTISRDNVQNTVYLEMNNLKPEDTAVYYCNANRGLAGPAYWGQGTQVTVSS,IIFSVYK,LVALITTNNNTM,NANRGLAGPAY,16.0,LVALIT-TNNNTM,NANRG-----------------LAGPAY,IIFSVYKLVALIT-TNNNTMNANRG-----------------LAGPAY,0.95430696,-0.4651202,3.3698604,2.8524103,4eig_B,CA1698 camel antibody fragment in complex with DHFR
QVQLVESGGGLVQVGGSLRLSCVVSGSDISGIAMGWYRQAPGKRREMVADIFSGGSTDYAGSVKGRFTISRDNAKKTSYLQMNNVKPEDTGVYYCRLYGSGDYWGQGTQVTVSS,SDISGIA,MVADIFSGGSTD,RLYGSGDY,17.0,MVADIF-SGGSTD,RLYG--------------------SGDY,SDISGIAMVADIF-SGGSTDRLYG--------------------SGDY,1.8291342,2.0598555,-1.4496539,-2.7074578,"6ui1_B,6ul6_C","Crystal structure of BoNT/A-LCHn domain in complex with VHH ciA-D12, ciA-B5, and ciA-H7;Crystal Structure of BoNT/A-LCHn domain in complex with VNA ciA-D12/11/ciA-B5 and VHH ciA-H7"
QVTLKESGGGLVQPGGSLRLSCAASGGISRVNVAGWYRQAPGQQREMVAVIRSGGRINYADFVKGRFTFSRDDAKQTIYLQMDNLKSEDTAVYYCYGSLLETGTFQYREYWGQGTQVTVSS,GISRVNV,MVAVIRSGGRIN,YGSLLETGTFQYREY,21.0,MVAVIR-SGGRIN,YGSLLET-------------GTFQYREY,GISRVNVMVAVIR-SGGRINYGSLLET-------------GTFQYREY,0.5768189,0.9991113,-0.25321507,1.3397608,"8fif_A,8fif_C,8fif_B",A2.3 Nanobody In Complex With Microcystin-LR
AVQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSGDKSDYTDSVKGRFTISRDNAKNTMYLQMNNLKPEDTATYYCARGLGIYIIRARGGYDHWGQGTQVTVSS,RTFSSYN,FVASITSSGDKSD,ARGLGIYIIRARGGYDH,16.0,FVASITSSGDKSD,ARGLGIYI-----------IRARGGYDH,RTFSSYNFVASITSSGDKSDARGLGIYI-----------IRARGGYDH,0.070333086,-0.6885049,-2.3423433,-2.8121483,4kml_B,Probing the N-terminal beta-sheet conversion in the crystal structure of the full-length human prion protein bound to a Nanobody
VQLQESGGCLVQAGGSLRLSCAASGSTFSTYTIGWFRQAPGKEREFVAAIHWDGGQTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARGRRYFDFTYSDVYDYWGQGTQVTVS,STFSTYT,FVAAIHWDGGQTY,AARGRRYFDFTYSDVYDY,13.0,FVAAIHWDGGQTY,AARGRRYFD----------FTYSDVYDY,STFSTYTFVAAIHWDGGQTYAARGRRYFD----------FTYSDVYDY,1.0235614,1.28979,0.0016863197,0.6748896,"6h15_C,6h15_D",Structure of LRP6 P3E3P4E4 in complex with VHH L-P2-B10
EVQLQESGGGLVQAGGSLRLSCAASGRTFSIYTIGWFRQAPGKEREFVAEITWSGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAITYTRGIYKYWGQGTQVTVSS,RTFSIYT,FVAEITWSGGSTY,AAITYTRGIYKY,11.0,FVAEITWSGGSTY,AAITYT----------------RGIYKY,RTFSIYTFVAEITWSGGSTYAAITYT----------------RGIYKY,-0.27763644,-2.316052,-2.4803743,2.1242073,6h16_B,Structure of LRP6 P3E3P4E4 in complex with VHH L-P2-D07
QVQLQESGGGLVQAGGSLRLSCEASGLTFSNYAMAWFRQAPEKEREFVAGISWTGSRTYYADSVRGRFTTSRDGHKNTVYLQMNDLKPEDTAVYLCAADLLGSGKDGTSVYEYWGQGTQVTVSS,LTFSNYA,FVAGISWTGSRTY,AADLLGSGKDGTSVYEY,18.0,FVAGISWTGSRTY,AADLLGSG-----------KDGTSVYEY,LTFSNYAFVAGISWTGSRTYAADLLGSG-----------KDGTSVYEY,0.47419456,1.1545404,-1.2271166,-3.0917392,"7aqz_C,7aqz_D",Co-Crystal Structure of Variant Surface Glycoprotein VSG2 in complex with Nanobody VSG2(NB14)
QVQLQESGGGLVQAGGSLTLSCAVSGLTFSNYAMGWFRQAPGKEREFVAAITWDGGNTYYTDSVKGRFTISRDNAKNTVFLQMNSLKPEDTAVYYCAAKLLGSSRYELALAGYDYWGQGTQVTVSS,LTFSNYA,FVAAITWDGGNTY,AAKLLGSSRYELALAGYDY,13.0,FVAAITWDGGNTY,AAKLLGSSR---------YELALAGYDY,LTFSNYAFVAAITWDGGNTYAAKLLGSSR---------YELALAGYDY,0.9427581,2.0224757,1.0275669,2.47007,"7aqy_C,7aqy_D",Co-Crystal Structure of Variant Surface Glycoprotein VSG2 in complex with Nanobody VSG2(NB11)
QVQLQESGGGLVQAGGSLRLSCTTSGLTFSNYAFSWFRQAPGEEREFVGAISWSGGRTDYADSVKGRFTISRDNAKNTFYLQMNSLKTEDTAVYYCAADLLGEGSRRSEYEYWGQGTQVTVSS,LTFSNYA,FVGAISWSGGRTD,AADLLGEGSRRSEYEY,16.0,FVGAISWSGGRTD,AADLLGEG------------SRRSEYEY,LTFSNYAFVGAISWSGGRTDAADLLGEG------------SRRSEYEY,0.48365602,1.2637995,0.53195864,1.1656649,"7aqx_C,7aqx_D",Co-Crystal Structure of Variant Surface Glycoprotein VSG2 in complex with Nanobody VSG2(NB9)
QVQLVESGGGLVQPGGRLRLSCAASGFTFRTYAMQWYRQSPGTERELVAAISNIGGVTDYGDSVKGRFTISRDNAKTTVYLEMNSLKPEDTATYYCSAVRLPQRYWGRGTQVTVSS,FTFRTYA,LVAAISNIGGVTD,SAVRLPQRY,17.0,LVAAISNIGGVTD,SAVR-------------------LPQRY,FTFRTYALVAAISNIGGVTDSAVR-------------------LPQRY,0.25248656,1.6806079,0.613503,2.424062,"7aqg_B,6gwn_B,6gwp_B,6gwq_B","Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-W175F) in Complex with Two Inhibitory Nanobodies (VHH-2g-42, VHH-2w-64);Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-stab) in Complex with an Inhibitory Nanobody (VHH-2g-42);Crystal Structure of Small Molecule Inhibitor TM5484 Bound to Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-W175F);Crystal Structure of Stabilized Active Plasminogen Activator Inhibitor-1 (PAI-1-stab) in Complex with Two Inhibitory Nanobodies (VHH-2g-42, VHH-2w-64)"
QVQLQESGGGLVQAGGSLRLSCAASGRTFNSAVMGWFRQAPGKERQFVATIDWSGEYTYYADSVKGRFTISRDNAKNTVYLQMTSLKPEDTALYYCAARLTLGQFDYWGQGTQVTVSS,RTFNSAV,FVATIDWSGEYTY,AARLTLGQFDY,12.0,FVATIDWSGEYTY,AARLT-----------------LGQFDY,RTFNSAVFVATIDWSGEYTYAARLT-----------------LGQFDY,2.1336174,3.3306785,-1.6422166,1.5700009,4ksd_B,Structures of P-glycoprotein reveal its conformational flexibility and an epitope on the nucleotide-binding domain
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCASYQATRSLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,ASYQATRSLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,ASYQATRSLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYASYQATRSLL--------SDYATWPYDY,-0.30720034,-0.23578733,-3.2546432,1.11848,"7z1c_E,7z1c_F,7z85_E,7z85_D,7z85_F",Nanobody H11-B5 and H11-F2 bound to RBD;CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-B5 nanobody complex
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCARTEYVSYLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,ARTEYVSYLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,ARTEYVSYLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYARTEYVSYLL--------SDYATWPYDY,-2.525563,-1.9049634,-3.714272,0.094165385,"7z1e_FFF,7z9r_Y,7z9r_X,7z9r_Z,7z86_Y,7z86_X,7z86_Z",Nanobody H11-H4 Q98R H100E bound to RBD;CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 2Up1Down conformation;CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-H4 Q98R H100E nanobody complex in 1Up2Down conformation
QVKLEESGGGSVQTGGSLRLTCAASGRTSRSYGMGWFRQAPGKEREFVSGISWRGDSTGYADSVKGRFTISRDNAKNTVDLQMNSLKPEDTAIYYCAAAAGSAWYGTLYEYDYWGQGTQVTVSS,RTSRSYG,FVSGISWRGDSTG,AAAAGSAWYGTLYEYDY,15.0,FVSGISWRGDSTG,AAAAGSAW-----------YGTLYEYDY,RTSRSYGFVSGISWRGDSTGAAAAGSAW-----------YGTLYEYDY,0.81053036,1.159732,1.8567836,0.41875404,"4krm_B,4krm_D,4krm_F,4krm_H,4krm_J,4krm_L,4krl_B","Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 3.5;Nanobody/VHH domain 7D12 in complex with domain III of the extracellular region of EGFR, pH 6.0"
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSFVMGWFRQAPGKEREFVASISRSGSVTRYADSAKGRFTISKDNAKNTVSLQMDNLNPDDTAVYYCAADLHRPYGPGSQRTDDYDTWGQGTQVTVSS,RTFSSFV,FVASISRSGSVTR,AADLHRPYGPGSQRTDDYDT,16.0,FVASISRSGSVTR,AADLHRPYGP--------GSQRTDDYDT,RTFSSFVFVASISRSGSVTRAADLHRPYGP--------GSQRTDDYDT,0.33042178,-0.5554652,-1.5593431,0.16712356,"6h1f_A,4s10_A,4s10_B,4s11_A",Structure of the nanobody-stabilized gelsolin D187N variant (second domain);Gelsolin nanobody shielding mutant plasma gelsolin from furin proteolysis
VQLAETGGGLVQAGGSLRLSCAASGTTFSKNAMAWFRQAPGKEREFVAGINWNAVSTNYADSVKGRFTVSRDNAKNTVYLQMNSLKPEDTAVYYCAGSSIYSDISGAATVWATSYNYWGQGTQVTVSS,TTFSKNA,FVAGINWNAVSTN,AGSSIYSDISGAATVWATSYNY,13.0,FVAGINWNAVSTN,AGSSIYSDISG------AATVWATSYNY,TTFSKNAFVAGINWNAVSTNAGSSIYSDISG------AATVWATSYNY,0.044453703,0.56871927,1.8049763,0.64190274,5e1h_B,Ricin toxin in complex with neutralizing single chain monoclonal antibodies (VHHs)
QVQLVESGGGLVQPGGSLRLSCVDSRSWINVYGANWYRQAPGKERELVAALTSGGTTNYADSVKGRFTISRDNAKNTVYLQMRDLKPEDTAVYYCNLERYTGSSVYPWGQGTQVTVSS,SWINVYG,LVAALTSGGTTN,NLERYTGSSVYP,15.0,LVAALT-SGGTTN,NLERYT----------------GSSVYP,SWINVYGLVAALT-SGGTTNNLERYT----------------GSSVYP,0.8687916,1.4024223,2.125401,1.5822446,"7z1x_B,7z1x_E",Crystal structure of human Gasdermin D complexed with nanobodies VHH-2 and VHH-6
QVQLVETGGGLVQPGGSLRLSCTASGFIFSANQMNWVRQAPGKGLEWLSGISTRGDTTSYADSVKGRFTISRDNAKNTLYLQMNSLQPDDTAVYFCARVCIRGPEPKLRCDDWGQGTQVTVSS,FIFSANQ,WLSGISTRGDTTS,ARVCIRGPEPKLRCDD,18.0,WLSGISTRGDTTS,ARVCIRGP------------EPKLRCDD,FIFSANQWLSGISTRGDTTSARVCIRGP------------EPKLRCDD,0.25560948,0.69456065,-4.0601645,-2.5771072,"7z1x_C,7z1x_F",Crystal structure of human Gasdermin D complexed with nanobodies VHH-2 and VHH-6
QVQLVESGGGLVQPGGSLRLSCAASGFTNDFYSIAWFRQAPGKEREGVSWLSVSDNTPTYVDSVKDRFTISRHNANNTVYLQMNMLKPEDTAIYYCAAGRFAGRDTWPSSYDYWGQGTQVTVSS,FTNDFYS,GVSWLSVSDNTPT,AAGRFAGRDTWPSSYDY,17.0,GVSWLSVSDNTPT,AAGRFAGR-----------DTWPSSYDY,FTNDFYSGVSWLSVSDNTPTAAGRFAGR-----------DTWPSSYDY,1.079842,1.4698263,2.7740443,3.114931,"7zxu_A,8cii_C,7zfb_M,7zfb_N,7oaq_AAA,7oap_AAA,8c3v_I,8c3v_K,8c3v_J,7zfe_Y,7zfe_X,7zfe_Z,7zfe_W,7zfc_M,8bh5_C","SARS-CoV-2 Delta-RBD complexed with BA.2-13 Fab and C1 nanobody;Nanobody H3 AND C1 bound to RBD with Kent mutation;SARS-CoV-2 Beta RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs;SARS-CoV-2 Omicron BA.4/5 RBD in complex with Beta-27 Fab and C1 nanobody;SARS-CoV-2 Omicron RBD in complex with Omi-32 Fab and nanobody C1;Delta-RBD complex with BA.2-07 fab, SARS1-34 fab and C1 nanobody;SARS-CoV-2 BA.2.12.1 RBD in complex with Beta-27 Fab and C1 nanobody;Nanobody H3 AND C1 bound to RBD;SARS-CoV-2 Omicron RBD in complex with nanobody C1, Omi-18 and Omi-31 Fabs"
QVQLVESGGGLVQAGGSLRLSCAASGFPVKRWSMTWYRQAPGKEREWVAAIRSAGHWTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGDFSYWYDYWGQGTQVTVSA,FPVKRWS,WVAAIRSAGHWTH,NVKDEGDFSYWYDY,9.0,WVAAIRSAGHWTH,NVKDEGD--------------FSYWYDY,FPVKRWSWVAAIRSAGHWTHNVKDEGD--------------FSYWYDY,1.0037099,0.6830169,-1.2640755,1.2001562,"6i6j_C,8apy_C",Crystal structure of the KDEL receptor bound to synthetic nanobody.;Crystal structure of the H12A variant of the KDEL receptor bound to sybody
QVQLVESGGRLVQAGDSLRLSCAASGRTFTTYLMGWFRQAPGKEREFVAAIRWSGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKLEDTAVYYCAAAARPSYSGDYGYTEALRYDYWGQGTQVTVSS,RTFTTYL,FVAAIRWSGGSTY,AAAARPSYSGDYGYTEALRYDY,11.0,FVAAIRWSGGSTY,AAAARPSYSGD------YGYTEALRYDY,RTFTTYLFVAAIRWSGGSTYAAAARPSYSGD------YGYTEALRYDY,1.0756148,0.5209592,-4.4902954,-0.056748927,5gxb_B,crystal structure of a LacY/Nanobody complex
QWQLVESGGGLVQAGGSLRLSCVGSGRAFSSGAMGWFRQTPGQEREFVAAISWSGGSTVYAESVKGRFTISMDNAKNTVYLRMNSLQPEDTAVYYCAAGTSTFALRRSPEYWGKGTPVTVSS,RAFSSGA,FVAAISWSGGSTV,AAGTSTFALRRSPEY,19.0,FVAAISWSGGSTV,AAGTSTF-------------ALRRSPEY,RAFSSGAFVAAISWSGGSTVAAGTSTF-------------ALRRSPEY,1.2906139,0.53671986,0.39939743,0.7943782,8ont_B,Structure of Setaria italica NRAT in complex with a nanobody
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYHMSWVRQAPGKGLEWISVINDSGDLTRYADSVKGRFTISRDNAKNTLYLQMNSLQPEDTAVYSCLKSSDFYSYSNADSRGQGTQVTVSS,FTFSSYH,WISVINDSGDLTR,LKSSDFYSYSNADS,17.0,WISVINDSGDLTR,LKSSDFY--------------SYSNADS,FTFSSYHWISVINDSGDLTRLKSSDFY--------------SYSNADS,-0.6190011,-0.78022945,-3.9927113,-2.8315597,7b2p_D,Cryo-EM structure of complement C4b in complex with nanobody B5
VTTSKPSLRLSCAASGRTFSTAAMGWFRQAPGKERDFVAGIYWTVGSTYYADSAKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAARRRGFTLAPTRANEYDYWGQGTQVTVSS,RTFSTAA,FVAGIYWTVGSTY,AARRRGFTLAPTRANEYDY,28.0,FVAGIYWTVGSTY,AARRRGFTL---------APTRANEYDY,RTFSTAAFVAGIYWTVGSTYAARRRGFTL---------APTRANEYDY,0.6621596,-0.26496154,-1.6071918,0.4262908,"6xvi_A,6xvi_C,6xvi_B,6xvi_D",Crystal structure of Megabody Mb-Nb207-c7HopQ_A12
DVQLVESGGGSVQAGESLRLSCAASGVTYKNYCIGWFRQAPGKDREGVVFINSDGGITYYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTASYYCAAGYRNYGQCATRYWGQGTQVTVSS,VTYKNYC,GVVFINSDGGITY,AAGYRNYGQCATRY,15.0,GVVFINSDGGITY,AAGYRNY--------------GQCATRY,VTYKNYCGVVFINSDGGITYAAGYRNY--------------GQCATRY,3.9661162,3.5961156,-2.6039314,-3.2608426,1zv5_A,Crystal structure of the variable domain of the camelid heavy-chain antibody D2-L29 in complex with hen egg white lysozyme
EVQLVESGGGLVQAGGSLRLSCAASGSDFSANAVGWYRQAPGKQRVVVASISSTGNTKYSNSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCWLFRFGIENYWGQGTQVTVSS,SDFSANA,VVASISSTGNTK,WLFRFGIENY,13.0,VVASIS-STGNTK,WLFRF------------------GIENY,SDFSANAVVASIS-STGNTKWLFRF------------------GIENY,1.9963113,0.25879836,-0.88723177,0.80513245,7b2m_D,Cryo-EM structure of complement C4b in complex with nanobody E3
QVQLVESGGGLVRPGGSLRLSCVGSGFTFSGYAMNWYRQAPGKALELVAGISNAGDLTHYEEPMKGRVAISRANDKNTVYLQMDDLKPEDTAVYRCHAPGVRVGTGERKDVWGQGAQVTVSS,FTFSGYA,LVAGISNAGDLTH,HAPGVRVGTGERKDV,26.0,LVAGISNAGDLTH,HAPGVRV-------------GTGERKDV,FTFSGYALVAGISNAGDLTHHAPGVRV-------------GTGERKDV,1.5322405,1.2536691,-1.8452446,-1.4880145,"7b27_CCC,7b27_DDD",RBD domain SARS-CoV2 in complex with neutralizing nanobody NM1230
DVQLVESGGGSVQAGGSLRLSCAASGYIASINYLGWFRQAPGKEREGVAAVSPAGGTPYYADSVKGRFTVSLDNAENTVYLQMNSLKPEDTALYYCAAARQGWYIPLNSYGYNYWGQGTQVTVSS,YIASINY,GVAAVSPAGGTPY,AAARQGWYIPLNSYGYNY,15.0,GVAAVSPAGGTPY,AAARQGWYI----------PLNSYGYNY,YIASINYGVAAVSPAGGTPYAAARQGWYI----------PLNSYGYNY,0.94102484,1.0496927,1.062739,-0.13644606,1zvh_A,Crystal structure of the VHH domain D2-L24 in complex with hen egg white lysozyme
VTTSKSSLRLSCAASGRTFSTAAMGWFRQAPGKERDFVAGIYWTVGSTYYADSAKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAARRRGFTLAPTRANEYDYWGQGTQVTVSS,RTFSTAA,FVAGIYWTVGSTY,AARRRGFTLAPTRANEYDY,28.0,FVAGIYWTVGSTY,AARRRGFTL---------APTRANEYDY,RTFSTAAFVAGIYWTVGSTYAARRRGFTL---------APTRANEYDY,0.6621596,-0.26496154,-2.1557224,0.6208158,"6xv8_A,6xv8_C,6xv8_B,6xv8_D",Crystal structure of Megabody Mb-Nb207-c7HopQ_G10
DVQLVESGGGSVQAGGSLRLSCAASGSTDSIEYMTWFRQAPGKAREGVAALYTHTGNTYYTDSVKGRFTISQDKAKNMAYLRMDSVKSEDTAIYTCGATRKYVPVRFALDQSSYDYWGQGTQVTVSS,STDSIEY,GVAALYTHTGNTY,GATRKYVPVRFALDQSSYDY,23.0,GVAALYTHTGNTY,GATRKYVPVR--------FALDQSSYDY,STDSIEYGVAALYTHTGNTYGATRKYVPVR--------FALDQSSYDY,1.1622694,1.5687023,-4.14743,-2.88144,"1zvy_A,6jb8_A,6jb9_A",Crystal structure of nanobody D3-L11 in complex with hen egg-white lysozyme;Crystal structure of nanobody D3-L11 (unbound form);Crystal structure of the VHH D3-L11 in complex with hen egg white lysozyme
QVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVSS,FPVNRYS,WVAGMSSAGDRSS,NVNVGFEY,13.0,WVAGMSSAGDRSS,NVNV--------------------GFEY,FPVNRYSWVAGMSSAGDRSSNVNV--------------------GFEY,0.414263,1.3943044,1.8598514,3.493586,"3ogo_H,3ogo_E,3ogo_G,3ogo_F,3k1k_C,3k1k_D,8xo9_A,8xoa_A,8xob_A,7v0v_A",GFP Nanobody NMR Structure;VMAT2 complex with MPP+;Structure of the GFP:GFP-nanobody complex at 2.8 A resolution in spacegroup P21212;VMAT2 protonated state;VMAT2 complex with noradrenaline in cytosol-facing state;Green fluorescent protein bound to enhancer nanobody
QVQLVESGGGLVQAGGSLRLSCAASGFPVDSQFMHWYRQAPGKEREWVAAIESYGDETYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRVLVGWGYYGQGTQVTVSA,FPVDSQF,WVAAIESYGDETY,RVLVGWGY,10.0,WVAAIESYGDETY,RVLV--------------------GWGY,FPVDSQFWVAAIESYGDETYRVLV--------------------GWGY,2.0367692,1.1180073,-1.8237815,2.5191948,7ngh_D,Structure of glutamate transporter homologue in complex with Sybody
DVQLQESGGGSVQAGGSLRLSCAASGDTFSSYSMAWFRQAPGKECELVSNILRDGTTTYAGSVKGRFTISRDDAKNTVYLQMVNLKSEDTARYYCAADSGTQLGYVGAVGLSCLDYVMDYWGKGTQVTVSS,DTFSSYS,LVSNILRDGTTT,AADSGTQLGYVGAVGLSCLDYVMDY,20.0,LVSNIL-RDGTTT,AADSGTQLGYVG---AVGLSCLDYVMDY,DTFSSYSLVSNIL-RDGTTTAADSGTQLGYVG---AVGLSCLDYVMDY,1.3951815,1.96342,0.63506705,1.512892,3g9a_B,Green fluorescent protein bound to minimizer nanobody
QVQLQESGGGLVQPGGSLRLSCAASGRTFSSYAMGWFRQAPGKQREFVAAIRWSGGYTYYTDSVKGRFTISRDNAKTTVYLQMNSLKPEDTAVYYCAATYLSSDYSRYALPQRPLDYDYWGQGTQVTVSS,RTFSSYA,FVAAIRWSGGYTY,AATYLSSDYSRYALPQRPLDYDY,13.0,FVAAIRWSGGYTY,AATYLSSDYSR-----YALPQRPLDYDY,RTFSSYAFVAAIRWSGGYTYAATYLSSDYSR-----YALPQRPLDYDY,-0.21806332,-0.67240906,-5.2946053,-0.19715732,"4kro_B,4krn_A",Nanobody/VHH domain EgA1;Nanobody/VHH domain EgA1 in complex with the extracellular region of EGFR
EVQLVESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGKEREFVVAINWSSGSTYYADSVKGRFTISRDNAKNTMYLQMNSLKPEDTAVYYCAAGYQINSGNYNFKDYEYDYWGQGTQVTVSS,RTFSSYA,FVVAINWSSGSTY,AAGYQINSGNYNFKDYEYDY,10.0,FVVAINWSSGSTY,AAGYQINSGN--------YNFKDYEYDY,RTFSSYAFVVAINWSSGSTYAAGYQINSGN--------YNFKDYEYDY,-0.20308769,0.5010062,-2.5290728,1.260076,4krp_B,Nanobody/VHH domain 9G8 in complex with the extracellular region of EGFR
QVQLVESGGGLVQAGGSLKLSCAASGFTFAHYAMVWFRQAPGKEREFVAGISWSGASTYYASSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYVAAARFGVGVDDDYSYWGQGTQVTVSS,FTFAHYA,FVAGISWSGASTY,AAARFGVGVDDDYSY,12.0,FVAGISWSGASTY,AAARFGV-------------GVDDDYSY,FTFAHYAFVAGISWSGASTYAAARFGV-------------GVDDDYSY,-1.3780339,-0.9467211,-2.7332954,1.6533964,"8c9x_I,8c9x_H,8c9x_J,8c9x_G,8c9x_F,8ci2_I,8ci2_G,8ci2_F,8cau_I,8cau_H,8cau_J,8cau_G,8cau_F",human alpha7 nicotinic receptor in complex with the C4 nanobody;human alpha7 nicotinic receptor in complex with the C4 nanobody and nicotine;human alpha7 nicotinic receptor in complex with the C4 nanobody under sub-saturating conditions
EVQLVESGGGLVQPGGSLRLSCAASGFTFDDYAMSWVRQAPGKGLEWIGRMYNNGRTSYNPSLKSLVTISRDNSKNTLYLQMNSLRAEDTATYYCARDNLGYRPSENLYGMDVWGQGTTVTVSS,FTFDDYA,WIGRMYNNGRTS,ARDNLGYRPSENLYGMDV,25.0,WIGRMY-NNGRTS,ARDNLGYRP----------SENLYGMDV,FTFDDYAWIGRMY-NNGRTSARDNLGYRP----------SENLYGMDV,1.8749393,-0.021540374,-1.2512736,-2.7451925,"7mjh_E,7mjh_D,7mjh_F,7mji_E",Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8;Cryo-EM structure of the SARS-CoV-2 N501Y mutant spike protein ectodomain bound to VH ab8 (focused refinement of RBD and VH ab8)
QVQLQESGGGLVQAGGSLRLSCAASGTIFEANIMGWYRQAPGKERELVAGIGYGSSTYYADSVKSRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAQNRDGWYFYYWGQGTQVTVSS,TIFEANI,LVAGIGYGSSTY,AAQNRDGWYFYY,9.0,LVAGIG-YGSSTY,AAQNRD----------------GWYFYY,TIFEANILVAGIG-YGSSTYAAQNRD----------------GWYFYY,2.9128838,1.6961039,-0.041902795,2.2472162,"8fxs_E,8fxs_D",Crystal structure of human pro-TGF-beta2 in complex with Nb9
QVQLQESGGGLVQAGGSLRLSCAASGYISNDDVMGWYRQAPGKEREFVAAISVGASTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAQSEGGYWFGYWGQGTQVTVSS,YISNDDV,FVAAISVGASTN,AAQSEGGYWFGY,8.0,FVAAIS-VGASTN,AAQSEG----------------GYWFGY,YISNDDVFVAAIS-VGASTNAAQSEG----------------GYWFGY,2.972219,2.3638988,2.5366561,3.0710876,8fxv_B,Crystal structure of human proTGF-beta2 in complex with Nb18
EVQLVESGGGLVQPGGSLRLSCAASGRTFSTNTMGWFRQAPGQEREFVALISGNGRILDYSDSAKGRFTISRDNAKNTVYLQMNSLKPEDTGVYFCAAEFRGRTLASYWGQGTQVTVSS,RTFSTNT,FVALISGNGRILD,AAEFRGRTLASY,15.0,FVALISGNGRILD,AAEFRG----------------RTLASY,RTFSTNTFVALISGNGRILDAAEFRG----------------RTLASY,2.0726154,1.5786029,1.6753863,1.0973284,8cml_A,Cryo-EM structure of complement C5 in complex with nanobodies UNbC5-1 and UNbC5-2
QVQLQESGGGLVQAGGSLRLSCAASERTFSSLGMGWFRQGPGKEREFAAAISWSGVSTYYADSVKGRFTISRDNDKNTVYLQMNSLKPDDTAVYYCAATSSWNDMALKSAGWYEYWGQGTQVTVSS,RTFSSLG,FAAAISWSGVSTY,AATSSWNDMALKSAGWYEY,13.0,FAAAISWSGVSTY,AATSSWNDM---------ALKSAGWYEY,RTFSSLGFAAAISWSGVSTYAATSSWNDM---------ALKSAGWYEY,0.50156736,0.6273889,-2.1727774,-0.6129764,7ar0_B,Co-Crystal Structure of Variant Surface Glycoprotein VSG2 in complex with Nanobody VSG2(NB19)
EVQLLQSGGDSVQAGGSLRLSCVGSLYSYCISAVSWYRQAPGKEREFVSWIHRDGTTSYADSVKGRFTISQDQPKNTVYLRMNSLKPEDTAMYYCKAETLPKFGRACRNADYWGQGTQVTVSS,YSYCISA,FVSWIHRDGTTS,KAETLPKFGRACRNADY,22.0,FVSWIH-RDGTTS,KAETLPKF-----------GRACRNADY,YSYCISAFVSWIH-RDGTTSKAETLPKF-----------GRACRNADY,1.308915,1.23644,0.4932875,2.1318514,"8irw_A,8irw_B",Structure of nanobody Nb9 against parathion
QVQLQESGGGSVQAGGSLRLSCAASGPTYSSYFMAWFRQAPGMEREGVAASSYDGSTTLYADSVKGRFTISQGNAKNTKFLLLNNLEPEDTAIYYCALRRRGWSNTSGWKQPGWYDYWGQGTQVTVSS,PTYSSYF,GVAASSYDGSTTL,ALRRRGWSNTSGWKQPGWYDY,21.0,GVAASSYDGSTTL,ALRRRGWSNT-------SGWKQPGWYDY,PTYSSYFGVAASSYDGSTTLALRRRGWSNT-------SGWKQPGWYDY,2.2088888,1.9102305,-0.22129281,-1.0666995,7e53_B,Crystal structure of sfGFP complexed with the nanobody nb2 at 2.2 Angstron resolution
QVQLVESGGGLVQAGGSLRLSCAASGSMFSDNVMGWYRQAPGKQRELVATIRTGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRHTIPVPSTPYDYWGQGTQVTVSS,SMFSDNV,LVATIRTGGSTN,RHTIPVPSTPYDY,8.0,LVATIR-TGGSTN,RHTIPV---------------PSTPYDY,SMFSDNVLVATIR-TGGSTNRHTIPV---------------PSTPYDY,2.2342064,1.1776655,1.3042347,0.30729854,"6v80_J,6v80_E",Crystal structure of human CD1d presenting alpha-Galactosylceramide in complex with NKT12 TCR and VHH nanobody 1D12
QVQLQESGGGLVQPGGSLRLSCAASGSGNSINVMGWYRQAPGKPRELVAEITSSGTTNYADSVKGRFSISRDNAKNTVPLQMNSLKPEDTAIYYCSAVLVRFGGLRRSYWGQGTQVTVSS,SGNSINV,LVAEITSSGTTN,SAVLVRFGGLRRSY,12.0,LVAEIT-SSGTTN,SAVLVRF--------------GGLRRSY,SGNSINVLVAEIT-SSGTTNSAVLVRF--------------GGLRRSY,1.5793344,1.5646961,-1.5532867,1.041502,"6rty_B,6rtw_B",Crystal structure of the Patched-1 (PTCH1) ectodomain in complex with nanobody NB64 and cholesterol-hemisuccinate;Crystal structure of the Patched ectodomain in complex with nanobody NB64
QVQLVESGGGLVQAGGSLRLSCVASGRTFSRYAMGWFRQAPGKEREFVAVIEWDGGTSYYVDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAGGNQYYSATYSIWNEYDFWGQGTQVTVSS,RTFSRYA,FVAVIEWDGGTSY,AAGGNQYYSATYSIWNEYDF,10.0,FVAVIEWDGGTSY,AAGGNQYYSA--------TYSIWNEYDF,RTFSRYAFVAVIEWDGGTSYAAGGNQYYSA--------TYSIWNEYDF,-1.0201827,-0.026962817,-2.5229585,0.7633365,7x2j_B,Crystal structure of nanobody Nb70 with SARS-CoV RBD
QVQLQESGGGLVQPGESLRLSCAASGSISTLNVMGWYRQAPGKQRELVAQITLDGSPEYADSVKGRFTITKDGAQSTLYLQMNNLKPEDTAVYFCKLENGGFFYYWGQGTQVTVST,SISTLNV,LVAQITLDGSPE,KLENGGFFYY,20.0,LVAQIT-LDGSPE,KLENG------------------GFFYY,SISTLNVLVAQIT-LDGSPEKLENG------------------GFFYY,1.7769135,2.2179494,0.74292547,0.2926728,7x2l_B,Crystal structure of nanobody 3-2A2-4 with SARS-CoV-2 RBD
EVQLQESGGGLVQAGGSLRLSCAASGSIFSGNAMGWYRQAPGKQREVVAVISAGNSSNYVDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVVKRGPQWGMEWGKGTLVTVSS,SIFSGNA,VVAVISAGNSSN,NVVKRGPQWGME,13.0,VVAVIS-AGNSSN,NVVKRG----------------PQWGME,SIFSGNAVVAVIS-AGNSSNNVVKRG----------------PQWGME,1.227029,1.1902074,2.710629,-0.34112102,"7r20_B,8qf5_A,8qf5_G",Anti-Arc nanobody E5;Complex between N-lobe of Arc and nanobody E5
QVQLQESGGGSVQTGGSLRLSCAASGYRYSDNCVGWFRQAPGREREAVATYNSGSSTWYADSVKGRFTISQDSAKSTVYLQMNNLKPEDTAMYYCAGRNRLGSYCYMTGDFAYWGQGTQVTVSS,YRYSDNC,AVATYNSGSSTW,AGRNRLGSYCYMTGDFAY,18.0,AVATYN-SGSSTW,AGRNRLGSY----------CYMTGDFAY,YRYSDNCAVATYN-SGSSTWAGRNRLGSY----------CYMTGDFAY,3.3403902,2.1518874,-0.22656353,1.2113154,7y58_B,"CryoEM structure of QacA (D411N), an antibacterial efflux transporter from Staphylococcus aureus"
QVQLVESGGGSVQAGGSLRLSCAASGDAGRRYCMAWFRQAPGKEREGVAFISTANGRTDYVDSVKGRFTISQNSAKNTVYLQMNSLKPEDTAMYYCASRGYGYLSCSSYSLAAYNYWGQGTQVTVSS,DAGRRYC,GVAFISTANGRTD,ASRGYGYLSCSSYSLAAYNY,15.0,GVAFISTANGRTD,ASRGYGYLSC--------SSYSLAAYNY,DAGRRYCGVAFISTANGRTDASRGYGYLSC--------SSYSLAAYNY,1.5466868,2.1473565,-2.1935732,-0.06827462,8rcq_B,Structural flexibility of Nucleoprotein of the Toscana virus in the presence of a nanobody.
DVQLVESGGGLVQPGGSLRLSCAASGEIASIIAIGWYRQAPGKQRESVALITRSGMITYGDSAQGRFTISRDDAKNTVYLHMDDLVPEDTAVYYCNAKKVSFGDYWGQGTQVTVSG,EIASIIA,SVALITRSGMIT,NAKKVSFGDY,20.0,SVALIT-RSGMIT,NAKKV------------------SFGDY,EIASIIASVALIT-RSGMITNAKKV------------------SFGDY,0.3352259,0.9681033,-0.80497956,0.6916202,8g0i_D,High Affinity nanobodies against GFP
QVQLQESGGGLVQPGGSLRLSCAASGSIYSLIAMGWYRQAPGKEHELVATISSGSTTYYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAYSDRLTDCSNCEADYWGQGTQVTVSH,SIYSLIA,LVATISSGSTTY,AAYSDRLTDCSNCEADY,13.0,LVATIS-SGSTTY,AAYSDRLT-----------DCSNCEADY,SIYSLIALVATIS-SGSTTYAAYSDRLT-----------DCSNCEADY,1.1890374,1.5588927,-2.0448408,2.6645455,"5f7l_B,5f7l_D",Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with Nanobody Nb-ER14
DVQLQESGGGLVQAGGSLRLSCAASGSISRFNAMGWWRQAPGKEREFVARIVKGFDPVLADSVKGRFTISIDSAENTLALQMNRLKPEDTAVYYCFAALDTAYWGQGTQVTVSS,SISRFNA,FVARIVKGFDPV,FAALDTAY,17.0,FVARIV-KGFDPV,FAAL--------------------DTAY,SISRFNAFVARIV-KGFDPVFAAL--------------------DTAY,1.9390836,0.16300762,1.164186,1.9509666,"5o2u_B,5o2u_D",Llama VHH in complex with p24
QVQLQESGGGLVQAGGSLRLSCAASGHTFNYPIMGWFRQAPGKEREFVGAISWSGGSTSYADSVKDRFTISRDNAKNTVYLEMNNLKPEDTAVYYCAAKGRYSGGLYYPTNYDYWGQGTQVTVSS,HTFNYPI,FVGAISWSGGSTS,AAKGRYSGGLYYPTNYDY,12.0,FVGAISWSGGSTS,AAKGRYSGG----------LYYPTNYDY,HTFNYPIFVGAISWSGGSTSAAKGRYSGG----------LYYPTNYDY,1.3112396,2.1092196,2.6971993,1.06708,"6a96_K,6a96_L,6a96_O,5o8f_K,5o8f_O,5ojm_K,5ojm_M,5ojm_L,5ojm_O,5ojm_N",Structure of a chimaeric beta3-alpha5 GABAA receptor in complex with nanobody Nb25 and pregnanolone;Structure of a chimaeric beta3-alpha5 GABAA receptor in complex with nanobody Nb25;Cryo-EM structure of the human alpha5beta3 GABAA receptor in complex with GABA and Nb25
VQLVESGGGLVQAGDSLRLSCAASGGTFSTFNMGWFRQDLGKEREFVAAIRWTGGRAYYGDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCARQGTNGGGYSEATSYNYWGQGTQVTVSS,GTFSTFN,FVAAIRWTGGRAY,ARQGTNGGGYSEATSYNY,13.0,FVAAIRWTGGRAY,ARQGTNGGG----------YSEATSYNY,GTFSTFNFVAAIRWTGGRAYARQGTNGGG----------YSEATSYNY,2.2785966,0.80381453,-2.0254376,-3.0770986,6c9w_B,Crystal Structure of a ligand bound LacY/Nanobody Complex
QVQLQESGGGLVQPGGSLRLSCAASGFAFSGYAMSWVRQAPGKGLEWVSGINRDGSTSYTAPVKGRFTISRDNAKNILYLQMNSLRPEDTAVYYCAKWLGGRDWYDRGQGTQVTVS,FAFSGYA,WVSGINRDGSTS,AKWLGGRDWYD,21.0,WVSGIN-RDGSTS,AKWLG-----------------GRDWYD,FAFSGYAWVSGIN-RDGSTSAKWLG-----------------GRDWYD,0.22384188,0.9960917,-4.3903484,-2.9605665,"3cfi_I,3cfi_C,3cfi_L,3cfi_F",Nanobody-aided structure determination of the EPSI:EPSJ pseudopilin heterdimer from Vibrio Vulnificus
GSLRLSCAASGFTFRSFGMSWVRQAPGKEPEWVSSISGSGSDTLYADSVKGRFTISRDNAKTTLYLQMNSLKPEDTAVYYCTIGGSLSRSSQGTQVTVSS,FTFRSFG,WVSSISGSGSDTL,TIGGSLSR,29.0,WVSSISGSGSDTL,TIGG--------------------SLSR,FTFRSFGWVSSISGSGSDTLTIGG--------------------SLSR,1.3908192,0.3719923,-3.2016284,-3.5616562,8oi2_B,Crystal structure of Alb1 megabody in complex with human serum albumin
VQLQESGGGLVQAGGSLRLSCAASGTIFSPHYMGWYRQAPGKEREFVAGIGFGTTTNYANSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARLYPILGHTYWGQGTQVTVSS,TIFSPHY,FVAGIGFGTTTN,AARLYPILGHTY,10.0,FVAGIG-FGTTTN,AARLYP----------------ILGHTY,TIFSPHYFVAGIG-FGTTTNAARLYP----------------ILGHTY,2.325899,2.4066014,1.8071525,1.3143353,"6c5w_C,6c5w_E",Crystal structure of the mitochondrial calcium uniporter
QVKLEESGGGLVQAGGSLRLSCSPSDRTFSAYAMGWFRQVPGREREFVATIRDSDASIYYTDSVKGRFTISRDNAKNTVYLQMNSLIPDDTAVYYCAARQYYSGRVYSTFREEYDYWGQGTQVTVSS,RTFSAYA,FVATIRDSDASIY,AARQYYSGRVYSTFREEYDY,18.0,FVATIRDSDASIY,AARQYYSGRV--------YSTFREEYDY,RTFSAYAFVATIRDSDASIYAARQYYSGRV--------YSTFREEYDY,-0.08952788,0.9457239,-1.7524717,0.45685822,7anq_B,Complete PCSK9 C-ter domain in complex with VHH P1.40
DVQLQESGGGLVQTGGSLTLSCATSGRSFSLYAMAWFRQAPGKEREFVAGVSRRGNTAYADAVKGRFTISRDNAANTVYLQMTSLKPEDTAVYFCAAFRVAVTTYTSQQANEYNYWGQGTQVTVSS,RSFSLYA,FVAGVSRRGNTA,AAFRVAVTTYTSQQANEYNY,18.0,FVAGVS-RRGNTA,AAFRVAVTTY--------TSQQANEYNY,RSFSLYAFVAGVS-RRGNTAAAFRVAVTTY--------TSQQANEYNY,0.08720883,-1.5655761,-4.578267,0.12701839,"6oz6_H,6oz6_E,6oz6_G,6oz6_F,6oyz_H,6oyz_E,6oyz_G,6oyz_F,6oyh_H,6oyh_E,6oyh_G,6oyh_F,8cxr_H,8cxr_E,8cxr_G,8cxr_F",Crystal structure of MraY bound to carbacaprazamycin;Crystal structure of MraY bound to 3'-hydroxymureidomycin A;Crystal structure of MraY bound to capuramycin;Crystal structure of MraY bound to a sphaerimicin analogue
QVQLVESGGGLVQAGGSLRLSCAASGSIFSINAMGWYRQAPGKQRELVAAITRGGRTNYADSVKGRFTLSRDNAKNTVYLQMNSLKPEDTAVYYCNVGRSRGYWGQGTQVTVSS,SIFSINA,LVAAITRGGRTN,NVGRSRGY,9.0,LVAAIT-RGGRTN,NVGR--------------------SRGY,SIFSINALVAAIT-RGGRTNNVGR--------------------SRGY,1.6669086,2.2550058,1.395678,1.0437386,"6b20_E,6b20_F",Crystal structure of a complex between G protein beta gamma dimer and an inhibitory Nanobody regulator
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYAMRWYRQAPGEEREFVAFISSVGGSTNYADSVKGRFTISRDNGKNTLYLQMNSLKPEDTAVYFCVARLSLISDSWGQGTQVTVSS,FTFSNYA,FVAFISSVGGSTN,VARLSLISDS,14.0,FVAFISSVGGSTN,VARLS------------------LISDS,FTFSNYAFVAFISSVGGSTNVARLS------------------LISDS,0.037597857,-0.66727006,-4.0651684,1.5698464,"5ja9_A,5ja9_B",Crystal structure of the HigB2 toxin in complex with Nb6
QVQLQESGGGLVQAGASLKLSCAASGRTFSSYAMGWFRQAPGKEREFVAAISRSGGDTKYADSVKGRFAISRDNDKNTVWLRMNSLKPEDTAVYYCAATTYASLSDTYIGEHIYDDWGQGTQVTVSS,RTFSSYA,FVAAISRSGGDTK,AATTYASLSDTYIGEHIYDD,15.0,FVAAISRSGGDTK,AATTYASLSD--------TYIGEHIYDD,RTFSSYAFVAAISRSGGDTKAATTYASLSD--------TYIGEHIYDD,-0.09669606,1.3451108,-0.36050624,0.8785985,"4n1h_B,4n1h_D",Structure of a single-domain camelid antibody fragment cAb-F11N in complex with the BlaP beta-lactamase from Bacillus licheniformis
QVQLQESGGGLVQPGGSLRLSCAASGFTFKMYAMSWVRQAPGKGLEWVSSINSAGGSTSYVDSVKGRFTISRDNAKNTLYLQMNSLKPDDTAVYYCVQGRNWPYDYRGQGTQVTVSS,FTFKMYA,WVSSINSAGGSTS,VQGRNWPYDY,17.0,WVSSINSAGGSTS,VQGRN------------------WPYDY,FTFKMYAWVSSINSAGGSTSVQGRN------------------WPYDY,0.87684464,0.49859017,-5.0039763,-3.0774372,"7nfq_C,7nfq_D",Fujian capmidlink domain in complex with Nb8193
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYYMSWVRQAPGEGREWVSSINRDGSNTYYADSVKGRFTIARDNVKNTLYLLMDSLKSDDTAVYYCTKGSNWPYDNWGQGTQVTVSS,FTFSNYY,WVSSINRDGSNTY,TKGSNWPYDN,20.0,WVSSINRDGSNTY,TKGSN------------------WPYDN,FTFSNYYWVSSINRDGSNTYTKGSN------------------WPYDN,1.6411558,1.1753341,-5.260001,-3.1726964,7nfr_B,Fujian capmidlink domain in complex with Nb8194
QVQLQESGGGLVQPGGSLRLSCAASGRTFSMYAMAWFRQAPGKQREFVGTISRSGDYALHADAVKGRFTISRDNAKNTVYLQMNSLKLEDTAVYYCAAGAYHSKDKTLYDYWGQGTQVTVSS,RTFSMYA,FVGTISRSGDYAL,AAGAYHSKDKTLYDY,15.0,FVGTISRSGDYAL,AAGAYHS-------------KDKTLYDY,RTFSMYAFVGTISRSGDYALAAGAYHS-------------KDKTLYDY,1.6136681,0.56865513,-4.7342787,0.2028696,"7nft_C,7nft_D",Fujian capbinding domain in complex with Nb8208
EVQLVESGGGLVQPGGSLRLSCAASGFNFSSSSIHWVRQAPGKGLEWVASISSSSGSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARFYSRYSWYGYSYGWSRAFDYWGQGTLVTVSS,FNFSSSS,WVASISSSSGSTS,ARFYSRYSWYGYSYGWSRAFDY,21.0,WVASISSSSGSTS,ARFYSRYSWYG------YSYGWSRAFDY,FNFSSSSWVASISSSSGSTSARFYSRYSWYG------YSYGWSRAFDY,-1.4514834,-2.1964045,-2.1029637,-2.9014585,"7rug_L,7ru6_L",Cryo-EM structure of the HIV-1 restriction factor human SERINC3;Human SERINC3-DeltaICL4
QVQLVESGGGLVQAGGSLRLSCAASGRTFSRSSMGWFRQAPGKEREFVASIVWADGTTLYGDSVKGRFTVSRDNVKNMVYLQMNNLKPEDTALYYCADNKFVRGLVAVRAIDYDYWGQGTQVTVS,RTFSRSS,FVASIVWADGTTL,ADNKFVRGLVAVRAIDYDY,15.0,FVASIVWADGTTL,ADNKFVRGL---------VAVRAIDYDY,RTFSRSSFVASIVWADGTTLADNKFVRGL---------VAVRAIDYDY,-0.8431128,-1.3167324,-1.8264668,0.13088739,"5boz_G,5boz_I,5boz_H,5boz_K,5boz_J,5boz_L",Ricin A chain bound to camelid nanobody (VHH9)(E1)
QVQLQESGGGLVQAGGSLRLSCAASGGTFSTYGMGWFRQAPGKEREFVAASSWTGANTYYADSVRGRFTISRDNAKNTVYLEMNSLKPEDTAVYYCAARRWLGGSYFDPGNYDFWGQGTQVTVSS,GTFSTYG,FVAASSWTGANTY,AARRWLGGSYFDPGNYDF,11.0,FVAASSWTGANTY,AARRWLGGS----------YFDPGNYDF,GTFSTYGFVAASSWTGANTYAARRWLGGS----------YFDPGNYDF,1.1267531,0.46058685,1.5258392,0.39884883,"5bop_A,5bop_C",Crystal structure of the artificial nanobody octarellinV.1 complex
QVQLVESGGGLVRPGGSLRLSCAASGSIFTIYAMGWYRQAPGKQRELVARITFGGDTNYADSVKGRFTISRDNAKNAVYLQMNSLKPEDTAVYYCNAEETIVEEADYWGQGTQVTVSS,SIFTIYA,LVARITFGGDTN,NAEETIVEEADY,11.0,LVARIT-FGGDTN,NAEETI----------------VEEADY,SIFTIYALVARIT-FGGDTNNAEETI----------------VEEADY,-2.5393293,-2.142036,-1.5075035,2.447844,"4xt1_C,5wb2_A,5wb1_A",Structure of a nanobody-bound viral GPCR bound to human chemokine CX3CL1;Ligand-free US28 with stabilizing intracellular nanobody;US28 bound to engineered chemokine CX3CL1.35 and nanobodies
QVQLVESGGGLVQAEGSLRLSCLVSGDIVRSNLMGWYRQAPGKQREFVARINPTGSANYADSVRGRFTISKDNSKKTLYLQMGSLQPEDTAVYYCRLIQNRDYWGQGTQVTVSS,DIVRSNL,FVARINPTGSAN,RLIQNRDY,18.0,FVARIN-PTGSAN,RLIQ--------------------NRDY,DIVRSNLFVARIN-PTGSANRLIQ--------------------NRDY,2.6505377,2.0550013,0.71572113,-0.33717912,8be5_N,Crystal structure of SOS1-KRasG12V-Nanobody22-Nanobody75
QVQLVESGGGLVQAGGSLRLSCAASRSSFTINRMGWYRQAPGKQRELVADITSGGNRNYADSVKGRFTIARDNAKNTAYLQMNSLKPEDTAVYYCNAKIHPWSVADLWGQGTQVTVSS,SSFTINR,LVADITSGGNRN,NAKIHPWSVADL,11.0,LVADIT-SGGNRN,NAKIHP----------------WSVADL,SSFTINRLVADIT-SGGNRNNAKIHP----------------WSVADL,1.102555,1.7913591,1.116325,0.74236566,8be4_C000,Crystal structure of SOS1-KRasG12V-Nanobody14
QVQLVESGGGLVQAGESLRLSCAASVSIFSINTMGWYRQAPGKPRELVARIFTGGSTYYVDSVKGRFTISRDNAKNTVYLQMNQLKPEDTGVYYCRLGADYWGQGTQVTVSS,SIFSINT,LVARIFTGGSTY,RLGADY,13.0,LVARIF-TGGSTY,RLG----------------------ADY,SIFSINTLVARIF-TGGSTYRLG----------------------ADY,1.2489718,1.028457,-4.4975805,-3.006584,"8be3_A00A,8be3_AA0A",Crystal structure of KRasG12V-Nanobody84
QVQLVESGGGLVQPGGSLRLSCAASRSISSINIMGWYRQAPGKERESVASHTRDGSTDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCTTLTGFPRIRSWGQGTQVTVSS,SISSINI,SVASHTRDGSTD,TTLTGFPRIRS,9.0,SVASHT-RDGSTD,TTLTG-----------------FPRIRS,SISSINISVASHT-RDGSTDTTLTG-----------------FPRIRS,2.8629305,2.9836378,1.6209219,2.2683446,8be2_N,Crystal structure of SOS1-Nanobody77
DVQLVESGGGLVHPGGSLRLSCAASGRTFSDYALGWFRQAPGKDREFVAAISWSGGSTYYADSVQGRFTISRDNDKNSVYLQMNSLKPEDTAVYYCAADKYYTGPGGESVYDYWGRGTQVTVSS,RTFSDYA,FVAAISWSGGSTY,AADKYYTGPGGESVYDY,17.0,FVAAISWSGGSTY,AADKYYTG-----------PGGESVYDY,RTFSDYAFVAAISWSGGSTYAADKYYTG-----------PGGESVYDY,1.7298442,1.5872179,0.38501072,-1.7894084,"4qlr_A,4qlr_B",Llama nanobody n02 raised against EAEC T6SS TssM
EVQVLESGGGLVQPGGSLRLSCAASGFTFSSYDMSWVRQAPGKGLEWVSGISYSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDVNFVPLVTFDYWGQGTLVTVSS,FTFSSYD,WVSGISYSGGSTY,ARDVNFVPLVTFDY,20.0,WVSGISYSGGSTY,ARDVNFV--------------PLVTFDY,FTFSSYDWVSGISYSGGSTYARDVNFV--------------PLVTFDY,-1.7354327,-0.42573482,-2.7399476,-2.9169524,"7yc5_E,7yc5_D,7yc5_F,7y6k_I,7y6k_E",Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with K202.B bispecific antibody;Cryo-EM structure of SARS-CoV-2 spike in complex with K202.B bispecific antibody
EVQLLESGGGLVQPGGSLRLSCAASGFTFSDYAMSWVRQAPGKGLEWVSWIYSGSGNKYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARFPIARTSNSQSSYDGMDVWGQGTLVTVSS,FTFSDYA,WVSWIYSGSGNKY,ARFPIARTSNSQSSYDGMDV,19.0,WVSWIYSGSGNKY,ARFPIARTSN--------SQSSYDGMDV,FTFSDYAWVSWIYSGSGNKYARFPIARTSN--------SQSSYDGMDV,1.2557065,-0.7249969,-1.7295256,-2.8348768,"7yc5_G,7yc5_I,7yc5_H,7y6k_J",Cryo-EM structure of SARS-CoV-2 receptor binding domain in complex with K202.B bispecific antibody;Cryo-EM structure of SARS-CoV-2 spike in complex with K202.B bispecific antibody
QVQLQESGGGSVQPGGSLTLSCAASGYAVSRYSMGWFRQAPGKENEGVAAIDSSGVGTTYADSVKGRFTISRDNAKDTVYLRMNSLKPEDTAIYYCASGFGLSLSRYTYAYWGQGTQVTVSS,YAVSRYS,GVAAIDSSGVGTT,ASGFGLSLSRYTYAY,16.0,GVAAIDSSGVGTT,ASGFGLS-------------LSRYTYAY,YAVSRYSGVAAIDSSGVGTTASGFGLS-------------LSRYTYAY,1.1977439,1.9642693,-0.36748475,-0.42103833,5kwl_7,expanded poliovirus in complex with VHH 10E
QVKLEESGGGSVQAGGSLRLSCAASGHTYSTYAMGWFRQVPGKEREGVARINVGGSSTWYADSVRDRFTISQDNAKNTVYLQMNSLKLEDTAIYYCTLHRFANTWSLGTLNVWGQGTQVTVSS,HTYSTYA,GVARINVGGSSTW,TLHRFANTWSLGTLNV,17.0,GVARINVGGSSTW,TLHRFANT------------WSLGTLNV,HTYSTYAGVARINVGGSSTWTLHRFANT------------WSLGTLNV,0.79027027,0.500721,-3.96443,0.78512067,"6u12_B,6u14_A,6u14_B",VHH R303 C33A/C102A in complex withthe LRR domain of InlB
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSDVMGWFRQAPGKEREFVAAVTRSGGKSYNADSVKGRFTISRDNAKNTVSLQMNSLKPEDTAVYYCAAGDTAITSWYGYDYWGQGTQVTVSS,RTFSSDV,FVAAVTRSGGKSY,AAGDTAITSWYGYDY,11.0,FVAAVTRSGGKSY,AAGDTAI-------------TSWYGYDY,RTFSSDVFVAAVTRSGGKSYAAGDTAI-------------TSWYGYDY,0.97709566,1.9341251,2.0590072,-0.17450172,"5da4_A,5da4_C,5da4_B",Structure of a nanobody recognizing the fumarate transporter SLC26Dg
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSDVMGWFRQAPGKEREFVAAVTRSGGKSYNADSVKGRFTISRDNAKNTVSLQMNSLKPEDTAVYYCAAGDTAITSWYGYDYWGQGTQVTVS,RTFSSDV,FVAAVTRSGGKSY,AAGDTAITSWYGYDY,12.0,FVAAVTRSGGKSY,AAGDTAI-------------TSWYGYDY,RTFSSDVFVAAVTRSGGKSYAAGDTAI-------------TSWYGYDY,0.97709566,1.9341251,1.8886318,-0.15202159,5da0_B,Structure of the the SLC26 transporter SLC26Dg in complex with a nanobody
QVQLVESGGGLVQAGGSLRLSCAASGFPVGRASMWWYRQAPGKEREWVAAISSYGWVTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCEVSVGTGYRGQGTQVTVSA,FPVGRAS,WVAAISSYGWVTA,EVSVGTGY,10.0,WVAAISSYGWVTA,EVSV--------------------GTGY,FPVGRASWVAAISSYGWVTAEVSV--------------------GTGY,1.1285145,0.26001477,-3.4114308,-0.26067758,"6lz2_B,6lz2_D",Crystal structure of a thermostable green fluorescent protein (TGP) with a synthetic nanobody (Sb44)
EVQLVESGGGSVQPGGSLRLSCTASGYTFSQEFVIWFRQAPGKEREIVSGISLRKGWTYYADSVKGRFTISQDNAKNTVYLQMNNLKPEDTAMYYCAAAPTATHALYFDYWGQGTQVTVSS,YTFSQEF,IVSGISLRKGWTY,AAAPTATHALYFDY,17.0,IVSGISLRKGWTY,AAAPTAT--------------HALYFDY,YTFSQEFIVSGISLRKGWTYAAAPTAT--------------HALYFDY,0.93603665,1.3085341,-1.8108093,1.8682103,3tpk_A,Crystal structure of the oligomer-specific KW1 antibody fragment
QVQLQESGGGLVQAGGSLRLSCTASGFTFDSYHMGWFRRAPGKEREFVAAVSRVTWLIDIADSVKGRFTISRDNAKNTVYLEMNSLKPEDTAQYFCAASQQRLSRSDVQYDYWGQGTQVTVSS,FTFDSYH,FVAAVSRVTWLID,AASQQRLSRSDVQYDY,15.0,FVAAVSRVTWLID,AASQQRLS------------RSDVQYDY,FTFDSYHFVAAVSRVTWLIDAASQQRLS------------RSDVQYDY,0.1305401,-1.5767729,-2.4611127,-2.9649775,6q6z_B,Structure of the plant immune signaling node EDS1 (enhanced disease susceptibility 1) in complex with nanobody ENB21
QVQLQESGGGLVQPGGSLRLSCIASGRTFNPYGMGWFRQVPGKERTFVSGITWIGGTTYYVNSVKGRFTISRDRAKNTVYLQMNSLKPEDTAVYYCAADKDNTGYNYWGQGTQVTVSS,RTFNPYG,FVSGITWIGGTTY,AADKDNTGYNY,16.0,FVSGITWIGGTTY,AADKD-----------------NTGYNY,RTFNPYGFVSGITWIGGTTYAADKD-----------------NTGYNY,3.0803642,2.8181658,0.46071374,1.464247,7a48_A,Crystal structure of the APH coiled-coil in complex with Nb49
QVQLVESGGGLVQAGGSLRLSCAASRRSSRSWAMAWFRQAPGKEREFVAKISGDGRLTTYGDSVKGRFTISRDNAEYLVYLQMDSLKPEDTAVYYCAADDNYVTASWRSGPDYWGQGTQVTVSS,RSSRSWA,FVAKISGDGRLTT,AADDNYVTASWRSGPDY,15.0,FVAKISGDGRLTT,AADDNYVT-----------ASWRSGPDY,RSSRSWAFVAKISGDGRLTTAADDNYVT-----------ASWRSGPDY,2.4777086,2.1839442,-1.1589073,1.1159306,"7rg7_A,7rga_A,7rga_C,7rga_B,7rga_E,7rga_D,7rga_G,7rga_F,3qxv_A,3qxv_C,3qxv_B,3qxv_E,3qxv_D,3qxw_A,3qxw_C,3qxw_B,3qxw_E,3qxw_D",Structure of an Anti-Methotrexate CDR1-4 Graft VHH Antibody in Complex with Methotrexate;Crystal structure of nanoCLAMP3:VHH in complex with MTX;Crystal structure of nanoclamp8:VHH in complex with MTX;Free structure of an anti-methotrexate CDR1-4 Graft VHH Antibody
QVQLQESGGGLVEAGGSLRLSCLGSGLTFSRYAMGWFRQAPGKEREFVASITRSGGSPNYADSVKGRFTISRDNAKNTVYLQMSSLKPEDTAVYYCAGRGSVYYDVWGQGTQVTVSS,LTFSRYA,FVASITRSGGSPN,AGRGSVYYDV,13.0,FVASITRSGGSPN,AGRGS------------------VYYDV,LTFSRYAFVASITRSGGSPNAGRGS------------------VYYDV,0.58799666,0.59431005,0.59458995,0.71062946,"6xw7_H,6xw7_C,6xw7_D,6xw7_G",Crystal structure of murine norovirus P domain in complex with Nanobody NB-5829 and glycochenodeoxycholate (GCDCA)
QVQLQESGGGLVQAGDSLRVSCAASGRTISSSPMGWFRQAPGKEREFVAAISGNGGNTYYLDSVKGRFTTSRDNAKNTVYLQLNNLKPEDTAIYYCAARSRFSAMHLAYRRLVDYDDWGQGTQVTVSS,RTISSSP,FVAAISGNGGNTY,AARSRFSAMHLAYRRLVDYDD,16.0,FVAAISGNGGNTY,AARSRFSAMH-------LAYRRLVDYDD,RTISSSPFVAAISGNGGNTYAARSRFSAMH-------LAYRRLVDYDD,0.7583613,0.8063867,-0.7964509,-0.5038478,"6xw6_C,6xw6_D",Crystal structure of murine norovirus P domain in complex with Nanobody NB-5853
QVQLQESGGGLVQAGGSLRLSCAASGRTFSLTTMGWFRQAPGEDRAFVTSISRAAYTYYADSVKGRFTISRDNAKNMVSLQMNSLKPEDTAVYVCAGKGQGGTWDYWGQGTQVTVSS,RTFSLTT,FVTSISRAAYTY,AGKGQGGTWDY,15.0,FVTSIS-RAAYTY,AGKGQ-----------------GGTWDY,RTFSLTTFVTSIS-RAAYTYAGKGQ-----------------GGTWDY,2.2613025,1.9981619,-4.61891,-2.8615274,"6xw5_C,6xw5_D",Crystal structure of murine norovirus P domain in complex with Nanobody NB-5820
EVQLVESGGGLVQAGDSLRLSCAASGLTFSRYAMGWFRQAPGNEREFVAVITASGRTTLYADSVKGRFTISRDNAKNTVALQMQSLKPEDTAVYYCAADYGTSRYTRRQSEYEYWGQGTQVTVSS,LTFSRYA,FVAVITASGRTTL,AADYGTSRYTRRQSEYEY,13.0,FVAVITASGRTTL,AADYGTSRY----------TRRQSEYEY,LTFSRYAFVAVITASGRTTLAADYGTSRY----------TRRQSEYEY,-0.1729112,-1.4046866,-4.2122498,-1.4840882,"6zwk_A,6zwk_C,6zwk_B,6zwk_E,6zwk_D,6zwk_F",Crystal structure of the phosphorylated C-terminal tail of histone H2AX in complex with a specific nanobody (C6 gammaXbody)
QVQLVESGGGLVQPGGSLRLSCAASGSIFRLDAMGWYRQAPGKQRELVAVIRSGGSTDYGDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNAVQILKTIYWGQGTQVTVSS,SIFRLDA,LVAVIRSGGSTD,NAVQILKTIY,10.0,LVAVIR-SGGSTD,NAVQI------------------LKTIY,SIFRLDALVAVIR-SGGSTDNAVQI------------------LKTIY,-0.6276311,-0.17866999,1.5725542,2.417191,"8oud_E,8oud_D,8oud_F",Structure of the human neutral amino acid transporter ASCT2 in complex with nanobody 469
AWQLVESGGGSVQPGGSLTLTCQASKSTFSTSGMRWERQAQGKGVEFVADISSDSTRKWYSDSVKGRFTISRSNWWRTVTLQMNDLKPEDTARYYCKDLESHHLRGQGTQVTVSS,STFSTSG,FVADISSDSTRKW,KDLESHHL,29.0,FVADISSDSTRKW,KDLE--------------------SHHL,STFSTSGFVADISSDSTRKWKDLE--------------------SHHL,2.2697446,1.9738148,-4.525627,-2.9521,8t5c_D,Lassa GPC Trimer in complex with Fab 8.11G and nanobody D5
QVQLVESGGGLVQAGGSLRLSCAASGSFFSINDMGWYRQAPGKQRELVAVISSGGSTNYADSVEGRSTISSDNAKNTVYLQLSSLKPEDTAVYYCNANVRLREYRTTSYHYWGQGTQVTVSS,SFFSIND,LVAVISSGGSTN,NANVRLREYRTTSYHY,13.0,LVAVIS-SGGSTN,NANVRLRE------------YRTTSYHY,SFFSINDLVAVIS-SGGSTNNANVRLRE------------YRTTSYHY,1.3991741,2.3485885,-0.22976042,1.1059489,"6fpv_A,6fpv_B",A llama-derived JBP1-targeting nanobody
QVQLQESGGGLVQPGGSLRLSCAASGSIFSDNDMGWYRQPPGKQREWVATITYDHVTWYADSVKGRFAISRDNAKNTVYLQMNDLKPEDTAVYYCNAVPGRRGSWGQGTQVTVSS,SIFSDND,WVATITYDHVTW,NAVPGRRGS,13.0,WVATIT-YDHVTW,NAVP-------------------GRRGS,SIFSDNDWVATIT-YDHVTWNAVP-------------------GRRGS,4.5702953,2.2829504,-0.4338622,-0.60390836,"7a4d_C,7a4d_D,7a4d_I,7a4d_J",Crystal structure of the APH coiled-coil in complex with nanobodies Nb28 and Nb30
QVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVAVARRSGDGAFYADSVQGRFTVSRDDAKTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVSS,RTISRYA,FVAVARRSGDGAF,AIDSDTFYSGSYDY,15.0,FVAVARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVAVARRSGDGAFAIDSDTF--------------YSGSYDY,-0.3579229,-0.5756862,2.3599398,1.0383859,8tb7_N,Cryo-EM Structure of GPR61-
QVQLQESGGGLVQPGGSLRLSCAASQFTFSSDWMYWVRQAPGKGLEWVSSISPGGAATAYAASVKGRFTISRDNAKNTLYLQMNSLKSEDTAVYYCSKTRAGTGRGQGTQVTVSS,FTFSSDW,WVSSISPGGAATA,SKTRAGTG,18.0,WVSSISPGGAATA,SKTR--------------------AGTG,FTFSSDWWVSSISPGGAATASKTR--------------------AGTG,0.31486008,2.589726,-5.8223944,-2.8182247,"7a4y_A,7a4y_C,7a4y_B",Crystal structure of the P5P6 coiled-coil in complex with nanobody Nb34.
QVQLQESGGGLVQAGGSLRLSCAASGSIFSINVMGWYRQAPGKQRELLASITSRGSTNYADSVKDRFTISRDNAKNTVYLQINSLKPEDTAVYYCNSRGWTTTRGDYDYWGQGTQVTVSS,SIFSINV,LLASITSRGSTN,NSRGWTTTRGDYDY,10.0,LLASIT-SRGSTN,NSRGWTT--------------TRGDYDY,SIFSINVLLASIT-SRGSTNNSRGWTT--------------TRGDYDY,0.4938726,1.0143881,-1.0856831,0.64949113,7a4t_A,Crystal structure of the GCN coiled-coil in complex with nanobody Nb39
QVQLQESGGGLVQAGGSLRLSCAASGSIFSINTMGWYRQAPGKQRELVAAIHSGGSTNYANSVKGRFTISRDNAANTVYLQMNSLKPEDTAVYYCNVKDYGAVLYEYDYWGQGTQVTVSS,SIFSINT,LVAAIHSGGSTN,NVKDYGAVLYEYDY,10.0,LVAAIH-SGGSTN,NVKDYGA--------------VLYEYDY,SIFSINTLVAAIH-SGGSTNNVKDYGA--------------VLYEYDY,0.24095246,1.6983954,0.4914831,0.4500702,"6ibl_C,6ibl_D,3p0g_B,6h7j_C,6h7j_D",ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST FORMOTEROL AND NANOBODY Nb80;ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND AGONIST ISOPRENALINE AND NANOBODY Nb80;Structure of a nanobody-stabilized active state of the beta2 adrenoceptor
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYKMNWVRQAPGKGLEWVSDISQSGASISYTGSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCARCPAPFTPFCFDVTSTTYAYRGQGTQVTVSS,FTFSNYK,WVSDISQSGASIS,ARCPAPFTPFCFDVTSTTYAY,17.0,WVSDISQSGASIS,ARCPAPFTPF-------CFDVTSTTYAY,FTFSNYKWVSDISQSGASISARCPAPFTPF-------CFDVTSTTYAY,-0.50674206,0.43365806,-3.938907,-2.7267604,"8iq6_N,8iq4_N",Cryo-EM structure of Carboprost-bound prostaglandin-F2-alpha receptor-miniGq-Nb35 complex;Cryo-EM structure of Latanoprost-bound prostaglandin-F2-alpha receptor-miniGq-Nb35 complex
QVQLQESGGGLVQAGGSLRLSCAASGRTSSAYAMGWFRQAPGKEREFVAGISSKGGSTYYGASMKGRFTISRDNAKNTVYLQMNGLAPEDTAVYYCAASDKYNFDTSHAGYGYWGQGTQVTVSS,RTSSAYA,FVAGISSKGGSTY,AASDKYNFDTSHAGYGY,14.0,FVAGISSKGGSTY,AASDKYNF-----------DTSHAGYGY,RTSSAYAFVAGISSKGGSTYAASDKYNF-----------DTSHAGYGY,3.1398485,3.057273,2.182501,1.103657,"4aq1_B,4aq1_D",Structure of the SbsB S-layer protein of Geobacillus stearothermophilus PV72p2 in complex with nanobody KB6
QVQLVESGGGLVQAGGSLRLSCAVSGRTTANYNMGWFRQAPGKEREFVAGIKWSSGSTYVADSAKGRFTISRDNAKNSVYLQMDSLKPEDTALYYCAANYYGVSWFLISPSSYDYWGQGTQVTVSS,RTTANYN,FVAGIKWSSGSTY,AANYYGVSWFLISPSSYDY,14.0,FVAGIKWSSGSTY,AANYYGVSW---------FLISPSSYDY,RTTANYNFVAGIKWSSGSTYAANYYGVSW---------FLISPSSYDY,-0.15063927,-0.12441099,-2.203528,1.134573,7pqg_B,Structure of thermostabilised human NTCP in complex with nanobody 87
QVQLQESGGGSVQAGGSLRLSCAASGFPISTYDMGWFRQAPGKEREGVVGITDSFSIKYEDSVKGRFTISRDNAKNALYLQMNSLKPEDTGMYYCAAGDARWSLLLRAEQYNYWGQGTQVTVSS,FPISTYD,GVVGITDSFSIK,AAGDARWSLLLRAEQYNY,15.0,GVVGIT-DSFSIK,AAGDARWSL----------LLRAEQYNY,FPISTYDGVVGIT-DSFSIKAAGDARWSL----------LLRAEQYNY,0.6785553,0.7164624,-1.9457383,0.42082316,"7e6u_B,7e6u_D",the complex of inactive CaSR and NB2D11
EVQLVESGGGLVQAGDSLTLSCAASGRTFSSVAMGWFRQAPGKERKFVANISWNGDSTYYTDSVKGRFTISRDNAKNTVYLQMSSLKPEDTAVYYCAADVRWTGDGHRADYWGQGTQVTVSS,RTFSSVA,FVANISWNGDSTY,AADVRWTGDGHRADY,14.0,FVANISWNGDSTY,AADVRWT-------------GDGHRADY,RTFSSVAFVANISWNGDSTYAADVRWT-------------GDGHRADY,1.8009303,2.2658505,-1.2296137,0.10173738,7pkl_L,Mechanistic understanding of antibody masking with anti-idiotypic antibody fragments
DVQLVESGGGSVQAGGSLRLSCAVSGYKDRNYCMGWFRRAPGKEREGVAVIDSSGRTAYADSVKGRFTISRDVALDTAYLQMNSLKPEDTAMYYCAAGWSSLGSCGTNRNRYNYWGQGTQVTVSS,YKDRNYC,GVAVIDSSGRTA,AAGWSSLGSCGTNRNRYNY,17.0,GVAVID-SSGRTA,AAGWSSLGS---------CGTNRNRYNY,YKDRNYCGVAVID-SSGRTAAAGWSSLGS---------CGTNRNRYNY,3.6377008,4.381117,0.20290393,-2.2482505,1ri8_A,Crystal Structure of the Camelid Single Domain Antibody 1D2L19 in complex with Hen Egg White Lysozyme
QVQLQESGGGSVQAGGSLRLSCVASGSIFSINAMDWYRQAPGKQRELVAGITSGGSTNYGDFVKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAAEVGGWGPPRPDYWGHGTQVTVSS,SIFSINA,LVAGITSGGSTN,AAEVGGWGPPRPDY,15.0,LVAGIT-SGGSTN,AAEVGGW--------------GPPRPDY,SIFSINALVAGIT-SGGSTNAAEVGGW--------------GPPRPDY,2.4914107,2.5419517,1.0982138,2.2516527,"6war_B,6war_D,6war_F,6war_H,6war_J,6war_L,6war_N,6war_P",Crystal structure of the MERS-CoV RBD bound by the neutralizing single-domain antibody MERS VHH-55
QVQLQESGGGLVQAGGSLRLSCAASGRTFSEYAMGWFRQAPGKEREFVATISWSGGSTYYTDSVKGRFTISRDNAKNTVYLQMNSLKPDDTAVYYCAAAGLGTVVSEWDYDYDYWGQGTQVTVSS,RTFSEYA,FVATISWSGGSTY,AAAGLGTVVSEWDYDYDY,11.0,FVATISWSGGSTY,AAAGLGTVV----------SEWDYDYDY,RTFSEYAFVATISWSGGSTYAAAGLGTVV----------SEWDYDYDY,-0.83667773,-0.39221716,-0.24952777,1.342341,"6waq_A,6waq_C",Crystal structure of the SARS-CoV-1 RBD bound by the cross-reactive single-domain antibody SARS VHH-72
EVQLVESGGGLVQPGGSLRLSCAASGRTSRSYGMGWYRQAPGKGRELVAGISWRGDSTGYADSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYCAFAAGSAWYGTLYEYDYWGQGTLVTVSS,RTSRSYG,LVAGISWRGDSTG,AFAAGSAWYGTLYEYDY,13.0,LVAGISWRGDSTG,AFAAGSAW-----------YGTLYEYDY,RTSRSYGLVAGISWRGDSTGAFAAGSAW-----------YGTLYEYDY,0.5638663,1.0277132,-2.6251833,-2.2961223,"7xl1_A,7xl1_B",Crystal structure of chimeric 7D12-Vob nanobody at 1.65 Angstrom
EVQLVESGGGLVQPGGSLRLSCAASGSVFKINVMAWYRQAPGKGRELVAGIISGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYYCAFITTESDYDLGRRYWGQGTLVTVSS,SVFKINV,LVAGIISGGSTS,AFITTESDYDLGRRY,14.0,LVAGII-SGGSTS,AFITTES-------------DYDLGRRY,SVFKINVLVAGII-SGGSTSAFITTES-------------DYDLGRRY,1.4090124,1.6685451,-3.2653525,-0.88797605,"7xl0_A,7xl0_B",Crystal structure of Vobarilizumab at 1.70 Angstrom
QVQLQESGGGLVQAGGSLRLSCAASERTFSTYAMGWFRQAPGREREFLAQINWSGTTTYYAESVKDRTTISRDNAKNTVYLEMNNLNADDTGIYFCAAHPQRGWGSTLGWTYWGQGTQVTVSS,RTFSTYA,FLAQINWSGTTTY,AAHPQRGWGSTLGWTY,22.0,FLAQINWSGTTTY,AAHPQRGW------------GSTLGWTY,RTFSTYAFLAQINWSGTTTYAAHPQRGW------------GSTLGWTY,1.1163048,1.8594447,-0.5261204,-0.008557558,4qo1_A,p53 DNA binding domain in complex with Nb139
QVQLVESGGGLVQTGDSLRLSCAASGRTFSRYAMGWFRQAPGKERELVAAINWSGGSTYYADFAKGRFTISRDNAKNMLYLRMSSLKPEDTAVYYCAAGGPEVEITRANEYDYWGQGTQVTVSS,RTFSRYA,LVAAINWSGGSTY,AAGGPEVEITRANEYDY,16.0,LVAAINWSGGSTY,AAGGPEVE-----------ITRANEYDY,RTFSRYALVAAINWSGGSTYAAGGPEVE-----------ITRANEYDY,1.0885931,1.742894,0.9414811,0.08368522,"6ysq_H,6ysq_G",The hC4Nb8 complement inhibitory nanobody in complex with C4b
QVQLQESGGGLVQAGGSLRLSCAASGTISRYWTMGWYRQAPGKERELVAGISEGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVTYRGPWFNRDPHYYWGQGTQVTVSS,TISRYWT,LVAGISEGGSTN,AVTYRGPWFNRDPHYY,8.0,LVAGIS-EGGSTN,AVTYRGPW------------FNRDPHYY,TISRYWTLVAGIS-EGGSTNAVTYRGPW------------FNRDPHYY,1.8760185,2.80269,2.0365329,1.9451532,8sbb_B,Cryo-EM structure of FtAlkB
QGQLVESGGGLVQAGGSLRLSCTGSGRAFVTPAVGWFRQAPGKEREFVGTINWSGSHTSYADPVKGRFTISRDNAKETVYLQMNNLKPEDADVYYCASRGVSGRYEYWGKGTPVTVSS,RAFVTPA,FVGTINWSGSHTS,ASRGVSGRYEY,19.0,FVGTINWSGSHTS,ASRGV-----------------SGRYEY,RAFVTPAFVGTINWSGSHTSASRGV-----------------SGRYEY,0.96124643,3.0128045,2.5789454,0.84585387,"8pnv_E,8pnv_D,8pnv_F,8pnv_K,8pnv_J,8pnv_L,8pnu_E,8pnu_D,8pnu_F,8pnu_K,8pnu_J,8pnu_L",Cryo-EM structure of styrene oxide isomerase;Cryo-EM structure of styrene oxide isomerase bound to benzylamine inhibitor
QGQLVESGGGLVQPGGSLRLSCADAGSIFNKFPMAWYRQAPGKERELVARISSGGSTNYADFVKGRFTISRDNAKSTLYLQMNSLKPEDTAMYYCARIINSASNIAYWGQGTRVTVSA,SIFNKFP,LVARISSGGSTN,ARIINSASNIAY,18.0,LVARIS-SGGSTN,ARIINS----------------ASNIAY,SIFNKFPLVARIS-SGGSTNARIINS----------------ASNIAY,1.519678,2.2032804,1.7399014,1.5261633,"8pnl_B,8pnl_D","Outward-open conformation of a Major Facilitator Superfamily (MFS) transporter MHAS2168, a homologue of Rv1410 from M. tuberculosis, in complex with an alpaca nanobody"
EVQLVESGGGLVQTGGSLRLSCTASGSIGSISVMGWYRQVPGTQYELVAGISRGGSTWYEDSVKGRFTISRDNAKNTLYLQMNSLKPEDTGMYYCAGGDYSDRLGSWGQGTQVTVSS,SIGSISV,LVAGISRGGSTW,AGGDYSDRLGS,18.0,LVAGIS-RGGSTW,AGGDY-----------------SDRLGS,SIGSISVLVAGIS-RGGSTWAGGDY-----------------SDRLGS,1.2793409,2.533287,-0.32464677,-2.7405226,"8b8i_A,8b8i_C,8b8i_B,8b8i_E,8b8i_D,8b8i_G,8b8i_F,8b8i_H",Nanobody (NbLumSyt1) bound to human Syt1
QVQLQESGGGLVQAGGSLRLSCAGSGRTFSTYDMAWFRQAPGKEREFVSSISSSGGNVVYRDSVKGRFTIARDNAANAVYLQMNSLKPEDTAVYYCAAKWLAADYNYWGQGTQVTVSS,RTFSTYD,FVSSISSSGGNVV,AAKWLAADYNY,15.0,FVSSISSSGGNVV,AAKWL-----------------AADYNY,RTFSTYDFVSSISSSGGNVVAAKWL-----------------AADYNY,1.7479484,0.044039905,0.8319122,1.6638985,6i8h_B,Structure of the plant immune signaling node EDS1 (enhanced disease susceptibility 1) in complex with nanobody ENB15
QVQLQESGGGLVQAGGSLRLSCATSTHTAGQYTMAWFRQAPGKEREFVAVLRWSDYSTDYANSVKNRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAGWPVKVISSADEYINWGQGTQVTVSS,HTAGQYT,FVAVLRWSDYSTD,AAGWPVKVISSADEYIN,14.0,FVAVLRWSDYSTD,AAGWPVKV-----------ISSADEYIN,HTAGQYTFVAVLRWSDYSTDAAGWPVKV-----------ISSADEYIN,0.8151247,0.1855039,-2.6220205,1.5528412,6i8g_B,Structure of the plant immune signaling node EDS1 (enhanced disease susceptibility 1) in complex with nanobody ENB73
QGQLVESGGGMVQAGGSLRLSCAASGRTFNGWTAAWFRQAPGKDREFVAAISRSGDYTYYTNSVKGRFTISRDSAKNNLYLQMDSLKPEDTAVYYCAAKTGTWATMDRRYDYWGQGTRVTVSA,RTFNGWT,FVAAISRSGDYTY,AAKTGTWATMDRRYDY,21.0,FVAAISRSGDYTY,AAKTGTWA------------TMDRRYDY,RTFNGWTFVAAISRSGDYTYAAKTGTWA------------TMDRRYDY,3.9902084,3.8422604,-3.2644312,-2.7935832,"6qgy_B,6qgy_D",Crystal structure of E.coli BamA beta-barrel in complex with nanobody B12
EVQLLESGGGLVQPGGSLRLSCAASGFTFSTYMMSWVRQAPGKGLEWVSSIEGSGSKTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKRDSSFGFDYWGQGTLVTVSS,FTFSTYM,WVSSIEGSGSKTY,AKRDSSFGFDY,19.0,WVSSIEGSGSKTY,AKRDS-----------------SFGFDY,FTFSTYMWVSSIEGSGSKTYAKRDS-----------------SFGFDY,1.173647,0.7824515,-3.031948,-2.7644355,"5tsj_1,5tsj_2",Thermus thermophilus V/A-ATPase bound to VH dAbs
EVQLVESGGGLVQAGGSLRLSCAASGRTFSDYVMGWFRQAPGKERTFVARIGWSGDLTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAIYYCAADERWGTGGKFDYWGQGTQVTVSS,RTFSDYV,FVARIGWSGDLTY,AADERWGTGGKFDY,11.0,FVARIGWSGDLTY,AADERWG--------------TGGKFDY,RTFSDYVFVARIGWSGDLTYAADERWG--------------TGGKFDY,1.807566,3.1398768,0.59816885,1.4298398,"6z1z_A,6z1z_B,6z20_B,6z20_D",Structure of the anti-CD9 nanobody 4C8;Structure of the EC2 domain of CD9 in complex with nanobody 4C8
EVQLVESGGRLVRTGGSLRLSCAASGRTFSNYVMGWFRQAPGKEREVVAAITWSGDITWHADFVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAATERWGLRAPADWGSWGQGTQVTVSS,RTFSNYV,VVAAITWSGDITW,AATERWGLRAPADWGS,14.0,VVAAITWSGDITW,AATERWGL------------RAPADWGS,RTFSNYVVVAAITWSGDITWAATERWGL------------RAPADWGS,-0.7223512,-1.0186307,-2.1441972,2.6329694,6z1v_B,Structure of the EC2 domain of CD9 in complex with nanobody 4E8
QVQLQESGGGLAQAGGSMRLSCIASGRNFFINIMNWYRQAPGKQRELVAQITRAGTTTYADSVKGRFTISRDNAKNTVYLQMSTLQSEDTAVYYCNVGASWGQGTQVTVSS,RNFFINI,LVAQITRAGTTT,NVGAS,17.0,LVAQIT-RAGTTT,NV-----------------------GAS,RNFFINILVAQIT-RAGTTTNV-----------------------GAS,-0.654092,-1.0783945,-2.649047,1.314296,"6ssi_I,6ssi_H,6ssi_J,6ssi_G,6ssi_F",Structure of the pentameric ligand-gated ion channel ELIC in complex with a PAM nanobody
QVQLQESGGGLVQAGGSLRLSCAASGFTFDDYTIGWFRQAPGKEREGVSLISSSLGSTYYADSVKGRITISRDNAKNTVYLQMNSLKPEDTAVYYCAAGRDADPTIFAILRSEYPFDYWGQGTQVTVSS,FTFDDYT,GVSLISSSLGSTY,AAGRDADPTIFAILRSEYPFDY,11.0,GVSLISSSLGSTY,AAGRDADPTIF------AILRSEYPFDY,FTFDDYTGVSLISSSLGSTYAAGRDADPTIF------AILRSEYPFDY,2.8595712,1.4786683,1.4718363,1.7712936,"6ssp_K,6ssp_L",Structure of the pentameric ligand-gated ion channel ELIC in complex with a NAM nanobody
QVQLVETGGGLVQAGGSLRLSCAASGNINSFNAMGWFRQAPGKQRELVAAITFGGRTNYADSVKGRFTISRDNTKGSVYLQMNSLKPEDTAVYYCAASENNLLTGVWHYWGRGTQVTVSS,NINSFNA,LVAAITFGGRTN,AASENNLLTGVWHY,13.0,LVAAIT-FGGRTN,AASENNL--------------LTGVWHY,NINSFNALVAAIT-FGGRTNAASENNL--------------LTGVWHY,1.6414516,3.0081782,1.7802454,1.353765,"7p2d_C,7np9_C",Structure of alphaMbeta2/Cd11bCD18 headpiece in complex with a nanobody;Structure of the human CR3 - CD11bCD18 specific nanobody hCR3Nb1
ELQLVESGGGLVQAGGSLTVSCAASGSAFSVNVMGWSRQAPGKERELVAGITRRGNTYYADTVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAALADIATMGPNDYWGQGTQVTVSG,SAFSVNV,LVAGITRRGNTY,AALADIATMGPNDY,15.0,LVAGIT-RRGNTY,AALADIA--------------TMGPNDY,SAFSVNVLVAGIT-RRGNTYAALADIA--------------TMGPNDY,1.1305751,1.6315622,-2.5502095,0.1735928,8h63_B,Crystal structure of Internalin A from Listeria monocytogenes with nanobody VHH10 bound
DVQLQASGGGSVQAGGSLRLSCAASGYTIGPYCMGWFRQAPGKEREGVAAINMGGGITYYADSVKGRFTISQDNAKNTVYLLMNSLEPEDTAIYYCAADSTIYASYYECGHGLSTGGYGYDSWGQGTQVTVSS,YTIGPYC,GVAAINMGGGITY,AADSTIYASYYECGHGLSTGGYGYDS,16.0,GVAAINMGGGITY,AADSTIYASYYEC--GHGLSTGGYGYDS,YTIGPYCGVAAINMGGGITYAADSTIYASYYEC--GHGLSTGGYGYDS,1.7317798,1.5583819,-1.9365957,0.73990816,"1jtp_A,1jtp_B,1jtt_A,1jto_A,1jto_B,1mel_A,1mel_B",Degenerate interfaces in antigen-antibody complexes;CRYSTAL STRUCTURE OF A CAMEL SINGLE-DOMAIN VH ANTIBODY FRAGMENT IN COMPLEX WITH LYSOZYME
QVQLVESGGGLVQAGGSLRLSCAASRRSSRSWAMAWFRQAPGKEREFVAKISGDGRLTTYGDSVKGRFTISRDKGKNTVYLQMDSLKPEDTAVYYCAADDNYVTASWRSGPDYWGQGTQVTVSS,RSSRSWA,FVAKISGDGRLTT,AADDNYVTASWRSGPDY,14.0,FVAKISGDGRLTT,AADDNYVT-----------ASWRSGPDY,RSSRSWAFVAKISGDGRLTTAADDNYVT-----------ASWRSGPDY,2.4777086,2.1839442,1.0030757,1.389919,"3qxt_A,3qxt_B,3qxu_A,3qxu_C,3qxu_B,3qxu_D",Free Structure of an Anti-Methotrexate CDR1-3 Graft VHH Antibody;Structure of an Anti-Methotrexate CDR1-3 Graft VHH Antibody in Complex with Methotrexate
QVQLVESGGGLVQAGGSLRLSCAASGRTFSSYVMGWFRQAPGKEREFVTAISWSGGSIHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYTCVAGFAGYGSFTSRSARDSDKYDYWGQGTKVTVSS,RTFSSYV,FVTAISWSGGSIH,VAGFAGYGSFTSRSARDSDKYDY,10.0,FVTAISWSGGSIH,VAGFAGYGSFT-----SRSARDSDKYDY,RTFSSYVFVTAISWSGGSIHVAGFAGYGSFT-----SRSARDSDKYDY,-0.18436256,-1.0082086,-3.6647692,-0.2644722,"6ey6_I,6ey6_K,6ey6_J,6ey6_M,6ey6_L,6ey6_O,6ey6_N,6ey6_P",C-terminal part (residues 315-516) of PorM with the llama nanobody nb130
QVQLQESGGGLVQPGGSLRLSCAASGIIFRSNGMAWYRQAPGKEREWVASITSFGDAIYRDSVKGRFTISRDNARNAVSLQTNSLKTEDTAVYYCNTYPVNSAWGQGTQVTVSS,IIFRSNG,WVASITSFGDAI,NTYPVNSA,16.0,WVASIT-SFGDAI,NTYP--------------------VNSA,IIFRSNGWVASIT-SFGDAINTYP--------------------VNSA,1.0375448,0.25221765,1.2804343,0.48388517,"6ukt_C,6tyl_C,6tyl_H",Cryo-EM structure of mammalian Ric-8A:Galpha(i):nanobody complex;Crystal structure of mammalian Ric-8A:Galpha(i):nanobody complex
QVQLQESGGGLVQAGGSLRLSCAASGGIVHISSMGWFRQAPGKQRELVATSPSNGDIRYADSVKGRFTLSRDNAKNTVSLQMNSLEPEDTAVYYCHSFLRHTASASYNNYYGQGTQVTVSS,GIVHISS,LVATSPSNGDIR,HSFLRHTASASYNNY,14.0,LVATSP-SNGDIR,HSFLRHT-------------ASASYNNY,GIVHISSLVATSP-SNGDIRHSFLRHT-------------ASASYNNY,2.4886472,-0.10080144,0.10866161,-1.3748755,"6ukt_E,6tyl_E,6tyl_J",Cryo-EM structure of mammalian Ric-8A:Galpha(i):nanobody complex;Crystal structure of mammalian Ric-8A:Galpha(i):nanobody complex
QVQLQESGGGLEQAGDSLRLSCAASGLIVSNYAMGWFRQAPGKEREFVAYINWNGGVTYYTNSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCARTSRASVTTRVADFGYWGQGTQVTVSS,LIVSNYA,FVAYINWNGGVTY,ARTSRASVTTRVADFGY,13.0,FVAYINWNGGVTY,ARTSRASV-----------TTRVADFGY,LIVSNYAFVAYINWNGGVTYARTSRASV-----------TTRVADFGY,-0.51139253,-0.5248314,-2.73482,-0.31036675,"6ukt_D,6tyl_D,6tyl_I",Cryo-EM structure of mammalian Ric-8A:Galpha(i):nanobody complex;Crystal structure of mammalian Ric-8A:Galpha(i):nanobody complex
QVQLQESGGGLVQAGGSLRLSCAASVRTSDTDGMAWFRQAPGKEREFVGGIRWNSATWYADFVKGRFTISRDNAKNTLYLQMNSLKPEDTALYYCARRAYGFDTDSRESAYSNWGQGTQVTVSS,RTSDTDG,FVGGIRWNSATW,ARRAYGFDTDSRESAYSN,14.0,FVGGIR-WNSATW,ARRAYGFDT----------DSRESAYSN,RTSDTDGFVGGIR-WNSATWARRAYGFDT----------DSRESAYSN,3.6174414,1.5726267,-2.709894,-0.26355612,6ukt_F,Cryo-EM structure of mammalian Ric-8A:Galpha(i):nanobody complex
EVQLVESGGGLVQPGGSLRLSCAASGRTFSYNPMGWFRQAPGKGRELVAAISRTGGSTYYPDSVEGRFTISRDNAKRMVYLQMNSLRAEDTAVYYCAAAGVRAEDGRVRTLPSEYTFWGQGTQVTVSS,RTFSYNP,LVAAISRTGGSTY,AAAGVRAEDGRVRTLPSEYTF,17.0,LVAAISRTGGSTY,AAAGVRAEDG-------RVRTLPSEYTF,RTFSYNPLVAAISRTGGSTYAAAGVRAEDG-------RVRTLPSEYTF,1.6387744,2.2692952,-2.451181,-2.3242962,"7eow_B,7a6o_B","High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine;Crystal Structure of the Complex of the Recombinant Von Willebrand Factor AIM-A1 domain and VHH81 at 2.1 Angstrom resolution"
EVQLVESGGGLVQPGGSLRLSCAASDYIYRRYRMGWYRQAPGKGREFVAAISGGSSINYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCAAYRIVSDPRVYWGQGTQVTVSS,YIYRRYR,FVAAISGGSSIN,AAYRIVSDPRVY,14.0,FVAAIS-GGSSIN,AAYRIV----------------SDPRVY,YIYRRYRFVAAIS-GGSSINAAYRIV----------------SDPRVY,-0.023989834,-0.38288218,-1.3667519,-1.9260919,"7t84_A,7t84_C,7t84_B,7t84_E,7t84_D,7t84_G,7t84_F,7t84_H",Structure of angiotensin II type I receptor (AT1R) nanobody antagonist AT118i4h32 G26D T57I variant
QVQLQESGGGLVQPGGSLRLSCAASGSTSSINAMGWYRQAPGKQREPVAISSSGGDTRYAEPVKGRFTISRDNAQNKVYLQMNSLKPEDTAVYYCWLNWGRTSVNSWGQGTQVTVSS,STSSINA,PVAISSSGGDTR,WLNWGRTSVNS,14.0,PVAISS-SGGDTR,WLNWG-----------------RTSVNS,STSSINAPVAISS-SGGDTRWLNWG-----------------RTSVNS,2.8951619,1.8422695,3.1879265,1.4130623,"6gk4_C,6gk4_F",Human NBD1 of CFTR in complex with nanobodies D12 and T8
QVQLQESGGGLVQAGSSLRLACAATGSIRSINNMGWYRQAPGKQRGMVAIITRVGNTDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTATYYCHAEITEQSRPFYLTDDYWGQGTQVTVSS,SIRSINN,MVAIITRVGNTD,HAEITEQSRPFYLTDDY,14.0,MVAIIT-RVGNTD,HAEITEQS-----------RPFYLTDDY,SIRSINNMVAIIT-RVGNTDHAEITEQS-----------RPFYLTDDY,-0.6811684,1.5930592,-1.5875643,-1.3240278,"6gk4_B,6gk4_E,6gkd_B,6gkd_G,6gkd_J,6gkd_M,6gkd_P,6gkd_S,6gjs_B",Human NBD1 of CFTR in complex with nanobodies D12 and T8;Human NBD1 of CFTR in complex with nanobodies D12 and T4;human NBD1 of CFTR in complex with nanobodies D12 and G3a
GSLRVSCAASGRTFTTYIMAWFRQAPGKEREFLAAMDQGRIQYYGDSVRGRFTISRDYAKNSVDLQLDGLRPEDTAVYYCAAGAGFWGLRTASSYHYWGQGTQVTVSS,RTFTTYI,FLAAMDQGRIQY,AAGAGFWGLRTASSYHY,34.0,FLAAMD-QGRIQY,AAGAGFWG-----------LRTASSYHY,RTFTTYIFLAAMD-QGRIQYAAGAGFWG-----------LRTASSYHY,1.7440373,-1.0911171,-5.778652,-0.31962162,"6hug_G,6huo_G,6huk_G,6huj_G,6hup_G","CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with alprazolam (Xanax), GABA and megabody Mb38.;CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with picrotoxin and megabody Mb38.;CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with diazepam (Valium), GABA and megabody Mb38.;CryoEM structure of human full-length heteromeric alpha1beta3gamma2L GABA(A)R in complex with picrotoxin, GABA and megabody Mb38.;CryoEM structure of human full-length alpha1beta3gamma2L GABA(A)R in complex with bicuculline and megabody Mb38."
QVQLVESGGGLVQAGGSLRLSCAASGLTFPAYAMGWYRQAPGKERELVAAITGDGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADRYVPAPPYYYWGQGTQVTVSS,LTFPAYA,LVAAITGDGSTN,AADRYVPAPPYYY,7.0,LVAAIT-GDGSTN,AADRYV---------------PAPPYYY,LTFPAYALVAAIT-GDGSTNAADRYV---------------PAPPYYY,3.6427767,3.9597578,3.9766557,3.1035025,8xld_B,Structure of the GFP:GFP-nanobody complex from Biortus.
EVQLLESGGGLVQPGGSLRLSCAASGFTFRDYEMWWVRQAPGKGLERVSAINPQGTRTYYADSVMGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKLPFTFDDWGQGTLVTVSS,FTFRDYE,RVSAINPQGTRTY,AKLPFTFDD,20.0,RVSAINPQGTRTY,AKLP-------------------FTFDD,FTFRDYERVSAINPQGTRTYAKLP-------------------FTFDD,-0.49514017,0.5699998,-3.1495302,-2.8457432,"5ihl_I,5ihl_B,5ihl_E,5ihl_G,5dmj_B,5dmj_E,5dmj_G",Structure of the extracellular domain of the CD40 in complex with 3H56-5 DAB;STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH 3H56-5 DAB
EVQLVESGGGQVETGGSLRLSCQASGSTFSDYVMAWFRQRPGKEREFVATISRNGGTTTYGSSVKGRFTISRDNAKSTVYLQMNSLKPEDTAVYYCYAVGGDGDSWGQGTQVTVSS,STFSDYV,FVATISRNGGTTT,YAVGGDGDS,18.0,FVATISRNGGTTT,YAVG-------------------GDGDS,STFSDYVFVATISRNGGTTTYAVG-------------------GDGDS,1.3857795,2.1834636,2.2322145,2.0543292,"7fg2_D,7fg3_D","Minor cryo-EM structure of S protein trimer of SARS-CoV2 with K-874A VHH, composite map;Major cryo-EM structure of S protein trimer of SARS-CoV2 with K-874, composite map"
QVQLQESGGGLVQAGGSLRLSCTASGRAFSWYVMGWFRQAPGKEREFVATVSGNGSRRDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASSTYYYTDPEKYDYWGQGTQVTVSS,RAFSWYV,FVATVSGNGSRRD,AASSTYYYTDPEKYDY,10.0,FVATVSGNGSRRD,AASSTYYY------------TDPEKYDY,RAFSWYVFVATVSGNGSRRDAASSTYYY------------TDPEKYDY,-1.1165506,-1.7147908,-0.62860316,0.91213804,"6gkd_C,6gkd_H,6gkd_K,6gkd_N,6gkd_Q,6gkd_T",human NBD1 of CFTR in complex with nanobodies D12 and G3a
QVQLVESGGGLVQAGGSLRLSCAASGYAYTYIYMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRFTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGYELRDRTYGQWGQGTQVTVSS,YAYTYIY,GVAAMDSGGGGTL,AAGGYELRDRTYGQ,12.0,GVAAMDSGGGGTL,AAGGYEL--------------RDRTYGQ,YAYTYIYGVAAMDSGGGGTLAAGGYEL--------------RDRTYGQ,2.463873,1.8754212,-1.5422189,0.81785554,"2p42_B,2p42_D,2p43_B,2p49_B,1bzq_K,1bzq_M,1bzq_L,1bzq_N","Complex of a camelid single-domain vhh antibody fragment with RNASE A at 1.8A resolution: SE3-mono-2 crystal form with three se-met sites (M34, M51, M83) in vhh scaffold;COMPLEX OF A DROMEDARY SINGLE-DOMAIN VHH ANTIBODY FRAGMENT WITH RNASE A;Complex of a camelid single-domain vhh antibody fragment with RNASE A at 1.65A resolution: SE3-mono-1 crystal form with three se-met sites (M34, M51, M83) in vhh scaffold;Complex of a camelid single-domain vhh antibody fragment with RNASE A at 1.4A resolution: native mono_1 crystal form"
KVQLQQSGGGAVQTGGSLKLTCLASGNTASIRAMGWYRRAPGKQREWVASLTTTGTADYGDFVKGRFTISRDNANNAATLQMDSLKPEDTAVYYCNADGRRFDGARWREYESWGQGTQVTISS,NTASIRA,WVASLTTTGTAD,NADGRRFDGARWREYES,25.0,WVASLT-TTGTAD,NADGRRFD-----------GARWREYES,NTASIRAWVASLT-TTGTADNADGRRFD-----------GARWREYES,0.6143263,0.38647002,1.9562678,-3.079446,4idl_A,Low melting temperature Anti-Cholera Toxin Llama VHH domain
QVQLVETGGGLVQPGGSLRLSCAASGFTFSSVYMNWVRQAPGKGPEWVSRISPNSGNIGYTDSVKGRFTISRDNAKNTLYLQMNNLKPEDTALYYCAIGLNLSSSSVRGQGTQVTVSS,FTFSSVY,WVSRISPNSGNIG,AIGLNLSSSSV,18.0,WVSRISPNSGNIG,AIGLN-----------------LSSSSV,FTFSSVYWVSRISPNSGNIGAIGLN-----------------LSSSSV,1.3617383,0.70882833,-4.705172,-2.983673,"6zxn_E,6zxn_D,6zxn_F",Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing nanobodies (Ty1)
QVQLVESGGALVQPGGSLRLSCVASGFTFSSFAMGWYRQAPGKECEWVATITITGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNPDPGCRRGQGTQVTVSS,FTFSSFA,WVATITITGGSTN,NPDPGCR,12.0,WVATITITGGSTN,NPD---------------------PGCR,FTFSSFAWVATITITGGSTNNPD---------------------PGCR,-0.7167094,-0.8398219,-3.7799387,-2.7318246,8q93_B,Crystal structure of the SARS-COV-2 RBD with neutralizing-VHHs Re30H02 and Re21D01
QVQLVETGGDLVQSGGSLRLACVLSGVTLDSYSIGWFRQAPGKEREGISYSEKSSGPTYYVDSVKGRFTVSRDNAKNTAYLQMNSLKPEDSGIYYCAADEAYYHEKGWQSPLGWPYWGQGTQVTVSS,VTLDSYS,GISYSEKSSGPTY,AADEAYYHEKGWQSPLGWPY,21.0,GISYSEKSSGPTY,AADEAYYHEK--------GWQSPLGWPY,VTLDSYSGISYSEKSSGPTYAADEAYYHEK--------GWQSPLGWPY,2.2855773,1.8506278,1.4325023,-0.36670244,8q94_B,Crystal structure of The SARS-COV-2 BA.2.75 RBD with neutralizing-VHHs Re32D03 and Ma3B12
QVQLVESGGGLVRTGGSLRLSCAASGSILQIWAMKWYRQAPGLQREWIATIPNSGEPFYASSVEGRFTGSRENEETVYLYLNNLEPEDTAVYYCEVNEGVPVREYWGQGTQVTVSS,SILQIWA,WIATIPNSGEPF,EVNEGVPVREY,23.0,WIATIP-NSGEPF,EVNEG-----------------VPVREY,SILQIWAWIATIP-NSGEPFEVNEG-----------------VPVREY,1.5463164,-0.40916428,-2.5129063,1.6246369,8q95_C,Crystal structure of the SARS-CoV-2 BA.1 RBD with neutralizing-VHHs Ma16B06 and Ma3F05
QVQLVESGGDLVQSGGSLKLACAVSGVTLDGYSIGWFRQAPGKEREAVSYSEKSNGPTYYVASVKGRFTISRDNAKNTAYLQMNNLKPEDTGIYYCAADEAYYHERGWQSPLGWPYWGQGTQVTVSS,VTLDGYS,AVSYSEKSNGPTY,AADEAYYHERGWQSPLGWPY,20.0,AVSYSEKSNGPTY,AADEAYYHER--------GWQSPLGWPY,VTLDGYSAVSYSEKSNGPTYAADEAYYHER--------GWQSPLGWPY,2.5295646,1.4026479,0.07139768,0.30790687,8q95_B,Crystal structure of the SARS-CoV-2 BA.1 RBD with neutralizing-VHHs Ma16B06 and Ma3F05
QLVESGGGLVQAGGSLRLSCVGTGNISSAYTMAWYRQAAGKEREVVAGILNGGSTHYADSVKGRFTISRDNAKNTVYLQMNSLQPEDTGVYCCHVVIESTRFVYDHYWGQGTRVTV,NISSAYT,VVAGILNGGSTH,HVVIESTRFVYDHY,20.0,VVAGIL-NGGSTH,HVVIEST--------------RFVYDHY,NISSAYTVVAGIL-NGGSTHHVVIEST--------------RFVYDHY,0.8609325,0.92903197,0.1642038,0.7289637,8ozb_A,Crystal structure of Nup35-Nb complex
QLVESGGGLVQAGGSLRLSCVGTGNISSAYTMAWYRQAAGKEREVVAGILNGGSTHYADSVKGRFTISRDNAKNTVYLQMNSLQPEDTGVYCCHVVIESTRFVYDHYWGQGTRVTVS,NISSAYT,VVAGILNGGSTH,HVVIESTRFVYDHY,19.0,VVAGIL-NGGSTH,HVVIEST--------------RFVYDHY,NISSAYTVVAGIL-NGGSTHHVVIEST--------------RFVYDHY,0.8609325,0.92903197,0.18351138,0.620923,8ozb_C,Crystal structure of Nup35-Nb complex
QVQLQESGGGLVQPGGSLRLSCTASESVASINIVGWYRQISGKERELVARISSGGTITDYSDSVKGRFTITRDNTKNTVYLQMNSLKRGDTAVYYCNAEYQYGSDWFHIWGQGTQVTVSS,SVASINI,LVARISSGGTITD,NAEYQYGSDWFHI,18.0,LVARISSGGTITD,NAEYQY---------------GSDWFHI,SVASINILVARISSGGTITDNAEYQY---------------GSDWFHI,0.14954117,2.0293298,-0.7730492,3.1141362,7nir_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8191 core
QVQLQESGGGLVQAGGSLRLSCAASGRSLSDYTMGWFRQAPGKEREFVTAITSDGVYANYADSVKGRFTISRDNAKNTAYLQMNSLKPEDTAVYYCAGKTRRSMLMTTGYDYWGQGTQVTVSS,RSLSDYT,FVTAITSDGVYAN,AGKTRRSMLMTTGYDY,10.0,FVTAITSDGVYAN,AGKTRRSM------------LMTTGYDY,RSLSDYTFVTAITSDGVYANAGKTRRSM------------LMTTGYDY,3.1988413,2.1344485,2.5897782,1.3895848,7nil_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8190 core
QVQLQESGGGLVQPGGSLRLSCAASGSDFSLYAMGWYRQVPGKERELVATITSGGTTNFADSARGRFTISRGNAKNTVYLQMNNLKPEDTAVYYCWSRGSYGRYLETWGQGTQVTVSS,SDFSLYA,LVATITSGGTTN,WSRGSYGRYLET,15.0,LVATIT-SGGTTN,WSRGSY----------------GRYLET,SDFSLYALVATIT-SGGTTNWSRGSY----------------GRYLET,1.4148643,2.2583842,3.1038334,2.8112967,7nik_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8189 core
QWQLVESGGGLVQPGGSLRLSCAASGSTFSSYAMGWYRQAPGKECELVAAISRAGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNAAAEGETGSNWSLCEEYDYWGKGTRVTVSS,STFSSYA,LVAAISRAGGSTN,NAAAEGETGSNWSLCEEYDY,12.0,LVAAISRAGGSTN,NAAAEGETGS--------NWSLCEEYDY,STFSSYALVAAISRAGGSTNNAAAEGETGS--------NWSLCEEYDY,0.7934596,1.3501173,3.4596715,2.9989085,7qbf_B,TC:CD320 in complex with nanobody TC-Nb34
QVQLQESGGGSVQAGGSLKLSCSVSGYTYSTYCIAWFRQVPGKEREGLAFIKNPEGNTDYADSVQGRFFISQDTVDNTVYLSMNSLKPEDTATYYCAGAVSNWVCGMSIKSQGYGMDYWGKGTQVTVSS,YTYSTYC,GLAFIKNPEGNTD,AGAVSNWVCGMSIKSQGYGMDY,25.0,GLAFIKNPEGNTD,AGAVSNWVCGM------SIKSQGYGMDY,YTYSTYCGLAFIKNPEGNTDAGAVSNWVCGM------SIKSQGYGMDY,2.534289,0.95192385,-0.06587817,0.87515205,"8ifn_A,8ifn_D,8ifn_F,8ido_C,8ido_D",Crystal structure of nanobody VHH-T148 with MERS-CoV RBD;MERS-CoV spike trimer in complex with nanobody VHH-T148
QVQLVESGGGVVQAGGSLRLSCAASGSIFSSNAMAWYRQAPGNVRRLVAAISSRGDNTNYEDSVRGRFTISRDNAENTVSLQMNSLKPEDTAIYYCNVGSFYRGNYYGGSSWGQGTQVTVSS,SIFSSNA,LVAAISSRGDNTN,NVGSFYRGNYYGGSS,17.0,LVAAISSRGDNTN,NVGSFYR-------------GNYYGGSS,SIFSSNALVAAISSRGDNTNNVGSFYR-------------GNYYGGSS,1.7943493,0.99946105,-1.7105927,-2.3305106,"7b5g_H,7b5g_B,7b5g_D,7b5g_F",Crystal structure of E.coli LexA in complex with nanobody NbSOS3(Nb14527)
QRQLVESGGGLVQPGGSLRLSCAASGTIFRLYDMGWFRQAPGKEREGVASITSGGSTKYADSVKGRFTISRDNAKNTVYLQMNSLEPEDTAVYYCNAEYRTGIWEELLDGWGKGTPVTVSS,TIFRLYD,GVASITSGGSTK,NAEYRTGIWEELLDG,13.0,GVASIT-SGGSTK,NAEYRTG-------------IWEELLDG,TIFRLYDGVASIT-SGGSTKNAEYRTG-------------IWEELLDG,-2.0543396,-0.16484527,-0.96855885,0.5681243,7ul3_C,"CryoEM Structure of Inactive H2R Bound to Famotidine, Nb6M, and NabFab"
KPSLRLSCAASGTIFRLYDMGWYRRVSGNQRELVASITSGGSTKYGDSVKGRFTISRDNAKNTVYLQMSSLKPEDTAVYYCNAEYRTGIWEELLDGWGQGTQVTVSS,TIFRLYD,LVASITSGGSTK,NAEYRTGIWEELLDG,31.0,LVASIT-SGGSTK,NAEYRTG-------------IWEELLDG,TIFRLYDLVASIT-SGGSTKNAEYRTG-------------IWEELLDG,-2.0292482,0.053944647,-3.0622814,-3.4531043,7ul4_D,CryoEM Structure of Inactive MOR Bound to Alvimopan and Mb6
QVQLQESGGGLVQAGGSLRLSCAASGYISDAYYMGWYRQAPGKEREFVATITHGTNTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVLETRSYSFRYWGQGTQVTVSS,YISDAYY,FVATITHGTNTY,AVLETRSYSFRY,8.0,FVATIT-HGTNTY,AVLETR----------------SYSFRY,YISDAYYFVATIT-HGTNTYAVLETR----------------SYSFRY,1.7684005,1.517965,-0.23877908,1.6704676,"5vnw_C,5vnw_D,5vnv_A",Crystal structure of Nb.b201;Crystal structure of Nb.b201 bound to human serum albumin
QVQLQESGGGLVQAGGSLRLSCAASGRMFSINSMGWYRQAPGKERELVATISEAGTTTYADSVRGRFTIARDNAKNTVYLQMNSLNPEDTAVYYCNAYIQLDSTIWFRAYWGQGTQVTVSS,RMFSINS,LVATISEAGTTT,NAYIQLDSTIWFRAY,11.0,LVATIS-EAGTTT,NAYIQLD-------------STIWFRAY,RMFSINSLVATIS-EAGTTTNAYIQLD-------------STIWFRAY,-0.36756495,-0.17946163,-2.0631366,2.278442,"6h71_C,6h71_D,6h72_C,6h72_D",GI.1 human norovirus protruding domain in complex with Nano-94;GI.1 human norovirus protruding domain in complex with Nano-94 and 2-fucosyllactose (2FL)
EVQLVESGGGLVQPGGSLRLSSAISGFSISSTSIDWVRQAPGKGLEWVARISPSSGSTSYADSVKGRFTISADTSKNTVYLQMNSLRAEDTAVYYTGRVAKALNSRSPSFVVNTYSSIGFDYRGQGTLVTVSS,FSISSTS,WVARISPSSGSTS,GRVAKALNSRSPSFVVNTYSSIGFDY,24.0,WVARISPSSGSTS,GRVAKALNSRSPS--FVVNTYSSIGFDY,FSISSTSWVARISPSSGSTSGRVAKALNSRSPS--FVVNTYSSIGFDY,-1.0114542,0.15191412,-1.037518,-2.9259222,"7d8b_B,7d8b_D",Engineering Disulphide-Free Autonomous Antibody VH Domains to modulate intracellular pathways
QVQLQESGGGLVMTGGSLRLSCAVSGRTIDVSVMAWFRQAPGKEREFVSGMRWSGMTTYSADSVKDRFTISRDKTKNTVYLQMNSLKPEDTAVYYCAARSRFIVGVPQARDLYDYWGQGTQVTVSS,RTIDVSV,FVSGMRWSGMTTY,AARSRFIVGVPQARDLYDY,17.0,FVSGMRWSGMTTY,AARSRFIVG---------VPQARDLYDY,RTIDVSVFVSGMRWSGMTTYAARSRFIVG---------VPQARDLYDY,-0.21571437,-0.34224027,-3.534369,1.2161779,"6h70_C,6h70_D,6h6z_C,6h6z_D",GI.1 human norovirus protruding domain in complex with Nano-62;GI.1 human norovirus protruding domain in complex with Nano-62 and 2-fucosyllactose (2FL)
QVQLQESGGGLVQAGGSLRLSCTASRRTGSNWCMGWFRQLAGKEPELVVALNFDYDMTYYADSVKGRFTVSRDSGKNTVYLQMNSLKPEDTAIYYCAARSGGFSSNRELYDGWGQGTQVTVSS,RTGSNWC,LVVALNFDYDMTY,AARSGGFSSNRELYDG,18.0,LVVALNFDYDMTY,AARSGGFS------------SNRELYDG,RTGSNWCLVVALNFDYDMTYAARSGGFS------------SNRELYDG,4.3650417,2.0669608,-3.0832875,-0.72042215,"2wzp_E,2wzp_D,2wzp_F,2wzp_K,2wzp_J,2wzp_L,2bse_E,2bse_D,2bse_F",Structure of Lactococcal Bacteriophage p2 Receptor Binding Protein in complex with a llama VHH domain;Structures of Lactococcal Phage p2 Baseplate Shed Light on a Novel Mechanism of Host Attachment and Activation in Siphoviridae
QVQLQESGGGSVQAGGSLRLSCTISDAIFSRYAVGWFRQAPGKECELVSTITPDSTTTHSDFVKGRFTLSRDNAKNTVYLQMHSLKPDDTAVYYCASRWRSVSEGCGGQGTQVTVSS,AIFSRYA,LVSTITPDSTTT,ASRWRSVSEGC,22.0,LVSTIT-PDSTTT,ASRWR-----------------SVSEGC,AIFSRYALVSTIT-PDSTTTASRWR-----------------SVSEGC,1.2952305,1.3355654,-2.1557739,-1.3019476,"8jly_A,8jjv_A",Structure of nanobody in complex with alpha-synuclein peptide;Structure of truncated form of nanobody in complex with alpha-synuclein peptide
QVQLVESGGGLVQAGGSLRLSCAASGFPVYRNRMHWYRQAPGKEREWVAAIESAGQETHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDEGWYWQTYDYWGQGTQVTVSA,FPVYRNR,WVAAIESAGQETH,NVKDEGWYWQTYDY,9.0,WVAAIESAGQETH,NVKDEGW--------------YWQTYDY,FPVYRNRWVAAIESAGQETHNVKDEGW--------------YWQTYDY,0.4807503,1.6709579,2.1683183,1.3259389,"7zkw_C,7zkw_D,7zk1_C",Crystal structure of cystinosin from Arabidopsis thaliana bound to sybody and nanobody;Crystal structure of cystinosin from Arabidopsis thaliana in complex with Cystine and sybody
QVQLVESGGGSAQPGGSLRLSCAVSGSVSELNTMGWFRQAPGKQRELVARITATSDATNYADSVKGRFTISRDNGWNTVYLQSNSLKPEDSAVYYCNVEGAPSWFSGIRSYWGQGTQVTVSS,SVSELNT,LVARITATSDATN,NVEGAPSWFSGIRSY,17.0,LVARITATSDATN,NVEGAPS-------------WFSGIRSY,SVSELNTLVARITATSDATNNVEGAPS-------------WFSGIRSY,2.221615,1.9851922,2.6609154,2.0519454,7zkz_C,Crystal structure of cystinosin from Arabidopsis thaliana bound to two nanobodies
QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALITVNGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAAWGYAWPLHQDDYWYWGQGTQVTVS,SISSITY,GVAALITVNGHTY,AAAAWGYAWPLHQDDYWY,14.0,GVAALITVNGHTY,AAAAWGYAW----------PLHQDDYWY,SISSITYGVAALITVNGHTYAAAAWGYAW----------PLHQDDYWY,0.61650366,-0.5590041,-3.1415706,-0.14597648,"7klw_C,7p7a_A,7p7a_D,7p78_Y,7p78_W,7p77_W,7p77_Y,7p77_X",SARS-CoV-2 spike protein in complex with sybody#68 in a 2up/1flexible conformation;Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding domain;SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation;SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
QVQLVESGGGLVQAGGSLRLSCAASGFPVYRDRMAWYRQAPGKEREWVAAIYSAGQQTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDVGHHYEYYDYWGQGTQVTVS,FPVYRDR,WVAAIYSAGQQTR,NVKDVGHHYEYYDY,8.0,WVAAIYSAGQQTR,NVKDVGH--------------HYEYYDY,FPVYRDRWVAAIYSAGQQTRNVKDVGH--------------HYEYYDY,-0.10537515,1.8454491,1.3821881,1.552156,7klw_B,Crystal structure of synthetic nanobody (Sb45+Sb68) complexes with SARS-CoV-2 receptor binding domain
QVQLQESGGGLVQAGGSLRLSCAASGNISAQAYMGWYRQAPGKERELVAGISYGATTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVISAGGGESIGYHFYWGQGTQVTVSS,NISAQAY,LVAGISYGATTY,AVISAGGGESIGYHFY,8.0,LVAGIS-YGATTY,AVISAGGG------------ESIGYHFY,NISAQAYLVAGIS-YGATTYAVISAGGG------------ESIGYHFY,2.991839,1.8156658,2.5903423,3.2623155,7upm_B,Tribbles (TRIB2) pseudokinase bound to nanobody Nb4.103
QVQLQESGGGLVQAGGSLRLSCAASGTIFVFDKMGWYRQAPGKEREFVATISRGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVRYTPWRRYSYWGQGTQVTVSS,TIFVFDK,FVATISRGGSTN,AVRYTPWRRYSY,8.0,FVATIS-RGGSTN,AVRYTP----------------WRRYSY,TIFVFDKFVATIS-RGGSTNAVRYTP----------------WRRYSY,0.24785408,0.2634518,-0.66260916,1.6270425,"7sl8_B,7sla_B",CryoEM structure of SGLT1 at 3.4 A resolution;CryoEM structure of SGLT1 at 3.15 Angstrom resolution
QVQLQESGGGLVQAGGSLRLSCAASGNISTRAGMGWYRQAPGKEREFVASINWGAITNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVEYKYGPQRSDTYYYWGQGTQVTVSS,NISTRAG,FVASINWGAITN,AVEYKYGPQRSDTYYY,8.0,FVASIN-WGAITN,AVEYKYGP------------QRSDTYYY,NISTRAGFVASIN-WGAITNAVEYKYGP------------QRSDTYYY,1.5501773,1.7264682,2.3313634,3.142192,7sl9_B,CryoEM structure of SMCT1
QVQLQESGGGLVQAGGSLRLSCAASGSIFALNIMGWYRQAPGKQRELVAAIHSGGTTNYANSVKGRFTISRDNAANTVYLQMNSLKPEDTAVYYCNVKDFGAIIYDYDYWGQGTQVTVSS,SIFALNI,LVAAIHSGGTTN,NVKDFGAIIYDYDY,10.0,LVAAIH-SGGTTN,NVKDFGA--------------IIYDYDY,SIFALNILVAAIH-SGGTTNNVKDFGA--------------IIYDYDY,-0.48093084,0.26327503,-1.5145239,0.24702185,"7bu6_B,7bu7_B,7xka_B,4ldl_B,4ldo_B,4lde_B,7xk9_B,6n48_B,4qkx_B,7bts_B,6h7o_C,6h7o_D,6h7n_C,6h7n_D,6h7m_C,6h7m_D,6h7l_C,6h7l_D","Structure of beta2 adrenoceptor bound to adrenaline and an engineered nanobody;Structure of beta2 adrenoceptor bound to hydroxybenzylisoproterenol and an engineered nanobody;Structure of human beta1 adrenergic receptor bound to epinephrine and nanobody 6B9;ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST XAMOTEROL AND NANOBODY Nb6B9;ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST SALBUTAMOL AND NANOBODY Nb6B9;Structure of human beta1 adrenergic receptor bound to BI-167107 and nanobody 6B9;ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND WEAK PARTIAL AGONIST CYANOPINDOLOL AND NANOBODY Nb6B9;ACTIVATED TURKEY BETA1 ADRENOCEPTOR WITH BOUND PARTIAL AGONIST DOBUTAMINE AND NANOBODY Nb6B9;Structure of human beta2 adrenergic receptor bound to constrained epinephrine;Structure of human beta2 adrenergic receptor bound to constrained isoproterenol;Structure of beta2 adrenergic receptor bound to BI167107, Nanobody 6B9, and a positive allosteric modulator;Structure of beta2 adrenoceptor bound to a covalent agonist and an engineered nanobody;Structure of beta2 adrenoceptor bound to BI167107 and an engineered nanobody;Structure of human beta1 adrenergic receptor bound to norepinephrine and nanobody 6B9"
QVQLQESGGGLVQAGGSLRLSCAASGYIFSSYAMGWYRQAPGKEREFVATIGWGTITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAQDLLYYSFPGDHAYWGQGTQVTVSS,YIFSSYA,FVATIGWGTITY,AAQDLLYYSFPGDHAY,8.0,FVATIG-WGTITY,AAQDLLYY------------SFPGDHAY,YIFSSYAFVATIG-WGTITYAAQDLLYY------------SFPGDHAY,-2.2186599,-2.7979183,-4.0306683,1.0471864,6o3c_B,"Crystal structure of active Smoothened bound to SAG21k, cholesterol, and NbSmo8"
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYKMNWVRQAPGKGLEWVSDISQSGARISYTGSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCARCPAPFTRDCFDVTSTTYAYRGQGTQVTVSS,FTFSNYK,WVSDISQSGARIS,ARCPAPFTRDCFDVTSTTYAY,17.0,WVSDISQSGARIS,ARCPAPFTRD-------CFDVTSTTYAY,FTFSNYKWVSDISQSGARISARCPAPFTRD-------CFDVTSTTYAY,-0.41909543,0.7595848,-3.711028,-2.9180465,8g2y_N,Cryo-EM structure of ADGRF1 coupled to miniGs/q
QVQLQESGGGLVQAGDSLRLSCVPSVRTSDNYIMGWFRQPPGKEREFVAAIRRSDGTTKYAASVKGRFAISRDVAKNAAYLQMNSLKAEDTAVYYCAAKYQSTFYSTMDVQYDYWGQGTQVTVSS,RTSDNYI,FVAAIRRSDGTTK,AAKYQSTFYSTMDVQYDY,20.0,FVAAIRRSDGTTK,AAKYQSTFY----------STMDVQYDY,RTSDNYIFVAAIRRSDGTTKAAKYQSTFY----------STMDVQYDY,4.021741,2.125204,-1.9041924,-0.45091355,"8hbj_F,8hbi_E",cocktail of FMDV (A/TUR/14/98) in complex with M678F and M688F;FMDV (A/TUR/14/98) in complex with M688F
QVQLVESGGGLVHPGGSLRLSCAASGRTGSRHAVAWFRQAPGKERDFVASINAVGLVRNYADSVLGRFSISRDFAKNEVYLQMNSLEPEDTAVYYCAARYYSGTYSSTYDRDDYDYWGQGTQVTVSS,RTGSRHA,FVASINAVGLVRN,AARYYSGTYSSTYDRDDYDY,18.0,FVASINAVGLVRN,AARYYSGTYS--------STYDRDDYDY,RTGSRHAFVASINAVGLVRNAARYYSGTYS--------STYDRDDYDY,0.7203348,-0.0067248344,-1.67172,0.10098225,5td8_E,Crystal structure of an Extended Dwarf Ndc80 Complex
QVQLVESGGGLVQAGGSLRLSCAASGFPVMYYNMHWYRQAPGKEREWVAAIESTGWWAHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDFGWRWEAYDYWGQGTQVTVSS,FPVMYYN,WVAAIESTGWWAH,NVKDFGWRWEAYDY,8.0,WVAAIESTGWWAH,NVKDFGW--------------RWEAYDY,FPVMYYNWVAAIESTGWWAHNVKDFGW--------------RWEAYDY,-1.3063935,-1.7349365,-1.797133,1.4583673,"8hbv_B,8hbw_B,8j1n_B",Structure of human UCP1 in the ATP-bound state;Structure of human UCP1 in the DNP-bound state;Structure of human UCP1 in the nucleotide-free state
QVQLVESGGGLVQAGGSLRLSCAASGRTLSSYAVGWFRQAPGLEREFVATISRSGGSTHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAATFTPDGSWYYTRGSSYDYWGQGTQVTVSS,RTLSSYA,FVATISRSGGSTH,AATFTPDGSWYYTRGSSYDY,10.0,FVATISRSGGSTH,AATFTPDGSW--------YYTRGSSYDY,RTLSSYAFVATISRSGGSTHAATFTPDGSW--------YYTRGSSYDY,1.3390315,1.9039041,0.52379954,0.67398775,"4tvs_a,4tvs_b","LAP1(aa356-583), H.sapiens, bound to VHH-BS1"
QVQLVESGGGLIKPGGSLRLSCAASGVRLSAYDMAWVRQAPGKGLEWVSAISSSGGSTYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTAVYYCVTLPDLCPGDNCTYPDASWGQGTMVTVSS,VRLSAYD,WVSAISSSGGSTY,VTLPDLCPGDNCTYPDAS,18.0,WVSAISSSGGSTY,VTLPDLCPG----------DNCTYPDAS,VRLSAYDWVSAISSSGGSTYVTLPDLCPG----------DNCTYPDAS,1.798216,1.4076624,-1.585804,-2.493322,"3qyc_A,3qyc_B",Structure of a dimeric anti-HER2 single domain antibody
QVQLVQSGGGLVQAGGSLRLSCAASVRFFSINTMGWYRQAPGKQRELVADITSSGSTNYADSGKGRFTISRDNAKNTVYLQMNRLKPEDTAVYYCHADYKYTTHNTAWGQGTQVTVSS,RFFSINT,LVADITSSGSTN,HADYKYTTHNTA,12.0,LVADIT-SSGSTN,HADYKY----------------TTHNTA,RFFSINTLVADIT-SSGSTNHADYKY----------------TTHNTA,0.92038196,1.0900422,-1.1149951,1.6464047,"7epb_C,7epb_D",Cryo-EM structure of LY354740-bound mGlu2 homodimer
QVQLVETGGGLVQPGGSLRLSCGASGSIFNMYAMGWYRQAPGKQREVVARIATDDSTMYPDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYYQRTVMSQPYWGQGTQVTVSS,SIFNMYA,VVARIATDDSTM,YYQRTVMSQPY,12.0,VVARIA-TDDSTM,YYQRT-----------------VMSQPY,SIFNMYAVVARIA-TDDSTMYYQRT-----------------VMSQPY,2.3709238,1.0290523,1.5359743,2.4825976,5eul_V,Structure of the SecA-SecY complex with a translocating polypeptide substrate
EVQLQQSGPELVKPGASVKMSCKASGYTFTSYVMHWVKQKPGQGLEWIGYINPYNDGTKYNEKFKGKATLTSDKSSSTAYMELSSLTSEDSAVYYCARGAYKRGYAMDYWGQGTSVTVSS,YTFTSYV,WIGYINPYNDGTK,ARGAYKRGYAMDY,47.0,WIGYINPYNDGTK,ARGAYK---------------RGYAMDY,YTFTSYVWIGYINPYNDGTKARGAYK---------------RGYAMDY,0.64384586,-0.79359305,-2.8369672,-2.951908,"5i0z_A,5i0z_B",Crystal structure of the single domain catalytic antibody 3D8-VH
QVQLQESGGGLVQPGGSLRLSCAASGFAFSSYELRWYRQAPGKQHELVAGITTGGNTYYADSVKGRFTISRDNAKNTVYLQMSNLRPEDTAVYACNANWDLLSDYWGQGTQVTVSS,FAFSSYE,LVAGITTGGNTY,NANWDLLSDY,17.0,LVAGIT-TGGNTY,NANWD------------------LLSDY,FAFSSYELVAGIT-TGGNTYNANWD------------------LLSDY,-0.4676253,0.66068983,-3.2551038,-1.7600856,6mxt_N,Crystal structure of human beta2 adrenergic receptor bound to salmeterol and Nb71
QVQLVESGGGSVQAGGSLRLSCAASGNIADIYYLGWFRQAPGKEREGVAALITYNGRTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYNGLIAAPLKVTRYWYWGQGTQVTVS,NIADIYY,GVAALITYNGRTY,AAAYNGLIAAPLKVTRYWY,14.0,GVAALITYNGRTY,AAAYNGLIA---------APLKVTRYWY,NIADIYYGVAALITYNGRTYAAAYNGLIA---------APLKVTRYWY,1.3526921,0.7893224,-1.2981873,0.4376666,"7p16_B,7p14_B",Structure of full-length rXKR9 in complex with a sybody at 3.66A;Structure of caspase-3 cleaved rXKR9 in complex with a sybody at 4.3A
DVQLVESGGGSVQAGGSLRLSCAASGRTFSRPVMAWFRQAPGKEREFVVAITWSGIRTSYADSVKGRFTISVDNAKDTVYLQMNSLKPEDTAVYYCAAGALPRTAHYEYDYWGLGTQVTVSS,RTFSRPV,FVVAITWSGIRTS,AAGALPRTAHYEYDY,14.0,FVVAITWSGIRTS,AAGALPR-------------TAHYEYDY,RTFSRPVFVVAITWSGIRTSAAGALPR-------------TAHYEYDY,0.0061823353,-0.47892898,-3.292979,0.41412455,6yu8_B,RNA Methyltransferase of Sudan Ebola Virus
QVQLVESGGGLVQAGDSLRLSCAASGRPFSNYAMGWFRQAPGKERERVASINWSGTDTDYADSVKGRFTISRDNAKRTLYLQMNTLKPEDTAVYYCAARVGVDYKYWGQGTQVTVSS,RPFSNYA,RVASINWSGTDTD,AARVGVDYKY,12.0,RVASINWSGTDTD,AARVG------------------VDYKY,RPFSNYARVASINWSGTDTDAARVG------------------VDYKY,1.5397377,3.0893183,2.0704725,0.6175421,"6vbg_C,6vbg_D",Lactose permease complex with thiodigalactoside and nanobody 9043
QVQLVESGGGTVPAGGSLRLSCAASGNTLCTYDMSWYRRAPGKGRDFVSGIDNDGTTTYVDSVAGRFTISQGNAKNTAYLQMDSLKPDDTAMYYCKPSLRYGLPGCPIIPWGQGTQVTVSS,NTLCTYD,FVSGIDNDGTTT,KPSLRYGLPGCPIIP,21.0,FVSGID-NDGTTT,KPSLRYG-------------LPGCPIIP,NTLCTYDFVSGID-NDGTTTKPSLRYG-------------LPGCPIIP,4.5507584,2.4954615,-2.4372978,-3.2700658,"1kxv_C,1kxv_D",Camelid VHH Domains in Complex with Porcine Pancreatic alpha-Amylase
QLQESGGGLVQPGGSLRLSCAASGFTFNNYWMYWVRRAPGKGLEWVSMINPGGIITKYAESVKGRFTISRDNAKNTLYLQMNSLTSEDTAVYYCAKDWATGLAKKGQGTQVTVSS,FTFNNYW,WVSMINPGGIITK,AKDWATGLAK,21.0,WVSMINPGGIITK,AKDWA------------------TGLAK,FTFNNYWWVSMINPGGIITKAKDWA------------------TGLAK,-0.33157468,0.21406388,-7.1795335,-3.0460002,3k74_B,Disruption of protein dynamics by an allosteric effector antibody
QVQLVESGGGLVQAGGSLRLSCAASGRTFSRYAMAWFRRAPGKEREFVAAISASAGTIFYTDSVKGRFTISRDHAKNTVSLQMNSLRPEDTAVYYCAAKTGTWATLDRRYDYWGQGTRVTVSA,RTFSRYA,FVAAISASAGTIF,AAKTGTWATLDRRYDY,16.0,FVAAISASAGTIF,AAKTGTWA------------TLDRRYDY,RTFSRYAFVAAISASAGTIFAAKTGTWA------------TLDRRYDY,0.9192131,2.006907,-2.423042,-2.8908002,6qgx_B,Crystal structure of E.coli BamA beta-barrel in complex with nanobody F7
QVQLQESGGGLVQAGGSLRLSCVASGRTFSSYAMGWFRQAPGKEREFVAAIDWSGGTASHADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASSYWSRSVDEYDYWGQGTQVTVSS,RTFSSYA,FVAAIDWSGGTAS,AASSYWSRSVDEYDY,11.0,FVAAIDWSGGTAS,AASSYWS-------------RSVDEYDY,RTFSSYAFVAAIDWSGGTASAASSYWS-------------RSVDEYDY,-0.46747953,0.889616,-0.021456584,0.94611603,"8e0e_B,8dam_B",nbF3:nbE8:CaV beta subunit 1b complex;nbF3:CaV beta subunit 2a complex
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYGMGWFRQAPGTEREFVAAISWSGDSTYYADSVKGRFTISIDKAKNTVYLQMNSLKPEDTAVYYCAADHALVVGGTYNYWGQGTQVTVSS,RTFSSYG,FVAAISWSGDSTY,AADHALVVGGTYNY,12.0,FVAAISWSGDSTY,AADHALV--------------VGGTYNY,RTFSSYGFVAAISWSGDSTYAADHALV--------------VGGTYNY,1.0261966,1.9922956,1.7678566,2.2927427,7s7r_B,Plasmodium falciparum protein Pf12 bound to nanobody G7
AVQLQESGGGLVQAGGSLRLSCTVSARTSSSHDMGWFRQAPGKEREFVAAISWSGGTTNYVDSVKGRFDISKDNAKNAVYLQMNSLKPEDTAVYYCAAKWRPLRYSDNPSNSDYNYWGQGTQVTVSS,RTSSSHD,FVAAISWSGGTTN,AAKWRPLRYSDNPSNSDYNY,17.0,FVAAISWSGGTTN,AAKWRPLRYS--------DNPSNSDYNY,RTSSSHDFVAAISWSGGTTNAAKWRPLRYS--------DNPSNSDYNY,3.927971,2.506415,1.6828716,0.78162724,"2xa3_A,7r73_A",crystal structure of the broadly neutralizing llama VHH D7 and its mode of HIV-1 gp120 interaction;Crystal structure of llama VHH antibody D7 in complex with HIV-1 gp120 core
QLQLVESGGGLVQPGGSLRLSCAASGFTFDSHDMAWVRQPHGKGLEYIATITSVGSNTYYSDSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAADLSTADWRANWAKGQGTQVTVSS,FTFDSHD,YIATITSVGSNTY,AADLSTADWRANWA,19.0,YIATITSVGSNTY,AADLSTA--------------DWRANWA,FTFDSHDYIATITSVGSNTYAADLSTA--------------DWRANWA,1.9260627,1.7461354,-2.3661015,-2.9057844,"7xy4_E,7xy4_D",Cryo-EM structure of SARS-CoV-2 spike in complex with VHH21
QVQLVESGGSLVQPGGSLRLSCAASGRFAESSSMGWFRQAPGKEREFVAAISWSGGATNYADSAKGRFTLSRDNTKNTVYLQMNSLKPDDTAVYYCAANLGNYISSNQRLYGYWGQGTQVTVSS,RFAESSS,FVAAISWSGGATN,AANLGNYISSNQRLYGY,14.0,FVAAISWSGGATN,AANLGNYI-----------SSNQRLYGY,RFAESSSFVAAISWSGGATNAANLGNYI-----------SSNQRLYGY,1.7797844,2.258422,2.7183182,3.0521894,6ir1_B,Crystal structure of red fluorescent protein mCherry complexed with the nanobody LaM4 at 1.9 Angstron resolution
QVQLVESGGGLVQAGGSLRLSCATSGFTFSDYAMGWFRQAPGKEREFVAAISWSGHVTDYADSVKGRFTISRDNVKNTVYLQMNSLKPEDTAVYSCAAAKSGTWWYQRSENDFGSWGQGTQVTVS,FTFSDYA,FVAAISWSGHVTD,AAAKSGTWWYQRSENDFGS,12.0,FVAAISWSGHVTD,AAAKSGTWW---------YQRSENDFGS,FTFSDYAFVAAISWSGHVTDAAAKSGTWW---------YQRSENDFGS,-0.23244649,-0.5622884,-2.6621773,-0.87488157,"6ir2_B,7saj_H,7saj_B,7saj_J,7saj_D,7saj_F",Crystal Structure of LaM2 Nanobody bound to mCherry;Crystal structure of red fluorescent protein mCherry complexed with the nanobody LaM2 at 1.4 Angstron resolution
QVQLQESGGGLVQAGGSLRLSCAASGSIFRIDAMGWYRQAPGKQRELVAHSTSGGSTDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNADVRTRWYASNNYWGQGTQVTVSS,SIFRIDA,LVAHSTSGGSTD,NADVRTRWYASNNY,8.0,LVAHST-SGGSTD,NADVRTR--------------WYASNNY,SIFRIDALVAHST-SGGSTDNADVRTR--------------WYASNNY,-0.3902041,0.51194084,0.7338632,1.088875,6gju_C,human NBD1 of CFTR in complex with nanobodies T2a and T4
QLLESGGGLVQPGGSLRLSCAASGFTFSDEDMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKSYGAFDYWGQGTLVTVS,FTFSDED,WVSAISGSGGSTY,AKSYGAFDY,21.0,WVSAISGSGGSTY,AKSY-------------------GAFDY,FTFSDEDWVSAISGSGGSTYAKSY-------------------GAFDY,2.261897,1.9570724,-0.72800446,-3.2029927,"3upc_A,3upc_C,3upc_B,3upc_E,3upc_D,3upc_G,3upc_F,3upc_I,3upc_H,3upc_J",A general strategy for the generation of human antibody variable domains with increased aggregation resistance
EVKLQESGGGLVQAGESLRLSCAVPPEVFDIRTVAWYRQVPLGKGRELLSSITPWNKTTYEDSVKDRFTISRDNAKYTVYLQMNDLKPEDTAVYYCAQGWGIASMRYWGQGTQVTVSS,EVFDIRT,LLSSITPWNKTT,AQGWGIASMRY,23.0,LLSSIT-PWNKTT,AQGWG-----------------IASMRY,EVFDIRTLLSSIT-PWNKTTAQGWG-----------------IASMRY,2.570355,1.9148244,-1.768007,-3.4167423,"6apo_A,6app_A",Anti-Marburgvirus Nucleoprotein Single Domain Antibody A;Anti-Marburgvirus Nucleoprotein Single Domain Antibody A Complexed with Nucleoprotein C-terminal domain
QVQLVESGGGLMQAGGSLRLSCAVSGRTFSTAAMGWFRQAPGKEREFVAAIRWSGGSAYYADSVKGRFTISRDKAKNTVYLQMNSLKYEDTAVYYCARTENVRSLLSDYATWPYDYWGQGTQVTVSS,RTFSTAA,FVAAIRWSGGSAY,ARTENVRSLLSDYATWPYDY,12.0,FVAAIRWSGGSAY,ARTENVRSLL--------SDYATWPYDY,RTFSTAAFVAAIRWSGGSAYARTENVRSLL--------SDYATWPYDY,-1.4686794,-0.26928627,-2.835538,0.33661908,"6z2m_D,6z2m_F,6z43_Y,6z43_X,6z43_Z,6yz5_F,6yz7_FFF,6yz7_DDD","Cryo-EM Structure of SARS-CoV-2 Spike : H11-D4 Nanobody Complex;H11-D4 complex with SARS-CoV-2 RBD;H11-D4, SARS-CoV-2 RBD, CR3022 ternary complex"
EVQLVESGGGLVQPGGSLRLSCVGSGRVRTINTAGWYRQAPGQEPEFLARITVGGTTSYADSVKGRFTISRDLAKSTVYLQMDYLKPEDTAVYYCNADFDFGSRTAWGQGTQVTVSS,RVRTINT,FLARITVGGTTS,NADFDFGSRTA,18.0,FLARIT-VGGTTS,NADFD-----------------FGSRTA,RVRTINTFLARIT-VGGTTSNADFD-----------------FGSRTA,0.9958412,2.0200534,-0.90641254,0.91659087,"8h7m_A,8h7m_B,8h7n_A,8h7r_A,8h7i_A,8h7i_B",Structure of nanobody 11A in complex with quinalphos;Structure of nanobody 11A in complex with triazophos;Structure of nanobody 11A in complex with coumaphos;Structure of nanobody 11A in complex with parathion
KAHNTESGEMLFTVKKSLRLSCTASGAIFSTYDVSWYRQAPEKPRELVAIITRGGNTHYADTVKGRFTISRDNAKKTVNLQMNSLKPEDTAVYYCHAGVQGAMLGPRNYWGQGTQVTVSS,AIFSTYD,LVAIITRGGNTH,HAGVQGAMLGPRNY,26.0,LVAIIT-RGGNTH,HAGVQGA--------------MLGPRNY,AIFSTYDLVAIIT-RGGNTHHAGVQGA--------------MLGPRNY,3.2213633,3.4814315,-1.9161556,-1.9410722,"7q6z_B,7q1u_B",Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to IMP-1575;Structure of Hedgehog acyltransferase (HHAT) in complex with megabody 177 bound to non-hydrolysable palmitoyl-CoA (Composite Map)
QVQLQESGGGLVQAGGSLRLSCAASGNIFAYYIMGWYRQAPGKERELVATIDIGGNTNYADSVKGRFTISRDNAKNNVYLQMNSLKPEDTAVYYCAVQAVPIRYRRYWGQGTQVTVSS,NIFAYYI,LVATIDIGGNTN,AVQAVPIRYRRY,9.0,LVATID-IGGNTN,AVQAVP----------------IRYRRY,NIFAYYILVATID-IGGNTNAVQAVP----------------IRYRRY,1.1938399,0.90789235,-0.42027444,2.3849952,7k65_B,Hedgehog receptor Patched (PTCH1) in complex with conformation selective nanobody TI23
QVQLQESGGGSVQAGGSLRLSCAASGYTDSRYCMAWFRQAPGKEREWVARINSGRDITYYADSVKGRFTFSQDNAKNTVYLQMDSLEPEDTATYYCATDIPLRCRDIVAKGGDGFRYWGQGTQVTVSS,YTDSRYC,WVARINSGRDITY,ATDIPLRCRDIVAKGGDGFRY,16.0,WVARINSGRDITY,ATDIPLRCRD-------IVAKGGDGFRY,YTDSRYCWVARINSGRDITYATDIPLRCRD-------IVAKGGDGFRY,0.8788197,2.4556084,-0.8222634,1.0778656,"2x89_A,2x89_C,2x89_B,4kdt_A,4kdt_B",Structure of the Beta2_microglobulin involved in amyloidogenesis;Structure of an early native-like intermediate of beta2-microglobulin amyloidosis
QVQLVESGGGLVQAGGSLRLSCGASGTFFRINDMGWYRQASGKQRELVASITRGGTTDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCKANRNWGREWDDYWGQGTQVTVSS,TFFRIND,LVASITRGGTTD,KANRNWGREWDDY,10.0,LVASIT-RGGTTD,KANRNW---------------GREWDDY,TFFRINDLVASIT-RGGTTDKANRNW---------------GREWDDY,0.7826273,1.0618211,-0.5433124,-3.3280761,"7nvm_N,7nvm_n,7nvl_N,7nvl_n,7nvo_N,7nvo_n,7nvn_N,7nvn_n","Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound;Human TRiC complex in open state with nanobody bound;Human TRiC complex in closed state with nanobody bound (Consensus Map);Human TRiC complex in closed state with nanobody and tubulin bound"
DVQLQESGGGLVQAGGSLRLSCAASGATGSTYDMGWFRQAPGKERESVAAINWGSAGTYYASSVRGRFTISRDNAKKTVYLQMNSLKPEDTAVYTCGAGRIGRSVFNLRRESWVTWWGQGTQVTVSS,ATGSTYD,SVAAINWGSAGTY,GAGRIGRSVFNLRRESWVTW,14.0,SVAAINWGSAGTY,GAGRIGRSVF--------NLRRESWVTW,ATGSTYDSVAAINWGSAGTYGAGRIGRSVF--------NLRRESWVTW,1.0261215,1.3147901,-1.5365771,-1.9699094,"1shm_A,1shm_B,1shm_E,1shm_D",Convergent solutions to VHH domain stabilization from natural and in vitro evolution
EVQLVESGGGLVQPGGSLRLSCAASGGTFSSIGMGWFRQAPGKEREFVAAISWDGGATAYADSVKGRFTISADNSKNTAYLQMNSLKPEDTAVYYCAKEDVGKPFDWGQGTLVTVSS,GTFSSIG,FVAAISWDGGATA,AKEDVGKPFD,14.0,FVAAISWDGGATA,AKEDV------------------GKPFD,GTFSSIGFVAAISWDGGATAAKEDV------------------GKPFD,1.3441068,2.2866888,2.339191,2.4603188,"8eyh_D,8eyg_E,8eyg_F,8f4p_D",SARS-CoV-2 spike protein trimer (down conformation) bound with a nanobody;SARS-CoV-2 spike protein bound with a nanobody;SARS-CoV-2 spike protein complexed with two nanobodies
QVQLQESGGGSVQAGGSLRLSCAASGYTYSSNCMAWFRQVPGKEREGVASINTRGGITYYADSVKGRFTISRDNAKNTVSLQMNSLKPEDTATYYCAAVREATYSDNRCSVRSYTYDYWGQGTQVTVSS,YTYSSNC,GVASINTRGGITY,AAVREATYSDNRCSVRSYTYDY,14.0,GVASINTRGGITY,AAVREATYSDN------RCSVRSYTYDY,YTYSSNCGVASINTRGGITYAAVREATYSDN------RCSVRSYTYDY,1.591149,2.3155894,-1.4308133,0.6474932,4w6y_B,Co-complex structure of the lectin domain of F18 fimbrial adhesin FedF with inhibitory nanobody NbFedF9
ESGEMLFTVKKSLRLSCAASGRTFSTAAMGWFRQAPGKERDFVAGIYWTVGSTYYADSAKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAARRRGFTLAPTRANEYDYWGQGTQVTVSS,RTFSTAA,FVAGIYWTVGSTY,AARRRGFTLAPTRANEYDY,23.0,FVAGIYWTVGSTY,AARRRGFTL---------APTRANEYDY,RTFSTAAFVAGIYWTVGSTYAARRRGFTL---------APTRANEYDY,0.6621596,-0.26496154,-3.0327084,0.64845353,6xux_A,Crystal structure of Megabody Mb-Nb207-cYgjK_NO
QVQLVESGGGLVQAGGSLRLSCVVSGSAVSDYAMGWYRQAPGKQRELVAAIYNSGRTNYVDSVKGRFTISKDNAKKTVYLQMNCLKPEDTADYFCNLLGATTMSNAVWGQGTQVTVSS,SAVSDYA,LVAAIYNSGRTN,NLLGATTMSNAV,16.0,LVAAIY-NSGRTN,NLLGAT----------------TMSNAV,SAVSDYALVAAIY-NSGRTNNLLGAT----------------TMSNAV,2.1430833,2.1642723,0.49036235,-0.16260755,"5nm0_A,5nm0_C,5nm0_B,5nm0_D,5nml_A,5nml_C,5nml_B,5nml_E,5nml_D,5nml_G,5nml_F,5nml_I,5nml_H,5nml_J","Nb36 Ser85Cys with Hg bound;Nb36 Ser85Cys with Hg, crystal form 1"
QVQLVESGGGLVKTGGSLRLSCAASGRTFSTYSMGWFRQAPGKEREFVAGMRWTGSSTFYSDSVKGRFTVSRNNAKDTVYLHMNSLKPEDTAVYYCAITTIVRAYYTEYTEADFGSWGQGTQVTVSS,RTFSTYS,FVAGMRWTGSSTF,AITTIVRAYYTEYTEADFGS,15.0,FVAGMRWTGSSTF,AITTIVRAYY--------TEYTEADFGS,RTFSTYSFVAGMRWTGSSTFAITTIVRAYY--------TEYTEADFGS,-2.9425395,-2.6592474,-4.813711,1.8277783,"8owt_FFF,8owt_CCC,7oaq_FFF,7oap_FFF",Nanobody H3 AND C1 bound to RBD;Nanobody H3 AND C1 bound to RBD with Kent mutation;SARS-CoV-2 spike RBD with A8 and H3 nanobodies bound
QVQLVESGGGLVQAGGSLRLSCAASGSIRSLNAMGWYRQAPGKQRELVAAITSRGSTRYGDFVKGRFTISRGNAKNTVYLQMNSLSVEDTAVYYCKQTQLGYDYWGQGTQVTVSS,SIRSLNA,LVAAITSRGSTR,KQTQLGYDY,13.0,LVAAIT-SRGSTR,KQTQ-------------------LGYDY,SIRSLNALVAAIT-SRGSTRKQTQ-------------------LGYDY,0.9881024,1.6822895,-2.0336323,-1.2045698,"7ocj_H,7ocj_B,7ocj_E,7ocj_G",Crystal structure of E.coli LexA in complex with nanobody NbSOS2(Nb14509)
QVQLQESGGGLVQPGGSLTLSCAASGFTFSSYSMYWVRQAPGKGLEWVSSINRVGSNTDYADSVKGRFTISRDNAKNTLYLQMNSLKSEDTALYYCAVGMYAAPPWRGQGTQVTVSS,FTFSSYS,WVSSINRVGSNTD,AVGMYAAPPW,18.0,WVSSINRVGSNTD,AVGMY------------------AAPPW,FTFSSYSWVSSINRVGSNTDAVGMY------------------AAPPW,0.33528534,0.371916,-5.997971,-2.955749,"5jmr_A,5jmr_B,5jmo_C,5jmo_D",X-ray structure of furin in complex with the inhibitory antibody Nb14;X-ray structure of the furin inhibitory antibody Nb14
QVQLVESGGGLVQAGESLRLSCAASKPTFRNFAAGWFRQTPGKDREFVAVIEYDGDSAYYADSVKGRFTISRDNAKNTVYLQMNRLKPGDTAVYICAIGGNHYDPSKYYTADEYDYWGQGTQVTVSS,PTFRNFA,FVAVIEYDGDSAY,AIGGNHYDPSKYYTADEYDY,16.0,FVAVIEYDGDSAY,AIGGNHYDPS--------KYYTADEYDY,PTFRNFAFVAVIEYDGDSAYAIGGNHYDPS--------KYYTADEYDY,1.4603847,0.9618268,-3.4623444,-3.3742468,8cwv_B,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 2-31 and a human antibody CC12.1 Fab
HVQLVESGGGLVQAGGSLRLSCAAPGRTFSTSAMGWFRQAPGKEREFVAAIDWSNTNIHYADTVKGRFTISTDTAKNTVYLQMNNLKPEDTAVYYCAQGGWGLTQPISVDYWGKGTQVTVSS,RTFSTSA,FVAAIDWSNTNIH,AQGGWGLTQPISVDY,15.0,FVAAIDWSNTNIH,AQGGWGL-------------TQPISVDY,RTFSTSAFVAAIDWSNTNIHAQGGWGL-------------TQPISVDY,0.7844533,2.0013075,2.4145963,1.2467093,8cwu_B,Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with a cross-neutralizing nanobody 1-21
QVQLVESGGGLVQAGGSLRLSCAASESTFSNYAMGWFRQAPGPEREFVATISQTGSHTYYRNSVKGRFTISRDNAKNTVYLQMNNMKPEDTAVYYCAAGDNYYYTRTYEYDYWGQGTQVTVSS,STFSNYA,FVATISQTGSHTY,AAGDNYYYTRTYEYDY,14.0,FVATISQTGSHTY,AAGDNYYY------------TRTYEYDY,STFSNYAFVATISQTGSHTYAAGDNYYY------------TRTYEYDY,0.63500893,1.8170375,-0.98550624,0.96426135,"4hem_E,4hem_G,4hem_F",Llama vHH-02 binder of ORF49 (RBP) from lactococcal phage TP901-1
EVQLLESGGGLVQPGGSLRLSCAASGFTFGNYDMAWVRQAPGKRPEWVSSIDTGGDITHYADSVKGRFTISRDNAKNTLYLQMNSLRPEDTAVYWCATDEEYALGPNEFDYYGQGTLVTVSS,FTFGNYD,WVSSIDTGGDITH,ATDEEYALGPNEFDY,19.0,WVSSIDTGGDITH,ATDEEYA-------------LGPNEFDY,FTFGNYDWVSSIDTGGDITHATDEEYA-------------LGPNEFDY,1.7183303,0.72911084,-0.951621,-3.3508875,"5nqw_C,5nqw_D",IgE-Fc in complex with single domain antibody 026
DVQLVESGGGLVQPGGSLRLSCEASGFSFDDYAIGWFRQAPGKEREGVSYISMSDGRTYVADSVTGRFTISSDNAKNTVYLQMNSLKLEDTAVYYCAAGRFVTFGSAWSFVGGGPYGIDYWGKGTLVTVSS,FSFDDYA,GVSYISMSDGRTY,AAGRFVTFGSAWSFVGGGPYGIDY,18.0,GVSYISMSDGRTY,AAGRFVTFGSAW----SFVGGGPYGIDY,FSFDDYAGVSYISMSDGRTYAAGRFVTFGSAW----SFVGGGPYGIDY,1.979206,1.7260009,0.8543985,2.7281356,4hep_G,Complex of lactococcal phage TP901-1 with a llama vHH (vHH17) binder (nanobody)
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIGWVRRAPGKGEEWVASIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWGGDGFYAMDYWGQGTLVTVSS,FNIKDTY,WVASIYPTNGYTR,ARWGGDGFYAMDY,20.0,WVASIYPTNGYTR,ARWGGD---------------GFYAMDY,FNIKDTYWVASIYPTNGYTRARWGGD---------------GFYAMDY,2.3359492,1.9652504,-0.23679651,-2.7507915,"3b9v_A,3b9v_C,3b9v_B,3b9v_D",Crystal Structure of an Autonomous VH Domain
QVKLQQSGGGMVQTGDSLRLSCVGSRRALSSTIVGWFRQIPGKEREFVGGIAWSSSDTWYADSVKGRFTISKDDAANGVHLQMSSLKPEDTAVYYCASALRRPGSDASDYTRIPDYPYWGQGTQVTVSS,RALSSTI,FVGGIAWSSSDTW,ASALRRPGSDASDYTRIPDYPY,25.0,FVGGIAWSSSDTW,ASALRRPGSDA------SDYTRIPDYPY,RALSSTIFVGGIAWSSSDTWASALRRPGSDA------SDYTRIPDYPY,1.9164305,1.4644057,-1.1796643,-0.78752226,"5vm4_A,5vm4_C,5vm4_B,5vm4_E,5vm4_D,5vm4_G,5vm4_F,5vm4_I,5vm4_H,5vm4_K,5vm4_J,5vm4_L,5vm6_A",The apo form of the triclocarban-binding single domain camelid nanobody VHH T10;The hapten triclocarban bound to the single domain camelid nanobody VHH T10
EVQLVESGGGLVQTGDSLRLSCAASGRTYTPYAMAWFRQAPGKEREFVAGIGGIDGTAAYADSVRGRATISRDSAKKTVYLQMNSLKPEDTAVYSCATRASMQVLTSPRVYPIWGRGTQVTVSS,RTYTPYA,FVAGIGGIDGTAA,ATRASMQVLTSPRVYPI,18.0,FVAGIGGIDGTAA,ATRASMQV-----------LTSPRVYPI,RTYTPYAFVAGIGGIDGTAAATRASMQV-----------LTSPRVYPI,3.1574023,2.4357386,1.2728596,-1.9025896,"5vm0_A,5vm0_B,5vlv_A",The hapten triclocarban bound to the single domain camelid nanobody VHH T9;The apo form of the triclocarban-binding single domain camelid nanobody VHH T9
QVQLQESGGGSVQTGGSLRLSCAGSGYTDNSCSMGWYRQAPGRERELIGTIISDGTTYYSDAVKGRFTISLDNAKNTVYLQMNNLKPEDTAMYICNTGWSQGSLVNRTTGWTRDCWSFGIWGQGTQVTVSS,YTDNSCS,LIGTIISDGTTY,NTGWSQGSLVNRTTGWTRDCWSFGI,18.0,LIGTII-SDGTTY,NTGWSQGSLVNR---TTGWTRDCWSFGI,YTDNSCSLIGTII-SDGTTYNTGWSQGSLVNR---TTGWTRDCWSFGI,1.3671457,1.3178343,1.4579942,1.4333048,"8iee_C,8iee_D",Crystal structure of nanobody VHH-31 with MERS-CoV RBD
EVQLVESGGGLVQPGGSLRLSCAASDFDFYDYEMSWVRQAPGKALEWIGNIYYSGDTFYNPSLKSRVTISRDNSKNTLYLQMNSLRAEDTATYYCARVESGSGWLDFWGQGTLVTVSS,FDFYDYE,WIGNIYYSGDTF,ARVESGSGWLDF,25.0,WIGNIY-YSGDTF,ARVESG----------------SGWLDF,FDFYDYEWIGNIY-YSGDTFARVESG----------------SGWLDF,-0.67128617,0.9040557,-1.3374116,-2.5694244,8di5_H,Cryo-EM structure of SARS-CoV-2 Beta (B.1.351) spike protein in complex with VH domain F6 (focused refinement of RBD and VH F6)
QVQLQESGGGLVLPGGSLRLSCATSGFTFSNSWMYWVRQAPGKGLEWVSRINAGGNTVDYKDSVKGRFSISRDNAKNTLYLQMNSLKPEDTAVYYCARGLNRYAYDSRGQGTQVTVSS,FTFSNSW,WVSRINAGGNTVD,ARGLNRYAYDS,19.0,WVSRINAGGNTVD,ARGLN-----------------RYAYDS,FTFSNSWWVSRINAGGNTVDARGLN-----------------RYAYDS,1.2956762,1.2141342,-4.623681,-3.2720852,"5usf_C,5usf_D",Leishmania donovani tyrosyl-tRNA synthetase in complex with nanobody and inhibitor
QVQLVESGGGLVQAGGSLSLSCAASGGDFSRNAMAWFRQAPGKEREFVASINWTGSGTYYLDSVKGRFTISRDNAKNALYLQMNNLKPEDTAVYYCARSTVFAEITGLAGYQSGSYDYWGQGTQVTVSS,GDFSRNA,FVASINWTGSGTY,ARSTVFAEITGLAGYQSGSYDY,14.0,FVASINWTGSGTY,ARSTVFAEITG------LAGYQSGSYDY,GDFSRNAFVASINWTGSGTYARSTVFAEITG------LAGYQSGSYDY,-0.108335175,0.30262238,0.045216784,0.5752805,4lgs_B,Ricin A chain bound to camelid nanobody (VHH4)
VQLVESGGGLVQPGGSLRLHCAASGSIASIYRTCWYRQGTGKQRELVAAITSGGNTYYADSVKGRFTISRDNAKNTIDLQMNSLKPEDTAVYYCNADEAGIGGFNDYWGQGTQVTVSS,SIASIYR,LVAAITSGGNTY,NADEAGIGGFNDY,17.0,LVAAIT-SGGNTY,NADEAG---------------IGGFNDY,SIASIYRLVAAIT-SGGNTYNADEAG---------------IGGFNDY,0.7756627,1.9532834,0.45087618,-1.4690084,4lgr_B,Ricin A chain bound to camelid nanobody (VHH3)
QVQLQESGGGLEQPGGSLRLSCATSGVIFGINAMGWYRQAPGKQRELVATFTSGGSTNYADFVEGRFTISRDNAKNTVYLQMNGLRPEDTAVYYCHATVVVSRYGLTYDYWGQGTQVTVSS,VIFGINA,LVATFTSGGSTN,HATVVVSRYGLTYDY,16.0,LVATFT-SGGSTN,HATVVVS-------------RYGLTYDY,VIFGINALVATFT-SGGSTNHATVVVS-------------RYGLTYDY,-0.080074586,-1.5074475,-1.8767197,2.0265965,"6gjq_H,6gjq_B,6gjq_D,6gjq_F",human NBD1 of CFTR in complex with nanobody T27
QVQLVESGGGLVQPGGSLRLSCAASGFTFKNADMNWYRQVPGQGLEWVTSIYSDGRTVYADSVKGRFTVSRDNPKSTVSLQMNSLKPEDTGVYYCMAGSKSGHELDHWGQGTQVTVSS,FTFKNAD,WVTSIYSDGRTV,MAGSKSGHELDH,18.0,WVTSIY-SDGRTV,MAGSKS----------------GHELDH,FTFKNADWVTSIY-SDGRTVMAGSKS----------------GHELDH,3.9923885,3.007145,-0.051850483,-2.694024,"7km5_C,7km5_D",Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1
EVQLLESGGGLVQPGGSLRLSCAASGFTFRGYSMAWVRQAPGKGLEWVSTISPIGTYTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKGSYSRGTPFDYWGQGTLVTVSS,FTFRGYS,WVSTISPIGTYTY,AKGSYSRGTPFDY,18.0,WVSTISPIGTYTY,AKGSYS---------------RGTPFDY,FTFRGYSWVSTISPIGTYTYAKGSYS---------------RGTPFDY,-0.063744165,0.86352956,-3.3998642,-2.731272,"6t2j_A,6t2j_B,6sc5_C,6sc5_B,6sc6_C,6sc6_B,6sc7_C,6sc7_B,6sc8_C,6sc8_B,6sc9_C,6sc9_B",dAb3;dAb3/HOIP-RBR-Ligand4;dAb3/HOIP-RBR-Ligand3;dAb3/HOIP-RBR-HOIPIN-8;dAb3/HOIP-RBR-Ligand2;dAb3/HOIP-RBR apo structure
EEQLVESGGGLVQPGGSLRLSCAASGFRFGSYYMSWVRQAPGKAPEWVSDINTRGETTRYSDSVKGRFTIARDNANNTVFLFMNRLKPEDTAVYYCAVAASGDTFEGRSDPDYWGQGTLVTVS,FRFGSYY,WVSDINTRGETTR,AVAASGDTFEGRSDPDY,22.0,WVSDINTRGETTR,AVAASGDT-----------FEGRSDPDY,FRFGSYYWVSDINTRGETTRAVAASGDT-----------FEGRSDPDY,1.8920436,1.2127229,-1.2982174,-2.4700139,"7y0n_I,7y0n_H,7y0n_G,7y0o_B",Interface of SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody;SARS-CoV-2 WT Spike in complex with R15 Fab and P14 Nanobody
QVQLVETGGLVQPGGSLRLSCAASGLTLDYYNIGWFRQAPGKEREWVSSISSSDGRKYYVNSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADRDRLPSAITYEYNYWGQGTQVTVSS,LTLDYYN,WVSSISSSDGRKY,AADRDRLPSAITYEYNY,14.0,WVSSISSSDGRKY,AADRDRLP-----------SAITYEYNY,LTLDYYNWVSSISSSDGRKYAADRDRLP-----------SAITYEYNY,2.5369225,2.509519,1.7048751,1.6400156,7tgi_B,Single-domain VHH intrabodies neutralize ricin toxin
QVQLQESGGGLVQAGGSLRLSCAASGRTLSSYAMGWFRQAPGKEREFVAAINRSGSTFYADAVKGRFTISRDNAKNTVYLQMNSLKPEDTAAYYCAADRFSPVVPGPIPVNTVDSWGQGTQVTVSS,RTLSSYA,FVAAINRSGSTF,AADRFSPVVPGPIPVNTVDS,11.0,FVAAIN-RSGSTF,AADRFSPVVP--------GPIPVNTVDS,RTLSSYAFVAAIN-RSGSTFAADRFSPVVP--------GPIPVNTVDS,1.6016439,2.5405478,2.491358,1.6380763,"3stb_A,3stb_B",A complex of two editosome proteins and two nanobodies
VQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSGDKSDYTDSVKGRFTISRDNAKNTMYLQMNNLKPEDTATYYCARGLGIYIIRARGGYDHWQQGTQVTVS,RTFSSYN,FVASITSSGDKSD,ARGLGIYIIRARGGYDH,18.0,FVASITSSGDKSD,ARGLGIYI-----------IRARGGYDH,RTFSSYNFVASITSSGDKSDARGLGIYI-----------IRARGGYDH,0.070333086,-0.6885049,-3.0034714,-2.783252,6heq_A,Prion nanobody 484
QVQLQESGGGLVQAGGSLRLSCAASGSTFGIRTMGWYRQAPGKQRDLVAIISSGGSTDYADSVKGRFTISRDNAKNTVYLQMDSLKPEDTAIYYCNARVGITMLAHWGQGTQVTVSS,STFGIRT,LVAIISSGGSTD,NARVGITMLAH,12.0,LVAIIS-SGGSTD,NARVG-----------------ITMLAH,STFGIRTLVAIIS-SGGSTDNARVG-----------------ITMLAH,1.3498303,2.2816086,-1.4282615,0.1577583,"4zg1_A,4zg1_C,4zg1_B,4zg1_E,4zg1_D,4zg1_F",Crystal structure of a nanobody raised against KDM5B
EVQLEESGGGLVQPGGSLRLSCAASGFNIKDTYIGWVRQAPGKGEEWVASIYPTSGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCAAGSIQKSLQTAESILEEFDYWGQGTLVTVSS,FNIKDTY,WVASIYPTSGYTR,AAGSIQKSLQTAESILEEFDY,21.0,WVASIYPTSGYTR,AAGSIQKSLQ-------TAESILEEFDY,FNIKDTYWVASIYPTSGYTRAAGSIQKSLQ-------TAESILEEFDY,1.0139136,1.9075614,0.04411982,-2.6897848,"6z3x_A,6z3x_B",Crystal structure of the designed antibody DesAb-anti-HSA-P1
QVQLVESGGGLVQAGGSLRLSCAASGLTFSRYVMGWFRQAPGKEREFVAAITWGGTPNYADSVKGRFTISRDNSKNTQYLQMNSLKPEDTAVYYCAAGLGWDSRYSQSYNYWGQGTQVTVSS,LTFSRYV,FVAAITWGGTPN,AAGLGWDSRYSQSYNY,10.0,FVAAIT-WGGTPN,AAGLGWDS------------RYSQSYNY,LTFSRYVFVAAIT-WGGTPNAAGLGWDS------------RYSQSYNY,0.48807314,0.9239652,-0.17306842,1.0577838,4nc2_B,Crystal structure of TcdB-B1 bound to B39 VHH
QVQLQESGGGLVQAGGSLRLSCAASGRTSSLYSMGWFRQAPGKEREFVAAISRNGANTYYTDSVKGRFTISRDNAKNTVELQMNSLKPEDTAVYYCAADRFPTMEVVTIMTNEYDYWGQGTQVTVSS,RTSSLYS,FVAAISRNGANTY,AADRFPTMEVVTIMTNEYDY,11.0,FVAAISRNGANTY,AADRFPTMEV--------VTIMTNEYDY,RTSSLYSFVAAISRNGANTYAADRFPTMEV--------VTIMTNEYDY,0.37181672,1.0803795,2.3644285,1.1876729,"4dka_A,4dka_B,4dk6_A,4dk6_B,4dk3_A,4dk3_B",Structure of Editosome protein
QVKLQQSGGGLVQPGGSLRLSCAASESTISINTLGWYRQAPGNQRELVATITTGGTTNYADSVKGRFTISRDNAKNTVYLQMNNLEPGDTAVYYCNLKRRDLQSRFGGYWGQGTQVTVSS,STISINT,LVATITTGGTTN,NLKRRDLQSRFGGY,17.0,LVATIT-TGGTTN,NLKRRDL--------------QSRFGGY,STISINTLVATIT-TGGTTNNLKRRDL--------------QSRFGGY,2.7970781,2.977559,0.94844323,1.7446325,"8g0w_H,8g0w_C,8g0w_D,8g0w_G",Crystal structure of human norovirus GII.4 P domain in complex with Nanobody M4
QVQLVESGGGSVQAGGSLRLSCAASGNTDSSYYMGWFRQGPGKEREGVASIYIRAGIPYYTDSVKGRFTISQDNAKNTIYLQMNSLKPEDTAMYFCAGSVRTTIQPFKGNYYNYWGRGTQVTVSS,NTDSSYY,GVASIYIRAGIPY,AGSVRTTIQPFKGNYYNY,16.0,GVASIYIRAGIPY,AGSVRTTIQ----------PFKGNYYNY,NTDSSYYGVASIYIRAGIPYAGSVRTTIQ----------PFKGNYYNY,1.3132707,0.6095998,-2.3930123,-0.46508902,"5mp2_C,5mp2_D",XcpQN012 in complex with VHH04
QVQLVESGGGLVQAGGSLRLSCVVSGSAVSDYAMGWYRQAPGKQRELVAAIYNSGRTNYVDSVKGRFTISKDNAKKTVYLQMNSLKPEDTADYFCNLLGATTMSNAVWGQGTQVTVSS,SAVSDYA,LVAAIYNSGRTN,NLLGATTMSNAV,15.0,LVAAIY-NSGRTN,NLLGAT----------------TMSNAV,SAVSDYALVAAIY-NSGRTNNLLGAT----------------TMSNAV,2.1430833,2.1642723,0.24094304,-0.34129435,"5nlu_A,5nlw_A",Structure of Nb36 crystal form 2;Structure of Nb36 crystal form 1
QVQLVESGGGLVQGSLRLSCAASGHTFNYPIMGWFRQAPGKEREFVGAISWSGGSTSYADSVKDRFTISRDNAKNTVYLEMNNLKPEDTAVYYCAAKGRYSGGLYYPTNYDYWGQGTQVTV,HTFNYPI,FVGAISWSGGSTS,AAKGRYSGGLYYPTNYDY,15.0,FVGAISWSGGSTS,AAKGRYSGG----------LYYPTNYDY,HTFNYPIFVGAISWSGGSTSAAKGRYSGG----------LYYPTNYDY,1.3112396,2.1092196,2.5035818,0.8580225,"7qnb_N,7qnc_G,7qnc_F,7qna_N,7qnd_K,7qnd_M,7qnd_L,7qn6_K,7qn6_M,7qn6_L,7qn7_G,7qn7_F,7qn5_G,7qn5_F,7qn8_K,7qn8_M,7qn8_L,7qn9_M,7qn9_L","Cryo-EM structure of human full-length extrasynaptic alpha4beta3delta GABA(A)R in complex with nanobody Nb25;Cryo-EM structure of human full-length extrasynaptic alpha4beta3delta GABA(A)R in complex with GABA, histamine and nanobody Nb25;Cryo-EM structure of human full-length beta3delta GABA(A)R in complex with nanobody Nb25;Cryo-EM structure of human full-length beta3delta GABA(A)R in complex with histamine and nanobody Nb25;Cryo-EM structure of human full-length extrasynaptic alpha4beta3delta GABA(A)R in complex with GABA, histamine and nanobody Nb25 in a pre-open/closed state;Cryo-EM structure of human full-length alpha4beta3gamma2 GABA(A)R in complex with GABA and nanobody Nb25;Cryo-EM structure of human full-length extrasynaptic alpha4beta3delta GABA(A)R in complex with THIP (gaboxadol), histamine and nanobody Nb25;Cryo-EM structure of human full-length extrasynaptic beta3delta GABA(A)R in complex with THIP (gaboxadol), histamine and nanobody Nb25;Cryo-EM structure of human full-length beta3gamma2 GABA(A)R in complex with GABA and nanobody Nb25"
EVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVATARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVS,RTISRYA,FVATARRSGDGAF,AIDSDTFYSGSYDY,15.0,FVATARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVATARRSGDGAFAIDSDTF--------------YSGSYDY,0.08542108,-0.32102722,2.6101167,1.9054961,"8r61_C,8r61_F,8r61_I,8r61_L,8r61_O,8r61_R",Structure of IgE delta epsilon 3-4 in complex with a kappa binding nanobody
QVQLQESGGGLVQAGESLRLSCAASGGTFIYYGMGWFRQAPGKEREFVASISQTGGDIYAMDFVKGRFTISRDNSKNTLYLQMNSLKPEDTAVYYCAAATSPYASRKLYEYKYWGQGTQVTVSS,GTFIYYG,FVASISQTGGDIY,AAATSPYASRKLYEYKY,15.0,FVASISQTGGDIY,AAATSPYA-----------SRKLYEYKY,GTFIYYGFVASISQTGGDIYAAATSPYA-----------SRKLYEYKY,0.14331678,1.4854094,-0.7063177,0.40182197,7nk2_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8202 core
QVQLQESGGGLVQPGGSLRLSCAASGSDFSLYAMGWYRQVPGKERELVATITIGGTTNFADSARGRFTISRGNAKNTVYLQMNNLKPEDTAVYYCWSRGSYGRYLETWGQGTQVTVSS,SDFSLYA,LVATITIGGTTN,WSRGSYGRYLET,15.0,LVATIT-IGGTTN,WSRGSY----------------GRYLET,SDFSLYALVATIT-IGGTTNWSRGSY----------------GRYLET,0.6269094,0.4476518,1.5317659,2.705742,7nk1_F,1918 Influenza virus polymerase heterotirmer in complex with vRNA promoters and Nb8201
QVQLQESGGGLVQPRGSLRLSCAASGSIAIIYTMGWYRQAPLKERELVATVTYGGNTNYADPVKGRFTISRDNNKNTEYLQMSSLQPEDTAVYYCYMRVRSTAWDTDDYWGQGTQVTVSS,SIAIIYT,LVATVTYGGNTN,YMRVRSTAWDTDDY,15.0,LVATVT-YGGNTN,YMRVRST--------------AWDTDDY,SIAIIYTLVATVT-YGGNTNYMRVRST--------------AWDTDDY,-1.5828731,-1.8703202,-1.2563924,0.44144523,7nk6_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8204
QVQLQESGGGLVQAGESLRLSCAASGGTLIYYGMGWFRQAPGKEREFVASISQAGGDIYAMDFVKGRFTISRDNSKNTLYLQLNTLKPEDTAVYYCAAATSPYASRKLYDYKYWGQGTQVTVSS,GTLIYYG,FVASISQAGGDIY,AAATSPYASRKLYDYKY,17.0,FVASISQAGGDIY,AAATSPYA-----------SRKLYDYKY,GTLIYYGFVASISQAGGDIYAAATSPYA-----------SRKLYDYKY,0.5372723,1.8683659,-0.11997135,0.5470832,7nkr_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8210
EVQLQASGGGSVQAGQSLRLSCATSGATSSSNCMGWFRQAPGKEREGVAVIDTGRGNTAYADSVQGRLTISLDNAKNTLYLQMNSLKPEDTAMYYCAADTSTWYRGYCGTNPNYFSYWGQGTQVTVSS,ATSSSNC,GVAVIDTGRGNTA,AADTSTWYRGYCGTNPNYFSY,19.0,GVAVIDTGRGNTA,AADTSTWYRG-------YCGTNPNYFSY,ATSSSNCGVAVIDTGRGNTAAADTSTWYRG-------YCGTNPNYFSY,3.7706919,2.9659877,0.027494147,0.35326463,1rjc_A,Crystal structure of the camelid single domain antibody cAb-Lys2 in complex with hen egg white lysozyme
QLQLVETGGGLVQAGGSLRLSCAASGRTFSSYSMGWFRQAPGKEREYVAAVNSNGDSTFYADSIKGRFTVSRDAAKNTVYLQMNSLKPEDTALYYCAAVYGRYTYQSPKSYEYWGQGTQVTVSS,RTFSSYS,YVAAVNSNGDSTF,AAVYGRYTYQSPKSYEY,14.0,YVAAVNSNGDSTF,AAVYGRYT-----------YQSPKSYEY,RTFSSYSYVAAVNSNGDSTFAAVYGRYT-----------YQSPKSYEY,2.1644108,2.3936124,-0.06651087,0.4610756,"7k7y_H,7k7y_C,7k7y_D,7k7y_F",Crystal structure of BoNT/E LC-HN domain in complex with VHH JLE-E9
DVQLQESGGGSVQAGGSLRLSCVVSGLTISNYCMRWFRQAPGKGREGVASINSAGTTYYADSVKGRFTMSRDNAKNTVYLDMNSLKPEDTAIYYCASSTRVWGGYCGGLDDATNNDWGQGTQVTVSS,LTISNYC,GVASINSAGTTY,ASSTRVWGGYCGGLDDATNND,18.0,GVASIN-SAGTTY,ASSTRVWGGY-------CGGLDDATNND,LTISNYCGVASIN-SAGTTYASSTRVWGGY-------CGGLDDATNND,1.747538,2.787991,-3.138911,-3.0853646,"5u65_A,5u65_B",Camel Nanobody VHH-5
QVQLQESGGGLVQAGASLRLSCTASGRTSSTYPMGWFRQGPGKEREFVAAISWAGSSTYYGDFVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCARAARPYAYGLDYSTEASYDYWGQGTQVTVSS,RTSSTYP,FVAAISWAGSSTY,ARAARPYAYGLDYSTEASYDY,14.0,FVAAISWAGSSTY,ARAARPYAYG-------LDYSTEASYDY,RTSSTYPFVAAISWAGSSTYARAARPYAYG-------LDYSTEASYDY,0.23961666,0.9481267,-0.7251762,-0.34991103,7nkc_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8207
QVQLQESGGGLVQPGGSLRLSCTASGGIFGISAMGWYRQAPGKERELVARITRSGSTNFADSVKDRFTISRDATENTVVLQMNSLKAEDTAVYYCNGQFWEVDNGNIDLWGQGTQVTVSS,GIFGISA,LVARITRSGSTN,NGQFWEVDNGNIDL,16.0,LVARIT-RSGSTN,NGQFWEV--------------DNGNIDL,GIFGISALVARIT-RSGSTNNGQFWEV--------------DNGNIDL,0.10388907,0.55629355,3.252796,3.357743,7nka_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8206
QVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVAVARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVS,RTISRYA,FVAVARRSGDGAF,AIDSDTFYSGSYDY,14.0,FVAVARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVAVARRSGDGAFAIDSDTF--------------YSGSYDY,-0.3579229,-0.5756862,2.3969715,1.3409057,7m74_N,ATP-bound AMP-activated protein kinase
QVQLQESGGGSVQAGGSLRLSCSGYTYSSNCVVWFRQTPGKEREVVASIYTGDNSTYYADSVKGRFTISLDNGKKTLYLQMDSLEAEDTARYYCAAGAATTQTMVACGRTPGPYELKYWGQGTQVTVSS,YTYSSNC,VVASIYTGDNSTY,AAGAATTQTMVACGRTPGPYELKY,25.0,VVASIYTGDNSTY,AAGAATTQTMVA----CGRTPGPYELKY,YTYSSNCVVASIYTGDNSTYAAGAATTQTMVA----CGRTPGPYELKY,4.733829,2.7361207,1.9509726,1.8426867,8idm_B,Crystal structure of nanobody VHH-227 with nanobody VHH-T71 and MERS-CoV RBD
QVQLVESGGAAVQTGGSLRLSCVASGFDLSNHAMAWVRQSPGKGLEYISGINNGGTTTTYGDSVKDRFTISRDNAKSTVYLQMNRLEADDTAVYYCVKSSYSDIVSARFDSWGKGTQVTVS,FDLSNHA,YISGINNGGTTTT,VKSSYSDIVSARFDS,25.0,YISGINNGGTTTT,VKSSYSD-------------IVSARFDS,FDLSNHAYISGINNGGTTTTVKSSYSD-------------IVSARFDS,0.86587584,2.6447854,-1.5993383,-3.0942805,8p88_C,X-ray structure of cardiotoxic light chain H3 in complex to neutralizing nanobody C4
QVQLVESGGALVEPGGSLRLSCVASGFPFNEYDMSWVRQAPGKGLEWVSTIKSDGAYTYYGDNVKGRFTISRDNAKNTLYLQMNSLKSEDTGVYYCAKEARIGVSGTYDYWGQGTQVTVS,FPFNEYD,WVSTIKSDGAYTY,AKEARIGVSGTYDY,20.0,WVSTIKSDGAYTY,AKEARIG--------------VSGTYDY,FPFNEYDWVSTIKSDGAYTYAKEARIG--------------VSGTYDY,1.1943463,1.4476451,-2.8622923,-3.6826265,"8p89_C,8p89_D",X-ray structure of cardiotoxic light chain H3 in complex to neutralizing nanobody B5
QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAITSGGGSTSYSDAVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAKGYVVDFLDLAEYDSWGQGTQVTVSS,FTFSSYA,WVSAITSGGGSTS,AKGYVVDFLDLAEYDS,16.0,WVSAITSGGGSTS,AKGYVVDF------------LDLAEYDS,FTFSSYAWVSAITSGGGSTSAKGYVVDF------------LDLAEYDS,-2.068965,-1.645916,-4.3683987,-3.0501463,5nbd_C,PglK flippase in complex with inhibitory nanobody
QVQLVESGGGSVQAGDSLRLSCTASGRTFTNYGMGWFRQAPGKEREFVAAIGRFGFPLYYSDSVKGRFTISRDNAKTTVYLQMHNLKPEDTAIYFCAARNPRATAEDVSAYDYWGQGTQVTVSS,RTFTNYG,FVAAIGRFGFPLY,AARNPRATAEDVSAYDY,17.0,FVAAIGRFGFPLY,AARNPRAT-----------AEDVSAYDY,RTFTNYGFVAAIGRFGFPLYAARNPRAT-----------AEDVSAYDY,2.2068412,1.1037409,-0.5781633,-0.06802702,"5nbm_E,5nbm_F,5nbl_E,5nbl_F",Crystal structure of the Arp4-N-actin(ATP-state) heterodimer bound by a nanobody;Crystal structure of the Arp4-N-actin(APO-state) heterodimer bound by a nanobody
QLQLVESGGGLVQAGGSLRLSCAASGSTSNINVMGWYRQAPGKQRELVATISSGDALNYANSVEGRFTISRDAAKNTVYLQMNSLKPEDSAVYICNAYVVSSYGYRASWNDYWGQGTQVTVSS,STSNINV,LVATISSGDALN,NAYVVSSYGYRASWNDY,14.0,LVATIS-SGDALN,NAYVVSSY-----------GYRASWNDY,STSNINVLVATIS-SGDALNNAYVVSSY-----------GYRASWNDY,0.87139493,0.5954567,-0.5947514,-0.664618,7wn0_B,Structure of PfENT1(Y190A) in complex with nanobody 19
QVKLEESGGGLVQAGGSLRLSCAASGRTYSTYAMGWFRQTPGKERELVAAINWSGGNTHYADSVKGRFTISRDNAKSTVYLQMNSLKPEDTAVYYCAAPKGHTGDHYWGPGTQVTVSS,RTYSTYA,LVAAINWSGGNTH,AAPKGHTGDHY,13.0,LVAAINWSGGNTH,AAPKG-----------------HTGDHY,RTYSTYALVAAINWSGGNTHAAPKG-----------------HTGDHY,2.3801968,3.1072936,2.4698112,1.3206191,6dyx_D,Structure of VHH R419 isolated from a pre-immune phage display library
EVQLQASGGGLVRPGGSLRLSCAASGFTFSSYAMMWVRQAPGKGLEWVSAINGGGGSTSYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAKYQAAVHQEKEDYWGQGTQVTVSS,FTFSSYA,WVSAINGGGGSTS,AKYQAAVHQEKEDY,17.0,WVSAINGGGGSTS,AKYQAAV--------------HQEKEDY,FTFSSYAWVSAINGGGGSTSAKYQAAV--------------HQEKEDY,-0.1912773,0.07324335,-2.6242733,-2.595405,"7n0r_C,7n0r_D",Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody C2
EVQLQASGGGLVQAGGSLRLSCAASGRTDSTQHMAWFRQAPGKEREFVTAIQWRGGGTSYTDSVKGRFTISRDNAKNTVYLEMNSLKPEDTAVYYCATNTRWTYFSPTVPDRYDYWGQGTQVTVSS,RTDSTQH,FVTAIQWRGGGTS,ATNTRWTYFSPTVPDRYDY,14.0,FVTAIQWRGGGTS,ATNTRWTYF---------SPTVPDRYDY,RTDSTQHFVTAIQWRGGGTSATNTRWTYF---------SPTVPDRYDY,0.57077587,1.0798143,-0.21259923,0.5681425,"7n0i_I,7n0i_K,7n0i_J,7n0i_L",Structure of the SARS-CoV-2 N protein C-terminal domain bound to single-domain antibody E2
QVQLVESGGGLVQPGGSLRLSCAASGITLDYYAIGWFRQAPGKEREGVSRIRSSDGSTNYADSVKGRFTMSRDNAKNTVYLQMNSLKPEDTAVYYCAYGPLTKYGSSWYWPYEYDYWGQGTQVTVSS,ITLDYYA,GVSRIRSSDGSTN,AYGPLTKYGSSWYWPYEYDY,11.0,GVSRIRSSDGSTN,AYGPLTKYGS--------SWYWPYEYDY,ITLDYYAGVSRIRSSDGSTNAYGPLTKYGS--------SWYWPYEYDY,0.0797685,0.71645725,-0.89195436,1.5515361,"7on5_A,7olz_C",Crystal structure of the SARS-CoV-2 neutralizing nanobody Re5D06;Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06
QVQLQESGGGLVQPGGSLRLSCAASGSIFSTNAMGWYRQAPGKQREQVATITSGSSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNAAGATIDLADFGSWGQGTQVTVSS,SIFSTNA,QVATITSGSSTN,NAAGATIDLADFGS,9.0,QVATIT-SGSSTN,NAAGATI--------------DLADFGS,SIFSTNAQVATIT-SGSSTNNAAGATI--------------DLADFGS,0.85953265,1.2846357,2.9029324,1.589741,"7unz_A,7unz_C",Crystal structure of H2 nanobody in complex with PfCSS
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGKEREFVAAISYSGSNTYDADSVKGRFAISRDNAKNTVYLQMNSLKPEDTAVYYCAAAGVYSGTYTDTEFDYWGQGTQVTVSS,RTFSSYA,FVAAISYSGSNTY,AAAGVYSGTYTDTEFDY,11.0,FVAAISYSGSNTY,AAAGVYSG-----------TYTDTEFDY,RTFSSYAFVAAISYSGSNTYAAAGVYSG-----------TYTDTEFDY,-0.24898246,0.3190323,0.30380994,1.4463513,"7uny_C,7uny_B",Crystal structure of D2 nanobody in complex with PfCSS
QVQLQQSGGGLVQAGGSLRLSCAASGRTHTPYAMGWFRQAPGKEREFVGGIGGVAATTTYADSVRGRFTISRDDAKATVYLQMNSLKPEDTAVYYCATRASMAVSTSPRVYPIWGQGTQVTVSS,RTHTPYA,FVGGIGGVAATTT,ATRASMAVSTSPRVYPI,13.0,FVGGIGGVAATTT,ATRASMAV-----------STSPRVYPI,RTHTPYAFVGGIGGVAATTTATRASMAV-----------STSPRVYPI,2.7956612,2.3163323,2.6815758,1.9160953,"5vl2_A,5vl2_C,5vl2_B,5vl2_E,5vl2_D,5vl2_G,5vl2_F,5vl2_H",The hapten triclocarban bound to the single domain camelid nanobody VHH T4
QVQLQESGGGLVQAGGSLRLSCTASGRTFGSYAMGWFRQAPGKDREFVAAISTTGRSTDNAGSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAARAQLMDRSRYSYDYWGQGTQVTVSS,RTFGSYA,FVAAISTTGRSTD,AARAQLMDRSRYSYDY,13.0,FVAAISTTGRSTD,AARAQLMD------------RSRYSYDY,RTFGSYAFVAAISTTGRSTDAARAQLMD------------RSRYSYDY,2.2033157,2.8650537,-2.9555519,-2.4372454,8p8a_Z,Structure of 5D3-Fab and nanobody(Nb17)-bound ABCG2
QVQLQESGGGLVQAGGSLRLSCAASGRSFSSYTMGWFRQAPGKEREFVAAIKWSGDITKYVDSVKGRFTISRDNSKNTVYLEMNSLKPEDTAVYYCGADNTWVGYPSSRSSMDYWGQGTQVTVSS,RSFSSYT,FVAAIKWSGDITK,GADNTWVGYPSSRSSMDY,12.0,FVAAIKWSGDITK,GADNTWVGY----------PSSRSSMDY,RSFSSYTFVAAIKWSGDITKGADNTWVGY----------PSSRSSMDY,0.62115294,1.2453622,-1.1104242,0.9057155,8p8j_Z,Structure of 5D3-Fab and nanobody(Nb96)-bound ABCG2
QVQLVQSGGGLVQAGGSLRLSCAASGGTFATSPMGWLRQAPGKGTEFVAAISPSGGDRIYADSVKGRFTISRDNAGNFIYLQMNSLKPEDTAVYYCAVRRRFDGTSYYTGDYDSWGQGTLVTVSS,GTFATSP,FVAAISPSGGDRI,AVRRRFDGTSYYTGDYDS,15.0,FVAAISPSGGDRI,AVRRRFDGT----------SYYTGDYDS,GTFATSPFVAAISPSGGDRIAVRRRFDGT----------SYYTGDYDS,1.8794988,1.5657355,0.20165136,-2.6458032,8b7w_H,Complex IL-17A/anti-IL-17A-76
QVQLVESGGGLVQAGGSLRLSCAASGYPHPYLHMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRFTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGYELRDRTYGHWGQGTQVTVSS,YPHPYLH,GVAAMDSGGGGTL,AAGGYELRDRTYGH,12.0,GVAAMDSGGGGTL,AAGGYEL--------------RDRTYGH,YPHPYLHGVAAMDSGGGGTLAAGGYEL--------------RDRTYGH,3.8893998,3.358941,2.5453317,1.7937391,4ppt_A,Engineered Dual Specific VHH Antibody in Complex with a Nickel (II) Ion
EVQLVESGGGLIQPGGSLRLSCAVSGFTVSKNYMSWVRQAPGKGLEWVSVVYSGGSKTYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARAVPHSPSSFDIWGQGTMVTVSS,FTVSKNY,WVSVVYSGGSKT,ARAVPHSPSSFDI,20.0,WVSVVY-SGGSKT,ARAVPH---------------SPSSFDI,FTVSKNYWVSVVY-SGGSKTARAVPH---------------SPSSFDI,2.6071546,1.3269348,-1.495584,-2.6699326,"7dv4_H,7dv4_B,7dv4_D,7dv4_F",Crystal structure of anti-CTLA-4 VH domain in complex with human CTLA-4
DVQLVESGGGSVQAGGSLRLSCAASGKFSHLVFLGWFRQAPGKEREGVAAGLGAYESGYYADSVKGRFTVSLDNAENTVYLQMNSLKPEDTALYYCAALVVLSRDNTEFIAHNYWGQGTQVTVSS,KFSHLVF,GVAAGLGAYESGY,AALVVLSRDNTEFIAHNY,15.0,GVAAGLGAYESGY,AALVVLSRD----------NTEFIAHNY,KFSHLVFGVAAGLGAYESGYAALVVLSRD----------NTEFIAHNY,1.2841488,0.41079116,-4.22806,0.4065364,7xrp_B,Cryo-EM structure of SARS-CoV-2 spike protein in complex with nanobody C5G2 (localized refinement)
QMQLVESGGGLVQAGGSLRLSCAVSGSIFSIITLAWYRQAPGKPRENVATITRGSRTSYCDSVKGRFTISKDNAKSTVYLQMNKLKPEDTADYYCNAEGPAGYWGQGTPVTVSA,SIFSIIT,NVATITRGSRTS,NAEGPAGY,19.0,NVATIT-RGSRTS,NAEG--------------------PAGY,SIFSIITNVATIT-RGSRTSNAEG--------------------PAGY,0.43700168,1.7570034,-4.653421,-2.1145942,"7ph3_C,7ph3_D","AMP-PNP bound nanodisc reconstituted MsbA with nanobodies, spin-labeled at position A60C"
QMQLVESGGGLVQAGGSLRLSCAVSGSIFSIITLAWYRQAPGKPRENVATITRGSRTSYCDSVKGRFTISKDNAKSTVYLQMNKLKPEDTADYYCNAEGPAGYWGQGTPVTVS,SIFSIIT,NVATITRGSRTS,NAEGPAGY,19.0,NVATIT-RGSRTS,NAEG--------------------PAGY,SIFSIITNVATIT-RGSRTSNAEG--------------------PAGY,0.43700168,1.7570034,-4.6759953,-2.0848958,"7ph2_C,7ph2_D","Nanodisc reconstituted MsbA in complex with nanobodies, spin-labeled at position A60C"
QMQLVESGGGLVQAGGSLRLSCAVSGSIFSIITLAWYRQAPGKPRENVATITRGSRTSYADSVKGRFCISKDNAKSTVYLQMNKLKPEDTADYYCNAEGPAGYWGQGTPVTVS,SIFSIIT,NVATITRGSRTS,NAEGPAGY,19.0,NVATIT-RGSRTS,NAEG--------------------PAGY,SIFSIITNVATIT-RGSRTSNAEG--------------------PAGY,0.43700168,1.7570034,-5.2313933,-1.9818292,"7ph7_C,7ph7_D","Nanodisc reconstituted MsbA in complex with nanobodies, spin-labeled at position T68C"
QLQLAESGGGLVQAGGSLNLSCIASRRTLSTSFMAWFRQVPGKEREFVAALRSSDGRPYYGDSVKGRFTVSRDNANTVYLQMNSLKPEDTAIYYCALNRGYSGTGYPSKQYEYNDWGQGTQVTVSS,RTLSTSF,FVAALRSSDGRPY,ALNRGYSGTGYPSKQYEYND,19.0,FVAALRSSDGRPY,ALNRGYSGTG--------YPSKQYEYND,RTLSTSFFVAALRSSDGRPYALNRGYSGTG--------YPSKQYEYND,2.6910331,1.2368286,1.0614423,1.5960164,7kbk_C,Ricin bound to VHH antibody V6E11
QVQLQESGGGLVQPGGSLRLSCAASGSIFSGNVMGWYRQAPGKLREWVAAITPQGVPNYADSVKGRFTISRDNAKNMLYLQMSSLKPEDTALYYCNRLPNYRSWGQGTQVTVSS,SIFSGNV,WVAAITPQGVPN,NRLPNYRS,14.0,WVAAIT-PQGVPN,NRLP--------------------NYRS,SIFSGNVWVAAIT-PQGVPNNRLP--------------------NYRS,0.8098543,2.0495658,-1.6241109,-3.0599825,"5f7w_C,5f7w_D,5f7y_C,5f7y_D,5f7k_C,5f7k_D,5f7m_C,5f7m_D,5f7n_C,5f7n_D,5f9a_C,5f9d_C,5f93_H,5f93_C,5f93_D,5f93_F,5f97_H,5f97_E,5f97_G,5f97_F,5f8q_C,5f8q_D,5f8r_C,5f8r_D,7zqt_B,7zqt_F",Blood group antigen binding adhesin BabA of Helicobacter pylori strain P436 in complex with Lewis b blood group B heptasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain A730 in complex with blood group H Lewis b hexasaccharide;Helicobacter pylori adhesin BabA bound to neutralising human antibody.;Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with blood group B Lewis b heptasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain S831 in complex with Nanobody Nb-ER19;Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with blood group A Lewis b pentasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with Nanobody Nb-ER19;Blood group antigen binding adhesin BabA of Helicobacter pylori strain P436 in complex with blood group H Lewis b hexasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain A730 in complex with blood group A type 1 hexasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with blood group A type-1 hexasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain S831 in complex with blood group H Lewis b hexasaccharide;Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with blood group H Lewis b hexasaccharide
QVQLQESGGGLVQAGGSLRLSCAASTRTTSRYTVGWFCQAPGKEREFVAAVHWSGGSTWYADSVKGRFTISRDNAKNTVYLQMNSLKQEDTAVYYCAAAEPRRYSYYMRPDEYNYWGQGTQVTVSS,RTTSRYT,FVAAVHWSGGSTW,AAAEPRRYSYYMRPDEYNY,13.0,FVAAVHWSGGSTW,AAAEPRRYS---------YYMRPDEYNY,RTTSRYTFVAAVHWSGGSTWAAAEPRRYS---------YYMRPDEYNY,1.2808282,0.5756089,-1.7461939,-0.087866545,7zw1_C,Human PRPH2-ROM1 hetero-dimer
QVQLQESGGGSVQAGGSLRLSCAASGYTYSTYCMGWFRQAPGKEREGVATIDSDGRTRYADSVKGRFTISEDNAKNTLYLQMNSLKPEDTAMYYCAADSGWVGYSLDPYQYNYWGQGTQVTVSS,YTYSTYC,GVATIDSDGRTR,AADSGWVGYSLDPYQYNY,13.0,GVATID-SDGRTR,AADSGWVGY----------SLDPYQYNY,YTYSTYCGVATID-SDGRTRAADSGWVGY----------SLDPYQYNY,2.4868505,2.74013,1.3947515,1.0677235,8hr2_C,Ternary Crystal Complex Structure of RBD with NB1B5 and NB1C6
QVQLQESGGGSVQAGGRLRLSCAASGDTYSSYCMGWFRQAPGKEREGVAAIYIGGDNTYYADSAKGRFTISQDYDKNTAYLQMNSLKSEDTAMYYCAAELFCPWPDIGTMSPAEYKYWGQGTQVTVSS,DTYSSYC,GVAAIYIGGDNTY,AAELFCPWPDIGTMSPAEYKY,18.0,GVAAIYIGGDNTY,AAELFCPWPD-------IGTMSPAEYKY,DTYSSYCGVAAIYIGGDNTYAAELFCPWPD-------IGTMSPAEYKY,1.3899852,2.2105842,-2.018865,0.89140767,8hr2_B,Ternary Crystal Complex Structure of RBD with NB1B5 and NB1C6
QVQLQESGGGLVQAGGSLRLSCAASGQTFSGYVTGWFRQAPGKEREFVALIAWSGGRLYYADSVQGRFTISRDNAETTVYLQMNSLKPEDTAVYYCAAKRGGAVTAAEWYDYWGQGTQVTVSS,QTFSGYV,FVALIAWSGGRLY,AAKRGGAVTAAEWYDY,13.0,FVALIAWSGGRLY,AAKRGGAV------------TAAEWYDY,QTFSGYVFVALIAWSGGRLYAAKRGGAV------------TAAEWYDY,0.2542864,-0.7925668,-3.8509967,0.11723417,"7lvw_G,7lvw_I,7lvw_H,7lvw_K,7lvw_J,7lvw_L,7lvu_A,7lvu_C,7lvu_B,7lvu_D",Structure of RSV F in Complex with VHH Cl184;Structure of RSV F-directed VHH Cl184
QVQLVESGGGLVQAGGSLRLSCAASGFPVAWNEMRWYRQAPGKEREWVAAIASIGVTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDYGMAFWYYDYWGQGTQVTVSA,FPVAWNE,WVAAIASIGVTTY,NVKDYGMAFWYYDY,9.0,WVAAIASIGVTTY,NVKDYGM--------------AFWYYDY,FPVAWNEWVAAIASIGVTTYNVKDYGM--------------AFWYYDY,-1.6862353,-1.8769281,-2.3518233,2.0668437,"8c02_B,8bzy_B",Structure of SLC40/ferroportin in complex with synthetic nanobody Sy3 in occluded conformation;Structure of SLC40/ferroportin in complex with vamifeport and synthetic nanobody Sy3 in occluded conformation
QVQLVESGGGLVQAGGSLRLSCAASGSIVNFETMGWYRQAPGKERELVATITNEGSSNYADSVKGRFTISGDNAKNTVSLQMNSLKPEDTAVYYCSATFGSRWPYAHSDHWGQGTQVTVS,SIVNFET,LVATITNEGSSN,SATFGSRWPYAHSDH,9.0,LVATIT-NEGSSN,SATFGSR-------------WPYAHSDH,SIVNFETLVATIT-NEGSSNSATFGSR-------------WPYAHSDH,2.0533006,2.4074879,3.3445044,2.653639,4lhj_B,Ricin A chain bound to camelid nanobody (VHH5)
QVQLVETGGGLVQAGGSLRLSCAASGSIFSLNAMGWFRQAPGKEREFVATINRSGGRTYYADSVKGRFTISRDNGKNMVYLQMHSLKPEDTAIYYCAAGTGWSPQTDNEYNYWGQGTQVTVSS,SIFSLNA,FVATINRSGGRTY,AAGTGWSPQTDNEYNY,13.0,FVATINRSGGRTY,AAGTGWSP------------QTDNEYNY,SIFSLNAFVATINRSGGRTYAAGTGWSP------------QTDNEYNY,2.245425,2.41568,1.210892,0.9490306,"6yo6_C,6ehg_C,6ru5_C",Structure of iC3b1;human complement C3 in complex with the hC3Nb1 nanobody;complement component C3b in complex with a nanobody
VQLVETGGGTVQTGGSLRLSCSASGGSFSRNAMGWFRQAPGKEREFVAAINWSASSTYYRDSVKGRFTVSRDNAKNTVYLHLNSLKLEDTAAYYCAGSSVYAEMPYADSVKATSYNYWGQGTQVTVSS,GSFSRNA,FVAAINWSASSTY,AGSSVYAEMPYADSVKATSYNY,19.0,FVAAINWSASSTY,AGSSVYAEMPY------ADSVKATSYNY,GSFSRNAFVAAINWSASSTYAGSSVYAEMPY------ADSVKATSYNY,1.7250104,1.9970249,-0.92890686,1.3303969,"4lhq_B,4lhq_D",Ricin A chain bound to camelid nanobody (VHH8)
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYKMNWVRQAPGKGLEWVSDISQSGASISYTGSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCARCPAPFTRDCFDVTSTTYAYRGQGTQVTVSS,FTFSNYK,WVSDISQSGASIS,ARCPAPFTRDCFDVTSTTYAY,17.0,WVSDISQSGASIS,ARCPAPFTRD-------CFDVTSTTYAY,FTFSNYKWVSDISQSGASISARCPAPFTRD-------CFDVTSTTYAY,-0.22858635,0.72427857,-3.6914794,-2.9081483,"7c2e_N,7f9y_N,8dcs_N,8dcr_N,7wu3_N,7wu2_N,7wui_N,7wuj_N,7wuq_N,8e3x_N,6x18_N,8jr9_N,7kh0_N,8k8j_N,7jjo_N,7s3i_N,8fu6_N,7tmw_N,7vab_N,6x1a_N,7ki1_N,7ki0_N,6x19_N,8e3y_N,8e3z_N,8f2a_N,8f2b_N,8h4i_D,8h4k_N,8h4l_N,7wbj_N,7jv5_N,8irr_N,7cx2_N,7cx3_N,7lll_N,7cx4_N,7lly_N,7x2c_E,7x2f_E,7x2d_E,8pm2_N,6wpw_N,7vqx_N,7s1m_N,7bz2_N,7t9n_N,8u26_N,7rg9_N,7rgp_N,7wcm_N,7wq4_N,7ckz_N,7cky_N,7ckx_N,7ckw_N,7vuh_N,7vuj_N,8f0j_N,8f0k_N,8ha0_N,7xz6_N,7xz5_N,8haf_N,8hao_N,8hao_F,7bw0_N,6b3j_N,7fig_N,7fim_N,7fin_N,7fiy_N,7dw9_N,8gd9_N,7rtb_N,8gdb_N,8gda_N,6m1h_C,6m1i_C,8jlz_N,6e3y_N,7xkd_N,7xke_N,7xkf_N,8pok_E,8flt_N,8flu_N,8flr_N,8fls_N,8flq_N,7vbi_N,7vbh_N,7ept_N,8x79_N,8x7a_N,6pb0_N,6pb1_N,7xw5_N,7xw6_N,7ra3_N,8kgk_E,8iw9_N,7piv_N,7piu_N,6wi9_N,7xji_N,7xjh_N,7xv3_N,6uus_N,6uun_N,7dur_N,7duq_N,8kh5_E,8kh4_E,7vvk_N,7vvj_N,7vvm_N,7vvl_N,7vvo_N,7vvn_N,8ww2_N,8f76_N,8hdo_N,8hdp_N,7crh_N,7jvq_N,7jvp_N,6wzg_N,7dty_N,8gw8_N,7f1o_E,8ium_N,8iuk_N,7f16_N,8xof_N,8uhb_N,6xox_N,7d3s_N,6p9y_N,6p9x_N,9axf_N,7xtc_N,7xtb_N,7xtq_N,7xt8_N,6vcb_N,7rbt_N,6lmk_N,8itf_N,8itm_N,8itl_N,6ni3_N,7f0t_E,8wg8_N,7y3g_N,7utz_N,7tzf_N,6uva_N,8jhb_N,8hti_N,6vn7_N,8w8a_N,8w8q_N,8i2g_N,8w89_N,8w88_N,8w87_N,7v35_N,7dhi_N,7dhr_N,7rmh_N,7rmi_N,7rmg_N,7dh5_N,5vai_N,8jiq_N,8jip_N,8jir_N,8jiu_N,8jit_N,7wcn_N,7tyx_N,7tyy_N,7tyw_N,7tyh_N,7tyi_N,7tyn_N,7tyo_N,7tyl_N,7tyf_N,7joz_N,7f23_E,7mbx_N,7wxw_D,7wxu_N,8izb_N,7ydp_D,7ydm_N,8wa3_N,6whc_N,7evm_N,7ljd_N,7ljc_N,7bb7_G,7bb6_B,5uz7_N,6gdg_E,7wy8_D,7wy5_N,6niy_N,8ioc_N,8iod_N,7d7m_E,3sn6_N,7xp5_N,7xp4_N,7xp6_N,7vui_N,7f4d_N,7f4i_N,7f4h_N,7yp7_N,6lpb_N,8wc6_N,7cfm_N,7cfn_N,7x8s_N,7x8r_N,7t9i_N,7e14_N,8wg7_N,8smv_N,9auc_N,6orv_NP,7v9l_N,7v9m_N","Ex4-D-Ala bound to the glucagon-like peptide-1 receptor/g protein complex (conformer 2);Cryo-EM structure of GPR119-Gs Complex with small molecule agonist MBX-2982;Cryo-EM structure of dopamine receptor 1 and mini-Gs complex with dopamine bound;Solabegron-activated dog beta3 adrenergic receptor;PTH-bound human PTH1R in complex with Gs (class5);Dopamine Receptor D1R-Gs-Rotigotine complex;cryo-EM structure of human Gastric inhibitory polypeptide receptor GIPR bound to tirzepatide;Cryo-EM structure of the GDP-bound dopamine receptor 1 and mini-Gs complex with Nb35;Human Amylin1 Receptor in complex with Gs and rat amylin peptide;Structure of A2BR bound to endogenous agonists adenosine;CRF1 Receptor Gs GPCR protein complex with CRF1 peptide;Cryo-EM structure of the tafluprost acid-bound human PTGFR-Gq complex;Small molecule agonist (PCO371) bound to human parathyroid hormone receptor type 1 (PTH1R);Serotonin 7 (5-HT7) receptor-Gs-Nb35 complex;Cryo-EM structure of the PGE2-bound EP2-Gs complex;Cryo-EM structure of GIPR splice variant 2 (SV2) in complex with Gs protein;Cryo-EM Structure of the Prostaglandin E Receptor EP4 Coupled to G Protein;Cryo-EM structure of the SV1-Gs complex.;Cryo-EM structure of GIPR splice variant 1 (SV1) in complex with Gs protein;TSHR-thyroid stimulating hormone-Gs-ML109 complex;Cryo-EM structure of the DMCHA-bound mTAAR9-Gs complex;Cryo-EM structure of the PAC1R-PACAP27-Gs complex;B2V2R-Gs protein subcomplex of a GPCR-G protein-beta-arrestin mega-complex;Cryo-EM structure of DHEA-ADGRG2-FL-Gs complex;Cryo-EM structure of the dopamine and LY3154207-bound D1 dopamine receptor and mini-Gs complex;PTHrP-PTH1R-Gs complex;M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure);Cryo-EM structure of parathyroid hormone receptor type 2 in complex with a tuberoinfundibular peptide of 39 residues and G protein;MRE-269 bound Prostacyclin Receptor G protein complex;FZD6 Gs complex;Cryo-EM structure of the gamma-MSH-bound human melanocortin receptor 3 (MC3R)-Gs complex;Human Cholecystokinin 1 receptor (CCK1R) Gs complex;Cryo-EM structure of dobutamine-bound beta1-adrenergic receptor in complex with heterotrimeric Gs-protein;Cryo-EM structure of the PEA-bound mTAAR1-Gs complex;Human secretin receptor Gs complex;cryo-EM of human GLP-1R bound to non-peptide agonist LY3502970;3.3 angstrom phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex;Gaussian Mixture Models based single particle refinement - GPCR (Substance P bound to active human neurokinin 1 receptor in complex with miniGs399 from EMPIAR-10786);Cryo-EM structure of the GTP-bound dopamine receptor 1 and mini-Gs complex with Nb35;Human thyrotropin analog TR1402 bound to human Thyrotropin receptor in complex with miniGs399 (composite structure);Cryo-EM structure of CD97/miniGs complex;Compound2_GLP-1R_OWL833_Gs complex structure;Native human TSH bound to human Thyrotropin receptor in complex with miniGs399 (composite structure);Cryo-EM structure of the human arginine vasopressin AVP-vasopressin receptor V2R-Gs signaling complex;Cryo-EM structure of the relaxin receptor RXFP1 in complex with heterotrimeric Gs;Cryo-EM structure of the PEA-bound TAAR1-Gs complex;Substance P bound to active human neurokinin 1 receptor in complex with miniGs399;Cryo-EM structure of Urocortin 1-bound Corticotropin-releasing factor 1 receptor in complex with Gs protein and Nb35;Cryo-EM structure of N-terminal modified human vasoactive intestinal polypeptide receptor 2 (VIP2R) in complex with PACAP27 and Gs;Cryo-EM structure of the compound 2-bound human GLP-1 receptor-Gs complex;Cryo-EM structure of the compound 2 and GLP-1-bound human GLP-1 receptor-Gs complex;GPR119-Gs-LPC complex;Cryo-EM structure of the P395-bound GPBAR-Gs complex;Cryo-EM structure of afamelanotide-bound melanocortin-1 receptor in complex with Gs protein, Nb35 and scFv16;Cryo-EM structure of alpha-MSH-bound melanocortin-1 receptor in complex with Gs protein and Nb35;Non peptide agonist PF-06882961, bound to Glucagon-Like peptide-1 (GLP-1) Receptor;Structural basis of ligand selectivity conferred by the human glucose-dependent insulinotropic polypeptide receptor;Cryo-EM structure of the GLP-1R/GCGR dual agonist MEDI0382-bound human GCGR-Gs complex;Lysophosphatidylserine receptor GPR174-Gs complex;Cryo-EM structure of CD97/Gq complex;PTH-bound human PTH1R in complex with Gs (class3);Calcitonin receptor in complex with Gs and human calcitonin peptide;CryoEM structure of human PAC1 receptor in complex with PACAP38;Cryo-EM structure of cell-free synthesized human histamine H2 receptor coupled to heterotrimeric Gs protein in lipid environment;Calcitonin Receptor in complex with Gs and salmon calcitonin peptide;Cryo-EM structure of the VPAC1R-VIP-Gs complex;the human PTH1 receptor bound to an intracellular biased agonist;Human Amylin3 Receptor in complex with Gs and rat amylin peptide;Cryo-EM structure of DHEA-ADGRG2-BT-Gs complex;DHA-bound FFAR4 in complex with Gq;Cryo-EM structure of Urocortin 1-bound Corticotropin-releasing factor 2 receptor in complex with Gs protein and Nb35;Cryo-EM structure of the GPR161-Gs complex;apo-ADGRG2 coupled to Gs;GLP-1 peptide hormone bound to Glucagon-Like peptide-1 (GLP-1) Receptor;Human SECR in complex with an engineered Gs heterotrimer;Cryo-EM structure of GPR119-Gs Complex with small molecule agonist AR231453;Cryo-EM structure of the VPAC1R-PACAP27-Gs complex;Molecular recognition of two endogenous hormones by the human parathyroid hormone receptor-1;Amylin 3 Receptor in complex with Gs and Pramlintide analogue peptide San45;ghrelin-bound ghrelin receptor in complex with Gq;cryo-EM of human Gastric inhibitory polypeptide receptor GIPR bound to GIP;SP6-11 biased agonist bound to active human neurokinin 1 receptor in complex with miniGs/q70;Cryo-EM structure of the Boc5-bound hGLP-1R-Gs complex;Human PTH1R in complex with PTH(1-34) and Gs;Treprostinil bound Prostacyclin Receptor G protein complex;Cryo-EM structure of Fenoldopam bound dopamine receptor DRD1-Gs signaling complex;Cryo-EM Structure of the Ro5256390-bound hTA1-Gs heterotrimer signaling complex;CryoEM structure of human PAC1 receptor in complex with maxadilan;GW9508-bound FFAR4 in complex with Gq;Non-peptide agonist (TT-OAD2) bound to the Glucagon-Like peptide-1 (GLP-1) Receptor;GPR110/Gs complex;FSHR-Follicle stimulating hormone-compound 716340-Gs complex;GLP-1R-Gs complex structure with a small molecule full agonist;Human PTH1R in complex with Abaloparatide and Gs;Structure of human calcium-sensing receptor in complex with chimeric Gq (miniGisq) protein in detergent;Cryo-EM structure of an activated VIP1 receptor-G protein complex;Cryo-EM structure of the adenosine A2A receptor bound to a miniGs heterotrimer;Cryo-EM structure of the WB4-24-bound hGLP-1R-Gs complex;Structural Basis of the Activation of Heterotrimeric Gs-protein by Isoproterenol-bound Beta1-Adrenergic Receptor;CryoEM Structure of the active Adrenomedullin 1 receptor G protein complex with adrenomedullin peptide;Cryo-EM structure of the GLP-1R/GCGR dual agonist SAR425899-bound human GLP-1R-Gs complex;ADGRL3/Gs complex;Cryo-EM structure of the agonist setmelanotide bound to the active melanocortin-4 receptor (MC4R) in complex with the heterotrimeric Gs protein at 2.6 A resolution.;Galanin-bound galanin receptor 2 in complex with Gq;Cannabinoid Receptor 1 bound to Fenofibrate coupling MiniGsq and Nb35 Complex;Oxyntomodulin-bound Glucagon-Like Peptide-1 (GLP-1) Receptor in complex with Gs protein;Semaglutide-bound Glucagon-Like Peptide-1 (GLP-1) Receptor in Complex with Gs protein;Calcitonin Receptor in complex with Gs and rat amylin peptide, bypass motif;Cryo-EM structure of Dopamine and LY3154207 bound dopamine receptor DRD1-Gs signaling complex;Structure of the murine trace amine-associated receptor TAAR7f bound to N,N-dimethylcyclohexylamine (DMCH) in complex with mini-Gs trimeric G protein;Human PTH1R in complex with M-PTH(1-14) and Gs;Isoproterenol-activated dog beta3 adrenergic receptor;Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385 (Cluster 5 conformation);Volta phase plate cryo-electron microscopy structure of a calcitonin receptor-heterotrimeric Gs protein complex;Cryo-EM structure of SHU9119-bound melanocortin-1 receptor in complex with Gs protein and Nb35;Cryo-EM structure of the adhesion GPCR ADGRF1 in complex with miniGs;Cryo-EM structure of PW0464 bound dopamine receptor DRD1-Gs signaling complex;DHA-bound FFAR4 in complex with Gs;Cryo-EM structure of the partial agonist salbutamol-bound beta2 adrenergic receptor-Gs protein complex.;Cryo-EM structure of Lys05 bound GPR30-Gq complex structure;CryoEM Structure of the active Adrenomedullin 2 receptor G protein complex with adrenomedullin peptide;cryo-EM of human Glucagon-like peptide 1 receptor GLP-1R in apo form;Structural basis for the tethered peptide activation of adhesion GPCRs;Cryo-EM structure of SKF83959 bound dopamine receptor DRD1-Gs signaling complex;Crystal structure of the beta2 adrenergic receptor-Gs protein complex;Cryo-EM structure of a class T GPCR in ligand-free state;Cryo-EM structure of the full agonist isoprenaline-bound beta2 adrenergic receptor-Gs protein complex.;GPR3/Gs complex;Cryo-EM structure of A77636 bound dopamine receptor DRD1-Gs signaling complex;Cryo-EM structure of SKF-83959-bound dopamine receptor 1 in complex with Gs protein;Allosteric modulator LY3154207 binding to SKF-81297-bound dopamine receptor 1 in complex with miniGs protein;ADGRL3/Gq complex;Cryo-EM structure of the PG-901-bound human melanocortin receptor 5 (MC5R)-Gs complex;GPR161 Gs heterotrimer;Cryo-EM structure of the CAD-bound mTAAR9-Gs complex;Cryo-EM structure of the tirzepatide-bound human GIPR-Gs complex;Calcitonin Receptor in complex with Gs and Pramlintide analogue peptide San45;PTH-bound human PTH1R in complex with Gs (class1);Cryo-EM structure of the SEP363856-bound TAAR1-Gs complex;GPR110/Gq complex;Calcitonin Receptor in complex with Gs and rat amylin peptide, CT-like state;AVP-V2R-Galphas-beta1-gamma2-Nb35 (L state);Cryo-EM structure of the non-acylated tirzepatide (LY3298176)-bound human GIPR-Gs complex;Cryo-EM structure of the METH-TAAR1 complex;Cryo-EM structure of apomorphine-bound dopamine receptor 1 in complex with Gs protein;Exendin-4-bound Glucagon-Like Peptide-1 (GLP-1) Receptor in complex with Gs protein;Cryo-EM structure of human vasoactive intestinal polypeptide receptor 2 (VIP2R) in complex with PACAP27 and Gs;Structure of A2BR bound to synthetic agonists BAY 60-6583;Cryo-EM structure of the GLP-1R/GCGR dual agonist MEDI0382-bound human GLP-1R-Gs complex;Crystal structure of dopamine D1 receptor in complex with G protein and a non-catechol agonist;Cryo-EM structure of the active, Gs-protein complexed, human CGRP receptor;Active human TGR5 complex with a synthetic agonist 23H;Cryo-EM structure of the INT-777-bound GPBAR-Gs complex;Human parathyroid hormone receptor-1 dimer;Active Melanocortin-4 receptor (MC4R)- Gs protein complex bound to agonist NDP-alpha-MSH at 2.86 A resolution.;Human olfactory receptor OR51E2 bound to propionate in complex with miniGs399;Cryo-EM structure of the activated Glucagon-like peptide-1 receptor in complex with G protein;Human Amylin1 Receptor in complex with Gs and salmon calcitonin peptide;Cryo-EM structure of the R399-bound GPBAR-Gs complex;Cryo-EM structure of the Glucagon-like peptide-1 receptor in complex with G protein, GLP-1 peptide and a positive allosteric modulator;GPR119-Gs-APD668 complex;GCGR-Gs complex in the presence of RAMP2;Cryo-EM structure of the RO5256390-TAAR1 complex;Cryo-EM structure of the GLP-1R/GCGR dual agonist SAR425899-bound human GCGR-Gs complex;PTH-bound human PTH1R in complex with Gs (class4);Cryo-EM structure of a class T GPCR in active state;Serotonin 6 (5-HT6) receptor-Gs-Nb35 complex;Substance P bound to active human neurokinin 1 receptor in complex with miniGs/q70;Human PTH1R in complex with PTHrP and Gs;Non peptide agonist CHU-128, bound to Glucagon-Like peptide-1 (GLP-1) Receptor;Cryo-EM structure of human V2 vasopressin receptor in complex with an Gs protein;Cryo-EM structure of the GIPR/GLP-1R/GCGR triagonist peptide 20-bound human GLP-1R-Gs complex;Cryo-EM structure of LPS-bound GPR174 in complex with Gs protein;Human PTH1R in complex with LA-PTH and Gs;Cryo-EM structures of peptide free and Gs-coupled GCGR;Cryo-EM structure of the tavapadon-bound D1 dopamine receptor and mini-Gs complex;Cryo-EM structure of a class A orphan GPCR;Cryo-EM structure of the non-acylated tirzepatide (LY3298176)-bound human GLP-1R-Gs complex;Tethered peptide activation mechanism of adhesion GPCRs ADGRG2 and ADGRG4;Cryo-EM structure of the Evatanepag-bound EP2-Gs complex;Cryo-EM structure of the GLP-1R/GCGR dual agonist Peptide 15-bound human GCGR-Gs complex;PTH-bound human PTH1R in complex with Gs (class2);Cryo-EM structure of the human PAC1 receptor coupled to an engineered heterotrimeric G protein;Serotonin 4 (5-HT4) receptor-Gs-Nb35 complex;Peptide-19 bound to the Glucagon-Like Peptide-1 Receptor (GLP-1R);Allosteric modulator LY3154207 binding to dopamine-bound dopamine receptor 1 in complex with miniGs protein;Cryo-EM structure of the adhesion GPCR ADGRD1 in complex with miniGs;GCGR-Gs signaling complex bound to a designed glucagon derivative;Human Amylin2 Receptor in complex with Gs and rat amylin peptide;CryoEM Structure of the active Adrenomedullin 2 receptor G protein complex with adrenomedullin 2 peptide;Cryo-EM structure of the fenoldopam-bound D1 dopamine receptor and mini-Gs complex;Cryo-EM structure of the tirzepatide (LY3298176)-bound human GLP-1R-Gs complex;A high-resolution cryo-electron microscopy structure of a calcitonin receptor-heterotrimeric Gs protein complex;Cryo-EM structure of the GIPR/GLP-1R/GCGR triagonist peptide 20-bound human GCGR-Gs complex;PAC1 GPCR Receptor complex;Cryo-EM Structure of the Prostaglandin E2 Receptor 4 Coupled to G Protein;AVP-V2R-Galphas-beta1-gamma2-Nb35(T state);cryo-EM of human Glucagon-like peptide 1 receptor GLP-1R bound to tirzepatide;Cryo-EM structure of peptide free and Gs-coupled GIPR;Human Amylin3 Receptor in complex with Gs and Pramlintide analogue peptide San385;PTHrP-bound human PTH1R in complex with Gs;Cryo-EM structures of peptide free and Gs-coupled GLP-1R;Cryo-EM structure of the GIPR/GLP-1R/GCGR triagonist peptide 20-bound human GIPR-Gs complex;Cryo-EM structure of the Taprenepag-bound EP2-Gs complex;Cryo-EM structure of the GPR174-Gs complex bound to endogenous lysoPS;Taspoglutide-bound Glucagon-Like Peptide-1 (GLP-1) Receptor in Complex with Gs Protein;Cryo-EM structure of the formoterol-bound beta2 adrenergic receptor-Gs protein complex.;Cryo-EM structure of the GPR61-Gs complex;Cryo-EM structure of DHEA-ADGRG2-BT-Gs complex at lower state;TSHR-Gs-M22 antibody-ML109 complex;Cryo-EM structure of the PGF2-alpha-bound human PTGFR-Gq complex;Cryo-EM structure of the human glucagon receptor in complex with Gs;Human Amylin2 Receptor in complex with Gs and salmon calcitonin peptide;Ex4-D-Ala bound to the glucagon-like peptide-1 receptor/g protein complex (conformer 1);Cryo-EM structure of cyanopindolol-bound beta1-adrenergic receptor in complex with heterotrimeric Gs-protein;Dog beta3 adrenergic receptor bound to mirabegron in complex with a miniGs heterotrimer;Cryo-EM structure of the GPR101-Gs complex;ST1936-5HT6R complex;CryoEM Structure of the glucagon receptor with a dual-agonist peptide;Cryo-EM structure of a class T GPCR in apo state;Human Amylin1 Receptor in Complex with Gs and human Calcitonin Gene-Related Peptide;Human Consensus Olfactory Receptor OR52c in Complex with Octanoic Acid (OCA) and G Protein;Human Amylin2 Receptor in complex with Gs and human calcitonin peptide;Cryo-EM structure of the GHRH-bound human GHRHR splice variant 1 complex;Cryo-EM structure of SKF-81297-bound dopamine receptor 1 in complex with Gs protein;luteinizing hormone/choriogonadotropin receptor(S277I)-chorionic gonadotropin-Gs complex"
AVQLVDSGGGSVQAGGSLRLSCAASGYTYSICTMGWYRQAPGEGLEWVSGINADGSNTHYTDSVKGRFTISRDNAKKTLYLQMNSLKPEDTAIYYCAAHGTYDKYAPCGGFAGTYTYWGQGTQVTVSS,YTYSICT,WVSGINADGSNTH,AAHGTYDKYAPCGGFAGTYTY,17.0,WVSGINADGSNTH,AAHGTYDKYA-------PCGGFAGTYTY,YTYSICTWVSGINADGSNTHAAHGTYDKYA-------PCGGFAGTYTY,2.302626,2.2557178,-1.9681637,-2.336151,"7tpr_E,7tpr_D",Camel nanobodies 7A3 and 8A2 broadly neutralize SARS-CoV-2 variants
QVQLQESGGGLVQTGGSLRLSCTASGRTFSSLAMGWFRQAPGKEREFVAAISWSTGITDYSDSVKGRFTMSRDNAKSTVYLQMNSLKPEDTAVYYCAAVDRHSPGSAWYNRNFGSWGQGTQVTVSS,RTFSSLA,FVAAISWSTGITD,AAVDRHSPGSAWYNRNFGS,14.0,FVAAISWSTGITD,AAVDRHSPG---------SAWYNRNFGS,RTFSSLAFVAAISWSTGITDAAVDRHSPG---------SAWYNRNFGS,1.1027066,1.159304,-0.093247965,1.4735394,"7nx0_E,7nx0_D",LTK:ALKAL1 complex stabilized by a Nanobody
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGKEREFVGAIDLSGLYKHYGDSVKGRFTISRDNAKNTVYLQMSSLKPEDTAVYYCAAAGIYYAGSYSPLLYDYWGQGTQVTVSS,RTFSSYA,FVGAIDLSGLYKH,AAAGIYYAGSYSPLLYDY,11.0,FVGAIDLSGLYKH,AAAGIYYAG----------SYSPLLYDY,RTFSSYAFVGAIDLSGLYKHAAAGIYYAG----------SYSPLLYDY,0.532283,0.7637117,0.7800748,0.9938839,7nj5_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8199 core
QVQLQESGGGLVQTGDSLRLSCAGAERSFNSYTMGWFRQAPGKEREFVAAIAFSGGFTYYAEAVKGRFTISRDSGKNTVYLQMNSLKPEDTAVYYCAARFYGGGYYYQQREYSFWGQGTQVTVSS,RSFNSYT,FVAAIAFSGGFTY,AARFYGGGYYYQQREYSF,18.0,FVAAIAFSGGFTY,AARFYGGGY----------YYQQREYSF,RSFNSYTFVAAIAFSGGFTYAARFYGGGY----------YYQQREYSF,1.4318633,1.1320109,-4.3860765,-0.564673,7nj4_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8198 core
QVQLQESGGGLVQAGDSLRLSCAASGRTFSGYIMAWFRQTPGKERELVARLGPSSSIQYYRDSVKGRFTLSRDNAKNTLYLQMNSLKPEDTAVYYCAFTLKWSSDYRSHNAYDYWGQGTQVTVSS,RTFSGYI,LVARLGPSSSIQY,AFTLKWSSDYRSHNAYDY,15.0,LVARLGPSSSIQY,AFTLKWSSD----------YRSHNAYDY,RTFSGYILVARLGPSSSIQYAFTLKWSSD----------YRSHNAYDY,-0.074515976,-1.0959898,-5.7990704,-0.76111364,7nj7_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8200 core
QVQLQESGGGLVQAGDSLRLSCTTSGSSLSRYGVGWFRQAPGEEREFGASISWNGATYYADSVKGRFTISRDNAKNTVYLQMNSLKAEDTAVYYCAARSDGYLTPYLSPVYWGQGTQVTVSS,SSLSRYG,FGASISWNGATY,AARSDGYLTPYLSPVY,15.0,FGASIS-WNGATY,AARSDGYL------------TPYLSPVY,SSLSRYGFGASIS-WNGATYAARSDGYL------------TPYLSPVY,2.2465982,3.1904168,2.0273361,1.0594456,7nj3_F,1918 H1N1 Viral influenza polymerase heterotrimer with Nb8196 core
VALVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVS,FPVNRYS,WVAGMSAGDRSS,NVNVGFEY,16.0,WVAGMS-AGDRSS,NVNV--------------------GFEY,FPVNRYSWVAGMS-AGDRSSNVNV--------------------GFEY,0.611383,1.4445187,1.4415305,3.5560546,6itc_C,Structure of a substrate engaged SecA-SecY protein translocation machine
QVQLVETGGGLVQPGGSLRLSCGASGSIFNMYAMGWYRQAPGKRREVVARIATDDSTMYPDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYYQRTVMSQPYWGQGTQVTVS,SIFNMYA,VVARIATDDSTM,YYQRTVMSQPY,13.0,VVARIA-TDDSTM,YYQRT-----------------VMSQPY,SIFNMYAVVARIA-TDDSTMYYQRT-----------------VMSQPY,2.3709238,1.0290523,-0.5336155,-0.7322721,6itc_V,Structure of a substrate engaged SecA-SecY protein translocation machine
QVQLQESGGGLVQAGGSLRLSCQASGNIFRINDMGWYRQAPGTQRELVAAITSGGSTKYADSVKGRFTISKDNAKNTVYLQMNSLKPEDTAVYYCAAEDRHRIGTVGYWGQGTQVTVSS,NIFRIND,LVAAITSGGSTK,AAEDRHRIGTVGY,12.0,LVAAIT-SGGSTK,AAEDRH---------------RIGTVGY,NIFRINDLVAAIT-SGGSTKAAEDRH---------------RIGTVGY,2.813317,3.4750595,2.4812236,1.3092175,1sjx_A,Three-Dimensional Structure of a Llama VHH Domain OE7 binding the cell wall protein Malf1
QVQLQESGGGLVQAGESLKLSCAASGNTFSGGFMGWYRQAPGKQRELVATINSRGITNYADFVKGRFTISRDNAKKTVYLEMNSLEPEDTAVYYCYTHYFRSYWGQGTQVTVSS,NTFSGGF,LVATINSRGITN,YTHYFRSY,15.0,LVATIN-SRGITN,YTHY--------------------FRSY,NTFSGGFLVATIN-SRGITNYTHY--------------------FRSY,1.8131512,0.22566503,-1.4829344,-1.3694861,1sjv_A,Three-Dimensional Structure of a Llama VHH Domain Swapping
EVQLVESGGGLVQPGGSLRLSCTASGYTFSHRYHRWFRQAPGKEREIVAVISQSGMRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAMYYCAAGTRKNVWTRQHPFDYWGQGTQVTVSS,YTFSHRY,IVAVISQSGMRTY,AAGTRKNVWTRQHPFDY,14.0,IVAVISQSGMRTY,AAGTRKNV-----------WTRQHPFDY,YTFSHRYIVAVISQSGMRTYAAGTRKNV-----------WTRQHPFDY,1.9886903,1.8000091,-0.7694508,1.4262974,3ln9_A,Crystal structure of the fibril-specific B10 antibody fragment
QVQLVQSGGGLVQAGGSLRLSCAFSGRTFSMYTMGWFRQAPGKEREFVAANRGRGLSPDIADSVNGRFTISRDNAKNTLYLQMDSLKPEDTAVYYCAADLQYGSSWPQRSSAEYDYWGQGTTVTVSS,RTFSMYT,FVAANRGRGLSPD,AADLQYGSSWPQRSSAEYDY,15.0,FVAANRGRGLSPD,AADLQYGSSW--------PQRSSAEYDY,RTFSMYTFVAANRGRGLSPDAADLQYGSSW--------PQRSSAEYDY,0.66755176,-0.46767604,-1.5396342,1.1390457,"6ezw_B,6f0d_A,6f0d_B",Crystal structure of a llama VHH antibody BCD090-M2 against human ErbB3 in space group C2;Crystal structure of a llama VHH antibody BCD090-M2 against human ErbB3 in space group P1 with cadmium ions
QVQLQESGGGLVQAGGSLRLSCAASGLTFSTNGMGWFRQAPGKEREFVFGVNWNGGNSYVADSVKGRFTISRDNAKNTVYLQMNSLKLEDTAVYYCAAKMGRRLAVSRTLEEYDFRGQGTQVTVSS,LTFSTNG,FVFGVNWNGGNSY,AAKMGRRLAVSRTLEEYDF,12.0,FVFGVNWNGGNSY,AAKMGRRLA---------VSRTLEEYDF,LTFSTNGFVFGVNWNGGNSYAAKMGRRLA---------VSRTLEEYDF,1.4574255,1.9598714,-1.5228252,-1.6977291,"8en2_C,8en2_D",Structure of GII.10 norovirus in complex with Nanobody 34
QVQLVETGGGLVQAGGSLRLSCAASGSIFSINAMGWFRQAPGKEREFVATINRSGGRTYYADSVKGRFTISRDNGKNMVYLQMHSLKPEDTAIYYCAAGTGWSPQTDCEYNYWGQGTQVTVSS,SIFSINA,FVATINRSGGRTY,AAGTGWSPQTDCEYNY,13.0,FVATINRSGGRTY,AAGTGWSP------------QTDCEYNY,SIFSINAFVATINRSGGRTYAAGTGWSP------------QTDCEYNY,2.1698408,2.5738506,0.7397621,0.89405686,"8oq3_C,8oq3_F",Structure of methylamine treated human complement C3
QVQLVESGGGLVQAGDSLRLSCAVSGRTFSSNVIGWFRQAPGKEREFVAAISWSTGSTYYGRSMKGRCAASRDNAKNTVALQLNSLKPEDTAVYYCAATLDWGKTLSDEYDYWGQGTQVTVSS,RTFSSNV,FVAAISWSTGSTY,AATLDWGKTLSDEYDY,19.0,FVAAISWSTGSTY,AATLDWGK------------TLSDEYDY,RTFSSNVFVAAISWSTGSTYAATLDWGK------------TLSDEYDY,-0.16957912,-0.49091518,-3.9494326,-0.6044614,"4ios_E,4ios_D,4ios_G,4ios_F",Structure of phage TP901-1 RBP (ORF49) in complex with nanobody 11.
QVQLVESGGGLVQAGGSLRLSCAASGRTDSISDMGWFRQAPGKEREFVAVVGWSGGGTDYAHSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVGSLRVGSFSVEYWGQGTQVTVSS,RTDSISD,FVAVVGWSGGGTD,AVGSLRVGSFSVEY,9.0,FVAVVGWSGGGTD,AVGSLRV--------------GSFSVEY,RTDSISDFVAVVGWSGGGTDAVGSLRV--------------GSFSVEY,0.61793333,0.8604976,0.9833499,2.6222153,"8cy9_E,8cy9_D,8cy9_F",SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-23
HVQLVESGGGLVQAGGSLRLSCAASGTISTLNAMGWYRQAPGKQRELLASISNLGTTYHADSVAGRFTISRGSAKNTVNLQMNSLKPDDTAVYYCNTRVLEGGTQIRDYWGQGTQVTVSS,TISTLNA,LLASISNLGTTY,NTRVLEGGTQIRDY,14.0,LLASIS-NLGTTY,NTRVLEG--------------GTQIRDY,TISTLNALLASIS-NLGTTYNTRVLEG--------------GTQIRDY,2.290003,3.8337011,1.6012068,0.8339109,"8cy6_E,8cy6_D,8cy6_F",SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-65
QVQLVESGGGLVQAGGSLRLSCAAAARFSTSAMGWFRQAPGKEREFVAAISWSNTNTHYADTVKGRFTISADTAKETVDLQMNSLKPEDTAVYYCVQGGWGIRQPIIVDYWGKGTQVTVSS,ARFSTSA,FVAAISWSNTNTH,VQGGWGIRQPIIVDY,16.0,FVAAISWSNTNTH,VQGGWGI-------------RQPIIVDY,ARFSTSAFVAAISWSNTNTHVQGGWGI-------------RQPIIVDY,-0.5175536,-0.07623926,0.5749153,0.7729319,"8cy7_E,8cy7_D,8cy7_F",SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
QVQLVESGGGLVQAGGSLRLSCAASGYHHPYIYMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRFTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGHHLRDHTYGQWGQGTQVTVSS,YHHPYIY,GVAAMDSGGGGTL,AAGGHHLRDHTYGQ,12.0,GVAAMDSGGGGTL,AAGGHHL--------------RDHTYGQ,YHHPYIYGVAAMDSGGGGTLAAGGHHL--------------RDHTYGQ,4.359935,2.9685526,1.7652214,1.1162128,3qsk_B,5 Histidine Variant of the anti-RNase A VHH in Complex with RNAse A
QVQLVESGGGLVQPGGSLRLSCAASGFTFNRYAMSWVRQAPGKGREWVSGIYSDGSETYYTESVKGRFTISRDNAKNMLYLQMNSLKPEDTALYYCAKDENAHEDYFNSGFDRKYDYWGQGTQVTVSS,FTFNRYA,WVSGIYSDGSETY,AKDENAHEDYFNSGFDRKYDY,16.0,WVSGIYSDGSETY,AKDENAHEDY-------FNSGFDRKYDY,FTFNRYAWVSGIYSDGSETYAKDENAHEDY-------FNSGFDRKYDY,0.858633,1.0824264,-3.0205944,-3.190068,8cyj_C,"RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25"
HVQLVESGGGLVQAGGSLRLSCATSGRTFSTYRMSWFRQAPGKEREFVATIIWSVGSTHYADSVKGRFTISRDNAKNMVYLQMNSLKPEDTAVYYCAAQRSDSSSWGYEDDYDYWGQGTQVTVSS,RTFSTYR,FVATIIWSVGSTH,AAQRSDSSSWGYEDDYDY,12.0,FVATIIWSVGSTH,AAQRSDSSS----------WGYEDDYDY,RTFSTYRFVATIIWSVGSTHAAQRSDSSS----------WGYEDDYDY,0.60128456,-1.0541513,-4.0913095,0.25162178,8cyj_B,"RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25"
QVQLVESGGGLVQAGGSLRLSCAASGRTFSTYAMAWFRQAPGKEREFVAGVARSADTTYYGDSVKGRFTISRDNAKNEVNLQMSSLKPEDTAVYYCAARSVIQYGIVPGNDFHYEYWGQGTQVTVSS,RTFSTYA,FVAGVARSADTTY,AARSVIQYGIVPGNDFHYEY,13.0,FVAGVARSADTTY,AARSVIQYGI--------VPGNDFHYEY,RTFSTYAFVAGVARSADTTYAARSVIQYGI--------VPGNDFHYEY,0.7968903,0.13973331,-1.8484266,0.9183431,8cyj_D,"RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25"
QVQLVESGGGLVQAGGSLRLSCTASGYDFSILAIAWYRQAPGKERELVAAISRVGSTDYADSVKGRFTISRDNTKNTVSLQMDSLKPEDTAVYYCNAGIPMTTVLSGLGFWGQGTQVTVSS,YDFSILA,LVAAISRVGSTD,NAGIPMTTVLSGLGF,13.0,LVAAIS-RVGSTD,NAGIPMT-------------TVLSGLGF,YDFSILALVAAIS-RVGSTDNAGIPMT-------------TVLSGLGF,-0.5862801,0.24817073,-2.668886,2.1277852,"8cyd_E,8cyd_D,8cyd_F",SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-45
QVQLVESGGGLVQTGGSLRLSCAASGRTFSNYVMGWFRQAPGKEREFVSSIEWNSENTFYANSVKGRFTISRDNAKNTVYLQMNSLKAEDTAVYYCAADRGSSYYYTRASEYTYWGQGTQVTVSS,RTFSNYV,FVSSIEWNSENTF,AADRGSSYYYTRASEYTY,11.0,FVSSIEWNSENTF,AADRGSSYY----------YTRASEYTY,RTFSNYVFVSSIEWNSENTFAADRGSSYY----------YTRASEYTY,0.9693461,1.4001993,-2.0940561,0.927818,8cyb_D,SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-8
HVQLVESGGGLVQAGGSLRLSCAASGRTFSRYAAGWFRQAPGKEREFVAVIEWDGDSAYYADPVKGRFTISRDNAKNTVYLQMNRLKPEDTAVYICAVGGNHYSRSKYYNLDEYDDWGQGTQVTVSS,RTFSRYA,FVAVIEWDGDSAY,AVGGNHYSRSKYYNLDEYDD,13.0,FVAVIEWDGDSAY,AVGGNHYSRS--------KYYNLDEYDD,RTFSRYAFVAVIEWDGDSAYAVGGNHYSRS--------KYYNLDEYDD,-0.871674,-0.057559043,-2.755373,-1.4094243,"8cyc_E,8cyc_D,8cyc_F",SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34
QVQLVESGGGSVQAGGSLRLSCAASGFTYSRKYMGWFRQAPGKEREGVAAIFIDNGNTIYADSVQGRFTISQDNAKNTVYLQMNSLKPEDTAMYYCAASSRWMDYSALTAKAYNSWGQGTQVTVSS,FTYSRKY,GVAAIFIDNGNTI,AASSRWMDYSALTAKAYNS,12.0,GVAAIFIDNGNTI,AASSRWMDY---------SALTAKAYNS,FTYSRKYGVAAIFIDNGNTIAASSRWMDY---------SALTAKAYNS,2.0055244,2.3358488,-1.3349205,0.6371986,"1mvf_A,1mvf_B",MazE addiction antidote
QVQLVESGGGLVQPGGSLRLSCAASGFTFSKYAMNWVRQPPGKGLEWVSGIRPSGDNPTYADSVEGRFTIIRDNDKKMVYLQMTSLKTEDTAVYYCTRGYGTMTIEGQGTQVTVSS,FTFSKYA,WVSGIRPSGDNPT,TRGYGTMTI,21.0,WVSGIRPSGDNPT,TRGY-------------------GTMTI,FTFSKYAWVSGIRPSGDNPTTRGY-------------------GTMTI,0.4607194,-0.15264413,-3.6778123,-2.7744305,"8fcz_C,8fcz_D,8fd0_C,8fd0_D,8fd1_C,8fd1_D",Crystal structure of photoactivated rhodopsin in complex with a nanobody;Crystal structure of bovine rod opsin in complex with a nanobody;Crystal structure of ground-state rhodopsin in complex with a nanobody
EVQLVESGGGLVQAGGSLGLSCSASGLLFSRNSAGWYRQAPGKQREFVARIRMGGSINYADTVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCSSWRTGFYEYWGQGTLVTVSS,LLFSRNS,FVARIRMGGSIN,SSWRTGFYEY,14.0,FVARIR-MGGSIN,SSWRT------------------GFYEY,LLFSRNSFVARIR-MGGSINSSWRT------------------GFYEY,2.055804,0.844782,-2.9688451,0.6275472,"7ssz_H,7ssz_E,7ssz_G,7ssz_F,8dfl_H,8dfl_E,8dfl_G,8dfl_F",Structure of human Kv1.3 with A0194009G09 nanobodies;Structure of human Kv1.3 with A0194009G09 nanobodies (alternate conformation)
EVKLVESGGGLVQPGGSLRLSCAASGSIFSINTMGWYRQTPGKQRDLVADISSGGSTKYGDSVKGRFTISRDNTKNTVYLQMNSLKPEDTAVYYCYGLSYSNDDYWGQGTQVTVSS,SIFSINT,LVADISSGGSTK,YGLSYSNDDY,15.0,LVADIS-SGGSTK,YGLSY------------------SNDDY,SIFSINTLVADIS-SGGSTKYGLSY------------------SNDDY,0.61665446,1.2166412,2.3274176,1.2588408,"7sr4_B,7sr4_D,7sr5_B,7sr5_D,7sr0_B,7sr0_D,7sr3_B,7sr3_D,7srk_B,7srk_D,7ssh_B,7ssh_D,7ssh_f,7ssh_F,7ssh_H,7ssh_J,7ssh_L,7ssh_N,7ssh_P,7ssh_b,7ssh_T,7ssh_V,7ssh_X,7ssh_R,7ssh_Z,7ssh_d,7stg_B,7stg_D,7stg_f,7stg_F,7stg_H,7stg_J,7stg_L,7stg_N,7stg_P,7stg_R,7stg_T,7stg_V,7stg_X,7stg_Z,7stg_b,7stg_d,7sqp_B,7sqp_D,7st3_F,7st3_B,7st3_d,7st3_f,7st3_H,7st3_J,7st3_L,7st3_N,7st3_P,7st3_b,7st3_T,7st3_V,7st3_X,7st3_R,7st3_Z,7st3_D","Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDL;Single chain trimer HLA-A*02:01 (Y108C, A163C) with Wilms tumor protein peptide RMFPNAPYL;Single chain trimer HLA-A*02:01 (Y108C) with HPV.16 E7 peptide YMLDLQPETTDL;Single chain trimer HLA-A*24:02 (Y108C, A163C) with 8mer peptide YPPVPETF;Consequences of HLA single chain trimer mutations on peptide presentation and binding affinity;Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDLYC;Single chain trimer HLA-A*02:01 (Y108A) with HPV.16 E7 peptide YMLDLQPETTDLYC;Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPET"
QVQLVESGGGLVQPGGSLRLSCAASGFTFDAYGMGWFRQDPGKEREFVAALIWSGSSTAYADSVKGRFTISRDNAKNTLYLQMNNPKPEDTAVYYCARHRTAGFSRRDYEYDYWGQGTQVTVSS,FTFDAYG,FVAALIWSGSSTA,ARHRTAGFSRRDYEYDY,13.0,FVAALIWSGSSTA,ARHRTAGF-----------SRRDYEYDY,FTFDAYGFVAALIWSGSSTAARHRTAGF-----------SRRDYEYDY,-0.7636224,-0.84338975,-2.8189542,1.4201436,"7yzw_A,7yzw_C,7yzw_B,7yzw_E,7yzw_D,7yzw_F",Llama nanobody VHH15 raised against the glycoprotein of Ebola virus
ESGGGLVQAGGSLRLSCAASGSISPKNWMGWYRQAPGKEREFVATIDYGANTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADYDYGDRQRYGHLYWGQGTQVTVSS,SISPKNW,FVATIDYGANTN,AADYDYGDRQRYGHLY,12.0,FVATID-YGANTN,AADYDYGD------------RQRYGHLY,SISPKNWFVATID-YGANTNAADYDYGD------------RQRYGHLY,5.473512,3.7912555,2.5729268,1.8366125,8dyp_B,Crystal structure of human cystine transporter cystinosin
QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDDGQLAYHYDYWGQGTQVTVS,FPVEVWR,GVAAIESYGHGTR,NVKDDGQLAYHYDY,8.0,GVAAIESYGHGTR,NVKDDGQ--------------LAYHYDY,FPVEVWRGVAAIESYGHGTRNVKDDGQ--------------LAYHYDY,1.202032,1.8316966,2.0047321,1.9636045,7d30_A,Structure of sybody MR17-SR31 fusion in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)
QVQLQESGGGSVQAGGSLTLSCAASGYANSNTCMGWFRQAPGKERERVAAISGVGTGTYYADSVKGRFTISRDNGKNTLFLQMNSLKPEDTAMYYCAAAPEGRAWCSRDPSGYNYWGQGTQVTVSS,YANSNTC,RVAAISGVGTGTY,AAAPEGRAWCSRDPSGYNY,15.0,RVAAISGVGTGTY,AAAPEGRAW---------CSRDPSGYNY,YANSNTCRVAAISGVGTGTYAAAPEGRAW---------CSRDPSGYNY,3.3882875,3.077671,1.7065232,1.6565571,"6rpj_H,6rpj_B,6rpj_D,6rpj_F",A Non-blocking anti-CTLA-4 Nanobody complexed with CTLA-4
QVQLQESGGGLVQPGGSLRLSCSASGFKFNDSYMSWVRRVPGKGLEWVAGIWEDSSAAHYRDSVKGRFTISRDNAKNMLYLQMSSLKSDDTGLYYCVRRGYSGDYRPINNPSSQGTQVTVSS,FKFNDSY,WVAGIWEDSSAAH,VRRGYSGDYRPINNP,26.0,WVAGIWEDSSAAH,VRRGYSG-------------DYRPINNP,FKFNDSYWVAGIWEDSSAAHVRRGYSG-------------DYRPINNP,2.3605196,1.5809242,-1.5677879,-2.6084802,"4c57_C,4c57_D,5y7z_C,5y7z_D,5y80_B",Structure of GAK kinase in complex with a nanobody;Complex structure of cyclin G-associated kinase with gefitinib
EVQLVESGGGLVQPGRSLRLSCAASGFDIDYYSIGWVRRAPGKGEELVARIYPSSSSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWHWAYSAWPGWYGMDYWGQGTLVTVSS,FDIDYYS,LVARIYPSSSSTS,ARWHWAYSAWPGWYGMDY,22.0,LVARIYPSSSSTS,ARWHWAYSA----------WPGWYGMDY,FDIDYYSLVARIYPSSSSTSARWHWAYSA----------WPGWYGMDY,-1.861629,-1.2326565,-1.9654787,-2.7334912,"7ooi_A,7ooi_B",Anti-EphA1 JD1 VH domain
QVQLVASGGGSVQAGGSLRLSCAASGYTFSSYPMGWYRQAPGKECELSARIFSDGSANYADSVKGRFTISRDNAANTAYLQMDSLKPEDTAVYYCAAGPGSGKLVVAGRTCYGPNYWGQGTQVTVSS,YTFSSYP,LSARIFSDGSAN,AAGPGSGKLVVAGRTCYGPNY,13.0,LSARIF-SDGSAN,AAGPGSGKLV-------VAGRTCYGPNY,YTFSSYPLSARIF-SDGSANAAGPGSGKLV-------VAGRTCYGPNY,3.5969527,3.179976,2.1613846,1.811811,"1kxt_B,1kxt_D,1kxt_F",Camelid VHH Domains in Complex with Porcine Pancreatic alpha-Amylase
QVQLVESGGGLVQAGGSLRLSCAASGSFFMSNVMAWYRQAPGKARELIAAIRGGDMSTVYDDSVKGRFTITRDDDKNILYLQMNDLKPEDTAMYYCKASGSSWGQGTQVTVSS,SFFMSNV,LIAAIRGGDMSTV,KASGSS,17.0,LIAAIRGGDMSTV,KAS----------------------GSS,SFFMSNVLIAAIRGGDMSTVKAS----------------------GSS,2.7253845,2.6193867,-1.0584004,-1.6415191,"2xv6_B,2xv6_D,2xt1_B,2xxc_B,2xxm_B",Crystal structure of a camelid VHH raised against the HIV-1 capsid protein C-terminal domain.;Crystal structure of the HIV-1 capsid protein C-terminal domain (146- 231) in complex with a camelid VHH.;Crystal structure of the HIV-1 capsid protein C-terminal domain (146- 220) in complex with a camelid VHH.;Crystal structure of the HIV-1 capsid protein C-terminal domain in complex with a camelid VHH and the CAI peptide.
EVQLQASGGGLVQAGDSLRLSCVAVSGRTISTFAMGWFRQAPGKEREFVATINWSGSSARYADPVEGRFTISRDDAKNTVYLEMSSLKPGDSAVYYCASGRYLGGITSYSQGDFAPWGQGTQVTVSS,RTISTFA,FVATINWSGSSAR,ASGRYLGGITSYSQGDFAP,21.0,FVATINWSGSSAR,ASGRYLGGI---------TSYSQGDFAP,RTISTFAFVATINWSGSSARASGRYLGGI---------TSYSQGDFAP,0.286491,-0.38232064,-2.3376606,0.2709332,"7r98_E,7r98_D,7r98_F",Structure of the SARS-CoV-2 N protein RNA-binding domain bound to single-domain antibody B6
QVQLVESGGGLVQPGGSLRLSCAASGSIFSIDYMGWYRQAPGKERELVAIKTSGGTTHYADSVKGRFTISRDNAKNTVYLQMNSLKPDDTAVYYCNARVYFGDRDYWGQGTQVTVSS,SIFSIDY,LVAIKTSGGTTH,NARVYFGDRDY,9.0,LVAIKT-SGGTTH,NARVY-----------------FGDRDY,SIFSIDYLVAIKT-SGGTTHNARVY-----------------FGDRDY,0.33299527,3.0846643,2.5078065,2.6747599,6qup_B,Structural signatures in EPR3 define a unique class of plant carbohydrate receptors
QVQLVESGGGSVQAGGSLRLSCAASGNIHHISYLGWFRQAPGKEREGVAALWTKDGNTYYADSVKGRFTVSLDNAKNTGYLQMNSLKPEDTALYYCAAADTGSDTPLWDWVYWYWGQGTQVTVSA,NIHHISY,GVAALWTKDGNTY,AAADTGSDTPLWDWVYWY,15.0,GVAALWTKDGNTY,AAADTGSDT----------PLWDWVYWY,NIHHISYGVAALWTKDGNTYAAADTGSDT----------PLWDWVYWY,2.5139017,1.3027505,-0.54980963,0.41578627,"6quz_E,6quz_F,6qv0_E,6qv0_F",Structure of ATPgS-bound outward-facing TM287/288 in complex with sybody Sb_TM35;Structure of ATP-bound outward-facing TM287/288 in complex with sybody Sb_TM35
QVQLVESGGGLVQAGGSLRLSCVASGSAPSFFAMAWYRQSPGNERELVAALSSLGSTNYADSVKGRFTISMDNAKNTVYLQMNNVNAEDTAVYYCAAGDFHSCYARKSCDYWGQGTQVTVS,SAPSFFA,LVAALSSLGSTN,AAGDFHSCYARKSCDY,17.0,LVAALS-SLGSTN,AAGDFHSC------------YARKSCDY,SAPSFFALVAALS-SLGSTNAAGDFHSC------------YARKSCDY,1.9195433,2.789649,-1.2058177,1.432785,"7sal_C,7sal_D",Crystal Structure of LaM6 Nanobody bound to mCherry
QVQLVESGGGLVQAGGSLRLSCAASGRTFSTSAMGWFRQAPGREREFVAAITWTVGNTIYGDSMKGRFTISRDRTKNTVDLQMDSLKPEDTAVYYCTARSRGFVLSDLRSVDSFDYKGQGTQVTVS,RTFSTSA,FVAAITWTVGNTI,TARSRGFVLSDLRSVDSFDY,17.0,FVAAITWTVGNTI,TARSRGFVLS--------DLRSVDSFDY,RTFSTSAFVAAITWTVGNTITARSRGFVLS--------DLRSVDSFDY,-0.2846397,-0.83056295,-5.29692,-0.5640432,7sai_C,Crystal Structure of Lag30 Nanobody bound to eGFP
QVQLVESGGRLVQAGDSLRLSCAASGRTFSTSAMAWFRQAPGREREFVAAITWTVGNTILGDSVKGRFTISRDRAKNTVDLQMDNLEPEDTAVYYCSARSRGYVLSVLRSVDSYDYWGQGTQVTVS,RTFSTSA,FVAAITWTVGNTI,SARSRGYVLSVLRSVDSYDY,20.0,FVAAITWTVGNTI,SARSRGYVLS--------VLRSVDSYDY,RTFSTSAFVAAITWTVGNTISARSRGYVLS--------VLRSVDSYDY,-0.5026913,-2.0672102,-5.5326195,-1.15467,"7sah_B,6lr7_B",Crystal Structure of LaG16 Nanobody bound to eGFP;Crystal structure of GFPuv complexed with the nanobody LaG16 at 1.67 Angstron resolution
QVQLVESGGSLVQPGGSLRLSCAASGRFAESSSMGWFRQAPGKEREFVAAISWSGGATNYADSAKGRFTLSRDNTKNTVYLQMNSLKPDDTAVYYCAANLGNYISSNQRLYGYWGQGTQVTVS,RFAESSS,FVAAISWSGGATN,AANLGNYISSNQRLYGY,15.0,FVAAISWSGGATN,AANLGNYI-----------SSNQRLYGY,RFAESSSFVAAISWSGGATNAANLGNYI-----------SSNQRLYGY,1.7797844,2.258422,2.663963,3.0521894,7sak_B,Crystal Structure of LaM4 Nanobody bound to mCherry
QVQLVEYGGGSVQAGGYLRLSCVASGSISLSSGMGWYRQAPGKERELVASISGGSSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASEQLTSGHAYWGQGTQVTVSS,SISLSSG,LVASISGGSSTN,AASEQLTSGHAY,11.0,LVASIS-GGSSTN,AASEQL----------------TSGHAY,SISLSSGLVASIS-GGSSTNAASEQL----------------TSGHAY,3.0923865,3.525084,3.4285328,2.5639646,7r9d_N,Crystal structure of Nb_0 in complex with Fab_8D3
QVQLQESGGGLVQPGGSLRLSCAASGSGFNNNAMGWYRQAPGKQRELVAAITSFGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCTAGWGATPRSYWGQGTQVTVSS,SGFNNNA,LVAAITSFGSTN,TAGWGATPRSY,10.0,LVAAIT-SFGSTN,TAGWG-----------------ATPRSY,SGFNNNALVAAIT-SFGSTNTAGWG-----------------ATPRSY,4.8905325,4.0427256,3.208374,2.9683752,"5g5r_B,5g5x_B",CBS domain tandem of site-2 protease from Archaeoglobus fulgidus in complex with llama Nanobody - nucleotide-bound form;CBS domain tandem of site-2 protease from Archaeoglobus fulgidus in complex with llama Nanobody - apo form
QVQLQESGGGLVQAGGSLRLSCAASGRTFSDYFMGWFRQAPGKEREFVAAVSWSGGSTYYADSVKGRFTISRDNAKNTVFLQMNSLKPEDTAVYYCAGGGSYYPMSPYDGMDYWGKGTQVTVSS,RTFSDYF,FVAAVSWSGGSTY,AGGGSYYPMSPYDGMDY,11.0,FVAAVSWSGGSTY,AGGGSYYP-----------MSPYDGMDY,RTFSDYFFVAAVSWSGGSTYAGGGSYYP-----------MSPYDGMDY,2.0273159,0.5288314,1.2314912,0.95675474,"7usv_C,7usv_D",Plasmodium falciparum protein Pfs230 D1 in complex with nanobody F10
QVQLQESGGGLVQAGGSLRLSCAASRSIFSIDTANWYRQPPGMQRELVATITRDGNANYADSVKGRFTISRDRARNTVYLQMNSLKPEDTGVYYCNAAIRTTVRTSAQEYWGQGTQVTVSS,SIFSIDT,LVATITRDGNAN,NAAIRTTVRTSAQEY,17.0,LVATIT-RDGNAN,NAAIRTT-------------VRTSAQEY,SIFSIDTLVATIT-RDGNANNAAIRTT-------------VRTSAQEY,1.1151311,1.4613862,0.11183056,0.4224097,"5m95_B,5m95_D,5m94_B,5m94_D",STAPHYLOCOCCUS CAPITIS DIVALENT METAL ION TRANSPORTER (DMT) IN COMPLEX WITH MANGANESE;Crystal structure of Staphylococcus capitis divalent metal ion transporter (DMT) in complex with nanobody
EVQLVESGGGLVQPGGSLRLSCAISGFSISSTSIDWVRQAPGKGLEWVARISPSSGSTSYADSVKGRFTISADTSKNTVYLQMNSLRAEDTAVYYCGRVAKALNSRSPSFVVNTYSSIGFDYRGQGTLVTVSS,FSISSTS,WVARISPSSGSTS,GRVAKALNSRSPSFVVNTYSSIGFDY,22.0,WVARISPSSGSTS,GRVAKALNSRSPS--FVVNTYSSIGFDY,FSISSTSWVARISPSSGSTSGRVAKALNSRSPS--FVVNTYSSIGFDY,-1.0114542,0.15191412,-2.493831,-2.8190124,"7xtp_C,7xtp_D",eIF4E in Complex with a Disulphide-Free Autonomous VH Domain
EVQLVESGGGLVQPGGSLRLSCTTSTSLFSITTMGWYRQAPGKQRELVASIKRGGGTNYADSMKGRFTISRDNARNTVFLEMNNLTTEDTAVYYCNAAILAYTGEVTNYWGQGTQVTVSS,SLFSITT,LVASIKRGGGTN,NAAILAYTGEVTNY,19.0,LVASIK-RGGGTN,NAAILAY--------------TGEVTNY,SLFSITTLVASIK-RGGGTNNAAILAY--------------TGEVTNY,0.67979676,1.3570374,-0.1981347,1.7358408,"8ee2_C,8ee2_D,8ee2_G,8ee2_H,8ee2_K,8ee2_L",Crystal Structure of Nanobody VHH219 Bound to Its Antigen PA14 Cif
QRQLVESGGGLVQPGGSLRLSCAASGSILYFNRMGWYRQAPGKQRELVAAITSGDSTNYADPVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNAKEKGWSFSLYDYWGQGTPVTVVK,SILYFNR,LVAAITSGDSTN,NAKEKGWSFSLYDY,13.0,LVAAIT-SGDSTN,NAKEKGW--------------SFSLYDY,SILYFNRLVAAIT-SGDSTNNAKEKGW--------------SFSLYDY,0.70184046,1.9862367,2.3439853,2.139351,"6hd9_A,6hdb_A,6hdc_A,6hda_A,6hd8_A,6swr_A,6swr_D",Crystal structure of the potassium channel MtTMEM175 with rubidium;Crystal structure of the lysosomal potassium channel MtTMEM175 T38A mutant soaked with zinc;Crystal structure of the potassium channel MtTMEM175 with cesium;Crystal structure of the potassium channel MtTMEM175 T38A variant in complex with a Nanobody-MBP fusion protein;Crystal structure of the potassium channel MtTMEM175 in complex with a Nanobody-MBP fusion protein;Crystal structure of the potassium channel MtTMEM175 with zinc
EVQLLESGGGLVQPGGSLRLSCAASGFTFSTFSMNWVRQAPGKGLEWVSYISRTSKTIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGGWALGDEIPSSFLEFDYWGQGTLVTVS,FTFSTFS,WVSYISRTSKTIY,ARGGWALGDEIPSSFLEFDY,20.0,WVSYISRTSKTIY,ARGGWALGDE--------IPSSFLEFDY,FTFSTFSWVSYISRTSKTIYARGGWALGDE--------IPSSFLEFDY,-1.9622853,-1.7791781,-5.281044,-2.7962239,"5n88_A,5n88_H",Crystal structure of antibody bound to viral protein
QVQLQESGGGLVQAGGSLRLSCEASGNVDRIDAMGWFRQAPGKQREFVGYISEGGILNYGDFVKGRFTISRDNAKNTVYLQMSNLKSEDTGVYFCAASHWGTLLIKGIEHWGKGTQVTVSS,NVDRIDA,FVGYISEGGILN,AASHWGTLLIKGIEH,19.0,FVGYIS-EGGILN,AASHWGT-------------LLIKGIEH,NVDRIDAFVGYIS-EGGILNAASHWGT-------------LLIKGIEH,0.16760775,1.0519909,-0.45346493,0.21511334,4wem_B,Co-complex structure of the F4 fimbrial adhesin FaeG variant ac with llama single domain antibody V1
QVQLQESGGGLVQPGGSLRLSCTASGSISSINAMGWYRQAPGSKREFVAHITNTGVTEFADSVKGRFTISRDNAKTTVDLQMNSLKPEDTAVYYCAATDWGTLLIKGIDHWGKGTQVTVSS,SISSINA,FVAHITNTGVTE,AATDWGTLLIKGIDH,16.0,FVAHIT-NTGVTE,AATDWGT-------------LLIKGIDH,SISSINAFVAHIT-NTGVTEAATDWGT-------------LLIKGIDH,0.87844795,2.4391403,-1.1354184,-1.2515361,4wen_B,Co-complex structure of the F4 fimbrial adhesin FaeG variant ac with llama single domain antibody V2
QVQLQQSGGGLVQAGGSLRLSCAASGRAFGYYYMGWFRQAPGKEREFVAAISWYDGSTSYADSVKGRFTISRDNAKNTVDLQMNSLKSEDTAVYYCAGDRSLTVVASSWRYWGQGTQVTVSS,RAFGYYY,FVAAISWYDGSTS,AGDRSLTVVASSWRY,12.0,FVAAISWYDGSTS,AGDRSLT-------------VVASSWRY,RAFGYYYFVAAISWYDGSTSAGDRSLT-------------VVASSWRY,-0.19065121,-0.07776111,-2.1128309,0.9868677,8heg_D,Pentamer of FMDV (A/TUR/14/98) in complex with M3F
QVQLVESGGGLVQSGGSLRLSCAASGSIFRTTGMNWYRQTPEKQREWVALITSHGTTSYAASVEGRFTISRDSAGTTVYLQMNSLKPEDAGVYYCTTRGYWGQGTQVTVSS,SIFRTTG,WVALITSHGTTS,TTRGY,19.0,WVALIT-SHGTTS,TT-----------------------RGY,SIFRTTGWVALIT-SHGTTSTT-----------------------RGY,2.11422,1.8833262,-3.8658354,-2.9193819,"8c3k_B,8c3l_B,8c3l_D",PaaR2 N-terminal domin in complex with nanobody 33;PaaR2 N-terminal domain in complex with nanobody 33
QVQLQESGGGLVQAGGSLRLSCAASGLTFDTYAMGWFRQAPGKKREYVAAISWTGISTYYADIAKGRFTISRDNAKNTLYLQMDSLKPEDTAVYYCAAQKSLNVPAPWDYWGQGTQVTVSS,LTFDTYA,YVAAISWTGISTY,AAQKSLNVPAPWDY,14.0,YVAAISWTGISTY,AAQKSLN--------------VPAPWDY,LTFDTYAYVAAISWTGISTYAAQKSLN--------------VPAPWDY,1.2582713,0.9489647,-4.4465,-2.7186534,"4weu_E,4weu_D",Co-complex structure of the F4 fimbrial adhesin FaeG variant ad with llama single domain antibody V3
QVQLQESGGGLVQPGGSLRLSCAASGSIFSIREWGWYRQAPGKQRELVATITSGGTTNYADSVRGRFTISRDNAKDTVYLQMNSLTPEDTAVYYCNAESDGWYGLSYWGQGTQVTVGP,SIFSIRE,LVATITSGGTTN,NAESDGWYGLSY,16.0,LVATIT-SGGTTN,NAESDG----------------WYGLSY,SIFSIRELVATIT-SGGTTNNAESDG----------------WYGLSY,0.79006034,1.8333324,2.6558125,1.8688228,"8et0_C,8et0_D",Crystal Complex of murine Cyclooxygenase-2 with alpaca nanobody F9
AGGSLRLSCAASGNIFDRGYMGWYRQAPGKERELVAGISYGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAYPLYDDPYYYWGQGTQVTVSS,NIFDRGY,LVAGISYGGSTY,AAYPLYDDPYYY,20.0,LVAGIS-YGGSTY,AAYPLY----------------DDPYYY,NIFDRGYLVAGIS-YGGSTYAAYPLY----------------DDPYYY,2.0972006,2.4442706,2.9232295,2.749341,"7qha_C,8b01_C",Cryo-EM structure of the Tripartite ATP-independent Periplasmic (TRAP) transporter SiaQM from Photobacterium profundum in amphipol;Cryo-EM structure of the Tripartite ATP-independent Periplasmic (TRAP) transporter SiaQM from Photobacterium profundum in a nanodisc
QVQLVESGGGLVQAGGSLRLSCAVSGRTISTFGMGWFRQAPGKEREFVATITRDEDMLLYADSVKGRFTISRDTAKNMVFLQMNSLKIEDTALYYCAVRRDSSWGYSRQSTEYDYWGQGTQVTVSS,RTISTFG,FVATITRDEDMLL,AVRRDSSWGYSRQSTEYDY,14.0,FVATITRDEDMLL,AVRRDSSWG---------YSRQSTEYDY,RTISTFGFVATITRDEDMLLAVRRDSSWG---------YSRQSTEYDY,2.8233001,0.20994705,-4.0733337,0.7250266,"8cxn_E,8cxn_D,8cxn_F",SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-57
QVQLVESGGGFAQAGGSLRLSCAASGSTFRFRAMGWFRQAPGKEREFVAGISWSGSTKYTDSVKGRFTISRDNAKNTVHLQMNNLTPEDTAVYYCAQSRAIEADDSRGYDYWGQGTQVT,STFRFRA,FVAGISWSGSTK,AQSRAIEADDSRGYDY,17.0,FVAGIS-WSGSTK,AQSRAIEA------------DDSRGYDY,STFRFRAFVAGIS-WSGSTKAQSRAIEA------------DDSRGYDY,0.4059259,0.502558,-0.57112545,1.007926,7a17_B,"Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody"
QVQLVESGGGFAQAGGSLRLSCAASGSTFRFRAMGWFRQAPGKEREFVAGISWSGSTKYTDSVKGRFTISRDNAKNTVHLQMNNLTPEDTAVYYCAQSRAIEADDSRGYDYWGQGTQVTVSS,STFRFRA,FVAGISWSGSTK,AQSRAIEADDSRGYDY,14.0,FVAGIS-WSGSTK,AQSRAIEA------------DDSRGYDY,STFRFRAFVAGIS-WSGSTKAQSRAIEA------------DDSRGYDY,0.4059259,0.502558,-0.22142757,0.94494504,"7a0v_B,7a0v_D,7a0v_F,7a17_D,7a17_F","Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody;Crystal structure of the 5-phosphatase domain of Synaptojanin1 in complex with a nanobody"
DVQLQESGGGLVQAGGSLRLSCTGSGRTFRNYPMAWFRQAPGKEREFVAGITWVGASTLYADFAKGRFTISRDNAKNTVYLQMNSLKPEDTAVYSCAAGRGIVAGRIPAEYADWGQGTQVTVSS,RTFRNYP,FVAGITWVGASTL,AAGRGIVAGRIPAEYAD,16.0,FVAGITWVGASTL,AAGRGIVA-----------GRIPAEYAD,RTFRNYPFVAGITWVGASTLAAGRGIVA-----------GRIPAEYAD,-0.81012315,0.26691878,-1.6335322,-1.8770039,"5f1k_C,5f1k_D",human CD38 in complex with nanobody MU1053
QVQLQESGGGLVQPGGSLRLSCAASGKLLSINVMGWYRQAPGKQRELVASITTGGRINYADSVKGRFTITRDNAKNTVYLQMDSLKPEDTAVYYCNADGIIAGLYQNDHWGQGTQVTVSS,KLLSINV,LVASITTGGRIN,NADGIIAGLYQNDH,11.0,LVASIT-TGGRIN,NADGIIA--------------GLYQNDH,KLLSINVLVASIT-TGGRINNADGIIA--------------GLYQNDH,-0.8692791,-1.2203202,1.3154987,2.1732285,"8r4b_C,8r4c_C",LRR domain of Roco protein from C. tepidum bound to the activating Nanobody NbRoco2;Roco protein from C. tepidum in the GTP state bound to the activating Nanobodies NbRoco1 and NbRoco2
EVQLVESGGGLVQPGGSLRLSCAASDSSFYDYEMSWVRQAPGKAQEWIGSMYPSGRTYINPSLKSLVTISRDNSKNTLYLQLNSLRAEDTAMYYCVSNWASGSTGDYWGQGTLVTVSS,SSFYDYE,WIGSMYPSGRTY,VSNWASGSTGDY,28.0,WIGSMY-PSGRTY,VSNWAS----------------GSTGDY,SSFYDYEWIGSMY-PSGRTYVSNWAS----------------GSTGDY,2.3725598,1.6112529,-1.016072,-1.6867149,"7vne_U,7vne_W,7vne_V",Structure of the SARS-CoV-2 spike glycoprotein in complex with a human single domain antibody n3113.1 (UUU-state)
DVQLQESGGGSVQAGGSLRLSCVASGVTSTRPCIGWFRQAPGKEREGVAVVNFRGDSTYITDSVKGRFTISRDEDSDTVYLQMNSLKPEDTATYYCAADVNRGGFCYIEDWYFSYWGQGTQVTVSS,VTSTRPC,GVAVVNFRGDSTY,AADVNRGGFCYIEDWYFSY,20.0,GVAVVNFRGDSTY,AADVNRGGF---------CYIEDWYFSY,VTSTRPCGVAVVNFRGDSTYAADVNRGGF---------CYIEDWYFSY,1.1299348,1.2608942,-1.8632689,0.045637846,5u64_B,Camel nanobody VHH-28
DVQLVESGGGLVQPGGSLRLSCAASGRTFSSYSMGWFRQAPGKAREFVVAISKGGYKYDAVSLEGRFTISRDNAKNTVYLQINSLRPEDTAVYYCASSRAYGSSRLRLADTYEYWGQGTLVTVSS,RTFSSYS,FVVAISKGGYKY,ASSRAYGSSRLRLADTYEY,18.0,FVVAIS-KGGYKY,ASSRAYGSS---------RLRLADTYEY,RTFSSYSFVVAIS-KGGYKYASSRAYGSS---------RLRLADTYEY,1.8507968,1.5165958,-3.76817,-1.1993188,8ijz_A,anti-VEGF mutant
QVQLVESGGGLVQPGGSLRLSCAASGFTFSDYVMTWVRQAPGKGPEWIATINTDGSTMRDDSTKGRFTISRDNAKNTLYLQMTSLKPEDTALYYCARGRVISASAIRGAVRGPGTQVTVSS,FTFSDYV,WIATINTDGSTM,ARGRVISASAIRGAV,20.0,WIATIN-TDGSTM,ARGRVIS-------------ASAIRGAV,FTFSDYVWIATIN-TDGSTMARGRVIS-------------ASAIRGAV,1.1011745,0.9908408,-3.5338142,-3.030461,"7ubx_C,7ubx_D",Structure of a pore forming fragment of Clostridium difficile toxin A in complex with VHH AA6
DVQLVESGGGLVNPGGSLRLSCAASGRTFSSYSMGWFRQAPGKEREFVVAISKGGYKYDAVSLEGRFTISRDNAKNTVYLQINSLRPEDTAVYYCASSRAYGSSRLRLADTYEYWGQGTLVTVSS,RTFSSYS,FVVAISKGGYKY,ASSRAYGSSRLRLADTYEY,18.0,FVVAIS-KGGYKY,ASSRAYGSS---------RLRLADTYEY,RTFSSYSFVVAIS-KGGYKYASSRAYGSS---------RLRLADTYEY,1.8507968,1.5165958,-1.7084275,1.5510807,8ijs_A,anti-VEGF nanobody mutant
QVQLQESGGGLVQPGGSLRLSCAASGSIFSGNAMGWYRQAPGKQRELVAAITSGGSTDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCHVDPRPWGYDVTDYDYWGQGTQVTVSS,SIFSGNA,LVAAITSGGSTD,HVDPRPWGYDVTDYDY,10.0,LVAAIT-SGGSTD,HVDPRPWG------------YDVTDYDY,SIFSGNALVAAIT-SGGSTDHVDPRPWG------------YDVTDYDY,1.348608,1.1958996,2.8245862,1.4085708,"5hvh_B,5hvg_B,5hvg_D",Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with two Inhibitory Nanobodies;Crystal Structure of Thrombin-activatable Fibrinolysis Inhibitor in Complex with an Inhibitory Nanobody (VHH-a204)
EVQLVESGGGLVQPGGSLRLSSAISGFSISSTSIDWVRQAPGKGLEWVARISPSSGSTSYADSVKGRFTISADTSKNTVYLQMNSLRAEDTAVYYTGRPLPEMGFFTQIPAMVDYRGQGTLVTVSS,FSISSTS,WVARISPSSGSTS,GRPLPEMGFFTQIPAMVDY,24.0,WVARISPSSGSTS,GRPLPEMGF---------FTQIPAMVDY,FSISSTSWVARISPSSGSTSGRPLPEMGF---------FTQIPAMVDY,-1.0091275,-0.21770662,-0.57741934,-2.9899118,7f07_C,Autonomous VH domain that interacts with eIF4E at the Capped mRNA Binding site.
QVQLVESGGGLVQAGGSLRLSCAASGRTFSNDALGWFRQAPRKEREFVAAINWNSGTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYSCAAASDYGLPREDFLYDYWGQGTQVTVSS,RTFSNDA,FVAAINWNSGTY,AAASDYGLPREDFLYDY,11.0,FVAAIN-WNSGTY,AAASDYGL-----------PREDFLYDY,RTFSNDAFVAAIN-WNSGTYAAASDYGL-----------PREDFLYDY,1.7832702,2.447801,0.16398348,-2.092312,7olz_B,Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06
QVQLVESGGGLVQPGGSLRLSCAASGYIYSAYCMGWFRQAPGKGLEGVAAIYIGGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAADVIPTETCLGGSWSGPFGYWGQGTLVTVSS,YIYSAYC,GVAAIYIGGGSTY,AADVIPTETCLGGSWSGPFGY,16.0,GVAAIYIGGGSTY,AADVIPTETC-------LGGSWSGPFGY,YIYSAYCGVAAIYIGGGSTYAADVIPTETC-------LGGSWSGPFGY,0.5067523,1.4708546,-3.8249648,-2.2942545,6rqm_B,A blocking anti-CTLA-4 Nanobody (KN044) complexed with CTLA-4
QVQLVESGGGLVQAGGSLRLSCAASGFPVAQEIMTWYRQAPGKEREWVAAISSIGDTTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVNVGFTYKGQGTQVTVSA,FPVAQEI,WVAAISSIGDTTA,AVNVGFTY,10.0,WVAAISSIGDTTA,AVNV--------------------GFTY,FPVAQEIWVAAISSIGDTTAAVNV--------------------GFTY,1.2189881,0.9910612,-1.0943656,1.3702116,"7p6k_I,7p6k_H,7p6k_G",Structure of homomeric LRRC8A Volume-Regulated Anion Channel in complex with synthetic nanobody Sb5
QWQLVESGGGLVQAGGSLRLSCTASGIILSINSMGWYRQTAGNEREWVAFSTAGGSTTYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNTPAGRVGGTWGQGTPVTVSS,IILSINS,WVAFSTAGGSTT,NTPAGRVGGT,13.0,WVAFST-AGGSTT,NTPAG------------------RVGGT,IILSINSWVAFST-AGGSTTNTPAG------------------RVGGT,0.7697628,0.34450918,-0.8855228,-0.8686154,"7yz9_B,7yzk_C,7yzk_D,7yzi_C,7yzi_E,7yzi_D",Structure of catalytic domain of Rv1625c bound to nanobody NB4;Structure of Mycobacterium tuberculosis adenylyl cyclase Rv1625c / Cya
QVQLVESGGGLVQAGGSLRLSCAASGYPWTYIYMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRFTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGDALVATRYGRWGQGTQVTVSS,YPWTYIY,GVAAMDSGGGGTL,AAGGDALVATRYGR,12.0,GVAAMDSGGGGTL,AAGGDAL--------------VATRYGR,YPWTYIYGVAAMDSGGGGTLAAGGDAL--------------VATRYGR,2.7245615,2.7315087,0.012950122,1.0192449,"2p4a_B,2p4a_D",X-ray structure of a camelid affinity matured single-domain vhh antibody fragment in complex with RNASE A
QVQLVESGGGLVQAGGSLRLACAASGRIFSSDTLAWFRRAPGKEREFVAASRWSGGGTDYADSVKGRFTFSRDNTRNTMCLEMNSLKPEDTAVYYCALRTARDSYYYTRNPTGYDYWGQGTQVTVSS,RIFSSDT,FVAASRWSGGGTD,ALRTARDSYYYTRNPTGYDY,18.0,FVAASRWSGGGTD,ALRTARDSYY--------YTRNPTGYDY,RIFSSDTFVAASRWSGGGTDALRTARDSYY--------YTRNPTGYDY,1.2090616,-0.11937752,-1.0399346,-3.1599271,"7sp6_C,7sp7_C,7sp8_C,7sp9_C,7spa_C","Chlorella virus Hyaluronan Synthase bound to UDP-GlcNAc;Chlorella virus Hyaluronan Synthase in the GlcNAc-primed, channel-open state;Chlorella virus hyaluronan synthase;Chlorella virus hyaluronan synthase inhibited by UDP;Chlorella virus Hyaluronan Synthase in the GlcNAc-primed channel-closed state"
QVQLVESGGGLVQAGGSLRLSCAASGSIFVNNAMGWYRQAPGKERELVAAISASGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADQDGYPYEYWGQGTQVTVSS,SIFVNNA,LVAAISASGGSTY,AADQDGYPYEY,7.0,LVAAISASGGSTY,AADQD-----------------GYPYEY,SIFVNNALVAAISASGGSTYAADQD-----------------GYPYEY,2.2947078,2.3689628,2.9185245,2.7988997,7utg_A,2D9 nanobody to BCL11A-exZF23 fragment
QVQLVETGGGLVQAGGSLRLSCAASGNIFSFNVMGWYRQAPGKQRELVAAITSGDTTTYADSVQGRFTISRDNAKNAVYLQMNSLTPEDTAVYFCNARRNPINGPYYTTAYWGQGTQVTVSS,NIFSFNV,LVAAITSGDTTT,NARRNPINGPYYTTAY,13.0,LVAAIT-SGDTTT,NARRNPIN------------GPYYTTAY,NIFSFNVLVAAIT-SGDTTTNARRNPIN------------GPYYTTAY,2.2759974,2.6697898,-0.24816783,-0.067588866,"5j1t_C,5j1s_C","TorsinA-LULL1 complex, H. sapiens, bound to VHH-BS2;TorsinAdeltaE-LULL1 complex, H. sapiens, bound to VHH-BS2"
SGGGLVQAGDSLRLSCAASGSTFSGYAMGWYRQAPGKERELVAAITSSGASTYYADSVRGRFTISRDDAKNTVYLQMNSLKPEDTAVYYCAALDEGYLDYDSWGQGTQVTVSS,STFSGYA,LVAAITSSGASTY,AALDEGYLDYDS,16.0,LVAAITSSGASTY,AALDEG----------------YLDYDS,STFSGYALVAAITSSGASTYAALDEG----------------YLDYDS,0.530322,1.0629994,2.2787585,2.1662602,8dtu_A,The complex of nanobody 5344N74D with BCL11A ZF6.
QVQLQESGGGLVQAGGSLRLSCAVSGRTFSNYYSGWFRQAPGKEREFLASIRWSDSTTNYADSVKGRFTISRDTAKNTVYLQMNSLKLEDTAVYHCAARRLATYDYWGQGTQVTVSS,RTFSNYY,FLASIRWSDSTTN,AARRLATYDY,14.0,FLASIRWSDSTTN,AARRL------------------ATYDY,RTFSNYYFLASIRWSDSTTNAARRL------------------ATYDY,2.000065,0.8099458,-2.0105712,0.050190568,"6h6y_H,6h6y_E,6h6y_G,6h6y_F",GI.1 human norovirus protruding domain in complex with Nano-7
RVQLVESGGGLVQAGGSLRLSCAASGFIFDSYAMGWYRQAPGKEMELVAAITSSGSSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAALDYVIDGYWGQGTQVTVSS,FIFDSYA,LVAAITSSGSSTY,AALDYVIDGY,9.0,LVAAITSSGSSTY,AALDY------------------VIDGY,FIFDSYALVAAITSSGSSTYAALDY------------------VIDGY,-0.8831021,-0.21669984,-1.0143242,0.19801074,"8dtn_A,8dtn_C,8dtn_E,8dtn_G",The complex of nanobody 6101 with BCL11A ZF6
QVQLVESGGGLVQAGGSLRLSCAASGFPVWQGEMAWYRQAPGKEREWVAAISSMGYKTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVMVGFWYAGQGTQVTVSA,FPVWQGE,WVAAISSMGYKTY,AVMVGFWY,10.0,WVAAISSMGYKTY,AVMV--------------------GFWY,FPVWQGEWVAAISSMGYKTYAVMV--------------------GFWY,1.1544347,-0.8329787,-3.3581686,0.35354012,7d2z_A,Structure of sybody SR31 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)
QVQLQESGGGSVAAGGSLRLSCAVSGVTASSVYMAWFRQAPGKEREGLAGINTVGYTTYADSVKGRFTISKDNSENTLYLQMNSLKPEDIALYYCAATYLLRFASLSATNFPYWGQGTQVTVSS,VTASSVY,GLAGINTVGYTT,AATYLLRFASLSATNFPY,19.0,GLAGIN-TVGYTT,AATYLLRFA----------SLSATNFPY,VTASSVYGLAGIN-TVGYTTAATYLLRFA----------SLSATNFPY,1.697769,-0.88118863,-4.3861947,0.604284,7vfa_D,the complex of SARS-CoV2 3CL and NB1A2
EVQLVESGGGLVQPGGSLRLSCAASGFTLDDYAIAWFRQAPGKEREGVSGIDSGDGSAYYADSVKGRFTISSDNAKNTVYLQMNSLRPEDTAVYYCARVRTGWGLNAPDYAMDYWGKGTLVTVSS,FTLDDYA,GVSGIDSGDGSAY,ARVRTGWGLNAPDYAMDY,16.0,GVSGIDSGDGSAY,ARVRTGWGL----------NAPDYAMDY,FTLDDYAGVSGIDSGDGSAYARVRTGWGL----------NAPDYAMDY,2.2823212,0.979318,2.201893,2.153241,"4grw_E,4grw_G",Structure of a complex of human IL-23 with 3 Nanobodies (Llama vHHs)
EVQLVESGGGLVQAGGSLRLSCAASGRTFSWSAVGWFRQAPGKEREFVAAIRWSGGSPYYADSVKDRFTISRDNAKNTVYLQMNSLRPEDTAVYLCGETSLFPTSRGSHYDTWGQGTQVTVSS,RTFSWSA,FVAAIRWSGGSPY,GETSLFPTSRGSHYDT,13.0,FVAAIRWSGGSPY,GETSLFPT------------SRGSHYDT,RTFSWSAFVAAIRWSGGSPYGETSLFPT------------SRGSHYDT,-0.7933337,-1.1456635,-3.2783146,-0.33832556,"4grw_I,4grw_H,5mzv_D",IL-23:IL-23R:Nb22E11 complex;Structure of a complex of human IL-23 with 3 Nanobodies (Llama vHHs)
QVQLQESGGGSVQAGGSLRLSCAVSGYTYSSKCLGWFRQAPGKEREGIATIYTGGGSTYYVDSVKGRFTISQDNAKNTVALQMNSLKPEDTAMYYCAASGAIAGIRLCLPGHTFYTYWGQGTQVTVSS,YTYSSKC,GIATIYTGGGSTY,AASGAIAGIRLCLPGHTFYTY,16.0,GIATIYTGGGSTY,AASGAIAGIR-------LCLPGHTFYTY,YTYSSKCGIATIYTGGGSTYAASGAIAGIR-------LCLPGHTFYTY,1.7798826,3.0668411,-2.238663,0.7086858,7vfb_B,the complex of SARS-CoV2 3cl and NB2B4
QVQLQESGGGLVQAGGSLRLSCAASGHTFNYPIMGWFRQAPGKEREFVGAISWSGGSTSYADSVKDRFTISRDNAKNTVYLEMNNLKPEDTAVYYCAAKGRYSGGLYYPTNYDYWGQGTQVTVS,HTFNYPI,FVGAISWSGGSTS,AAKGRYSGGLYYPTNYDY,13.0,FVGAISWSGGSTS,AAKGRYSGG----------LYYPTNYDY,HTFNYPIFVGAISWSGGSTSAAKGRYSGG----------LYYPTNYDY,1.3112396,2.1092196,2.5500464,1.06708,"5o8f_M,5o8f_L,5o8f_N",Structure of a chimaeric beta3-alpha5 GABAA receptor in complex with nanobody Nb25 and pregnanolone
QVQLVESGGGLVQAGGSLRLSCAASGATFITYGMTWFRQAPGKEREFVAAVTGNGAGTTYLPSVKGRFTISRDNAKNTVYLQMSSLKPEDTAVYYCGGRRWVPATAVDQVAYWGQGTQVTVSS,ATFITYG,FVAAVTGNGAGTT,GGRRWVPATAVDQVAY,12.0,FVAAVTGNGAGTT,GGRRWVPA------------TAVDQVAY,ATFITYGFVAAVTGNGAGTTGGRRWVPA------------TAVDQVAY,0.07031592,0.5852295,-0.4403354,0.57141316,"7djy_A,7djy_C,7djy_B,7djy_D",Clec4f Nanobody 322
DVQLQASGGGLVQPGGSLRVSCAASGFTFSSYHMAWVRQAPGKGLEWVSTINPGDGSTYYADSVKGRFTISRDNAKNTLYLQMNSLKSEDTAVYYCAKYSGGALDAWGQGTQVTVSS,FTFSSYH,WVSTINPGDGSTY,AKYSGGALDA,18.0,WVSTINPGDGSTY,AKYSG------------------GALDA,FTFSSYHWVSTINPGDGSTYAKYSG------------------GALDA,0.98257047,1.8448857,-3.0966225,-2.856018,1ieh_A,SOLUTION STRUCTURE OF A SOLUBLE SINGLE-DOMAIN ANTIBODY WITH HYDROPHOBIC RESIDUES TYPICAL OF A VL/VH INTERFACE
QVQLVESGGGLVQAGGSLRLSCTASGRTGTIYSMAWFRQAPGKEREFLATVGWSSGITYYMDSVKGRFTISRDKGKNTVYLQMDSLKPEDTAVYYCTATRAYSVGYDYWGQGTQVTVS,RTGTIYS,FLATVGWSSGITY,TATRAYSVGYDY,15.0,FLATVGWSSGITY,TATRAY----------------SVGYDY,RTGTIYSFLATVGWSSGITYTATRAY----------------SVGYDY,-1.1040987,-0.82873356,-2.8663273,0.5890947,"6qtl_A,6qtl_E,6qtl_D,6qtl_H",Caffeine recognizing nanobody
QVQLVESGGGLVQAGGSLRLSCTASGRTGTIYSMAWFRQAPGKEREFLATVGWSSGITYYMDSVKGRFTISRDKGKNTVYLQMDSLKPEDTAVYYCTATRAYSVGYDYWGQGTQVTVSS,RTGTIYS,FLATVGWSSGITY,TATRAYSVGYDY,14.0,FLATVGWSSGITY,TATRAY----------------SVGYDY,RTGTIYSFLATVGWSSGITYTATRAY----------------SVGYDY,-1.1040987,-0.82873356,-2.7995067,0.5890947,"8ftg_A,8ftg_C,8ftg_B,8ftg_E,8ftg_D,8ftg_G,8ftg_F,8ftg_H,6qtl_C,6qtl_B,6qtl_G,6qtl_F",Biophysical and Structural Characterization of an Anti-Caffeine VHH Antibody;Caffeine recognizing nanobody
QVQLVESGGGLAQAGGSLRLSCAASGRTFSMDPMAWFRQPPGKEREFVAAGSSTGRTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAAPYGANWYRDEYAYWGQGTQVTVSS,RTFSMDP,FVAAGSSTGRTTY,AAAPYGANWYRDEYAY,11.0,FVAAGSSTGRTTY,AAAPYGAN------------WYRDEYAY,RTFSMDPFVAAGSSTGRTTYAAAPYGAN------------WYRDEYAY,1.5862073,1.2255114,1.9472702,0.31426352,"4nbx_B,4nby_C,4nby_B,4nc1_C,4nc1_D",Crystal Structure of TcdA-A2 Bound to A20.1 VHH and A26.8 VHH;Crystal Structure of Clostridium difficile Toxin A fragment TcdA-A1 Bound to A20.1 VHH;Crystal Structure of TcdA-A2 Bound to Two Molecules of A20.1 VHH
QVKLEESGGGLVQAGGSLRLSCAASERTFSRYPVAWFRQAPGAEREFVAVISSTGTSTYYADSVKGRFTISRDNAKVTVYLQMNNLKREDTAVYFCAVNSQRTRLQDPNEYDYWGQGTQVTVSS,RTFSRYP,FVAVISSTGTSTY,AVNSQRTRLQDPNEYDY,18.0,FVAVISSTGTSTY,AVNSQRTR-----------LQDPNEYDY,RTFSRYPFVAVISSTGTSTYAVNSQRTR-----------LQDPNEYDY,0.67871076,0.66814435,-4.0231657,0.14648253,"4nbz_B,4nbz_D,4nc1_E,4nc1_F,4nc0_B",Crystal Structure of TcdA-A2 Bound to A20.1 VHH and A26.8 VHH;Crystal Structure of TcdA-A1 Bound to A26.8 VHH;Crystal Structure of TcdA-A2 Bound to A26.8 VHH
AVQLVESGGGLVQPGGSLRLSCAASVSISRIYVMAWYRQAPGKQREVVAVIRYDGTTNYPDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNANVETWGQGTQVTVSS,SISRIYV,VVAVIRYDGTTN,NANVET,13.0,VVAVIR-YDGTTN,NAN----------------------VET,SISRIYVVVAVIR-YDGTTNNAN----------------------VET,0.13370505,-0.8204346,-1.8281841,1.8529065,"8gq5_a,8gq5_c,8gq5_b,8gq5_e,8gq5_d,8gq5_g,8gq5_f,8gq5_i,8gq5_h,8gq5_k,8gq5_j,8gq5_m,8gq5_l,8gq5_o,8gq5_n,8gq5_p,8gni_C,8gnj_C","Human SARM1 bounded with NMN and Nanobody-C6, Conformation 2;Human SARM1 bounded with NMN and Nanobody-C6, double-layer structure;Human SARM1 bounded with NMN and Nanobody-C6, Conformation 1"
EVQLLESGGGLVQPGGSLRLSCAASGFTFEEYAMLWVRQAPGKGLEWVSGINARGYTTYYADSVKGRFTISRDNSKNTLYLQMNSLRTEDTAVYYCAKPWYPFMASKGSEFDYWGQGTLVTVSS,FTFEEYA,WVSGINARGYTTY,AKPWYPFMASKGSEFDY,19.0,WVSGINARGYTTY,AKPWYPFM-----------ASKGSEFDY,FTFEEYAWVSGINARGYTTYAKPWYPFM-----------ASKGSEFDY,-0.7646083,-0.09974119,-3.2712028,-3.0795355,"2vyr_E,2vyr_G,2vyr_F,2vyr_I,2vyr_H,2vyr_K,2vyr_J,2vyr_L",Structure of human MDM4 N-terminal domain bound to a single domain antibody
QVQLVETGGGLVQAGGSLRLSCAASGRTFNNDVMAWFRQAPGTEREFVALITAGGGTHYADSVKGRFVISRDNDKNMAYLQMNSLKSEDTAIYYCGADENPPGWPSRWSSAYDYWGQGTQVTVSS,RTFNNDV,FVALITAGGGTH,GADENPPGWPSRWSSAYDY,17.0,FVALIT-AGGGTH,GADENPPGW---------PSRWSSAYDY,RTFNNDVFVALIT-AGGGTHGADENPPGW---------PSRWSSAYDY,2.9221997,2.0274692,0.38971144,0.9380575,"6z6v_H,6z6v_G",Globular head of C1q in complex with the nanobody C1qNb75
QLQLVETGGGLVQPGGSLRLACVASESVFEMYTVAWYRQAPGKQRELVAGITDEGRTNYADFVKGRFTISRDNSKKTVHLQMDNLNPEDTAVYYCKLEHDLGYYDYWGQGTQVTVSS,SVFEMYT,LVAGITDEGRTN,KLEHDLGYYDY,23.0,LVAGIT-DEGRTN,KLEHD-----------------LGYYDY,SVFEMYTLVAGIT-DEGRTNKLEHD-----------------LGYYDY,2.080163,1.7778198,-0.471264,2.2494159,"7lzp_C,7lzp_F",LC/A-JPU-B9-JPU-A11-JPU-G11
QVQLVETGGGLVQAGDSLTLSCAATGRTLDYYALGWFRQVPGNKREFVAAINWLGGSTYYADSVRGRFTLSRDNSKSTLYLNMNNLIPDDTAVYYCAADFSIAYSGTYPPAYAEYDYDYWGQGTQVTVSS,RTLDYYA,FVAAINWLGGSTY,AADFSIAYSGTYPPAYAEYDYDY,25.0,FVAAINWLGGSTY,AADFSIAYSGT-----YPPAYAEYDYDY,RTLDYYAFVAAINWLGGSTYAADFSIAYSGT-----YPPAYAEYDYDY,-0.94071966,-0.9113357,-6.8280444,-3.6203492,"7lzp_B,7lzp_E",LC/A-JPU-B9-JPU-A11-JPU-G11
QVQLVETGGALVQPGQSLTLSCTTSENVFGIYGMAWLRQAPGRQRELVASITSRGTAHYHDSVKGRFTISRESGKTTAYLQTTSVNPEDTAIYYCNSGPYWGQGTQVTVSS,NVFGIYG,LVASITSRGTAH,NSGPY,30.0,LVASIT-SRGTAH,NS-----------------------GPY,NVFGIYGLVASIT-SRGTAHNS-----------------------GPY,1.3295002,0.81777585,-0.65079755,-0.98118275,"7lzp_G,7lzp_H",LC/A-JPU-B9-JPU-A11-JPU-G11
QVQLQESGGGLVQPGGSLRLSCAASGTIFSRNIMGWYRQAPGKERELVASIYSDRSTWYAESVEGRFTISRDNVKNTLYLQMNSLKPEDTAMYYCRDRTLGSWGQGTQVTVSS,TIFSRNI,LVASIYSDRSTW,RDRTLGS,14.0,LVASIY-SDRSTW,RDR---------------------TLGS,TIFSRNILVASIY-SDRSTWRDR---------------------TLGS,2.7493918,1.5515875,-0.25664902,1.7906249,5omn_C,GII.10 Vietnam 026 protruding domain in complex with Nanobody Nano-27
QVQLQESGGGLVQSGGSLRLSCAASRNINSMHVVGWYRQAPGNQRELVASITDDGSTDYVDSVKGRFTISRDIAENTVYLQMNSLNPEDTAVYYCKGTIVVFTTPMHYWGKGTQVTVSS,NINSMHV,LVASITDDGSTD,KGTIVVFTTPMHY,18.0,LVASIT-DDGSTD,KGTIVV---------------FTTPMHY,NINSMHVLVASIT-DDGSTDKGTIVV---------------FTTPMHY,1.71253,1.4009978,-3.0847023,0.59439427,5omm_C,GII.10 Vietnam 026 protruding domain in complex with Nanobody Nano-14
IVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVS,FPVNRYS,WVAGMSSAGDRSS,NVNVGFEY,15.0,WVAGMSSAGDRSS,NVNV--------------------GFEY,FPVNRYSWVAGMSSAGDRSSNVNV--------------------GFEY,0.414263,1.3943044,1.2060026,3.493586,8thr_A,Structure of the human vesicular monoamine transporter 2 (VMAT2) bound to tetrabenazine in an occluded conformation
QVQLVESGGGLVQAGGSLRLSCAASGFPVESENMHWYRQAPGKEREWVAAIYSTGGWTLYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVQVGYWYEGQGTQVTVS,FPVESEN,WVAAIYSTGGWTL,AVQVGYWY,10.0,WVAAIYSTGGWTL,AVQV--------------------GYWY,FPVESENWVAAIYSTGGWTLAVQV--------------------GYWY,2.5639126,-0.7110946,-2.841676,0.036135614,"7a29_E,7a29_D,7a29_F,7a25_E,7a25_D,7a25_F",Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23);Cryo-EM structure of the SARS-CoV-2 spike protein bound to neutralizing sybodies (Sb23) 2-up conformation
QVQLVESGGGLVQAGGSLRLSCAASGFPVYSWNMWWYRQAPGKEREWVAAIESHGDSTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYVWVGHTYYGQGTQVTVSA,FPVYSWN,WVAAIESHGDSTR,YVWVGHTY,10.0,WVAAIESHGDSTR,YVWV--------------------GHTY,FPVYSWNWVAAIESHGDSTRYVWV--------------------GHTY,1.4453636,0.48840863,-1.302845,2.423331,7c8v_A,Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)
QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDDGQLAYHYDYWGQGTQVTVSA,FPVEVWR,GVAAIESYGHGTR,NVKDDGQLAYHYDY,9.0,GVAAIESYGHGTR,NVKDDGQ--------------LAYHYDY,FPVEVWRGVAAIESYGHGTRNVKDDGQ--------------LAYHYDY,1.202032,1.8316966,1.939872,1.9440615,7c8w_A,Structure of sybody MR17 in complex with the SARS-CoV-2 S receptor-binding domain (RBD)
QVQLQESGGGLVQAGGSLRLSCAKSGRTFRAYAMGWFRQAPGKEREFVAAIDWSAAITNYADSVKGRFTILRDKGMNTAYLQMNSLEPEDTAVYYCAATYSTIAPRTSYDFWGQGTQVTVSS,RTFRAYA,FVAAIDWSAAITN,AATYSTIAPRTSYDF,16.0,FVAAIDWSAAITN,AATYSTI-------------APRTSYDF,RTFRAYAFVAAIDWSAAITNAATYSTI-------------APRTSYDF,-0.78929585,-0.353229,-2.6734676,0.5214926,"6xw4_C,6xw4_D",Crystal structure of murine norovirus P domain in complex with Nanobody NB-5867
QVQLVESGGGLVQAGGSLRLSCAASGRTFSSYVMGWFRQAPGKEREFVTAISWSGGSIHYADSVKGRFTISRDNAKNTVYLLQMNSKPEDTAVYTCVAGFAGYGSFTSRSARDSDKYDYWGQGTKVTVSS,RTFSSYV,FVTAISWSGGSIH,VAGFAGYGSFTSRSARDSDKYDY,17.0,FVTAISWSGGSIH,VAGFAGYGSFT-----SRSARDSDKYDY,RTFSSYVFVTAISWSGGSIHVAGFAGYGSFT-----SRSARDSDKYDY,-0.18436256,-1.0082086,-3.733892,-0.2263003,5fwo_A,Llama nanobody PorM_130
QVQLVESGGGLVQAGGSLRLSCAASGRTFSSYGMGWFRQAPGKEREFVAAIRWNGGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAGRWDKYGSSFQDEYDYWGQGTQVTVSS,RTFSSYG,FVAAIRWNGGSTY,AAGRWDKYGSSFQDEYDY,8.0,FVAAIRWNGGSTY,AAGRWDKYG----------SSFQDEYDY,RTFSSYGFVAAIRWNGGSTYAAGRWDKYG----------SSFQDEYDY,1.0237827,1.6314707,0.4227956,1.1130521,"5imk_B,5imm_B,5iml_B,5imo_B",Nanobody targeting human Vsig4 in Spacegroup C2;Nanobody targeting human Vsig4 in Spacegroup P212121;Nanobody targeting mouse Vsig4 in Spacegroup P212121;Nanobody targeting mouse Vsig4 in Spacegroup P3221
QVQLVETGGGLVQAGGSLRLSCAASGSIFSINAMGWFRQAPGKEREFVATINRSGGRTYYADSVKGRFTISRDNGKNMVYLQMHSLKPEDTAIYYCAAGTGWSPQTDNEYNYWGQGTQVTVSS,SIFSINA,FVATINRSGGRTY,AAGTGWSPQTDNEYNY,13.0,FVATINRSGGRTY,AAGTGWSP------------QTDNEYNY,SIFSINAFVATINRSGGRTYAAGTGWSP------------QTDNEYNY,2.1504693,2.3781576,1.0335217,1.0753427,7qiv_C,Structure of human C3b in complex with the EWE nanobody
QVQLQESGGGLVQAGGSLRLSCAASGGTFKSGGMAWFRQAGYIDTNNDGWIEGDELYKAREFAAGISWSGGSTDYEDSVKGRFTISRDNAKNTMYLQMNSLKPEDTAVYYCAAARRFRAGVVTRADDVDYWGKGTQVTVSS,GTFKSGG,FAAGISWSGGSTD,AAARRFRAGVVTRADDVDY,30.0,FAAGISWSGGSTD,AAARRFRAG---------VVTRADDVDY,GTFKSGGFAAGISWSGGSTDAAARRFRAG---------VVTRADDVDY,0.764278,1.1046987,-2.0637798,-2.7871416,"6y1r_A,6y1r_C,6y1r_B,6y1r_E,6y1r_D",Nb22-LBT
QLQLVESGGGLVQPGGSLRLSCEASGKVFMINAMGWYRQAPGKQRELVAFISRRGNINYADSVKGRFTISRDNAKNTVYLQMNSLRPEDTAIYYCSADPRSNLDDGRYWGKGTPVTVSS,KVFMINA,LVAFISRRGNIN,SADPRSNLDDGRY,15.0,LVAFIS-RRGNIN,SADPRS---------------NLDDGRY,KVFMINALVAFIS-RRGNINSADPRS---------------NLDDGRY,1.2346385,0.55276215,1.790785,2.4829495,"7qic_C,7qia_C",Structure of magnesium-bound EleNRMT in complex with two nanobodies at 4.1A;Structure of apo-EleNRMT in complex with two nanobodies at 3.5A
QLQLVESGGGLVLAGGSLRLSCAASVRTFSHYALGWFRQAPGKEREFVAAIRWTGSSANYADSVKGRFTISRDNAKNTVDLRMNSLKPEDTAVYYCAARTVYRPGFEDPNEYAYWGQGTRVTVSS,RTFSHYA,FVAAIRWTGSSAN,AARTVYRPGFEDPNEYAY,15.0,FVAAIRWTGSSAN,AARTVYRPG----------FEDPNEYAY,RTFSHYAFVAAIRWTGSSANAARTVYRPG----------FEDPNEYAY,0.7683249,-0.6170732,-1.9555602,1.3993266,"7qic_B,7qia_B",Structure of magnesium-bound EleNRMT in complex with two nanobodies at 4.1A;Structure of apo-EleNRMT in complex with two nanobodies at 3.5A
QVQLVETGGGLVQPGGSLRLSCTASGFTFSMHAMTWYRQAPGKQRELVAVITSHGDRANYTDSVRGRFTISRDNTKNMVYLQMNSLKPEDTAVYYCNVPRYDSWGQGTQVTVSS,FTFSMHA,LVAVITSHGDRAN,NVPRYDS,16.0,LVAVITSHGDRAN,NVP---------------------RYDS,FTFSMHALVAVITSHGDRANNVP---------------------RYDS,-0.48357394,-1.8778574,-1.0797441,1.0212438,5dxw_A,Crystal structure of mouse PD-L1 nanobody
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIGWVRRAPGKGEELVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCYYHYYGWHPGYGLSYSSGQGTLVTVSS,FNIKDTY,LVARIYPTNGYTR,YYHYYGWHPGYGLSYS,22.0,LVARIYPTNGYTR,YYHYYGWH------------PGYGLSYS,FNIKDTYLVARIYPTNGYTRYYHYYGWH------------PGYGLSYS,1.061903,0.41377354,-1.4832665,-2.40183,"3p9w_H,3p9w_B,3p9w_D,3p9w_F",Crystal structure of an engineered human autonomous VH Domain in complex with VEGF
QVQLQESGGGSVQAGGSLKLSCAASGRSFSTYAMGWFRQAPGQDREFVATISWTDSTDYADSVKGRFTISRDNAKNTGYLQMNSLKPEDTAVYYCAADRWASSRRNVDYDYWGQGTQVTVSS,RSFSTYA,FVATISWTDSTD,AADRWASSRRNVDYDY,14.0,FVATIS-WTDSTD,AADRWASS------------RRNVDYDY,RSFSTYAFVATIS-WTDSTDAADRWASS------------RRNVDYDY,-0.43224266,-0.3732307,-3.3771675,-2.697963,"7om5_A,7om5_B,7om4_B",Anti-EGFR nanobody EgB4;Nanobody EgB4 bound to the full extracellular EGFR-EGF complex
QVQLQESGGGLVQAGGSLRLSCAASVRTFSNYAMGWFRQAPGKEREFVAAISWSGDGPYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAASYLSLNFPDDLRGQGTQVTVSS,RTFSNYA,FVAAISWSGDGPY,AASYLSLNFPDDL,10.0,FVAAISWSGDGPY,AASYLS---------------LNFPDDL,RTFSNYAFVAAISWSGDGPYAASYLS---------------LNFPDDL,-0.59300065,-1.1149731,-1.7759511,-0.23463523,"8tzu_H,8tzu_C,8tzu_G",OC43 S1b domain in complex with WNb 293 and WNb 317
QVQLQESGGGSVQAGDSLRLSCVASGRTFSSYALGWFRRAPGKEREFVAAISWSGGTTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAALWDGGSWYPEGLSDFGSWGQGTQVTVSS,RTFSSYA,FVAAISWSGGTTY,AALWDGGSWYPEGLSDFGS,14.0,FVAAISWSGGTTY,AALWDGGSW---------YPEGLSDFGS,RTFSSYAFVAAISWSGGTTYAALWDGGSW---------YPEGLSDFGS,-0.19101444,-0.57907903,-2.8330314,-3.0587668,"8tzu_E,8tzu_D",OC43 S1b domain in complex with WNb 293 and WNb 317
QVQLQESGGGLVQAGGSLRLSCAASGRTGSTYDMGWFRQAPGKERESVAAINWDSARTYYASSVRGRFTISRDNAKKTVYLQMNSLKPEDTAVYTCGAGEGGTWDSWGQGTQVTVSS,RTGSTYD,SVAAINWDSARTY,GAGEGGTWDS,13.0,SVAAINWDSARTY,GAGEG------------------GTWDS,RTGSTYDSVAAINWDSARTYGAGEG------------------GTWDS,2.2217019,3.016646,0.594202,-0.8983137,1g9e_A,SOLUTION STRUCTURE AND RELAXATION MEASUREMENTS OF AN ANTIGEN-FREE HEAVY CHAIN VARIABLE DOMAIN (VHH) FROM LLAMA
DVQLVESGGGLVQPGGSLRLSCAASGRTFSSYSMGWFRQAPGKEREFVVAISKGGYKYDAVSLEGRFTISRDNAKNTVYLQINSLRPEDTAVYYCASSRAYGSSRLRLADTYEYWGQGTLVTVSS,RTFSSYS,FVVAISKGGYKY,ASSRAYGSSRLRLADTYEY,17.0,FVVAIS-KGGYKY,ASSRAYGSS---------RLRLADTYEY,RTFSSYSFVVAIS-KGGYKYASSRAYGSS---------RLRLADTYEY,1.8507968,1.5165958,-1.7996215,1.3901508,"8iiu_A,8iiu_B",anti-VEGF nanobody
QVQLVETGGGLVQAGGSLRLSCATSGTIFSRATMAWYRQTPGKQREWVTTITTSGNTNYADSVKGRFTISRDNAESTLYLQMNSLKPEDTAVYYCNAQFLSSRTNYWGKGTQVTVSS,TIFSRAT,WVTTITTSGNTN,NAQFLSSRTNY,16.0,WVTTIT-TSGNTN,NAQFL-----------------SSRTNY,TIFSRATWVTTIT-TSGNTNNAQFL-----------------SSRTNY,1.8338596,2.1393204,-1.250772,0.588109,8pih_C,Structure of Api m1 in complex with two nanobodies
EVQLVESGGGLVQAGGSLRLSCAASGSSFSSYTMGWFRQAPGKEREIVAGIRWSDESPIYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCAARLVPPGIPIPRTSESMRYWGKGTLVTVSS,SSFSSYT,IVAGIRWSDESPI,AARLVPPGIPIPRTSESMRY,12.0,IVAGIRWSDESPI,AARLVPPGIP--------IPRTSESMRY,SSFSSYTIVAGIRWSDESPIAARLVPPGIP--------IPRTSESMRY,2.636136,2.8305535,2.4102817,1.6972346,6v7y_F,Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D5
QVQLVESGGGLVQAGGSLRLSCAASGSIFSINAMGWYRQAPGKQRDFLAVISSSGSTNYADSVKGRFTISRDNAKNTAYLQMNSLKVEDTAVYYCAAHVAGFDEYNYWGQGTQVTVSS,SIFSINA,FLAVISSSGSTN,AAHVAGFDEYNY,11.0,FLAVIS-SSGSTN,AAHVAG----------------FDEYNY,SIFSINAFLAVIS-SSGSTNAAHVAG----------------FDEYNY,0.84679955,2.2742496,-2.7858794,0.075018704,"6v7z_E,6v7z_F",Human CD1d presenting alpha-Galactosylceramide in complex with VHH nanobody 1D22
QVQLVESGGGLVQAGGSLRLSCAASQRTFSPYVGGWFRQAPGKEREFVAAISWSGGTKLYADSVKGRFTISRDNAKNTVYLQMNTLKREDTAVYYCAARRINEVLTTAPDYDFWGQGTQVTVSS,RTFSPYV,FVAAISWSGGTKL,AARRINEVLTTAPDYDF,12.0,FVAAISWSGGTKL,AARRINEV-----------LTTAPDYDF,RTFSPYVFVAAISWSGGTKLAARRINEV-----------LTTAPDYDF,1.1246864,1.0501705,0.3890748,1.1180286,"5vak_B,5van_B,5vaq_B","Crystal Structure of Beta-Klotho, Domain 1;Crystal Structure of Beta-Klotho in Complex with FGF21CT;Crystal Structure of Beta-Klotho"
QVQLQESGGGLVQAGGSLRLSCAASGRTFSNDHMGWFRKAPGKEREFVAAITPGTEKTYYADSVKGRFAFSRDNAKNTVYLQMNSLKPEDTAVYYCVATPYYRGSYYAASTYTYWGQGTQVTVSS,RTFSNDH,FVAAITPGTEKTY,VATPYYRGSYYAASTYTY,12.0,FVAAITPGTEKTY,VATPYYRGS----------YYAASTYTY,RTFSNDHFVAAITPGTEKTYVATPYYRGS----------YYAASTYTY,2.385122,2.422183,3.0468657,0.7938846,"5lwf_C,5lwf_D",Structure of a single domain camelid antibody fragment cAb-G10S in complex with the BlaP beta-lactamase from Bacillus licheniformis
QVQLVESGGGLVQPGGSLRLSCAASGFPVKYEHMYWYRQAPGKEREWVAAINSAGNETHYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDIGWWAAYDYWGQGTQVTVPP,FPVKYEH,WVAAINSAGNETH,NVKDIGWWAAYDY,10.0,WVAAINSAGNETH,NVKDIG---------------WWAAYDY,FPVKYEHWVAAINSAGNETHNVKDIG---------------WWAAYDY,0.06802114,1.4847816,2.8742063,3.7391818,"7omt_A,7omm_C",Cryo-EM structure of N. gonorhoeae LptDE in complex with ProMacrobodies (MBPs have not been built de novo);Crystal structure of ProMacrobody 21 with bound maltose
QVQLVESGGGSVQAGGSLRLSCAASGSISSITYLGWFRQAPGKEREGVAALATYYGHTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYSGIWTPLGVWATYEYWGQGTQVTVPP,SISSITY,GVAALATYYGHTY,AAAYSGIWTPLGVWATYEY,15.0,GVAALATYYGHTY,AAAYSGIWT---------PLGVWATYEY,SISSITYGVAALATYYGHTYAAAYSGIWT---------PLGVWATYEY,0.8475173,0.66839385,-2.9026365,-0.17400342,7omm_D,Cryo-EM structure of N. gonorhoeae LptDE in complex with ProMacrobodies (MBPs have not been built de novo)
EVQLVESGGGLVQPGRSLRLSCAASGFDIAYYSIGWVRRAPGKGEELVARIYPSSSSTSYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCARWHYDYADWPGGYGMDYWGQGTLVTVSS,FDIAYYS,LVARIYPSSSSTS,ARWHYDYADWPGGYGMDY,22.0,LVARIYPSSSSTS,ARWHYDYAD----------WPGGYGMDY,FDIAYYSLVARIYPSSSSTSARWHYDYAD----------WPGGYGMDY,-1.1039952,-0.74287283,-1.7869028,-2.7205598,"7omn_A,7omn_C,7omn_B",Anti-EphA1 JD1-1 VH domain
QVQLQESGGGLVQAGGSLRLSCAASPGISRYKTMGWYRQAPGKERSFVAAITWGGLTYYADSVKGRFTVSRDNAKNTVYLQMNSLKPEDTAVYYCSVDGGTRADPYHYYWGQGTQVTVSS,GISRYKT,FVAAITWGGLTY,SVDGGTRADPYHYY,10.0,FVAAIT-WGGLTY,SVDGGTR--------------ADPYHYY,GISRYKTFVAAIT-WGGLTYSVDGGTR--------------ADPYHYY,2.1154838,2.2857966,-0.34097105,1.082618,"8f8v_A,8f8v_B,8f8w_H,8f8w_C,8f8w_D,8f8w_G,8f8x_C,8f8x_D",Crystal structure of Nb.X0;Crystal structure of Nb.X0 bound to the afucosylated human IgG1 fragment crystal form I;Crystal structure of Nb.X0 bound to the afucosylated human IgG1 fragment crystal form II
QVQLQESGGGLVQAGDSLRLSCVASGRAFSSYGMGWFRQAPGKERAFVAAISRSGGLTQYAESLKGRFAISRDNAKNTVYLQMGSLKPEDTAVYYCAGDLYGLGSHMENEYDSWGQGTQVTVSS,RAFSSYG,FVAAISRSGGLTQ,AGDLYGLGSHMENEYDS,16.0,FVAAISRSGGLTQ,AGDLYGLG-----------SHMENEYDS,RAFSSYGFVAAISRSGGLTQAGDLYGLG-----------SHMENEYDS,0.2060968,0.76387155,-1.7679405,-0.66996455,"3k80_A,3k80_B",Structure of essential protein from Trypanosoma brucei
EVQPQESGGGLAQAGGSLRLSCVVSGITFASEAWGWYRRAPGKQRELIAAINNEGRTNYVDSVKGRFTVSRDNAKNVMYLQMNSLKPEDTAVYYCNANLQTGTLSGARLYWGQGTQVTVSS,ITFASEA,LIAAINNEGRTN,NANLQTGTLSGARLY,20.0,LIAAIN-NEGRTN,NANLQTG-------------TLSGARLY,ITFASEALIAAIN-NEGRTNNANLQTG-------------TLSGARLY,2.918223,3.0537605,1.1799128,-2.1129415,"3k81_A,3k81_B",Structure of the central interaction protein from the Trypanosoma brucei editosome in complex with single domain antibodies
QVQLVESGGGVVQPGRSLRLSCAASGFTFSSYGMHWVRQAPGKEREWVAVISDDGSNKYYADSVKGRFTISRDNSKNTLYLQMNSLRVEDTAVYYCAKDRGTMRVVVYDTLDIWGQGTLVTVSS,FTFSSYG,WVAVISDDGSNKY,AKDRGTMRVVVYDTLDI,17.0,WVAVISDDGSNKY,AKDRGTMR-----------VVVYDTLDI,FTFSSYGWVAVISDDGSNKYAKDRGTMR-----------VVVYDTLDI,-1.1475861,-0.5736349,-2.9212456,0.09078252,7vke_B,Crystal structure of human CD38 ECD in complex with UniDab(TM) F11A
QVQLVETGGGSVQAGDSLTLSCAASERIFSHYAMGWYRQVPGKEREPVAALRLKGTETNYADSVEGRFTISRDNAKNTMYLRMSSLKPEDTAVYYCAAGSYAAILYAPSYWGQGTQVTVSS,RIFSHYA,PVAALRLKGTETN,AAGSYAAILYAPSY,17.0,PVAALRLKGTETN,AAGSYAA--------------ILYAPSY,RIFSHYAPVAALRLKGTETNAAGSYAA--------------ILYAPSY,0.0847029,1.1902035,0.7087807,0.2333219,7th3_B,Single-domain VHH intrabodies neutralize ricin toxin
QVQLVESGGGSVQAGGSLRLSCTASGFTFDDSDMGWYHQAPGNECELVSAIFSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAMYYCAAATTTVASPPVRHVCNGYWGQGTQVTVSS,FTFDDSD,LVSAIFSDGSTY,AAATTTVASPPVRHVCNGY,13.0,LVSAIF-SDGSTY,AAATTTVAS---------PPVRHVCNGY,FTFDDSDLVSAIF-SDGSTYAAATTTVAS---------PPVRHVCNGY,4.9453497,3.7131433,0.59824306,0.9016774,"5e7f_A,5e7f_C,5e7f_B,5e7b_A","Complex between lactococcal phage Tuc2009 RBP head domain and a nanobody (L06);Structure of a nanobody (vHH) from camel against phage Tuc2009 RBP (BppL, ORF53)"
EVQLVESGGGLVQPGGSLRLSCAASGFTVSSYGMSWVRQAPGKGPEWVSGIRGSDGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKQGENDGPFDHRGQGTLVTVS,FTVSSYG,WVSGIRGSDGSTY,AKQGENDGPFDH,20.0,WVSGIRGSDGSTY,AKQGEN----------------DGPFDH,FTVSSYGWVSGIRGSDGSTYAKQGEN----------------DGPFDH,2.9507008,2.1336193,-1.7232027,-3.0132794,"6j7w_A,6j7w_B",Crystal Structure of Human BCMA in complex with UniAb(TM) VH
QVQLVESGGGLVQPGGSLRLSCAASGFTFSRYWMYWVRQAPGKGPEWLSHMNPSGSDIKYTDSVKGRFTISRDNAKNTLYLQMNSLKPDDTAVYYCVADRRALGSPEYWGQGTQVTVSS,FTFSRYW,WLSHMNPSGSDIK,VADRRALGSPEY,15.0,WLSHMNPSGSDIK,VADRRA----------------LGSPEY,FTFSRYWWLSHMNPSGSDIKVADRRA----------------LGSPEY,1.1442858,-0.3568393,-4.1193614,-2.6233466,"7bc6_B,7bc7_B",Cryo-EM structure of the proton coupled folate transporter at pH 6.0 bound to pemetrexed;Cryo-EM structure of the outward open proton coupled folate transporter at pH 7.5
EVQLQASGGGLVEAGGSLRLSCTTSGLTFSSVTMGWFRQAPGKEREFVAAIRWKFGNLGYADSVKGRFTVSRDNAKNTVYLQMNSLKPEDTAVYYCAAARVGEIIAVLISPSNYAYWGQGTQVTVSS,LTFSSVT,FVAAIRWKFGNLG,AAARVGEIIAVLISPSNYAY,15.0,FVAAIRWKFGNLG,AAARVGEIIA--------VLISPSNYAY,LTFSSVTFVAAIRWKFGNLGAAARVGEIIA--------VLISPSNYAY,0.09626224,-1.7658485,-2.9302819,0.78329057,7q3q_B,Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobody VHH-12
EVQLVESGGGTVQPGGSLRLSCEVSGTGFTINAMGWDRQAPGKQRELVATITRGDRIHYADSVKGRFAISRDKDKNTVYLEMNNLKPEDTAVYYCDVAAFDSSDYEVLDSWGQGTQVTVSS,TGFTINA,LVATITRGDRIH,DVAAFDSSDYEVLDS,19.0,LVATIT-RGDRIH,DVAAFDS-------------SDYEVLDS,TGFTINALVATIT-RGDRIHDVAAFDS-------------SDYEVLDS,-0.105924405,-0.13496144,-0.2582438,0.88797516,7q3r_G,Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09
EVQLVESGGGLVQAGGSLRLSCAASGRAFSRYFMGWFRQAPGKEREFVAGISRSGGSTDYANFVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAATVDYSGTLTAARGREDYDDWGQGIQVTVSS,RAFSRYF,FVAGISRSGGSTD,AATVDYSGTLTAARGREDYDD,12.0,FVAGISRSGGSTD,AATVDYSGTL-------TAARGREDYDD,RAFSRYFFVAGISRSGGSTDAATVDYSGTL-------TAARGREDYDD,-0.6881034,-0.43626896,-3.3861113,0.47132993,7q3r_F,Crystal structure of SARS-CoV-2 RBD in complex with the neutralizing nanobodies VHH-F04 and VHH-G09
EVQLEESGGGLVRPGGSLRLSCAASGFPFSKYFMSWVRQAPGKGLEWVSTISASGNYETYTESVKGRFTIARDNAKNTLYLQMNSLKPEDTAVYYCAKGSWARDMTRGQGTQVTVSS,FPFSKYF,WVSTISASGNYET,AKGSWARDMT,20.0,WVSTISASGNYET,AKGSW------------------ARDMT,FPFSKYFWVSTISASGNYETAKGSW------------------ARDMT,-0.38017395,-0.56886685,-3.7443721,-2.894894,8c5h_N,NbSyt1 anti-(rat Synaptotagmin-1) nanobody bound to target cytosolic domain of Synaptotagmin-1
ESGEMLFTVKKDSLRLSCASSRSIDGINIMRWYRQAPGKQRGMVAVVTGWGSTNYVDSVKGRFIISRDSAKDTVYLQMNNLKPEDTAVYSCNAIYRGSEYWGQGTQVTVSS,SIDGINI,MVAVVTGWGSTN,NAIYRGSEY,33.0,MVAVVT-GWGSTN,NAIY-------------------RGSEY,SIDGINIMVAVVT-GWGSTNNAIY-------------------RGSEY,1.8182501,1.652721,-2.6046531,-3.095507,"8ahl_K,8ahl_E,8ahl_L,8ahl_F,8afe_I,8afe_C,8afe_J,8afe_D,8afh_C,8afh_D,8afh_I,8afh_J,8afh_M,8afh_N,8afh_S,8afh_T,8afm_I,8afm_C,8afm_J,8afm_D,8afl_C,8afl_D,8ajb_E,8ajb_F,8ajb_K,8ajb_L,8ajb_Q,8ajb_R,8ajb_W,8ajb_X,8aix_C,8aix_D,8aix_I,8aix_J,8aix_O,8aix_P,8aix_S,8aix_T,8aia_I,8aia_C,8aia_J,8aia_D","Cryo-EM structure of crescentin filaments (wildtype, C1 symmetry and large box);Cryo-EM structure of crescentin filaments (stutter mutant, C2 symmetry and large box);Cryo-EM structure of crescentin filaments (wildtype, C2 symmetry and large box);Cryo-EM structure of crescentin filaments (wildtype, C1 symmetry and small box);Cryo-EM structure of crescentin filaments (stutter mutant, C1 symmetry and small box);Cryo-EM structure of crescentin filaments (stutter mutant, C2, symmetry and small box);Cryo-EM structure of crescentin filaments (wildtype, C2 symmetry and small box);Cryo-EM structure of crescentin filaments (stutter mutant, C1 symmetry and large box)"
QVQLVESGGGLVQAGGSLRLSCVASGGTFSNYGMGWFRQAPGKEREFVAAVRWSGDSTYYSDSVKGRFTISRDNAKNTVYLQMNGLKPEDTAVYYCARRLNWRFISNWDKESEYAYWGQGTQVTVSS,GTFSNYG,FVAAVRWSGDSTY,ARRLNWRFISNWDKESEYAY,11.0,FVAAVRWSGDSTY,ARRLNWRFIS--------NWDKESEYAY,GTFSNYGFVAAVRWSGDSTYARRLNWRFIS--------NWDKESEYAY,-0.10490099,-0.5471045,-1.2492766,0.605451,8opr_C,Structure of the EA1 surface layer of Bacillus anthracis
QVQLVESGGGLVQPGGSLRLSCAASGIAFSRNAVGWYRQAPGKQRELVARSNTVGATNYADSVKGRFTISRDNDKSTVYLQMNSLKPEDTAVYYCNIYLYGDRTGSTLNSWGQGTQVTVSS,IAFSRNA,LVARSNTVGATN,NIYLYGDRTGSTLNS,12.0,LVARSN-TVGATN,NIYLYGD-------------RTGSTLNS,IAFSRNALVARSN-TVGATNNIYLYGD-------------RTGSTLNS,0.5114253,0.6385428,-0.26928633,1.2634258,8opr_B,Structure of the EA1 surface layer of Bacillus anthracis
QVQLQESGGGLVQAGGSLNLSCVASGSSHFNSMGWYRQAPGKQRDLVADISNDGVTNYADSVKDRFTISTNNAKNAVYLQMNNLKPEDTAVYYCNAVAVAGRAFSYWGQGTQVTVSS,GSSHFNS,LVADISNDGVTN,NAVAVAGRAFSY,18.0,LVADIS-NDGVTN,NAVAVA----------------GRAFSY,GSSHFNSLVADIS-NDGVTNNAVAVA----------------GRAFSY,3.4892712,2.709807,3.6640236,1.8842249,"7o3b_A,7o3b_C,7o3b_B,7o0s_A",Crystal structure of the TTBK2-CEP164 complex bound to a camelid nanobody;Crystal structure of the N-terminal domain of CEP164(1-109) bound to camelid nanobody 36Z
AVQLQASGGGFVQPGGSLRLSCAASGWAETFGHMGWFRQAPGKEREFVSAIDWWDTVHYYADSVKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCAYWDMDYLQNSIPVDYWGQGTQVTVSS,WAETFGH,FVSAIDWWDTVHY,AYWDMDYLQNSIPVDY,17.0,FVSAIDWWDTVHY,AYWDMDYL------------QNSIPVDY,WAETFGHFVSAIDWWDTVHYAYWDMDYL------------QNSIPVDY,-1.2995452,0.113622844,1.1939285,2.2350218,"8k3k_D,8k45_E,8k45_D,8k47_I,8k46_I,8k46_E,8k46_G",A potent and broad-spectrum neutralizing nanobody for SARS-CoV-2 viruses including all major Omicron strains;The crystal structure of nanobody Nb4 in complex with receptor binding domain (RBD) of BA.1 Spike protein
QVQLVESGGGLVQAGGGSLRLSCAASGYPHPYLHMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRFTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGYQLRDRTYGHWGQGTQVTVSS,YPHPYLH,GVAAMDSGGGGTL,AAGGYQLRDRTYGH,13.0,GVAAMDSGGGGTL,AAGGYQL--------------RDRTYGH,YPHPYLHGVAAMDSGGGGTLAAGGYQL--------------RDRTYGH,3.9873497,3.457354,2.3645613,2.002808,4pou_B,VHH-metal in Complex with RNase A
QVQLQESGGGLVQAGGSLRLSCAASGRTFSTYAVGWFRQAPGKEREFVGYFGTRGGRTYYADSVKGRFTIAIDNAKNTVYLQMNSLKLDDTAVYYCAVRMPYSGDYRSSGTYDYWGQGTQVTVSS,RTFSTYA,FVGYFGTRGGRTY,AVRMPYSGDYRSSGTYDY,14.0,FVGYFGTRGGRTY,AVRMPYSGD----------YRSSGTYDY,RTFSTYAFVGYFGTRGGRTYAVRMPYSGD----------YRSSGTYDY,1.8043392,1.372975,-1.3261013,0.4674601,"1u0q_A,1u0q_B",Structure of a Llama VHH domain raised against a carbazole molecule
QVQLVESGGGLVQAGGSLRLSCAASGYPHPYLHMGWFRQAPGKEREGVAAMDSGGGGTLYADSVKGRFTISRDKGKNTVYLQMDSLKPEDTATYYCAAGGYQLRDRTYGHWGQGTQVTVSS,YPHPYLH,GVAAMDSGGGGTL,AAGGYQLRDRTYGH,12.0,GVAAMDSGGGGTL,AAGGYQL--------------RDRTYGH,YPHPYLHGVAAMDSGGGGTLAAGGYQL--------------RDRTYGH,3.9873497,3.457354,2.3378572,1.4101713,4poy_A,Engineered Dual Specific VHH antibody
QVQLVESGGGLVQAGGSLKLSCTTSGRPFSTFDLAWFRQAPGKEREFVSGLRRGGSTFYADSVSGRFTISGGSTKNTLYLQMNSLKPEDTAIYYCARSITGYGLVDSASHYTIWGQGTQVTVSS,RPFSTFD,FVSGLRRGGSTF,ARSITGYGLVDSASHYTI,20.0,FVSGLR-RGGSTF,ARSITGYGL----------VDSASHYTI,RPFSTFDFVSGLR-RGGSTFARSITGYGL----------VDSASHYTI,0.24332449,1.7625533,0.79299015,1.1290936,6eqi_B,Structure of PINK1 bound to ubiquitin
QVQLQESGGGLVQAGGSLRLSCAASGNIFDVDIMGWYRQAPGKERELVASITDGGSTDYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAVAYPDIPTYFDYDSDNFYWGQGTQVTVSS,NIFDVDI,LVASITDGGSTD,AAVAYPDIPTYFDYDSDNFY,8.0,LVASIT-DGGSTD,AAVAYPDIPT--------YFDYDSDNFY,NIFDVDILVASIT-DGGSTDAAVAYPDIPT--------YFDYDSDNFY,1.5662607,1.7371601,2.8606398,2.9715426,"6do1_C,6do1_E,6do1_D,6do1_F,6os0_D",Structure of nanobody-stabilized angiotensin II type 1 receptor bound to S1I8;Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to angiotensin II
QVQLVENGGGCVQATGSLRLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYADSVKGRFTISRDSAKGTVYLQMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,14.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,1.1719135,1.0887399,"7zmn_K,7zmn_C",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G3-048
QVQLVESGGGLVQAGGSLRLSCAASERTFTIYAMGWFRQAPGKEREFVAAISRSGENTDYADSVKGRFTISRDNNKNTISLQMNSLKPEDTAVYYCAAGRAILVHTTKKEYDHWGQGTQVTVSS,RTFTIYA,FVAAISRSGENTD,AAGRAILVHTTKKEYDH,12.0,FVAAISRSGENTD,AAGRAILV-----------HTTKKEYDH,RTFTIYAFVAAISRSGENTDAAGRAILV-----------HTTKKEYDH,-0.40221748,-0.43540603,-1.0162492,1.3481793,"7noz_R,6ruv_S,6ruv_R,6ru3_C",Structure of the SCIN stabilized C3bBb convertase bound to Properdin and a the non-inhibitory nanobody hFPNb1;Structure of the nanobody stablized properdin bound alternative pathway proconvertase C3b:FB:FP;Crystal structure of the FP specific nanobody hFPNb1
QLQLVESGGGLVQAGGSLRLSCAASGRTFSSYAMGWFRQAPGKEREFVAVVNWSGRRTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYNCAAGKWDGSYYGAPDYWGQGTQVTVSS,RTFSSYA,FVAVVNWSGRRTY,AAGKWDGSYYGAPDY,10.0,FVAVVNWSGRRTY,AAGKWDG-------------SYYGAPDY,RTFSSYAFVAVVNWSGRRTYAAGKWDG-------------SYYGAPDY,0.6427218,0.38209438,-4.1922784,-1.8790128,6iyn_A,Solution structure of camelid nanobody Nb26 against aflatoxin B1
EVQLVESGGGLVQAGGSLRLSCAASASIFRALNVGYYRQTPGRQRELIAGISGGGSTHYADPVKGRFTISRDNAKNRVDLQMNNLKPEDTAVYYCNAGPTLTTGDAGPYWGQGTQVTVSS,SIFRALN,LIAGISGGGSTH,NAGPTLTTGDAGPY,17.0,LIAGIS-GGGSTH,NAGPTLT--------------TGDAGPY,SIFRALNLIAGIS-GGGSTHNAGPTLT--------------TGDAGPY,2.7792747,1.1345385,0.36938852,-0.6755541,"6oc8_A,6oc8_C,6oc8_B,6oc8_D",Crystal structure of a VHH against the capsid protein from BLV
QVQLQESGGGLVQPGGSLRLSCAASGRTISRYAMSWFRQAPGKEREFVAVARRSGDGAFYADSVQGRFTVSRDDAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVSA,RTISRYA,FVAVARRSGDGAF,AIDSDTFYSGSYDY,15.0,FVAVARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISRYAFVAVARRSGDGAFAIDSDTF--------------YSGSYDY,-0.3579229,-0.5756862,2.2907774,1.3409057,7o31_X,Crystal structure of the anti-PAS Fab 1.2 in complex with its epitope peptide and the anti-Kappa VHH domain
QVQLVESGGGLVQAGGSLRLSCAASGFPVYAYEMYWYRQAPGKEREWVAAISSSGTWAGYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDWGASWAYYDYWGQGTQVTVS,FPVYAYE,WVAAISSSGTWAG,NVKDWGASWAYYDY,8.0,WVAAISSSGTWAG,NVKDWGA--------------SWAYYDY,FPVYAYEWVAAISSSGTWAGNVKDWGA--------------SWAYYDY,-1.4317875,-0.5334955,-2.3682082,1.8167765,"6zpl_E,6zpl_F,6zbv_B","Inward-open structure of human glycine transporter 1 in complex with a benzoylisoindoline inhibitor and sybody Sb_GlyT1#7;Inward-open structure of human glycine transporter 1 in complex with a benzoylisoindoline inhibitor, sybody Sb_GlyT1#7 and bound Na and Cl ions."
EVQLVESGGGLVQPGGSLRLSCAVSISIFDIYAMDWYRQAPGKQRDLVATSFRDGSTNYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYLCHVSLYRDPLGVAGGMGVYWGKGALVTVSS,SIFDIYA,LVATSFRDGSTN,HVSLYRDPLGVAGGMGVY,19.0,LVATSF-RDGSTN,HVSLYRDPL----------GVAGGMGVY,SIFDIYALVATSF-RDGSTNHVSLYRDPL----------GVAGGMGVY,1.4447838,0.77329886,-1.2523563,0.7066061,"6ck8_A,6ck8_C,6ck8_B,6fyt_I",Structure of H1 (A/solomon Islands/3/06) Influenza Hemagglutinin in complex with SD38;Crystal structure of anti-influenza single-domain llama antibody SD38
EVQLLVSGGGLVQPGGSLRLSCAASGFTFKAYPMMWVRQAPGKGLEWVSEISPSGSYTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAKDPRKLDYWGQGTLVTVSS,FTFKAYP,WVSEISPSGSYTY,AKDPRKLDY,20.0,WVSEISPSGSYTY,AKDP-------------------RKLDY,FTFKAYPWVSEISPSGSYTYAKDP-------------------RKLDY,0.5636929,1.4945365,-4.516344,-3.053467,"5fv2_A,5fv2_C,5fv2_B",Crystal structure of hVEGF in complex with VH domain antibody
QVQLVESGGGLVQTGGSLRLSCAASGRTFRRNTMGWFRQAPGKVREFVAAISWSGDRTYCADSVKGRFTISRDNAKNTVDLLMNSLKPEDTAIYYCAADGTASVFNSYASADRNKYNYWGQGTQVTVSS,RTFRRNT,FVAAISWSGDRTY,AADGTASVFNSYASADRNKYNY,14.0,FVAAISWSGDRTY,AADGTASVFNS------YASADRNKYNY,RTFRRNTFVAAISWSGDRTYAADGTASVFNS------YASADRNKYNY,1.8895732,2.0938077,-2.0920591,-1.6927769,7na9_D,Crystal structure of BoNT/B-LC-JSG-C1
QVQLVESGGGSVQSGGSLTLSCAASGSTYSSHCMGWFRQAPGKEREGVALMTRSRGTSYADSVKGRFTISQDNTKNILYLQMNSLKPEDTAMYYCAAVPRAGIESGAYCKWNMKDSGSWGQGTQVTVSS,STYSSHC,GVALMTRSRGTS,AAVPRAGIESGAYCKWNMKDSGS,16.0,GVALMT-RSRGTS,AAVPRAGIESG-----AYCKWNMKDSGS,STYSSHCGVALMT-RSRGTSAAVPRAGIESG-----AYCKWNMKDSGS,2.122535,1.458383,-1.1518116,0.13307518,6knm_A,Apelin receptor in complex with single domain antibody
QLQLVESGGGLVQPGGSLRLSCEASGKVFMINAMGWYRQAPGKQRELVAFISRRGNINYADSVKGRFTISRDNAKNTVYLQMNSLRPEDTAIYYCSADPRSNLDDGRYWGKGTPVTV,KVFMINA,LVAFISRRGNIN,SADPRSNLDDGRY,17.0,LVAFIS-RRGNIN,SADPRS---------------NLDDGRY,KVFMINALVAFIS-RRGNINSADPRS---------------NLDDGRY,1.2346385,0.55276215,1.5556818,2.4829495,"7qjj_C,7qjj_F,7qji_C,7qji_F",X-Ray Structure of a Mn2+ soak of EleNRMT in complex with two Nanobodies at 4.6A;X-Ray Structure of apo-EleNRMT in complex with two Nanobodies at 4.1A
QLVESGGGLVLAGGSLRLSCAASVRTFSHYALGWFRQAPGKEREFVAAIRWTGSSANYADSVKGRFTISRDNAKNTVDLRMNSLKPEDTAVYYCAARTVYRPGFEDPNEYAYWGQGTRVTV,RTFSHYA,FVAAIRWTGSSAN,AARTVYRPGFEDPNEYAY,18.0,FVAAIRWTGSSAN,AARTVYRPG----------FEDPNEYAY,RTFSHYAFVAAIRWTGSSANAARTVYRPG----------FEDPNEYAY,0.7683249,-0.6170732,-2.286095,1.3801291,"7qjj_B,7qjj_G,7qji_B,7qji_G",X-Ray Structure of a Mn2+ soak of EleNRMT in complex with two Nanobodies at 4.6A;X-Ray Structure of apo-EleNRMT in complex with two Nanobodies at 4.1A
QVQLQESGGGLVQPGGSLRLSCAPSGPFSPNSMGWYRQAPGKQRELVAVMTIDGRTNYQDSVKGRFTISRDYVKNTAYLQMNNLKPDDTAVYICNAETRGFMHWGQGTQVTVSS,GPFSPNS,LVAVMTIDGRTN,NAETRGFMH,19.0,LVAVMT-IDGRTN,NAET-------------------RGFMH,GPFSPNSLVAVMT-IDGRTNNAET-------------------RGFMH,4.112991,3.1169066,1.8194897,-0.30798763,5dfz_E,Structure of Vps34 complex II from S. cerevisiae.
QVQLQESGGGLVQAGGSLRLSCAASGTIFYYEIMGWYRQAPGKEREFVATIDQGGITNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAVPDVFVGRGWDYLIYWGQGTQVTVSS,TIFYYEI,FVATIDQGGITN,AVPDVFVGRGWDYLIY,8.0,FVATID-QGGITN,AVPDVFVG------------RGWDYLIY,TIFYYEIFVATID-QGGITNAVPDVFVG------------RGWDYLIY,-1.8044237,-0.8735779,-0.7792117,1.3999729,"8jtx_B,8jtw_B,8jty_B",hOCT1 in complex with nb5660 in inward facing fully open conformation;hOCT1 in complex with nb5660 in inward facing partially open 2 conformation;hOCT1 in complex with nb5660 in inward facing partially open 1 conformation
QVQLQESGGGLVQAGGSLRLSCAASGRIFSSTRMGWFRQAPGKDREFIASIVWGTTTTYYVDSVKGRFTISRDNAKNMVFLQMNSLKPEDTAVYYCAAKIYYSGTYLAFNPDYWGQGTQVTVSS,RIFSSTR,FIASIVWGTTTTY,AAKIYYSGTYLAFNPDY,13.0,FIASIVWGTTTTY,AAKIYYSG-----------TYLAFNPDY,RIFSSTRFIASIVWGTTTTYAAKIYYSG-----------TYLAFNPDY,-0.91021013,-1.5589198,-5.6204576,-2.3506198,"7zau_H,7zau_B,7zau_D,7zau_F",Fascin-1 in complex with Nb 3E11
QVQLQESGGGLVQTGGSLRLSCKASGRAFARYDLAWSRQAPGKQREFVASIGVTRNPPYYSGSVKGRFTVSRDNAKETVYLQMNDLKPEDSAVYYCAAKDASVTVATIEDYPYWGRGTQVTVSS,RAFARYD,FVASIGVTRNPPY,AAKDASVTVATIEDYPY,21.0,FVASIGVTRNPPY,AAKDASVT-----------VATIEDYPY,RAFARYDFVASIGVTRNPPYAAKDASVT-----------VATIEDYPY,-0.3907731,-0.18716194,-0.9557819,-0.8334195,"7r63_A,7r63_C,7r63_B,7r63_D","Nb82, a nanobody against voltage gated sodium channels Nav1.4 and Nav1.5"
GSLRLSCAASGRTFSTAAMGWFRQAPGKERDFVAGIYWTVGSTYYADSAKGRFTISRDNAKNTVYLQMDSLKPEDTAVYYCAARRRGFTLAPTRANEYDYWGQGTQVTVSS,RTFSTAA,FVAGIYWTVGSTY,AARRRGFTLAPTRANEYDY,26.0,FVAGIYWTVGSTY,AARRRGFTL---------APTRANEYDY,RTFSTAAFVAGIYWTVGSTYAARRRGFTL---------APTRANEYDY,0.6621596,-0.26496154,-2.227742,1.0166314,"6qd6_A,6qd6_C,6qd6_B,6qd6_E,6qd6_D,6qd6_G,6qd6_F,6qd6_I,6qd6_H,6qd6_J",Molecular scaffolds expand the nanobody toolkit for cryo-EM applications: crystal structure of Mb-cHopQ-Nb207
EVQLVESGGGLVQAGGSLRLFCAASGFTFGTSNMAWLRQAPGKRREWVALITISGYTDYADSVKDRFTISRDNAKNTVSLQMNSLKPEDTAIYFCARRVGSEYDLWGQGTQVTVSS,FTFGTSN,WVALITISGYTD,ARRVGSEYDL,16.0,WVALIT-ISGYTD,ARRVG------------------SEYDL,FTFGTSNWVALIT-ISGYTDARRVG------------------SEYDL,0.9314887,-0.05878842,-4.643557,-3.4457114,4orz_C,HIV-1 Nef protein in complex with single domain antibody sdAb19 and an engineered Hck SH3 domain
VQLVESGGGLVQAGGSLSLSCSASGRSLSNYYMGWFRQAPGKERELLGNISWRGYNIYYKDSVKGRFTISRDDAKNTIYLQMNRLKPEDTAVYYCAASILPLSDDPGWNTYWGQGTQVTVS,RSLSNYY,LLGNISWRGYNIY,AASILPLSDDPGWNTY,16.0,LLGNISWRGYNIY,AASILPLS------------DDPGWNTY,RSLSNYYLLGNISWRGYNIYAASILPLS------------DDPGWNTY,1.6142628,0.32824457,1.2926872,1.5677164,"5m2i_G,5m2i_I,5m2i_H,5m2i_K,5m2i_J,5m2i_L",Structure of human Tumor Necrosis Factor (TNF) in complex with the Llama VHH1
QVQLQESGGGLVQAGESLRLSCAASGTIFRLYDMGWYRRVSGNQRELVASITSGGSTKYGDSVKGRFTISRDNAKNTVYLQMSSLKPEDTAVYYCNAEYRTGIWEELLDGWGQGTQVTVSS,TIFRLYD,LVASITSGGSTK,NAEYRTGIWEELLDG,16.0,LVASIT-SGGSTK,NAEYRTG-------------IWEELLDG,TIFRLYDLVASIT-SGGSTKNAEYRTG-------------IWEELLDG,-2.0292482,0.053944647,-3.2276258,-3.3868034,"8hn1_D,8hnn_N,7ul2_D,7ul5_D,7ymj_D,8k2w_N,6vi4_C,6vi4_D",Cryo-EM structure of AdTx1-alpha1AAR-Nb6;CryoEM Structure of Inactive NTSR1 Bound to SR48692 and Nb6;CryoEM Structure of Inactive SSTR2 bound to Nb6;Cryo-EM structure of alpha1AAR-Nb6 complex bound to tamsulosin;Nanobody-Enabled Monitoring of Kappa Opioid Receptor States;Structure of CXCR3 complexed with antagonist AMG487;Structure of CXCR3 complexed with antagonist SCH546738
QGQLVESGGGLVQAGGSLTLSCAASVRDISFFAVGWFRQAPGKQRELVAQMTSLRKINYADSVKGRFTISRDDAKNTVSLQMNSLKPEDTAVYYCHASLPGLPYWGQGTPVTVSA,RDISFFA,LVAQMTSLRKIN,HASLPGLPY,17.0,LVAQMT-SLRKIN,HASL-------------------PGLPY,RDISFFALVAQMT-SLRKINHASL-------------------PGLPY,1.0512749,-1.0483298,-3.688825,1.3926747,"6qv1_E,6qv1_F",Structure of ATPgS-bound outward-facing TM287/288 in complex with nanobody Nb_TM1
QVQLVESGGGSVQAGGSLRLSCAASGYTYSTCRKGWYRQAPGKERELVASITADGATYYLDSVKGRLTISQDNAKNTVYLQMNSLKPEDTAVYYCAASVKDFTCTFNSWGQGTQVTVSS,YTYSTCR,LVASITADGATY,AASVKDFTCTFNS,12.0,LVASIT-ADGATY,AASVKD---------------FTCTFNS,YTYSTCRLVASIT-ADGATYAASVKD---------------FTCTFNS,3.4857829,3.93789,0.8930399,3.1157036,7r4r_D,The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody
QVQLVESGGGSVQAGGSLRLSCAASGYTINTDAVAWFRQAPGKGDERVAVIYTGSGNTNYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTALYYCASGYYGASGYDFNNWGQGTQVTVSS,YTINTDA,RVAVIYTGSGNTN,ASGYYGASGYDFNN,15.0,RVAVIYTGSGNTN,ASGYYGA--------------SGYDFNN,YTINTDARVAVIYTGSGNTNASGYYGA--------------SGYDFNN,2.1931436,2.5199976,-2.2590804,-2.921045,"7r4q_E,7r4q_D",The SARS-CoV-2 spike in complex with the 1.29 neutralizing nanobody
QVQLQESGGGLVQAGGSLRLTCALSERTSTSYAQGWFRQPPGKEREFVASLRTHDGNTHYTDSVKGRFTISRDNAENTLYLQMNSLKTEDTAVYYCAASLGYSGAYASGYDYWGQGTQVTVSS,RTSTSYA,FVASLRTHDGNTH,AASLGYSGAYASGYDY,18.0,FVASLRTHDGNTH,AASLGYSG------------AYASGYDY,RTSTSYAFVASLRTHDGNTHAASLGYSG------------AYASGYDY,2.9151225,3.815526,1.3885491,1.2051537,5tjw_K,Influenza A virus Nucleoprotein in Complex with Inhibitory Nanobody
QVQLQESGGGLVQAGGSLTLSCAASGRTFSNNAMGWFRQAPGKEREFVAAISWTGGLLFYADSVNGRFTISRDNAKRTVTLQMNSLKPEDTAVYYCAARPQGDYVTAHYDYWGQGTQVTVSS,RTFSNNA,FVAAISWTGGLLF,AARPQGDYVTAHYDY,13.0,FVAAISWTGGLLF,AARPQGD-------------YVTAHYDY,RTFSNNAFVAAISWTGGLLFAARPQGD-------------YVTAHYDY,2.4625952,1.2931978,-0.9517643,1.3745692,3k7u_A,Structure of essential protein from Trypanosoma brucei
QVQLVESGGGLVQAGGSLRLSCAASGRSFSTYAMGWFRQAPGKEREFVAAISWSHGITYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADSIPYGDSRYRNPGYWGQGTQVTVSS,RSFSTYA,FVAAISWSHGITY,AADSIPYGDSRYRNPGY,8.0,FVAAISWSHGITY,AADSIPYG-----------DSRYRNPGY,RSFSTYAFVAAISWSHGITYAADSIPYG-----------DSRYRNPGY,0.79731315,0.6709285,-0.9085967,0.9163137,"7tjc_A,7tjc_B",VHH Chl-B2 in complex with Chloramphenicol
EVQLLESGGGLVQPGGSLRLSCAASGFSFSHSPMNWVRQAPGKGLEWVSYISYNSSSIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARGLTESLELTADWFDYWGQGTLVTVSS,FSFSHSP,WVSYISYNSSSIY,ARGLTESLELTADWFDY,19.0,WVSYISYNSSSIY,ARGLTESL-----------ELTADWFDY,FSFSHSPWVSYISYNSSSIYARGLTESL-----------ELTADWFDY,-1.7559216,-1.5815674,-2.6046286,-3.0222344,"4kfz_C,4kfz_D",Crystal structure of LMO2 and anti-LMO2 VH complex
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYAMAWFRQAPGKEREFVARISGVGTNTYYTDSVKGRVTISRDNAKNTVYLQMNSLKPEDTAVYYCAASIYGYYSDTSYYTRLNNYLYWGQGTQVTVSS,RTFSSYA,FVARISGVGTNTY,AASIYGYYSDTSYYTRLNNYLY,12.0,FVARISGVGTNTY,AASIYGYYSDT------SYYTRLNNYLY,RTFSSYAFVARISGVGTNTYAASIYGYYSDT------SYYTRLNNYLY,-0.35302797,-0.04202476,-3.2897418,0.5845069,7eh3_A,Structure of Nanobody Nb23 in solution using NMR spectroscopy
QVQLQESGGGSVQAGGSLRLSCAASGYQYSLLCMAWFRQVLGEGREGVAFITTYNGAMRYADTVKGRFTVSQDKDKNTVYLQMNSLKPEDTAIYYCAAGRWRFGDICHEGSGYNYWGQGTQVTVSS,YQYSLLC,GVAFITTYNGAMR,AAGRWRFGDICHEGSGYNY,21.0,GVAFITTYNGAMR,AAGRWRFGD---------ICHEGSGYNY,YQYSLLCGVAFITTYNGAMRAAGRWRFGD---------ICHEGSGYNY,1.5227576,1.5025604,-4.362764,-2.8380916,3jbe_7,Complex of poliovirus with VHH PVSS8A
QVQLQESGGGSVQAGGSLRLSCAASEYIPSANCMRWFRQAPKEREWVASVLRGGYTWHADSVKGRFTISGDNAKTAAYLQMNSLKPEDTAIYYCAYSNTCPGASADFRSWGQGTQVTVSS,YIPSANC,WVASVLRGGYTW,AYSNTCPGASADFRS,18.0,WVASVL-RGGYTW,AYSNTCP-------------GASADFRS,YIPSANCWVASVL-RGGYTWAYSNTCP-------------GASADFRS,2.6956375,2.2631607,-2.0633085,-3.00514,3jbg_7,Complex of poliovirus with VHH PVSS21E
QVQLQESGGGSVQTGGSLRLSCAASEYTQSSACMGWFRQAPGKEREGVAGISRFFGTAYYADSVKGRFTISQDKAKNTVYLQMNSLKPEDTAIYYCAAGQGCLTTIQALGGAYGYNAWGQGTQVTVSS,YTQSSAC,GVAGISRFFGTAY,AAGQGCLTTIQALGGAYGYNA,15.0,GVAGISRFFGTAY,AAGQGCLTTI-------QALGGAYGYNA,YTQSSACGVAGISRFFGTAYAAGQGCLTTI-------QALGGAYGYNA,1.3596262,0.89529514,-0.2424859,1.4192293,3jbc_7,Complex of Poliovirus with VHH PVSP29F
QVQLQESGGGLVQPGGSLRLSCAASGFTFRRYLMGWARQVPGKGLEWVSGIYSDGSTYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAKDRMDGSTWPERDFGSWGQGTQVTVSS,FTFRRYL,WVSGIYSDGSTY,AKDRMDGSTWPERDFGS,13.0,WVSGIY-SDGSTY,AKDRMDGS-----------TWPERDFGS,FTFRRYLWVSGIY-SDGSTYAKDRMDGS-----------TWPERDFGS,1.0672365,-0.51006544,-2.8432176,-2.7611423,7lx5_A,The SARS-CoV-2 spike protein receptor binding domain bound to neutralizing nanobodies WNb 2 and WNb 10
QVQLVESGGGLVQAGGSLRLSCAASGSISSISTMGWYRQAPGKERELVAAITSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNFKYYSGSYFYKSEYDYWGKGTPVTVSS,SISSIST,LVAAITSGGSTN,NFKYYSGSYFYKSEYDY,9.0,LVAAIT-SGGSTN,NFKYYSGS-----------YFYKSEYDY,SISSISTLVAAIT-SGGSTNNFKYYSGS-----------YFYKSEYDY,0.68224615,1.6712006,1.9782376,2.8044417,8qot_B,Structure of the mu opioid receptor bound to the antagonist nanobody NbE
QVQLVESGGGLVQAGGSLRLSCAASGSIFRINDMGWYRQAPGKQRELVAAITSGGSTNYADSVKGRFTISRDNAKKMVYLQMNSLKPEDTAVYYCHADFSTGWAPYDYWGQGTQVTVSS,SIFRIND,LVAAITSGGSTN,HADFSTGWAPYDY,10.0,LVAAIT-SGGSTN,HADFST---------------GWAPYDY,SIFRINDLVAAIT-SGGSTNHADFST---------------GWAPYDY,1.4817231,1.9439679,1.6888962,0.35647506,"6qx4_C,6qx4_E",Structure of the Bacillus anthracis Sap S-layer assembly domain
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNSAMSWVRQAPGKGLEWVSSISGSGGNTYSADSVKGRFTISRDNAKNSLYLQMNSLRAEDTAVYYCARDWYGMDVWGQGTTVTVSS,FTFSNSA,WVSSISGSGGNTY,ARDWYGMDV,19.0,WVSSISGSGGNTY,ARDW-------------------YGMDV,FTFSNSAWVSSISGSGGNTYARDW-------------------YGMDV,0.46982428,0.10703206,-1.722794,-3.0103528,1t2j_A,Crystal structure of a Human VH domain
EVQLQASGGGFVQPGGSLRLSCAASGDTWWSSAMGWFRQAPGKEREFVSAISFYPTEYTYYADSKGRFTISRDNSKNTVYLQMNSLRAEDTATYYCAWIAWGPWMRTSWYWGQGTQVTVSS,DTWWSSA,FVSAISFYPTEYT,AWIAWGPWMRTSWY,21.0,FVSAISFYPTEYT,AWIAWGP--------------WMRTSWY,DTWWSSAFVSAISFYPTEYTAWIAWGP--------------WMRTSWY,-0.8477053,-1.8179094,-3.9302957,1.6489711,7xqv_B,The complex of nanobody Rh57 binding to GTP-bound RhoA active form
DVQLQESGGGLVQAGGSLRLSCAASGRTGSTYDMGWFRQAPGKERESVAAINWDSARTYYASSVRGRFTISRDNAKKTVYLQMNSLKPEDTAVYTCGAGEGGTWDSWGQGTQVTVSS,RTGSTYD,SVAAINWDSARTY,GAGEGGTWDS,14.0,SVAAINWDSARTY,GAGEG------------------GTWDS,RTGSTYDSVAAINWDSARTYGAGEG------------------GTWDS,2.2217019,3.016646,0.591418,-0.95927465,1hcv_A,LLAMA HEAVY CHAIN VARIABLE DOMAIN AGAINST ALPHA SUBUNIT OF HCG (HUMAN CHORIONIC GONADOTROPIN)
QVQLQESGGGLVQPGGSLRLSCAASGRTISSYAMSWFRQAPGKEREFVATARRSGDGAFYADSVQGRFTVSRDNAKNTVYLQMNSLKPEDTAVYYCAIDSDTFYSGSYDYWGQGTQVTVSS,RTISSYA,FVATARRSGDGAF,AIDSDTFYSGSYDY,13.0,FVATARRSGDGAF,AIDSDTF--------------YSGSYDY,RTISSYAFVATARRSGDGAFAIDSDTF--------------YSGSYDY,0.193237,-0.192877,2.431677,1.9875908,8gsi_F,Structure of the cobolimab Fab
QVQLQESGGGLVPAGGSLRLSCVDSGRTFSSTVMAWFRQAPGKEREFVATIRWSGGNTYYADSVKGRFTISRDNARNTVYLQMNSLKPEDTAVYYCAGGTYYGTLSYKYDFWGRGTQVTVSS,RTFSSTV,FVATIRWSGGNTY,AGGTYYGTLSYKYDF,15.0,FVATIRWSGGNTY,AGGTYYG-------------TLSYKYDF,RTFSSTVFVATIRWSGGNTYAGGTYYG-------------TLSYKYDF,0.03148704,0.4405595,-3.9716632,0.27446896,"4ocl_C,4ocl_F,4ocn_C,4ocn_F,4ocm_C,4ocm_F","Crystal Structure of the Rpn8-Rpn11 MPN domain heterodimer, crystal form Ib;Crystal Structure of the Rpn8-Rpn11 MPN domain heterodimer, crystal form II;Crystal Structure of the Rpn8-Rpn11 MPN domain heterodimer, crystal form Ia"
EVQLVESGGGLVQPGGSLRLSCAASGRAHSDYAMAWFRQAPGQEREFVAGIGWSGGDTLYADSVRGRFTNSRDNSKNTLYLQMNSLRAEDTAVYYCAARQGQYIYSSMRSDSYDYWGQGTLVTVSS,RAHSDYA,FVAGIGWSGGDTL,AARQGQYIYSSMRSDSYDY,19.0,FVAGIGWSGGDTL,AARQGQYIY---------SSMRSDSYDY,RAHSDYAFVAGIGWSGGDTLAARQGQYIY---------SSMRSDSYDY,2.000403,2.555863,2.9083016,3.042658,8coh_A,Structure of the complement C5 specific nanobody TPP-3444
EVQLVESGGGLVQPGGSLRLSCAASGRAFSDYAMAWFRQAPGQEREFVAGIGWSGGDTLYADSVRGRFTNSRDNSKNTLYLQMNSLRAEDTAVYYCAARQGQYIYSSMRSDSYDYWGQGTLVTVSS,RAFSDYA,FVAGIGWSGGDTL,AARQGQYIYSSMRSDSYDY,19.0,FVAGIGWSGGDTL,AARQGQYIY---------SSMRSDSYDY,RAFSDYAFVAGIGWSGGDTLAARQGQYIY---------SSMRSDSYDY,1.6037905,2.3532019,2.5538027,2.8802323,8coe_B,complement C5 in complex with the LCP0195 nanobody
QVQLQESGGGLVQPGGSLRLSCSASGSSFSINTMGWYRQALGKQRELVANINSGGSTNYIDSVKGRFTISRDNAKNMVYLQMNSLKPEDTAVYFCNAARPLRPEGGRWLNYWGQGTQVTVSS,SSFSINT,LVANINSGGSTN,NAARPLRPEGGRWLNY,15.0,LVANIN-SGGSTN,NAARPLRP------------EGGRWLNY,SSFSINTLVANIN-SGGSTNNAARPLRP------------EGGRWLNY,3.6402395,3.822441,-0.57224894,-2.0311525,"7o06_A,7o06_B",Crystal structure of the N-terminal domain of CEP164(1-109) bound to camelid nanobody 10Z
DVQFVESGGGSVHAGGSLRLNCATSGYIYSTYCMGWFRQAPGKEREGVAHIYTNSGRTYYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTAIYYCAARPSIRCASFSATEYKDWGQGTQVTVSS,YIYSTYC,GVAHIYTNSGRTY,AARPSIRCASFSATEYKD,16.0,GVAHIYTNSGRTY,AARPSIRCA----------SFSATEYKD,YIYSTYCGVAHIYTNSGRTYAARPSIRCA----------SFSATEYKD,0.58568734,1.2710611,-1.3966348,0.3919559,"5fuc_E,5fuc_V",Biophysical and cellular characterisation of a junctional epitope antibody that locks IL-6 and gp80 together in a stable complex: implications for new therapeutic strategies
QVQLVESGGGLVQAGGSLRLSCAASGFPVGRVMYWYRQAPGKEREWVAAISSHGDMTAYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCEVYVGYFYHGQGTQVTVSA,GFPVGRV,WVAAISSHGDMTA,EVYVGYFY,11.0,WVAAISSHGDMTA,EVYV--------------------GYFY,GFPVGRVWVAAISSHGDMTAEVYV--------------------GYFY,0.32590327,-0.9022261,-2.983405,0.8739224,7l1v_S,Orexin Receptor 2 (OX2R) in Complex with G Protein and Small-Molecule Agonist Compound 1
QLVQAGGSLRLSCAASGGTFATSPMGWLRQAPGKGTEFVAAISPSGGDRIYADSVKGRFTISRDNAGNFIYLQMNSLKPEDTAVYYCAVRRRFDGTSYYTGDYDSWGQGTLVTVSS,GTFATSP,FVAAISPSGGDRI,AVRRRFDGTSYYTGDYDS,25.0,FVAAISPSGGDRI,AVRRRFDGT----------SYYTGDYDS,GTFATSPFVAAISPSGGDRIAVRRRFDGT----------SYYTGDYDS,1.8794988,1.5657355,0.15926446,-2.787378,"6rbb_I,6rbb_H,6rbb_K,6rbb_J",CRYSTAL STRUCTURE OF the VhH-domain of anti-IL-17A antibody netakimab
VQLAETGGGLAQAGGSLRLSCAASGSIFSINAMGWYRQAPGKERELVADISGSGRTNYADSVKGRFTISRDNAKNTVSLQMNSLKPEDTAVYYCNVVGGSYYYDEYNYWGQGTQVTVSS,SIFSINA,LVADISGSGRTN,NVVGGSYYYDEYNY,12.0,LVADIS-GSGRTN,NVVGGSY--------------YYDEYNY,SIFSINALVADIS-GSGRTNNVVGGSY--------------YYDEYNY,-0.63362604,0.121338814,1.6393554,1.771723,"6obo_C,6obo_D",Ricin A chain bound to VHH antibody V6A6
QVQLVETGGGGLVQAGGSLRLSCAASGSISSLNAMGWYRQAPGKERELVADISASGRTNYADSVKGRFTISRDNAKNTVSLQMNSLKPEDTAVYYCNAVGGTYYYDEYDYWGQGTQVTVS,SISSLNA,LVADISASGRTN,NAVGGTYYYDEYDY,10.0,LVADIS-ASGRTN,NAVGGTY--------------YYDEYDY,SISSLNALVADIS-ASGRTNNAVGGTY--------------YYDEYDY,0.10214885,0.9847914,2.8728306,1.5305336,6obm_B,Ricin A chain bound to VHH antibody V6A7
QVQLAETGGGLVQPGGARTLSCAASESISSFYFMGWYRQAPGKPRELVAEISNYGRTDYGDSLKGRFTISRDNAANTVNLQMNNLAPEDTALYYCNARKWERSVLEDYWGQGTQVTVSS,SISSFYF,LVAEISNYGRTD,NARKWERSVLEDY,22.0,LVAEIS-NYGRTD,NARKWE---------------RSVLEDY,SISSFYFLVAEIS-NYGRTDNARKWE---------------RSVLEDY,0.7893719,1.5065378,-2.5960972,-2.0296059,6obc_B,Ricin A chain bound to camelid
QLVETGGGLVQPGGSLRLSCAASGSIFSINAMGWYRQAPGKERELVADISSSGRINEADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVLAGSHYYDEYEYWGQGTQVTVS,SIFSINA,LVADISSSGRIN,NVLAGSHYYDEYEY,13.0,LVADIS-SSGRIN,NVLAGSH--------------YYDEYEY,SIFSINALVADIS-SSGRINNVLAGSH--------------YYDEYEY,-1.074222,0.08194685,2.1192138,3.0887446,"6obg_C,6obg_D",Ricin A chain bound to VHH antibody V8E6
QLQLVETGGGLVQAGGSLRLSCAASGSIFSMHAMGWFRQAPGRERELVAVAPTGRPSDYADFAKGRFTISRDNAKNTVSLQMHSLEPEDTAVYYCNAQLWERYVLNDYWGQGTQVTV,SIFSMHA,LVAVAPTGRPSD,NAQLWERYVLNDY,18.0,LVAVAP-TGRPSD,NAQLWE---------------RYVLNDY,SIFSMHALVAVAP-TGRPSDNAQLWE---------------RYVLNDY,-1.0346314,-0.8209971,-2.7485504,-0.3174302,6obe_B,Ricin A chain bound to VHH antibody V6H8
QVQLVESGGGSVQAGGSLRLSCTASGYTIGPYCMGWFRQAPGGEREAVAAINMGGGITYYADSVKGRFTISRDNAKNTVTLQMNSLKPEDTAMYYCAADSTIYASYYECGHGLSTGGYGYDSWGQGTQVTVSS,YTIGPYC,AVAAINMGGGITY,AADSTIYASYYECGHGLSTGGYGYDS,13.0,AVAAINMGGGITY,AADSTIYASYYEC--GHGLSTGGYGYDS,YTIGPYCAVAAINMGGGITYAADSTIYASYYEC--GHGLSTGGYGYDS,1.7317798,1.6684052,-2.6425703,-0.08175713,1zmy_A,cAbBCII-10 VHH framework with CDR loops of cAbLys3 grafted on it and in complex with hen egg white lysozyme
QVQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSGDKSDYTDSVKGRFTISRDNAKNTMYLQMNNLKPEDTATYYCARGGGSVWIWYEGGGTQVTVSS,RTFSSYN,FVASITSSGDKSD,ARGGGSVWIWY,17.0,FVASITSSGDKSD,ARGGG-----------------SVWIWY,RTFSSYNFVASITSSGDKSDARGGG-----------------SVWIWY,1.7608272,0.74179316,-2.7715394,-2.8591757,8fq7_A,Nanobody with WIW inserted in CDR3 loop to Inhibit Growth of Alzheimer's Tau fibrils
EVQLVQSGAEVKKPGASVKVSCKTSGYTFTNYGINWVRQAPGQGLEWIGYIYIGAGDTDYSEKFKGRATITSDTSASTVYMELSSLRSEDTAVYYCAGTGTRFVYWGQGTLVTVSS,YTFTNYG,WIGYIYIGAGDTD,AGTGTRFVY,45.0,WIGYIYIGAGDTD,AGTG-------------------TRFVY,YTFTNYGWIGYIYIGAGDTDAGTG-------------------TRFVY,1.8744565,1.1021293,-1.2140388,-3.090883,"7kqy_A,7kqy_C,7kqy_B,7kqy_E,7kqy_D,7kqy_F","Crystal Structure and Characterization of Human Heavy-Chain only Antibodies reveals a novel, stable dimeric structure similar to Monoclonal Antibodies"
EVQLVESGGGLVQPGGSLRLSCAASGFNIKDTYIHWVRQAPGKGLEWVARIYPTNGYTRYADSVKGRFTISADTSKNTAYLQMNSLRAEDTAVYYCSRWGGDGFYAMDYWGQGTLVTVSS,FNIKDTY,WVARIYPTNGYTR,SRWGGDGFYAMDY,20.0,WVARIYPTNGYTR,SRWGGD---------------GFYAMDY,FNIKDTYWVARIYPTNGYTRSRWGGD---------------GFYAMDY,2.413228,1.6502014,-1.0642864,-2.8858187,"6zqk_A,6zqk_C",HER2-binding scFv-Fab fusion 841
QVQLVQSGAEVKKPGASVKVSCKASGYSFTGYFINWVREAPGQGLEWMGHISSSYATSTYNQKFQGRVTFTVDTSSSTAYMELSSLRSEDTAVYYCVRSGNYEEYAMDYWGQGTLVTVSS,YSFTGYF,WMGHISSSYATST,VRSGNYEEYAMDY,46.0,WMGHISSSYATST,VRSGNY---------------EEYAMDY,YSFTGYFWMGHISSSYATSTVRSGNY---------------EEYAMDY,-0.49349037,-1.2697731,-2.6524374,-2.8729236,"6zqk_B,6zqk_D",HER2-binding scFv-Fab fusion 841
QVKLEESGGGLVQAEGSLRLSCVTSGRIEGILLVGWYRQGPGKQRDVVASIDRNGNTRYDGSAEGRFTIARENANTVYLQMNNLRPEDSNVYVCGALSSGVNPWAWGQGTQVTVSS,RIEGILL,VVASIDRNGNTR,GALSSGVNPWA,28.0,VVASID-RNGNTR,GALSS-----------------GVNPWA,RIEGILLVVASID-RNGNTRGALSS-----------------GVNPWA,2.5465453,2.4949942,-3.794533,-3.262242,"6dbd_A,6dbd_C,6dbd_B,6dbd_D",Crystal Structure of VHH R326
QVKLEESGGGLVQAGGSLRLSCAASGSTFSIYTMGWFRQAPGKEREFVADISWNGGSTYYADSVKGRFTIYRDNYKNTVYLQMNSLKPEDTAVYYCNADDLMIDRDYWGQGTQVTVSS,STFSIYT,FVADISWNGGSTY,NADDLMIDRDY,12.0,FVADISWNGGSTY,NADDL-----------------MIDRDY,STFSIYTFVADISWNGGSTYNADDL-----------------MIDRDY,-1.2312087,-0.51259995,-0.5279647,1.1598692,"6dbe_A,6dbe_B",Crystal Structure of VHH R330
QVKLEESGGGSVQAGGSLRLSCAASGHTYSTYCMGWFRQVPGKEREGVARINVGGSSTWYADSVRDRFTISQDNAKNTVYLQMNSLKLEDTAIYYCTLHRFCNTWSLGTLNVWGQGTQVTVSS,HTYSTYC,GVARINVGGSSTW,TLHRFCNTWSLGTLNV,17.0,GVARINVGGSSTW,TLHRFCNT------------WSLGTLNV,HTYSTYCGVARINVGGSSTWTLHRFCNT------------WSLGTLNV,0.92768914,0.5131966,-3.889837,0.9750199,"6dbf_B,6dbg_C,6dbg_D,6dba_A,6dba_B",Crystal Structure of VHH R303 in complex with InlB-LRR-IR;Crystal Structure of VHH R303 in complex with InlB-LRR;Crystal Structure of VHH R303
QVQLVESGGGLVQPGGSLRLSCAASGFTFSNYWMYWVRQAPGKGLEWVSEINTNGLITKYPDSVKGRFTISRDNAKNTLYLQMNSLKPEDTALYYCARSPSGFNRGQGTQVTVSS,FTFSNYW,WVSEINTNGLITK,ARSPSGFN,16.0,WVSEINTNGLITK,ARSP--------------------SGFN,FTFSNYWWVSEINTNGLITKARSP--------------------SGFN,0.9705855,1.1713046,-4.883067,-3.2436378,5m2j_D,Complex between human TNF alpha and Llama VHH2
QVQLQESGGGSVQAGGSLRLSCAASGRTFSKNAMGWFRQAPGKEREFVVAISWSGRNTYYADSVKGRFTISRDNAKNTVDLQMNSLKPEDSAVYYCAVGGDWRVYDISFYYTAHQYEYWGQGTQVTVSS,RTFSKNA,FVVAISWSGRNTY,AVGGDWRVYDISFYYTAHQYEY,12.0,FVVAISWSGRNTY,AVGGDWRVYDI------SFYYTAHQYEY,RTFSKNAFVVAISWSGRNTYAVGGDWRVYDI------SFYYTAHQYEY,-0.06658292,-1.8306469,-2.5296774,-0.081415236,8dam_C,nbF3:nbE8:CaV beta subunit 1b complex
DVQLQESGGGLVQPGGSLRLSCAASGNIVSIDAAGWFRQAPGKQREPVATILTGGATNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCYAPMIYYGGRYSDYWGQGTQVTVS,NIVSIDA,PVATILTGGATN,YAPMIYYGGRYSDY,14.0,PVATIL-TGGATN,YAPMIYY--------------GGRYSDY,NIVSIDAPVATIL-TGGATNYAPMIYY--------------GGRYSDY,0.5030282,1.3499348,-0.09963362,0.55743736,"5hm1_A,5hm1_C,5hm1_B",Llama VHH 2E7 in complex with gp41
QVQLQESGGGLVQPGGSLKLSCAASGFTFSRYAMSWYRQAPGKERESVARISSGGGTIYYADSVKGRFTISREDAKNTVYLQMNSLKPEDTAVYYCYVGGFWGQGTQVTVSS,FTFSRYA,SVARISSGGGTIY,YVGGF,13.0,SVARISSGGGTIY,YV-----------------------GGF,FTFSRYASVARISSGGGTIYYV-----------------------GGF,-0.3268482,-1.3942702,1.3913338,2.8103745,"5h8d_A,5h8o_A",Crystal structure of an ASC-binding nanobody in complex with the CARD domain of ASC;Crystal structure of an ASC binding nanobody
QVQLQESGGGLVQPGGSLRLSCAASGFTFSNYAMSWVRQAPGKGLEVVSDIGSGGDRITYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAVYYCANQYGRGPGTQVTVSS,FTFSNYA,VVSDIGSGGDRIT,ANQYG,16.0,VVSDIGSGGDRIT,AN-----------------------QYG,FTFSNYAVVSDIGSGGDRITAN-----------------------QYG,0.28247052,0.75113857,-1.7515852,-2.8703752,5c3l_D,Structure of the metazoan Nup62.Nup58.Nup54 nucleoporin complex.
QVQLVESGGGLVQAGGSLRLSCAASGFPVYRDRMAWYRQAPGKEREWVAAIYSAGQQTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVKDVGHHYEYYDYWGQGTQVTVSA,FPVYRDR,WVAAIYSAGQQTR,NVKDVGHHYEYYDY,9.0,WVAAIYSAGQQTR,NVKDVGH--------------HYEYYDY,FPVYRDRWVAAIYSAGQQTRNVKDVGH--------------HYEYYDY,-0.10537515,1.8454491,1.1963695,1.552156,"7n0h_X,7n0h_Z,7n0g_Y,7n0g_X,7n0g_Z,7kgj_B","CryoEm structure of SARS-CoV-2 spike protein (S-6P, 1-up) in complex with sybodies (Sb45);Crystal structure of synthetic nanobody (Sb45) complexes with SARS-CoV-2 receptor binding domain;CryoEM structure of SARS-CoV-2 spike protein (S-6P, 2-up) in complex with sybodies (Sb45)"
ESGEMLFTVKKSLRLSCAASTNLRSYAMAWFRQAPGKEREFVSFINWNYGNTRYADSVKGRFTISRDNAKITVYLQMNSLKPEDTAVYYCAAATIGRLAGIDSTTLYDYWGQGTQVTVSS,TNLRSYA,FVSFINWNYGNTR,AAATIGRLAGIDSTTLYDY,22.0,FVSFINWNYGNTR,AAATIGRLA---------GIDSTTLYDY,TNLRSYAFVSFINWNYGNTRAAATIGRLA---------GIDSTTLYDY,0.89969224,1.7198168,-3.980366,0.66235006,7pqq_B,Structure of thermostabilised human NTCP in complex with Megabody 91
QVQLQESGGGLVQAGGSLRLSCAASAAAAAAAAAGWYRQAPGKERAAAAAAAAAAAAAAADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAAAAAAAAAAYWGQGTQVTVSS,AAAAAAA,AAAAAAAAAAAA,AAAAAAAAAAAY,12.0,AAAAAA-AAAAAA,AAAAAA----------------AAAAAY,AAAAAAAAAAAAA-AAAAAAAAAAAA----------------AAAAAY,1.5611043,0.53748786,0.0019650608,0.2504757,8e99_E,Human GluN1a-GluN2A-GluN2C triheteromeric NMDA receptor in complex with Nb-4
QVQLVESGGGLVQAGGSLRLSCAASGRAIRSYFMAWFRQAPGKEREFVAAVEYIFNTYYADSVKGRFTISRDNAKNTVFLQMNSLKPEDTAVYYCAAGVGASVSVSESWYNYWGQGTQVTVSS,RAIRSYF,FVAAVEYIFNTY,AAGVGASVSVSESWYNY,10.0,FVAAVE-YIFNTY,AAGVGASV-----------SVSESWYNY,RAIRSYFFVAAVE-YIFNTYAAGVGASV-----------SVSESWYNY,1.2716664,-0.7534257,-3.9942706,-0.19937772,"6nfj_B,6nfj_E",Structure of Beta-Klotho in Complex with FGF19 C-terminal peptide
QMQLVESGGGLVQAGGSLTLSCAASGRTFSDYDMGWFRQAPGKAREFVARISRSGRMTSLADSVKGRFTISRDNGKRTVYLQMNSLKPEDTAVYYCAADPQWSRVRSGADYWGQGTRVTVSA,RTFSDYD,FVARISRSGRMTS,AADPQWSRVRSGADY,16.0,FVARISRSGRMTS,AADPQWS-------------RVRSGADY,RTFSDYDFVARISRSGRMTSAADPQWS-------------RVRSGADY,2.095602,1.1041934,-1.7124169,-2.627989,6qgw_B,Crystal structure of E.coli BamA beta-barrel in complex with nanobody E6
QVQLVESGGGLVQAGGSLRLSCAASGFPVEVWRMEWYRQAPGKEREGVAAIESYGHGTRYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNVYDDGQLAYHYDYWGQGTQVTVSA,FPVEVWR,GVAAIESYGHGTR,NVYDDGQLAYHYDY,9.0,GVAAIESYGHGTR,NVYDDGQ--------------LAYHYDY,FPVEVWRGVAAIESYGHGTRNVYDDGQ--------------LAYHYDY,0.11137017,1.0119481,1.8110046,1.7865107,7can_A,Structure of sybody MR17-K99Y in complex with the SARS-CoV-2 S Receptor-binding domain (RBD)
AVQLVDSGGGLVQAGGSLRLSCVVSGSIFSINAMGWYRQAPGKQRDLVARISGDSSTYYIDSVKGRFTISRDNAANTVYLQMNSLKPEDTAVYYCAARRLPIGDYTDWGQGTQVTVSS,SIFSINA,LVARISGDSSTY,AARRLPIGDYTD,15.0,LVARIS-GDSSTY,AARRLP----------------IGDYTD,SIFSINALVARIS-GDSSTYAARRLP----------------IGDYTD,1.9048012,2.5254188,-2.621079,0.16067666,"7r74_B,7r74_D",Crystal structure of llama VHH antibody in complex with HIV-1 HXBC2 gp120 core
QVQLVESGGGLVQPGGSLRLSCAASGSIFSINAMGWYRQAPGKQRELVAHITSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNEAGDPFLGSTWNGPPAFGSWGQGTQVTVSS,SIFSINA,LVAHITSGGSTN,NEAGDPFLGSTWNGPPAFGS,9.0,LVAHIT-SGGSTN,NEAGDPFLGS--------TWNGPPAFGS,SIFSINALVAHIT-SGGSTNNEAGDPFLGS--------TWNGPPAFGS,1.0243584,1.2936448,1.9496174,0.85180825,8dp0_B,Structure of p110 gamma bound to the Ras inhibitory nanobody NB7
QVQLQESGGGLVAAGGSLRLSCAASGNIFDVDIMGWYRQAPGKERELVASITDGGSTNYADSVKGRFTISRDNAKNTVYLAMASLKPEDTAVYYCAAVAYPDIPTYFDYDSDNFYWGQGTQVTVSS,NIFDVDI,LVASITDGGSTN,AAVAYPDIPTYFDYDSDNFY,11.0,LVASIT-DGGSTN,AAVAYPDIPT--------YFDYDSDNFY,NIFDVDILVASIT-DGGSTNAAVAYPDIPT--------YFDYDSDNFY,1.6312319,1.9518234,2.676852,2.8772216,"6os1_D,6os2_D",Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV026;Structure of synthetic nanobody-stabilized angiotensin II type 1 receptor bound to TRV023
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMGWVRQAPGKGPEVVSLISGSGGSTWYDDSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARHAPSTEAPDYWGQGTLVTVSS,FTFSSYA,VVSLISGSGGSTW,ARHAPSTEAPDY,18.0,VVSLISGSGGSTW,ARHAPS----------------TEAPDY,FTFSSYAVVSLISGSGGSTWARHAPS----------------TEAPDY,0.5625269,-0.7977149,-1.1261084,-2.4884157,"3zhd_A,3zhd_B",The crystal structure of single domain antibody 8-4 scaffold.
QVQLVESGGGSVQAGGSLRLSCAASGSIFSINAMGWYRQAPGKQRELVAAITRRGSTNYADFVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCKARIEPDSSWGTEYEYWGQGTQVTVSS,SIFSINA,LVAAITRRGSTN,KARIEPDSSWGTEYEY,10.0,LVAAIT-RRGSTN,KARIEPDS------------SWGTEYEY,SIFSINALVAAIT-RRGSTNKARIEPDS------------SWGTEYEY,1.3597915,1.6982185,-0.0025709718,0.32384998,"7zra_H,7zra_E,7zra_G,7zra_F",Crystal structure of E.coli LexA in complex with nanobody NbSOS1(Nb14497)
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMGWVRQAPGKGPEWVSLISGSGGSTWYDDSVKGRFTISRDNSKNLLYLQMNSLRAEDTAVYYCARHAPSTEAPDYWGQGTLVTVSS,FTFSSYA,WVSLISGSGGSTW,ARHAPSTEAPDY,19.0,WVSLISGSGGSTW,ARHAPS----------------TEAPDY,FTFSSYAWVSLISGSGGSTWARHAPS----------------TEAPDY,0.5439972,-1.1805426,-2.01704,-2.576688,3zhl_A,The crystal structure of single domain antibody 8-14 scaffold
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSAISGSGGSTYYADSVKGRFTISRDNSKNLLYLQMNSLRAEDTAVYYCARHAPSTEAPDYWGQGTLVTVSS,FTFSSYA,WVSAISGSGGSTY,ARHAPSTEAPDY,19.0,WVSAISGSGGSTY,ARHAPS----------------TEAPDY,FTFSSYAWVSAISGSGGSTYARHAPS----------------TEAPDY,0.7128845,-0.05646208,-1.9563425,-2.849404,"3zhk_A,3zhk_B",The crystal structure of single domain antibody 2x1 scaffold
QVQLQESGGGSVQAGGSLRLSCAASGYTFSSYCLGWFRQAPGKEREGVAAIDSDGSTSYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTAMYYCAAEGGPSLSYCTGGYGFLLSGLMYNSWGQGTQVTVSS,YTFSSYC,GVAAIDSDGSTS,AAEGGPSLSYCTGGYGFLLSGLMYNS,13.0,GVAAID-SDGSTS,AAEGGPSLSYCTG--GYGFLLSGLMYNS,YTFSSYCGVAAID-SDGSTSAAEGGPSLSYCTG--GYGFLLSGLMYNS,2.110131,2.210936,-1.8401468,1.1551511,7fat_B,Structure Determination of the RBD-NB1A7
QVQLQESGGGSVQAGGSLRLSCAASGYTVSVGCMAWFRQAPGKEREGVAGIDASGITKYSDSVKGRFTISKDNAKNALDLQMNGLKPEDTAMYHCAAGLVRGSCTDVLDHPSYLGVWGQGTQVTVSS,YTVSVGC,GVAGIDASGITK,AAGLVRGSCTDVLDHPSYLGV,19.0,GVAGID-ASGITK,AAGLVRGSCT-------DVLDHPSYLGV,YTVSVGCGVAGID-ASGITKAAGLVRGSCT-------DVLDHPSYLGV,2.1906965,2.624179,-1.887294,0.29032856,"7fau_B,7fau_D",Structure Determination of the NB1B11-RBD Complex
QVQLVESGGGLVQAGDSLRLACAASGITFSSYTMGWFRQAPGKEREYIARITGSGSNTYYADSVKGRYTISRDNAKNTAYLQMNSLKPEDTANYYCAARDDGRMYQGFYDFEYWGQGTQVTVSS,ITFSSYT,YIARITGSGSNTY,AARDDGRMYQGFYDFEY,13.0,YIARITGSGSNTY,AARDDGRM-----------YQGFYDFEY,ITFSSYTYIARITGSGSNTYAARDDGRM-----------YQGFYDFEY,1.8335651,2.2421303,0.4132139,-0.15069848,6gci_B,Structure of the bongkrekic acid-inhibited mitochondrial ADP/ATP carrier
QVQLQESGGGLVQAGASLRLSCAASERLTVDYAIGWFRQAPGKEREFVAAISWGGGLTVYGESVEGRFTISRDIAKNTMNLQMNVLRPEDTANYYCAASRISYRVWNTIPYNKLTLWGRGTQVTVSS,RLTVDYA,FVAAISWGGGLTV,AASRISYRVWNTIPYNKLTL,22.0,FVAAISWGGGLTV,AASRISYRVW--------NTIPYNKLTL,RLTVDYAFVAAISWGGGLTVAASRISYRVW--------NTIPYNKLTL,-0.51413524,0.2347793,-3.3327525,1.8168924,4i13_B,Nanobody ca1697 binding to the DHFR.folate binary complex
QVQLVESGGGLAKPGGSLRLSCVATGTFRSMEDVGWYRQAPGKDRELVAEITTLGKVTYADSVKGRFTISRDDAKNAVYLQMSDLKSEDTAVYYCNIEADQTKGIGYVVYPYWGQGTRVTVSS,TFRSMED,LVAEITTLGKVT,NIEADQTKGIGYVVYPY,20.0,LVAEIT-TLGKVT,NIEADQTK-----------GIGYVVYPY,TFRSMEDLVAEIT-TLGKVTNIEADQTK-----------GIGYVVYPY,1.4915489,0.588687,0.52872765,0.5775968,"7nqa_C,7nqa_D",Crystal structure of Nucleoporin-98 nanobody MS98-6 complex solved at 2.2A resolution
QVQLVESGGGLVQPGGSLRLLCVASGRPFNDYDMGWFRQAPGKEREFVASISWSGRVTDYSDSMKGRCTVSRDNAKGTMFLQMSNLVPRDTAVYYCAAARRRWTFKATNTEEFYETWGQGTQVTVSS,RPFNDYD,FVASISWSGRVTD,AAARRRWTFKATNTEEFYET,22.0,FVASISWSGRVTD,AAARRRWTFK--------ATNTEEFYET,RPFNDYDFVASISWSGRVTDAAARRRWTFK--------ATNTEEFYET,0.19173953,0.71743166,-2.5969958,1.7940223,7nqk_B,Cryo-EM structure of the mammalian peptide transporter PepT2
QVQLQESGGGLVQAGASLRLSCAASERLTVDYAIGWFRQAPGKEREFVAAISWGGGLTVYGESVEGRFTISRDIAKNTMNLQMNVLRPEDTANYYCAASRISYAVWNTIPYNKLTLWGRGTQVTVSS,RLTVDYA,FVAAISWGGGLTV,AASRISYAVWNTIPYNKLTL,22.0,FVAAISWGGGLTV,AASRISYAVW--------NTIPYNKLTL,RLTVDYAFVAAISWGGGLTVAASRISYAVW--------NTIPYNKLTL,-0.5853222,0.1218124,-3.0283139,1.8515086,4i1n_B,R104A-ca1697 nanobody binding to the binary DHFR.folate complex
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYVMGWFRQAPGKEREFVAAISWSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAADLASSRDVSSWYWGQGTQVTVSS,RTFSSYV,FVAAISWSGGSTN,AADLASSRDVSSWY,9.0,FVAAISWSGGSTN,AADLASS--------------RDVSSWY,RTFSSYVFVAAISWSGGSTNAADLASS--------------RDVSSWY,0.09944091,0.08702031,0.25181526,1.3454373,5lhr_B,The catalytic domain of murine urokinase-type plasminogen activator in complex with the active site binding inhibitory nanobody Nb22
QVQLQESGGGLVQAGGSLRLSCAASGTIFSIDAFGWYRQAPGKQREWVAGITSGSSTIYADFVKGRFTISRDNAKNTVFLQMNSLKPEDTAVYYCNRAKPPTYYSLEPWGKGTQVTVSS,TIFSIDA,WVAGITSGSSTI,NRAKPPTYYSLEP,13.0,WVAGIT-SGSSTI,NRAKPP---------------TYYSLEP,TIFSIDAWVAGIT-SGSSTINRAKPP---------------TYYSLEP,-0.7210472,-0.42561403,-2.4334228,-3.1373727,"8en6_C,8en6_D",Structure of GII.4 norovirus in complex with Nanobody 76
QVQLQESGGGLVQPGGSLRLSCAASGDIFSIYLMGWYRQSPGKQRELVATITSSGETKHVYSVKGRFTISRENAKNAWYLQMNSLKPEDTGVYYCHAVTGVIASSWGQGTQVTVSS,DIFSIYL,LVATITSSGETK,HAVTGVIASS,18.0,LVATIT-SSGETK,HAVTG------------------VIASS,DIFSIYLLVATIT-SSGETKHAVTG------------------VIASS,-0.39746276,0.33591473,-2.114743,1.3985434,"8en4_C,8en4_D",Structure of GII.4 norovirus in complex with Nanobody 53
QVQLQESGGGLVQAGGSLRLSCTVSGRTDSESTMGWFRQAAGKGREFVAAMNWRYATTYHTDSVKGRFTISKDSAKNTMYLQMNSLKPEDTAVYYCAHRYIYGSLSDSGSYDNWGQGTQVTVSS,RTDSEST,FVAAMNWRYATTY,AHRYIYGSLSDSGSYDN,18.0,FVAAMNWRYATTY,AHRYIYGS-----------LSDSGSYDN,RTDSESTFVAAMNWRYATTYAHRYIYGS-----------LSDSGSYDN,1.7291621,1.4399818,-3.6540005,-2.5969877,"8en3_C,8en3_D",Structure of GII.17 norovirus in complex with Nanobody 45
QVQLVESGGGLVQAGGSLRLSCVVSGSTFSDYAMGWYRQAAGEQRELVAAIYSTGRTNYIDSVKGRFTISRDNAKTTVYLQMNSLKPEDTAVYYCNLLGATTMINTKWGQGTQVTVSS,STFSDYA,LVAAIYSTGRTN,NLLGATTMINTK,14.0,LVAAIY-STGRTN,NLLGAT----------------TMINTK,STFSDYALVAAIY-STGRTNNLLGAT----------------TMINTK,1.2961999,1.8302091,-2.5804276,-1.7060578,6xzu_A,Complex of C-terminal domain of murine complement C3b with the hC3Nb3 nanobody
QVQLQESGGGLVQAGGSLNLACVSSGRTFSTWLMGWFRQAPGKEREFVASIDWRSSSTTYADSVKGRFTISRDNAKNTMYLQMTGLKPEDTAVYYCASDRDHYSGTYYGRRFVEEYDYWGQGTQVTVSS,RTFSTWL,FVASIDWRSSSTT,ASDRDHYSGTYYGRRFVEEYDY,16.0,FVASIDWRSSSTT,ASDRDHYSGTY------YGRRFVEEYDY,RTFSTWLFVASIDWRSSSTTASDRDHYSGTY------YGRRFVEEYDY,-0.5204829,-0.77828044,-1.5728627,0.60535306,"8en1_C,8en1_D",Structure of GII.4 norovirus in complex with Nanobody 30
QVQLQESGGGLVQAGGSLRLSCAASGRTFSSYRMGWYRQAPGKEREFVAAITGSGDSTNYADSVKGRFTVSGNSARNLVYLQMNSLKPEDTAVYLCVAYRTGGPPQWGQGTQVTVSS,RTFSSYR,FVAAITGSGDSTN,VAYRTGGPPQ,15.0,FVAAITGSGDSTN,VAYRT------------------GGPPQ,RTFSSYRFVAAITGSGDSTNVAYRT------------------GGPPQ,2.6656911,3.0603728,-0.46732754,0.76757246,8en0_D,Structure of GII.17 norovirus in complex with Nanobody 7
QVQLQESGGGSVQAGETLRLSCTASGFTFDDSDMGWYRQAPGNECELVSSISSDGSTYYADSVKGRFTISQDNAKNTVYLQMNSLKPEDTGVYYCAAEGHRYELGTCAALDYWGRGTQVTVSS,FTFDDSD,LVSSISSDGSTY,AAEGHRYELGTCAALDY,17.0,LVSSIS-SDGSTY,AAEGHRYE-----------LGTCAALDY,FTFDDSDLVSSIS-SDGSTYAAEGHRYE-----------LGTCAALDY,3.767636,2.9200335,2.8843787,2.1124036,7qvk_BBB,NM-02 in complex with HER2-ECD
VQLQESGGGLVQPGGSLRLSCAASGFTFSSAIMTWVRQAPGKGREWVSTIGSDGSITTYADSVKGRFTISRDNARNTLYLQMNSLKPEDTAVYYCTSAGRRGPGTQVTVSS,FTFSSAI,WVSTIGSDGSITT,TSAGR,17.0,WVSTIGSDGSITT,TS-----------------------AGR,FTFSSAIWVSTIGSDGSITTTS-----------------------AGR,1.0256885,-0.2512365,-4.8720484,-3.021177,6jsz_D,"BACE2 xaperone complex with N-{3-[(5R)-3-amino-5-methyl-9,9-dioxo-2,9lambda6-dithia-4-azaspiro[5.5]undec-3-en-5-yl]-4-fluorophenyl}-5-(fluoromethoxy)pyrazine-2-carboxamide"
QVQLVESGGGSVQAGGSLRLSCAASGDIETIWYLGWFRQAPGKEREGVAALSTVTGSTYYADSVKGRFTVSLDNAKNTVYLQMNSLKPEDTALYYCAAAYTGWMAPLWQWVYSYWGQGTQVTVS,DIETIWY,GVAALSTVTGSTY,AAAYTGWMAPLWQWVYSY,14.0,GVAALSTVTGSTY,AAAYTGWMA----------PLWQWVYSY,DIETIWYGVAALSTVTGSTYAAAYTGWMA----------PLWQWVYSY,-0.98870987,-1.4118754,-3.1926973,0.3434298,"8cni_A,8cni_C","PHT1 in the outward facing conformation, bound to Sb27"
QVQLVESGGGLVQPRGSLRLSCAASGFTFSRAAMSWYRQAPGKEREMVSTIGSFGVSTNYSDSVKGRFTISRDNAKNTVYLHMNSLKPEDTAVYYCNARYRSSYPWGQGTQVTVSS,FTFSRAA,MVSTIGSFGVSTN,NARYRSSYP,12.0,MVSTIGSFGVSTN,NARY-------------------RSSYP,FTFSRAAMVSTIGSFGVSTNNARY-------------------RSSYP,-0.05061952,1.598337,1.4028478,0.8853652,7rnn_C,Human ASIC1a-Nb.C1 complex
QVQLAESGGGLVQAGGSLRLSCAASGRTFSDYAMGWFRQAPGKERDFVAGITSSGGGTYYADSVKGRFTITRDNYKNTLYLQMDSLKPEDTAVYYCKGTADGSSSLGYLEVWGQGTLVTVSS,RTFSDYA,FVAGITSSGGGTY,KGTADGSSSLGYLEV,15.0,FVAGITSSGGGTY,KGTADGS-------------SSLGYLEV,RTFSDYAFVAGITSSGGGTYKGTADGS-------------SSLGYLEV,2.2335598,1.8679768,1.4993017,1.3456576,"7kc9_C,7kc9_F,7kdm_C,7kdm_F",Ricin bound to VHH antibody V5G1;Ricin bound to VHH antibody V5G6
QVQLVESGGGVVQAGGSLRLSCAASGRTFSSRAMGWFRQAPGEGREFVATISWSGSYTEYADSVKGRVTISRDNAKNTVYLQMNSLKPGDTAVYHCAAKNGGAASNYPNDYVYWGQGTQVTVSS,RTFSSRA,FVATISWSGSYTE,AAKNGGAASNYPNDYVY,14.0,FVATISWSGSYTE,AAKNGGAA-----------SNYPNDYVY,RTFSSRAFVATISWSGSYTEAAKNGGAA-----------SNYPNDYVY,2.3338249,1.0471128,-4.8444357,-3.250242,"6f2w_B,6f2g_B",Bacterial asc transporter crystal structure in open to in conformation
QVQLQESGGGLVQPGGSLRLSCAASGFTFSSYYMSWVRQAPGKGPEWVSGINTGGVGTRYADSVKGRFTISRDNAKNTLYLQMNSLKPEDTALYYCAIGEGGNRNYWGQGTQVTVSS,FTFSSYY,WVSGINTGGVGTR,AIGEGGNRNY,15.0,WVSGINTGGVGTR,AIGEG------------------GNRNY,FTFSSYYWVSGINTGGVGTRAIGEG------------------GNRNY,2.2172163,2.7768059,-2.7330782,-3.1547554,"6fe4_I,6fe4_H,6fe4_J,6fe4_G,6fe4_F",Crystal structure of the complex between Shiga toxin Stx2 B subunit and neutralising Nb113
QVQLVETGGGLVQAGGSLRLSCVASGGTFSSYAMGWFRQAPGKERDFVAGISLSGAGTYYQDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCKATGERGYGDQGYLEVWGRGTLVTVSS,GTFSSYA,FVAGISLSGAGTY,KATGERGYGDQGYLEV,14.0,FVAGISLSGAGTY,KATGERGY------------GDQGYLEV,GTFSSYAFVAGISLSGAGTYKATGERGY------------GDQGYLEV,1.3399372,0.9128121,0.84024733,1.847161,7kdu_C,Ricin bound to VHH antibody V5E4
DVQLQASGGGSVQAGGSLRLSCAASGYTIGPYCMGWFRQAPGKEREGVAAINSGGGSTYYADSVKGRFTISQDNAKNTVYLLMNSLEPEDTAIYYCAADSTIYASYYECGHGLSTGGYGYDSWGQGTQVTVSS,YTIGPYC,GVAAINSGGGSTY,AADSTIYASYYECGHGLSTGGYGYDS,16.0,GVAAINSGGGSTY,AADSTIYASYYEC--GHGLSTGGYGYDS,YTIGPYCGVAAINSGGGSTYAADSTIYASYYEC--GHGLSTGGYGYDS,2.5263138,1.942032,-1.1876167,0.7475826,1xfp_A,Crystal structure of the CDR2 germline reversion mutant of cAb-Lys3 in complex with hen egg white lysozyme
QVQLVESGGGLVQAGGSLRLSCAPSGRTSSTYTMGWFRQAPGKEREFVAAISWTGTPYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCAAARPGLFIFVSDYARTAKYDYWGQGTQVTVPP,RTSSTYT,FVAAISWTGTPY,AAARPGLFIFVSDYARTAKYDY,11.0,FVAAIS-WTGTPY,AAARPGLFIFV------SDYARTAKYDY,RTSSTYTFVAAIS-WTGTPYAAARPGLFIFV------SDYARTAKYDY,1.0018964,-0.54079807,0.7000649,1.9172022,8g8w_C,Molecular mechanism of nucleotide inhibition of human uncoupling protein 1
QVQLVESGGGLVQAGDSLRLSCAASGLTLKNYAMGWFRQAPGKEHEFVAVISWSGSGTSYADSVEGRFTISRDNAKNTAFLQMSSLKPEDTAVYYCAARDGGYGSRWPDEYTYWGQGTQVTVPP,LTLKNYA,FVAVISWSGSGTS,AARDGGYGSRWPDEYTY,16.0,FVAVISWSGSGTS,AARDGGYG-----------SRWPDEYTY,LTLKNYAFVAVISWSGSGTSAARDGGYG-----------SRWPDEYTY,0.43263075,-0.53667253,-2.1648712,-1.1423461,8g8w_B,Molecular mechanism of nucleotide inhibition of human uncoupling protein 1
QVQLVETGGGLVQPGGSLKLSCAASGSISSPNVMGWYRQAPGKQRELVATMTSGGNTYSEDSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCNARDMWDRSHEYWGQGTQVTVSS,SISSPNV,LVATMTSGGNTY,NARDMWDRSHEY,13.0,LVATMT-SGGNTY,NARDMW----------------DRSHEY,SISSPNVLVATMT-SGGNTYNARDMW----------------DRSHEY,4.31037,3.5759006,3.7175605,2.4985995,7kd2_C,Ricin bound to VHH antibody V11B2
QVQLVESGGGLVQPGGSLRLSCVASGFTFSSTPMNWFRQAPGKEREFVAGVGSRNDIAYYADSVKGRFTVSRDDAKNTVYLQMNSLKPEDTGVYYCKRPAGRIEDELWGQGTQVTVSS,FTFSSTP,FVAGVGSRNDIAY,KRPAGRIEDEL,14.0,FVAGVGSRNDIAY,KRPAG-----------------RIEDEL,FTFSSTPFVAGVGSRNDIAYKRPAG-----------------RIEDEL,-0.8755292,-0.4751076,1.9199018,0.93252665,7kd0_C,Ricin bound to VHH antibody V2C11
EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKEREIVSAVSGSGGSTYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARLKKYAFDYWGQGTLVTVSS,FTFSSYA,IVSAVSGSGGSTY,ARLKKYAFDY,16.0,IVSAVSGSGGSTY,ARLKK------------------YAFDY,FTFSSYAIVSAVSGSGGSTYARLKK------------------YAFDY,-0.15702376,-1.1622863,-1.2337726,0.8489252,1vhp_A,"VH-P8, NMR"
EVQLVESGGGLVQPGGSLRLSSAISGFSISSTSIDWVRQAPGKGLEWVARISPSSGSTSYADSVKGRFTISADTSKNTVYLQMNSLRAEDTAVYYTGRVAKDLNSSSPSFVVNTYSSFGFDYRGQGTLVTVSS,FSISSTS,WVARISPSSGSTS,GRVAKDLNSSSPSFVVNTYSSFGFDY,24.0,WVARISPSSGSTS,GRVAKDLNSSSPS--FVVNTYSSFGFDY,FSISSTSWVARISPSSGSTSGRVAKDLNSSSPS--FVVNTYSSFGFDY,-0.2544602,0.7720431,-0.889962,-2.8825614,7d6y_B,eIF4E in Complex with a Disulphide-Free Autonomous VH Domain
GSLRLSCAASGHTFNYPIMGWFRQAPGKEREFVGAISWSGGSTSYADSVKDRFTISRDNAKNTVYLEMNNLKPEDTAVYYCAAKGRYSGGLYYPTNYDYWGQGTQVTVSS,HTFNYPI,FVGAISWSGGSTS,AAKGRYSGGLYYPTNYDY,26.0,FVGAISWSGGSTS,AAKGRYSGG----------LYYPTNYDY,HTFNYPIFVGAISWSGGSTSAAKGRYSGG----------LYYPTNYDY,1.3112396,2.1092196,2.6868274,1.2036498,"8pvb_O,7a5v_O,7pc0_F,6qfa_K,6qfa_M,6qfa_L,6qfa_O,6qfa_N,7pbz_F,7pbd_F","GABA-A receptor bound by a-Cobratoxin;CryoEM structure of a human gamma-aminobutyric acid receptor, the GABA(A)R-beta3 homopentamer, in complex with histamine and megabody Mb25 in lipid nanodisc;Structure of GABAAR determined by cryoEM at 100 keV;a1b3 GABA-A receptor + GABA;a1b3 GABA-A receptor + GABA + Zn2+;CryoEM structure of a beta3K279T GABA(A)R homomer in complex with histamine and megabody Mb25"
QVQLQESGGGLVQAGGSLRVSCAASGRTFTAYIMAWFRQAPGKEREFLAAMDQGRIQYYGDSVRGRFTISRDYAKNSVDLQLDGLRPEDTAVYYCAAGAGFWGLRTASSYHYWGQGTQVTVSS,RTFTAYI,FLAAMDQGRIQY,AAGAGFWGLRTASSYHY,20.0,FLAAMD-QGRIQY,AAGAGFWG-----------LRTASSYHY,RTFTAYIFLAAMD-QGRIQYAAGAGFWG-----------LRTASSYHY,1.6297375,-1.4771508,-6.252112,-0.28369695,"7qne_G,6i53_G",Cryo-EM structure of the human synaptic alpha1-beta3-gamma2 GABAA receptor in complex with Megabody38 in a lipid nanodisc;Cryo-EM structure of human full-length synaptic alpha1beta3gamma2 GABA(A)R in complex with Ro15-4513 and megabody Mb38
QVQLVENGGGCVKAGGSLRLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYADSVKGRFTISRDNAENTVYLQMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVMVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,14.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,1.3040497,2.7482817,"7zmt_C,7zmt_K,7zmv_K,7zmv_E,7zmv_G,7zmv_F",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G5-006
QVQLVENGGGNVQAGGSLRLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYADSVKGRFTISRDSAKGTVYLQMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,13.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,1.4091096,2.027745,"7zmp_C,7zmp_K",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G3-055
QVQLVENGGGNVQAGGSLRLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYAYSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,12.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,0.18239106,1.6965013,"7zmq_K,7zmq_C",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G2*-006
QVQLVENGGGCVQAGGSLKLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYAYSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,13.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,-0.34398997,1.2154756,"7zmr_C,7zmr_K",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G2*-011
QVQLVENGGGCVQATGSLRLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYADSVKGRFTISRDSAKGTVYLQMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVMVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,15.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,1.0325683,1.0219455,7zms_K,Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G4-043
QVQLQESGGGLVQAGGSLRLSCTASGRTFSNTVMGWFRQAPGKEREFLAHILWSGGLAYYADSVKGRFTISRDNAKNIVYLQMNSLKPEDTAVYYCAARDFGFGNNYDYWGQGTQVTVSS,RTFSNTV,FLAHILWSGGLAY,AARDFGFGNNYDY,10.0,FLAHILWSGGLAY,AARDFG---------------FGNNYDY,RTFSNTVFLAHILWSGGLAYAARDFG---------------FGNNYDY,1.6484339,0.46746755,-0.7447488,1.4775445,"7kjh_A,7kjh_B",Plasmodium falciparum protein Pf12p bound to nanobody B9
QVQLQESGGGLVQPGGSLRLSCAASGIIFSSHVMGWYRQAPGKQRELVASFSGDTGAKYADSVKGRFIIRRENAKNMVTLYLQMNSLKPEDTAAYYCHVDRFGTEYWGQGTQVTVSS,IIFSSHV,LVASFSGDTGAK,HVDRFGTEY,19.0,LVASFS-GDTGAK,HVDR-------------------FGTEY,IIFSSHVLVASFS-GDTGAKHVDR-------------------FGTEY,0.61430043,-0.0065206885,0.8128131,0.82318074,7kji_A,Plasmodium falciparum protein Pf12p bound to nanobody D9
VQLVESGGGLVQAGGSLRLSCAASGPTLSNYAVGWFRQAPGKEREFVAGINWSSGLRYKDVVKGRFTVSRDNVKDTVYLQMNSLKPEDTAVYYCAARFGGMLPLQPSGYANWGQGTQVTVSS,PTLSNYA,FVAGINWSSGLR,AARFGGMLPLQPSGYAN,15.0,FVAGIN-WSSGLR,AARFGGML-----------PLQPSGYAN,PTLSNYAFVAGIN-WSSGLRAARFGGML-----------PLQPSGYAN,2.5927188,1.3784716,0.8843449,1.5435147,"8b18_B,8b19_B,8b17_B,8b1i_B,8b1h_B,8b1k_B,8b1j_B,8b1a_B,8b1c_B,8b1e_B,8b1d_B,8b1g_B,8b1f_B,8b1b_B",DtpB-Nb132-SL;DtpB-Nb132-AQ;DtpB-Nb132-ALA;DtpB-Nb132-NV;DtpB-Nb132-AL;DtpB-Nb132-APF;DtpB-Nb132-AW;DtpB-Nb132-AF;DtpB-Nb132-KV;DtpB-Nb132-MS;DtpB-Nb132-AFA;DtpB-Nb132-AI;DtpB-Nb132-AWA;DtpB-Nb132-AV
QVQLQESGGGLVQAGGSLRLSCAASGSIFSINRMGWYRQAPGKQRELVAAITSGGSTNYAYSVKGRFTISRDNAKNTVYLQMNSLKPEDTAIYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVSA,SIFSINR,LVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,12.0,LVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRLVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6640115,1.2471315,-0.26089245,0.6547919,"7zml_K,7zml_E,7zml_G,7zml_F",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G1-001
QVQLQENGGGCVQAGGSLRLSCAASGSIFSINRMGWYRQAPGKQRELVAAITSGGSTNYAYSVKGRFTISRDNAKNTVYLQMNSLKPEDTAIYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVSA,SIFSINR,LVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,14.0,LVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRLVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6640115,1.2471315,-0.81618017,0.14212865,"7zmm_K,7zmm_E,7zmm_G,7zmm_F",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G2-001
QVQLQESGGGLVQAGGSLRLSCAASGFTFSRAAMRWVRRAPERGLEWVANINAGDGSASYADFVKGRFTASRDKAGNRLYLQMDNLRPNDTAVYYCIYNGHRGQGTQVTVSS,FTFSRAA,WVANINAGDGSAS,IYNGH,26.0,WVANINAGDGSAS,IY-----------------------NGH,FTFSRAAWVANINAGDGSASIY-----------------------NGH,1.1146879,0.52399004,-0.8083169,-2.8401983,3zkx_C,TERNARY BACE2 XAPERONE COMPLEX
QVQLVENGGGCVQAGGSLRLSCAASGSIFSINRMTWYRQAPGKEREWVAAITSGGSTNYADSVKGRFTISRDSAKGTVYLYMNSLKPEDTAVYYCEAYGTYTLAPTGEGEYDDYWGQGTQVTVS,SIFSINR,WVAAITSGGSTN,EAYGTYTLAPTGEGEYDDY,14.0,WVAAIT-SGGSTN,EAYGTYTLA---------PTGEGEYDDY,SIFSINRWVAAIT-SGGSTNEAYGTYTLA---------PTGEGEYDDY,0.6130894,1.1652652,0.6779138,1.5147772,"7zmo_C,7zmo_K",Crystal structure of human RECQL5 helicase APO form in complex with engineered nanobody (Gluebody) G3-052
QVKLEESGGGLVQAGRSLRLSCAASEHTFSSHVMGWFRQAPGKERESVAVIGWRDISTSYADSVKGRFTISRDNAKKTLYLQMNSLKPEDTAVYYCAARRIDAADFDSWGQGTQVTVSS,HTFSSHV,SVAVIGWRDISTS,AARRIDAADFDS,14.0,SVAVIGWRDISTS,AARRID----------------AADFDS,HTFSSHVSVAVIGWRDISTSAARRID----------------AADFDS,0.3630409,0.3311236,0.36641896,0.92322856,"8hxq_A,8hxq_B",Nanobody1 in complex with human BCMA ECD
DVQLVESGGGLVQPGGSLRLSCAASGSIFSIYAMGWYRQAPGKQRELVASISSGGGTNYADSVKGRFTISGDNAKNTVYLQMNSLKPEDTAVYYCKREDYSAYAPPSGSRGRGTQVTVSS,SIFSIYA,LVASISSGGGTN,KREDYSAYAPPSGS,12.0,LVASIS-SGGGTN,KREDYSA--------------YAPPSGS,SIFSIYALVASIS-SGGGTNKREDYSA--------------YAPPSGS,-0.62703764,-0.8096568,-1.2762225,-2.1702476,"4x7e_C,4x7e_D,4x7d_C,4x7d_D,4x7c_C,4x7c_D",Crystal structure of Saga-2006 GII.4 P domain in complex with Nano-85;Crystal structure of norovirus GII.10 P domain in complex with Nano-85;Crystal structure of 2012 NSW GII.4 P domain in complex with Nano-85
DVQLVESGGGLVQPGGSLRLSCAASESILSFNHMAWYRQGPGEQRELVAVITREGSTDYADSVKGRFTISRDNAKNMVYLLMSNLRPEDTAVYYCNRGISNPWGQGTQVTVSS,SILSFNH,LVAVITREGSTD,NRGISNP,19.0,LVAVIT-REGSTD,NRG---------------------ISNP,SILSFNHLVAVIT-REGSTDNRG---------------------ISNP,0.42796728,1.9423183,-1.3291106,-2.058664,"4x7f_C,4x7f_D",Crystal structure of norovirus GII.10 P domain in complex with Nano-25
QLQLVESGGGLVQPGGSLRLSCVVSGSDFNTYIMGWYRQVPGKPRELVADITTEGKTNYGGSVKGRFTISRDNAKNTVYLQMFGLKPEDAGNYVCNADWKMGAWTAGDYGIDYWGKGTLVTVSS,SDFNTYI,LVADITTEGKTN,NADWKMGAWTAGDYGIDY,23.0,LVADIT-TEGKTN,NADWKMGAW----------TAGDYGIDY,SDFNTYILVADIT-TEGKTNNADWKMGAW----------TAGDYGIDY,1.5384861,0.861851,-2.0405629,-1.5379057,6ul6_B,Crystal Structure of BoNT/A-LCHn domain in complex with VNA ciA-D12/11/ciA-B5 and VHH ciA-H7
KVQLQQSGGGSVTPGGSLRLSCAASGSISDFAAMAWYRQAPGKERDWVGTIFSAGALLYAEPVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCRLYAEAIYWGQGTQVTVSS,SISDFAA,WVGTIFSAGALL,RLYAEAIY,17.0,WVGTIF-SAGALL,RLYA--------------------EAIY,SISDFAAWVGTIF-SAGALLRLYA--------------------EAIY,0.83702606,-1.5322088,-1.727228,2.8742347,"6u54_A,6u53_A",Anti-Zaire ebolavirus Nucleoprotein Single Domain Antibody Zaire C (ZC);Anti-Zaire ebolavirus Nucleoprotein Single Domain Antibody Zaire C (ZC) Complexed with Zaire ebolavirus Nucleoprotein C-terminal Domain 634-739
QVQLQESGGGLVQPGGSLRLSCTASGFTLAEYGVGWFRQAPGKERELVALIAVGGTTHSIDSVKGRFTISRDNMKNTVYLQMNSLNVEDTAVYYCNAYSSAYDRNYWGQGTQVTVSS,FTLAEYG,LVALIAVGGTTH,NAYSSAYDRNY,17.0,LVALIA-VGGTTH,NAYSS-----------------AYDRNY,FTLAEYGLVALIA-VGGTTHNAYSS-----------------AYDRNY,1.3431188,1.9391171,0.14910941,2.4945385,6u55_A,Anti-Zaire ebolavirus Nucleoprotein Single Domain Antibody Zaire E (ZE) Complexed with Sudan ebolavirus Nucleoprotein C-terminal Domain 634-738
SVQLVESGGALVQPGGSLRLSCAASGFPVNRYSMRWYRQAPGKEREWVAGMSSAGDRSSYEDSVKGRFTISRDDARNTVYLQMNSLKPEDTAVYYCNVNVGFEYWGQGTQVTVSH,FPVNRYS,WVAGMSSAGDRSS,NVNVGFEY,15.0,WVAGMSSAGDRSS,NVNV--------------------GFEY,FPVNRYSWVAGMSSAGDRSSNVNV--------------------GFEY,0.414263,1.3943044,1.5808349,3.493586,5wts_A,Green fluorescent protein linked MTide-02 inhibitor in complex with mdm2
QVQLVESGGGLVQAGGSLRLSCAASGFPVKNFEMEWYRKAPGKEREWVAAIQSGGVETYYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCFVYVGRSYIGQGTQVTVS,FPVKNFE,WVAAIQSGGVETY,FVYVGRSY,11.0,WVAAIQSGGVETY,FVYV--------------------GRSY,FPVKNFEWVAAIQSGGVETYFVYV--------------------GRSY,1.5640143,0.48261207,0.97917175,1.8883395,"7p78_H,7p78_B,7p78_D,7p79_H,7p79_B,7p79_D,7p77_A,7p77_D,7p77_H",SARS-CoV-2 spike protein in complex with sybodyb#15 in a 1up/1up-out/1down conformation.;SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 1up/1up-out/1down conformation;SARS-CoV-2 spike protein in complex with sybody#15 and sybody#68 in a 3up conformation
DVQLVESGGGSVQAGGSLRLSCAASGSTDSIEYMTWFRQAPGKAREGVAALYTHTGNTYYTDSVKGRFTISQDKAKNMAYLRMDSVKSEDTAIYTCGATRKAVPVRFALDQSSYDYWGQGTQVTVSS,STDSIEY,GVAALYTHTGNTY,GATRKAVPVRFALDQSSYDY,23.0,GVAALYTHTGNTY,GATRKAVPVR--------FALDQSSYDY,STDSIEYGVAALYTHTGNTYGATRKAVPVR--------FALDQSSYDY,1.6044571,1.8985931,-3.905615,-2.8071682,"6jb2_A,6jb5_A",Crystal structure of nanobody D3-L11 mutant Y102A in complex with hen egg-white lysozyme (form II);Crystal structure of nanobody D3-L11 mutant Y102A in complex with hen egg-white lysozyme
QVQLQESGGGLVQAGGSLRLSCAASGRFFSSYAMGWFRQAPGKEREFVAAISWSGGSTYYADSVKGRFTTSRDNAKNTVYLLMNSLKPEDTAVYYCAAAREGAYYPDSYYRTVRYDYWGQGTQVTVSS,RFFSSYA,FVAAISWSGGSTY,AAAREGAYYPDSYYRTVRYDY,11.0,FVAAISWSGGSTY,AAAREGAYYP-------DSYYRTVRYDY,RFFSSYAFVAAISWSGGSTYAAAREGAYYP-------DSYYRTVRYDY,0.3044596,1.2354914,-0.5740046,1.6709666,8emz_B,Structure of GII.17 norovirus in complex with Nanobody 2
QVQLQESGGGLVQPGSSLRLSCAASGFTFGGYAMHWVRQAPGKGPEWVSSINSGGDITNYATSVKGRFSISRDNPSKTLYLQMNSLRPEDSAVYYCKTQLANRDYRGQGTQVTVSS,FTFGGYA,WVSSINSGGDITN,KTQLANRDY,23.0,WVSSINSGGDITN,KTQL-------------------ANRDY,FTFGGYAWVSSINSGGDITNKTQL-------------------ANRDY,1.8369929,1.2478764,-2.4765248,-3.2674408,"8emy_G,8emy_I,8emy_H,8emy_K,8emy_J,8emy_L",Structure of GII.4 norovirus in complex with Nanobody 82
QVQLQESGGGLVQAGGSLRLSCAASGSIFDLGRMGWYRQAPGKEREFVAGIDYGGNTNYADSVKGRFTISRDNDTVYLQMNSLKPEDTAVYYCAAGIVGDVVGWIYYLYWGQGTQVTVSS,SIFDLGR,FVAGIDYGGNTN,AAGIVGDVVGWIYYLY,10.0,FVAGID-YGGNTN,AAGIVGDV------------VGWIYYLY,SIFDLGRFVAGID-YGGNTNAAGIVGDV------------VGWIYYLY,1.0807309,0.39603359,2.4868972,4.0170846,"7nbb_H,7nbb_D",Branched Lys48- and Lys63-linked tri-ubiquitin (K48-K63-Ub3) in complex with synthetic nanobody NbSL3
QVQLVESGGGLVQSGGSLRLSCAASGSIDSLYHMGWYRQAPGKERELVARVQDGGSTAYKDSVKGRFTISRDFSRSTMYLQMNSLKPEDTAIYYCAAKSTISTPLSWGQGTQVTVSS,SIDSLYH,LVARVQDGGSTA,AAKSTISTPLS,15.0,LVARVQ-DGGSTA,AAKST-----------------ISTPLS,SIDSLYHLVARVQ-DGGSTAAAKST-----------------ISTPLS,2.6515884,4.0817213,2.1107476,2.2622385,"7t5f_C,7t5f_F",Botulinum neurotoxin Type B Light Chain complexed with nanobodies JLJ-G3 and JNE-B10
QVQLVESGGGLVQPGGSLRLSCAASGFPFHAYYMSWVRQAPGKGLEWVSHIGNGGIITRYADSVKGRFTISRDNAKNTLYLQMTNLKPEDTALYYCTLGTRDDLGPERGQGTQVTVSS,FPFHAYY,WVSHIGNGGIITR,TLGTRDDLGPE,17.0,WVSHIGNGGIITR,TLGTR-----------------DDLGPE,FPFHAYYWVSHIGNGGIITRTLGTR-----------------DDLGPE,0.255176,-1.0843525,-4.4122815,-3.2447689,"7t5f_B,7t5f_E",Botulinum neurotoxin Type B Light Chain complexed with nanobodies JLJ-G3 and JNE-B10
AAQLQESGGGLVQPGGSLRLSCAASGRTFSSYNMGWFRQAPGKGREFVASITSSGDKSDYTDSVKGRFTISRDNAKNTMYLQMNNLKPEDTATYYCARGLGIYIIRARGGYDHWGQGTQVTVSS,RTFSSYN,FVASITSSGDKSD,ARGLGIYIIRARGGYDH,17.0,FVASITSSGDKSD,ARGLGIYI-----------IRARGGYDH,RTFSSYNFVASITSSGDKSDARGLGIYI-----------IRARGGYDH,0.070333086,-0.6885049,-2.3423433,-2.8717535,4n9o_B,Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bound to a Nanobody
QVQLQESGGGLVQAGGSLRLSCAASGRIFSTNVMGWFRQAPGKEREFVATVGRIGGSTVYADFVKGRFTLSRDNAKNMVYLQMNSLKPEDTAVYYCGARIGGSDRLAPENYGYWGQGTQVTVSS,RIFSTNV,FVATVGRIGGSTV,GARIGGSDRLAPENYGY,12.0,FVATVGRIGGSTV,GARIGGSD-----------RLAPENYGY,RIFSTNVFVATVGRIGGSTVGARIGGSD-----------RLAPENYGY,1.395192,0.7380637,-0.26165664,0.35304832,"6hjx_I,6hjx_H,6hjx_J,6hjx_G,6hjx_F,6hjy_J,6hjy_F",X-ray structure of a pentameric ligand gated ion channel from Erwinia chrysanthemi (ELIC) 7'C pore mutant (L238C) in complex with nanobody 72;X-ray structure of a pentameric ligand gated ion channel from Erwinia chrysanthemi (ELIC) Delta8 truncation mutant in complex with nanobody 72
VQLQESGGGLVQAGGSLRLSCAASGRIFSTNVMGWFRQAPGKEREFVATVGRIGGSTVYADFVKGRFTLSRDNAKNMVYLQMNSLKPEDTAVYYCGARIGGSDRLAPENYGYWGQGTQVTVSS,RIFSTNV,FVATVGRIGGSTV,GARIGGSDRLAPENYGY,13.0,FVATVGRIGGSTV,GARIGGSD-----------RLAPENYGY,RIFSTNVFVATVGRIGGSTVGARIGGSD-----------RLAPENYGY,1.395192,0.7380637,-0.12916942,0.35965276,"6hjy_I,6hjy_H,6hjy_G",X-ray structure of a pentameric ligand gated ion channel from Erwinia chrysanthemi (ELIC) Delta8 truncation mutant in complex with nanobody 72
QVKLQQSGGGSVQEGGSLRLSCASSGAFFRAGPMGWYRRAPGNERELVAGISRNGRTIYAPSLKDRFTISRDDDNNILYLQMSDLTPGDTAVYYCNLNVRTAVAGRNDYWGQGTQVTVSS,AFFRAGP,LVAGISRNGRTI,NLNVRTAVAGRNDY,26.0,LVAGIS-RNGRTI,NLNVRTA--------------VAGRNDY,AFFRAGPLVAGIS-RNGRTINLNVRTA--------------VAGRNDY,0.96199423,0.89010704,0.3747366,-3.0324948,"6u50_C,6u51_A,6u51_C,6u52_A,6u52_C",Anti-Sudan ebolavirus Nucleoprotein Single Domain Antibody Sudan B (SB);Anti-Sudan ebolavirus Nucleoprotein Single Domain Antibody Sudan B (SB) Complexed with Sudan ebolavirus Nucleoprotein C-terminal Domain 610-738;Anti-Sudan ebolavirus Nucleoprotein Single Domain Antibody Sudan B (SB) Complexed with Sudan ebolavirus Nucleoprotein C-terminal Domain 634-738
QGQLVESGGGLVQAGGSLRLSCAASGIIFRELGIDWYRQAPGKQRELVASIASAGMTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCHTLPRFSHLWGQGTRVTVSS,IIFRELG,LVASIASAGMTN,HTLPRFSHL,12.0,LVASIA-SAGMTN,HTLP-------------------RFSHL,IIFRELGLVASIA-SAGMTNHTLP-------------------RFSHL,1.5984751,0.49811065,0.9801641,0.7154851,"5ocl_A,5ocl_C,5ocl_F,5ocl_H",Nanobody-anti-VGLUT nanobody complex
QVQLQESGGGLVQAGDSLRLSCAASGRTWSIYGMGWFRQAPGKEREFVAGITWRGGNTHYADFVKGRFTISRDNVKNTVYLQMNSLKPEDTAVYYCAANPNPSGSSVYRRNDYWGQGTQVTVSS,RTWSIYG,FVAGITWRGGNTH,AANPNPSGSSVYRRNDY,12.0,FVAGITWRGGNTH,AANPNPSG-----------SSVYRRNDY,RTWSIYGFVAGITWRGGNTHAANPNPSG-----------SSVYRRNDY,2.1268892,2.174131,-0.27963966,0.09727007,"5ocl_B,5ocl_E,5ocl_D,5ocl_G",Nanobody-anti-VGLUT nanobody complex
DVQLQESGGGLVQAGHSLRLSCVGSGSRFDNYAMGWFRQAPGKEREFVAAISWSSGTTRYLDTVKGRFTISRDNAKSTVYLQMNSLKPEDTAVYYCAARYQPRYYDSGDMDGYEYDNWGQGTQVTVSS,SRFDNYA,FVAAISWSSGTTR,AARYQPRYYDSGDMDGYEYDN,16.0,FVAAISWSSGTTR,AARYQPRYYD-------SGDMDGYEYDN,SRFDNYAFVAAISWSSGTTRAARYQPRYYD-------SGDMDGYEYDN,2.046509,1.2853438,-1.7574494,1.8998127,5f1o_B,human CD38 in complex with nanobody MU551
VTTSYGSLRLSCTASRVTLDYHDIGWFRQAPGKEREGVSYISSSGGSTNYADSVKGRFTISRDNAKNTVYLQMNSLKPEDTAVYYCARSSAYGSSWLNPSRYDYWGQGTQVTVSS,VTLDYHD,GVSYISSSGGSTN,ARSSAYGSSWLNPSRYDY,27.0,GVSYISSSGGSTN,ARSSAYGSS----------WLNPSRYDY,VTLDYHDGVSYISSSGGSTNARSSAYGSS----------WLNPSRYDY,2.798624,1.3680414,1.5211718,0.9620375,7qe5_B,Structure of the membrane domains of the sialic acid TRAP transporter HiSiaQM from Haemophilus influenzae
